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ABSTRACT 
 
 The research outlined in this dissertation involves the development and 
demonstration of a mass spectrometry-based proteomics approach to characterize the 
global level molecular response of Shewanella oneidensis MR-1 to chromate exposure.  
The proteomics approach is centered on a high performance technique of multi-
dimensional on-line liquid chromatographic separations with subsequent tandem mass 
spectrometric detection.  Since very complex proteome samples are digested into peptides 
and then directly measured by MS, this technique is termed shotgun proteomics.  This 
approach affords the identification and quantification of complex mixtures by directly 
analyzing their proteolytic peptides and then using computational techniques to 
reassemble the protein information.  The research goals for this dissertation project were 
two-fold:  (1) enhancement of the experimental and computational methodologies to 
permit deeper and more confident proteome characterizations, and (2) demonstration of 
this optimized approach for the comprehensive investigation of the molecular level 
response of the bacterium S. oneidensis to chromate insult.  To address research needs, 
we developed a single-tube lysis method for cell lysis-proteome digestion to enable 
investigations of small amounts of cellular biomass, and identified suitable bioinformatic 
approaches to mine post-translational modifications from proteome datasets.  These 
advancements were then utilized to examine the molecular level response of S. oneidensis 
to chromate insult, which was accomplished by varying chromate concentrations, 
dosages, and time points.  These measurements provided the first global proteome-level 
observation of the dynamic changes of S. oneidensis  in response to chromate insult. 
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Chapter 1 
Introduction to Shewanella oneidensis Microbiology with Respect to Chromate 
Exposure using Mass Spectrometry Technology 
 
Introduction 
 Utilizing mass spectrometry technology to decipher global metabolic pathways 
and regulatory networks has increased understanding of these cellular processes in 
biological systems.  The application of mass spectrometry based proteomics falls under 
the area of systems biology.  Systems biology as defined by Ideker et al [1] is the 
integration of data from a number of technologies in order to build a comprehensive 
model to predict cellular pathway responses in a variety of organisms.  This approach 
generally utilizes metabolomic, genomic, transcriptomic, and proteomic datasets in some 
fashion in order to catalog potential metabolic pathway members.  The proteomics 
portion of systems biology encompasses three areas of emerging technology (1) 
improvement of mass spectrometry instrumentation, (2) improvements in separation of 
complex mixtures, and (3) continuous advancement in the computational software 
utilized for mining the resulting datasets.  The research in this dissertation contributed to 
a Department of Energy (DOE) project designed to utilize a systems biology approach 
with the proteomics portion of the project presented in this dissertation.  The goal of this 
dissertation is to understand the chromate response in Shewanella oneidensis (Figure 1.1) 
for the purposes of bioremediation. 
The use of proteomics based analyses began with two-dimensional 
polyacrylamide gel electrophoresis (2-D PAGE) in 1975 [2].  This method separates
2 
 
Figure 1.1.  An integrated approach to understand chromate exposure in S. oneidensis. 
The dissertation comprised the proteomic portion of the project depicted by the tandem 
mass spectrum in the figure.  The bacterial cell is S. oneidensis imaged by atomic force 
microscopy (AFM) (courtesy of K. Chourey).  The double helix DNA strand depicts the 
availability of the genome sequence (courtesy of G. Wickham) and the RNA expression 
cluster depicts the transcriptomic portion of the project (courtesy of D. Thompson).
3 
mixtures of proteins first by the isoelectric point of each individual protein and then by 
the molecular mass of the protein [2-4].  This initial work demonstrated the utility of 
separating complex mixtures of proteins in order to answer questions pertaining to the 
expression levels and subsequent metabolic pathway information of cellular proteins 
responding to a perturbation.  The initial work with 2-D PAGE was limited by the 
inability to identify the differential spots on the gel easily.  Identification of the protein 
species was accomplished initially by N-terminal Edman degradation [5, 6].  Edman 
degradation was developed by Edman and Begg [6] and operates by progressively 
cleaving the N-terminal amino acid residue from the protein.  This residue is then 
separated chromatographically in order to determine its identity.  The first application of 
Edman degradation required 5.0 mg of purified protein [6]. 
Mass Spectrometry Based Proteomics 
 Mass Spectrometry was not originally amenable to working with more fragile 
biomolecules such as proteins due to limitations in the types of ionization sources used 
previously (i.e. chemical and electron ionization [7]).  Electron ionization was the first 
ionization source created for mass spectrometric detection of organic molecules and was 
developed in the late 1920’s [8].  This ionization method employs the use of electrons 
ejected off a heated filament which bombards a gas phase analyte that has been injected 
into the ionization space.  This method of ionization works well for molecules that have a 
high vapor pressure [8].  The mechanism of chemical ionization occurs through the 
interaction of the sample analyte desorbed from a probe with ions that are produced in the 
source (i.e. a reagent gas) leading to a reduction in the fragmentation of the molecular 
4 
species [8].  This method of ionization was created to circumvent the harshness of 
electron ionization, which fragmentation of the molecular species is common.   
During the early 1990’s, Hillenkamp et al [9] described a new, more gentle means 
of creating ionized proteins, defined as matrix assisted laser desorption ionization 
(MALDI).  Now, gel spots identified in the 2-D PAGE gels could be excised, the 
protein(s) digested, and analyzed using MALDI-MS with a method designated as peptide 
mass fingerprinting (PMF).  The number of intact unique peptide masses to be identified 
for a given protein can be as few as three to four using PMF [10].  This method works 
well for less complex mixtures such as gel spots, however, this methodology is not 
amenable to complex mixtures of proteins without the initial 2-D PAGE separation of the 
proteins.  Therefore, a gel-free methodology was developed due to the cumbersome 
nature of 2-D PAGE.   
 In MALDI, the peptides/proteins are spotted onto a conductive metal plate and 
dried within the embedded matrix that is ablated by a laser [9].  The laser causes 
ionization of the matrix, which is generally an acid, creating positively charged ions by 
desorbing both the matrix and the embedded analyte off the surface.  Following 
desorption, there are ion-molecule reactions between the matrix (the ion) and the analyte 
(the molecule), resulting in an ionized analyte.  The charged analyte can now be injected 
into the mass analyzer for subsequent detection.  Primarily, MALDI ionization is 
conducted under vacuum [8], however, there is an atmospheric pressure source available 
that was developed by Laiko et al [11]. 
Electrospray is also a gentle ionization source similar to MALDI-MS, but the 
peptides/proteins remain in solution.  Electrospray ionization (ESI) was first described 
5 
and developed by Fenn et al [12] as a method of atmospheric ionization for large 
biomolecules such as DNA and proteins.  ESI is a solution-based ionization method and 
creates ions by applying high voltage (in the range of kilovolts) to a silica capillary 
causing ionized droplets to be sprayed from the tip of the silica [8].  Due to Columbic 
repulsion of the ionized analyte within the droplet, each droplet formed breaks apart into 
smaller droplets causing desolvation of the ionized analyte and creating a Taylor cone.  
With respect to electrospray ionization in mass spectrometry, the Taylor cone is a plume 
of charged droplets emitted from the electrospray tip.  The droplets form due to the 
voltage difference between the electrospray tip and the opening of the mass spectrometer 
[8].  The droplets undergo further desolvation within a heated metal capillary that 
transfers the ions into the vacuum of the mass spectrometer [8] (Figure 1.2).  This method 
of ionization is easily coupled to a number of mass spectrometers as described below.  In 
addition, the primary advantage of this ionization technique for analysis of biomolecules 
is the ability to couple this ionization source directly to the chromatographic separation of 
complex mixtures of proteins/peptides as discussed below [13-16]. 
There are a number of mass spectrometer designs amenable to acquiring large 
amounts of data on peptides or proteins with a relatively rapid data acquisition speed.  
However, the mass spectrometer chosen for a given proteomics experiment is dependent 
on the properties of the sample to be analyzed (intact proteins or digested peptides) and 
the capabilities of the mass analyzer such as the ability to perform data-dependent 
MS/MS, the mass resolution, the dynamic range, and the mass range.  Data-dependent 
MS/MS allows for an unbiased selection of ions to be isolated and subsequently 
fragmented.  This capability is necessary when attempting to catalog the members of a 
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Figure 1.2.  Original design of the electrospray ionization source.   
Reprinted Figure 1 from Science, Vol. 246, Fenn et al, Electrospray ionization for mass 
spectrometry of large biomolecules, pages 64-71, Copyright 1989 with permission from 
AAAS.
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complex mixture (i.e. a proteome).  The mass resolution for a mass analyzer is defined as 
the peak width at half of the maximum height for that peak [17, 18].  The dynamic range 
is the ability of an ion lower in concentration compared to another ion to be detected in 
concurrence with the abundant ion within the same experiment [19, 20].  The mass range 
of a mass analyzer is a continuum of m/z values from lower m/z to greater m/z detected by 
the mass spectrometer and determines the type of biomolecule, intact protein or digested 
peptide, which can be utilized for an experiment. 
Mass analyzers that have the ability to detect and analyze intact proteins include 
the Fourier transform ion cyclotron resonance (FT-ICR) [21, 22], Orbitrap [23], and time 
of flight (TOF) [24].  The benefits of using an FT-ICR include the high mass accuracy (in 
the ppm range), high mass resolution, and ability to be coupled with chromatographic 
separation [25, 26].  In addition, the FT-ICR has been coupled to the linear trapping 
quadrupole (LTQ) to form a hybrid instrument with enhanced capabilities [22].  The 
Orbitrap operates in a similar fashion as the FT-ICR, utilizing the ions’ oscillation 
frequency as the method of detection.  This mass analyzer differs from the FT-ICR in the 
respect that the Orbitrap does not use a super-conducting magnet.  The Orbitrap is also 
interfaced as a hybrid instrument with the LTQ, allowing high resolution full mass 
spectra to be acquired in the Orbitrap and ion fragmentation with subsequent MS/MS to 
be acquired in the LTQ.  The time of flight mass analyzer is also found as a hybrid 
instrument with a quadrupole or an ion trap [27, 28].   
Some mass analyzers do not have the capability to detect intact proteins, but are 
very useful for peptide detection and analysis, including the three-dimensional ion trap 
(LCQ) [29] and the LTQ [30].  The LTQ is a second generation design based on the 
8 
principles of the LCQ.  Improvements made by Stafford et al [29] allowed the LCQ to be 
coupled readily with peptide detection.  The LCQ has been used in many studies on 
shotgun proteomics due to it’s capabilities of data-dependent MS/MS, dynamic range, 
and data acquisition speed allowing the LCQ to be coupled to liquid chromatographic 
separation.  However, improvements to the design of the ion trap led to the 
commercialization of the LTQ [30].  The LTQ improves on the capabilities of the LCQ 
with an even faster data acquisition speed leading to the detection of more than five times 
as many protein identifications and four times as many MS/MS spectra acquired during 
the same time period [31, 32].  The increased dynamic range observed with the LTQ in 
comparison to the LCQ is due to the increased data acquisition speed and the increased 
trapping volume leading to a larger ion population without the space-charging effects of 
the three dimensional ion trap [30]. 
Liquid Chromatographic Separation of Biomolecules 
The development of electrospray led to improvements in the second area of 
proteomics:  separation of complex mixtures of peptides/proteins.  Electrospray allows 
for online separation of peptides/proteins to be coupled to mass spectrometry.  This gel-
free method of separating complex mixtures is less time consuming, more sensitive, and 
more reproducible than gel-based methods.  A large number of studies published in 
proteomics utilize reverse phase (RP) separation online with mass spectrometry.  This is 
due to the liquid phase used in RP separation consisting of an aqueous to organic 
gradient.  These two types of solvents readily disperse into droplets that desolvate in the 
heated capillary rapidly.  The addition of strong cation exchange (SCX) online with RP 
was introduced by Washburn et al [33].  This allowed unbiased separation of peptides 
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first based on their affinity for the negatively charged resin of the SCX column followed 
by separation based on hydrophobicity.  2-D PAGE separation is limited based on the 
protein molecular weight (proteins > 180 kDa) and isoelectric point (pI within the range 
of 5-10) [33].  The unbiased separation of peptides/proteins is required for global 
detection studies like shotgun proteomics experiments.  Another form of separation, 
isoelectric focusing (IEF), has emerged as an alternative to SCX as the second dimension 
of separation [34, 35].  This form of separation is performed with either intact proteins or 
peptides.  This is a gel-based method predominantly [34] utilizing IPG strips available 
commercially, but can also be liquid-based with a commercially available apparatus (i.e. 
the MicroRotofor cell from Bio-Rad, Hercules, CA). 
Advancements in Computational Biology 
Computational biology or algorithm development is an emerging area of 
development due to the large advancements described above, however there is still more 
progress that must be made in order increase the confidence of subsequent MS/MS data 
analysis.  The development of data-dependent MS/MS coupled to liquid chromatographic 
separation increased the number of acquired spectra [36, 37] so now the average LC-MS 
experiment acquires hundreds of thousands of MS/MS [20, 38].  Due to the large number 
of MS/MS acquired, manual interpretation of spectra is unfeasible.  Therefore, the 
development of computational algorithms created an automated approach for MS/MS 
data analysis. 
The algorithm Sequest [39] was the first written for mining peptide identifications 
from data-dependent MS/MS.  This algorithm requires the presence of a database that 
contains the predicted protein sequences present in the complex peptide mixture being 
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analyzed.  Subsequent to the release of Sequest, a number of other algorithms have been 
released freely or commercially packaged [40-44].  The key for an algorithm to be 
deemed successful is based on a number of criteria including (1) accuracy of MS/MS 
identification, (2) the length of time for searching a MS/MS, (3) ease of setting the 
criteria parameters for an algorithm, and (4) availability of the algorithm for use to the 
general scientific community.  Each subsequent algorithm attempts to improve on the 
speed and accuracy of matching the MS/MS acquired against a theoretical spectrum 
generated from the provided protein database.  Increasing the accuracy of matching the 
MS/MS acquired has been a challenge with respect to identifying post-translational 
modified proteins [45].  Three search algorithms, DBDigger [44], InsPecT [40], and 
Sequest [39] are evaluated in this dissertation and their abilities to search shotgun 
proteomics data for post-translational modifications (PTMs) are discussed in detail in 
Chapters 2 and 5. 
PTMs are chemical modifications found on the amino acid residues of proteins 
and can be due to consequences of either biological or inorganic chemical processes [46-
51].  These modifications, when due to an enzymatic process, are sometimes involved in 
cellular signaling and transcriptional activation control [52-55].  Oxidation is an example 
of an inorganic chemical modification process and can be due to an increase in the 
presence of free radicals within the cytosol that are subsequently quenched by proteins 
[46, 47].  Determining the identity and relative stoichiometry of the modified version of 
the residue in contrast to the unmodified counterpart is an emerging challenge in mass 
spectrometry based proteomics [45, 56].  This area is an emerging challenge due to 
advancements that have led to the routine cataloguing of the unmodified protein 
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complement in both bacterial cultures and tissue samples.  However, the low 
stoichiometry of the modified counterpart has led to a large effort in enriching for the 
PTM of interest [55, 57, 58].  There are efforts being made to determine from a global 
proteome dataset the identity of post-translationally modified proteins [59, 60]. 
 Bacteria are amenable subjects for large-scale studies, such as the shotgun 
proteomics studies described in this dissertation for a number of reasons.  First, many 
bacterial lab strains are easily cultivatable under laboratory conditions, where cellular 
material is not a limiting factor.  Second, the environmental importance of a growing list 
of bacterial species have been implicated in biogeochemical cycling [61-65] and fouling 
of energy pipelines [66].  Finally, a large number of bacteria have been characterized 
both physiologically and biochemically creating a vast literature database to search.  In 
addition, the availability of an immense number of bacterial genome sequences from both 
isolates and environmental communities [67-78] is required for properly searching the 
MS/MS data.   
Shewanella oneidensis MR-1 
 S. oneidensis MR-1 is a gram-negative γ-proteobacteria first isolated from Lake 
Oneida, NY by Myers and Nealson [61] as Alteromonas putrefaciens.  A. putrefaciens 
was renamed Shewanella putrefaciens by Myers and Nealson [79].  Then, in 1999 S. 
putrefaciens was renamed S. oneidensis MR-1 by Venkataswaran et al [80].  S. 
oneidensis was enriched from the lake sediments as a manganese and iron reducing 
bacterial species.  The genome was published by Heidelberg et al [69], which facilitated 
work in better understanding the metabolic capabilities of this bacterium.  S. oneidensis is 
facultatively anaerobic indicating that the bacterium prefers molecular oxygen as the 
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terminal electron acceptor for respiration; however, a number of electron acceptors can 
be utilized under anaerobic growth conditions [61].  In addition to manganese and iron, S. 
oneidensis was found to utilize many other compounds as terminal electron acceptors for 
respiration under anaerobic conditions [81-86].  Some other electron acceptors found to 
be utilized by S. oneidensis include fumarate and nitrate [81], elemental sulfur [85], and 
nitrite [87].  In fact, as a result of other unpublished work, the estimation is that of over a 
dozen electron acceptors may be utilized by S. oneidensis [88, 89].  The energetics of 
various electron acceptors have been determined with oxygen being most favorable 
followed by trivalent iron, nitrate, tetravalent manganese, and nitrite [90]. 
 Since S. oneidensis has such a vast repertoire of electron acceptors for utilization, 
there must be an extensive regulatory and sensory system in place for recognizing this 
array of respiratory molecules.  Upon completion of the genome sequence annotation 
[69], the identification of a large number of genes involved in environmental responses 
were identified.  This included the annotation of 88 two-component response regulatory 
genes [69], three separate pathways for chemotaxis signaling, and 29 methyl-accepting 
chemotaxis protein receptors (chemoreceptors) [91].  The large number of response 
regulatory proteins is expected to be due to the diverse environments in which S. 
oneidensis may be found including marine, freshwater, and soil sediments [69].  Nealson 
et al [88] performed the first comprehensive study on chemotaxis response in S. 
oneidensis.  The authors found S. oneidensis responded dramatically to the presence of 
nitrate and nitrite by accumulating around wells containing the electron acceptors [88].  
In addition, the authors found that the bacterium did not demonstrate any type of 
response to the transition metals Mn(IV) oxide and Fe(III) citrate.  However, a 
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subsequent study by Bencharit and Ward [92] found that S. oneidensis indeed 
demonstrates a chemotactic response using swarm plate assays to a variety of transition 
metals utilized as terminal electron acceptors including Mn(IV) and Fe(III). 
 S. oneidensis also contains a number of transcriptional regulatory proteins that 
have been elucidated in a number of studies [93-97].  Understanding the role of 
transcriptional regulators in response to gene expression is necessary to understand global 
regulatory and metabolic pathway function.  EtrA, electron transport regulator A, was 
found to be 73.6% identical to the Escherichia coli protein Fnr, fumarate/nitrate 
regulator, and was found to functionally complement the fnr mutant in E. coli [93].  
Another study using a gene replacement strategy [94] knocked out etrA in S. oneidensis 
and found that growth with fumarate and nitrate as terminal electron acceptors was 
reduced in the mutant cultures.  The corresponding terminal reductase activities for the 
electron acceptors was also reduced in the mutant strain, indicating that EtrA may control 
transcription of the corresponding reductase genes [94].  A comparative transcriptomic 
study found that the mutant strain of the etrA gene knockout affected the transcriptional 
levels of 69 genes in S. oneidensis [95].  In addition, putative regulatory sequences 
demonstrating conservation with fnr regulatory sequences were identified upstream of 26 
operons with affected transcript levels.  The corresponding mRNAs from fumarate 
reductase were not only found to be repressed in the mutant strain, but contained a 
putative fnr sequence as well [94].  Another global regulator, Fur (ferric uptake 
regulator), has been studied in detail by transcriptomics and proteomics [96, 97].  These 
studies identified that Fur was involved in the negative regulation of iron transport genes 
and a putative Fur box was identified upstream of a number of affected genes [96].  
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Therefore, the presence of perhaps other transcriptional regulators, which respond to 
transition metals, is likely to be encoded in the genome as well. 
 As a result of the apparent respiratory versatility of S. oneidensis, initial work 
focused on understanding the enzymatic mechanism involved in using these transition 
metals as electron acceptors [66, 79, 81-84, 90, 98-103].  This work included attempts to 
isolate and characterize the terminal electron acceptor reductases [86, 102, 104-110].  
First, prior to isolation of S. oneidensis MR-1, the utilization of metals for growth was not 
known to occur.  Myers and Nealson [79] determined that a proton motive force was 
being generated, which is direct evidence for respiratory growth in response to reduction 
of Mn(IV) and Fe(III) when added as the sole electron acceptors to the growth media.  
Now, that growth coupled to metal reduction was known, the next step was to determine 
the enzymes involved in the direct reduction of the metals.  A number of studies followed 
that demonstrated the role of a number of cytochromes and reductases from S. oneidensis 
that were essential to the electron transport chain activated in response to Mn(IV) and 
Fe(III) [81, 100, 102, 104-119].  Primarily, the identification of outer membrane 
cytochromes that were required for metal reduction indicated that S. oneidensis may 
require direct contact with the surface for reduction to occur [104-107].  After the 
genome sequence had been published [69], Meyer et al [117] and Yang et al [119] found 
that the S. oneidensis genome encodes a large number of cytochromes.  In addition, 
terminal reductase activity for a number of electron acceptors was also found to be 
located in membrane protein preparations [86, 102, 120].  Direct contact with the surface 
may explain the lack of metal ion transporters in the genome compared to other bacterial 
species [69]. 
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S. oneidensis Cr(VI) Toxicity and Transformation 
Another transition metal utilized as a reductant by S. oneidensis is the hexavalent 
species of chromium [Cr(VI)] in the form of chromate (CrO42-) or dichromate (Cr2O72-) 
[86].  Chromate is a serious pollutant caused by human activities and discharged as liquid 
waste at many industrial and governmental facilities [121-123].  Traditionally, the 
process for remediating these contaminated waste sites has involved costly chemical 
methods [124, 125].  Therefore, the idea of using a natural environmental bacterium that 
demonstrates an enzymatic ability to reduce Cr(VI) to insoluble Cr(III) hydroxides in 
addition to a tolerance for various concentrations of Cr(VI) is more economical and 
environmentally friendly [126].  The use of bacteria for remediation has been proposed 
and implemented on a number of pollutants in the United States [126-131]. 
S. oneidensis has demonstrated Cr reductase activity in the cytoplasmic 
membrane [86], however, there are not any known reports on the growth of S. oneidensis 
utilizing Cr(VI) as the sole electron acceptor [132].  Myers et al [86] demonstrated the Cr 
reductase activity in anaerobically grown cultures utilizing fumarate as the electron 
acceptor with Cr(VI) added to the purified membrane fractions subsequently.  The 
hypothesized pathway for reduction of Cr(VI) proceeds first via a one electron transfer 
yielding Cr(V) [86].  This is based on evidence from Myers et al [86], which found the 
reductase activity was inhibited by substances known to inhibit members of multi-
component electron transport chains.  In addition, Viamajala et al [133] demonstrated 
that the kinetic activity of the Cr reductase in S. oneidensis must involve at least three 
separate enzymes.  The three enzymes are unknown, but one is described as being 
relatively slow and there are two that are enzymatically fast but susceptible to inhibition 
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by nitrite when nitrate is used as the electron acceptor [133].  This indicates that Cr 
reductase activity in S. oneidensis may be non-specific.  These kinetics measurements 
were taken on S. oneidensis grown anaerobically with nitrate or fumarate as the electron 
acceptor.  Direct evidence for Cr(VI) reduction in S. oneidensis was accomplished by 
Daulton et al [134] identifying extracellular precipitates of Cr(III) surrounding the 
outside of the bacterial cells.  In addition, Cr(III) precipitates in the cytoplasm of S. 
oneidensis have been imaged by transmission electron microscopy [135].  However, there 
is also evidence that Cr(VI) reduction may occur indirectly via reduction of Fe(III) to 
Fe(II) first [131, 136, 137]. 
 Cr reductase activity is not novel to S. oneidensis, rather a number of other 
bacteria have shown this activity previously.  This includes S. alga BrY, a relative of S. 
oneidensis, where S. alga was found to be proficient in Cr(VI) reduction following a 
starvation period [137].  The starvation period causes the cells to decrease in volume 
allowing them to penetrate further into subsurface environments where Cr(VI) 
concentrations may be greater.  In addition to S. alga, other bacterial species encode 
soluble Cr(VI) reductase proteins that have been purified, including Pseudomonas putida 
MK1 [138], P. putida PRS2000 [139], and Pseudomonas ambigua G-1 [140].  
 Even though many bacterial species have demonstrated either direct enzymatic or 
indirect chemical reduction of Cr(VI), the bacterial species must demonstrate a minimum 
level of resistance to Cr(VI) toxicity in order to be used as an agent of bioremediation.  
The toxic effects of Cr(VI) include inhibition of sulfate uptake [141] and the generation 
of reactive oxygen species (ROS).  The ROS cause oxidative damage to DNA [126] 
leading to mutations that can manifest as cancer in humans [142, 143].  Therefore, a great 
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deal of work has been dedicated to understanding the mechanisms of resistance in 
addition to the level of resistance of various bacterial species [144-146].   
The minimum inhibitory concentration (MIC) for aerobically grown S. oneidensis 
was found to be 2 mM [147].  For anaerobically grown S. oneidensis, inhibition was 
found to be at a much lower concentration [135].  An extensive physiological study on 
the toxicity effects of Cr(VI) and Cr(III) was performed by Viamajala et al [146].  This 
study found that cultures grown under aerobic or anaerobic conditions would cease to 
divide at a measurable rate until all Cr(VI) had been reduced; indicating an inhibition of 
some metabolic process caused by the presence of Cr(VI).  Interestingly, the authors 
hypothesize that the primary toxicity of Cr may be due to the trivalent species remaining 
bound to the reductases and causing precipitates to form in the cytoplasm [146]. 
S. oneidensis is not the only bacterium that demonstrates resistance to Cr toxicity.  
Members of the genus Pseudomonas have demonstrated resistance to Cr(VI) toxicity via 
chromosomal and plasmid-borne genes [148-153].  In addition, members of the genus 
Alcalignes were also found to demonstrate Cr(VI) resistance via plasmid-borne genes 
[154, 155].  Specifically, the ChrA gene was isolated from Pseudomonas and Alcalignes 
as responsible for chromate resistance [151, 155] and may encode an active efflux pump 
that expels Cr(VI) from the bacterium.  There is a protein, SO0986, encoded in the 
genome of S. oneidensis that demonstrates significant sequence similarity to the ChrA 
gene in Peudomonas aeruginosa, however, there is no expression evidence to indicate 
that active efflux of Cr(VI) is used as the mechanism in S. oneidensis.  In fact, as 
described above, the molecular mechanisms involved in chromate toxicity and reduction 
in S. oneidensis remain largely unknown. 
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Due to the fact that very little is known at the molecular level about chromate 
exposure in S. oneidensis, the first goal of the dissertation involved the completion of a 
number of proteomic studies to improve understanding regarding chromate exposure in S. 
oneidensis (Figure 1.3).  This was accomplished by first a global study of acute chromate 
shock found in Chapter 3 in order to understand the initial response of S. oneidensis to 
sub-lethal levels of chromate.  Also in Chapter 3, a global chronic exposure study is 
outlined demonstrating how the bacterium might respond to sub-lethal concentrations of 
chromate over an extended period of time.  This work was followed by a dosage response 
study in Chapter 4, the purpose of which was to understand how the bacterium responds 
to various levels of sub-lethal concentrations of chromate.  Finally in Chapter 6, the time 
during transformation of chromate from the hexavalent species to the trivalent species is 
explored; giving possible evidence of proteins that may be transporting and reducing the 
sub-lethal concentration of chromate in wildtype and ∆2426 mutant cultures.  The ∆2426 
mutant was created based on evidence from previous studies [147, 156] that the protein, 
SO2426, was highly up-regulated in response to acute chromate exposure.  In addition, 
Cr(VI) reduction assays indicated that the ∆2426 mutant was deficient in Cr(VI) 
transformation in addition to a number of other transition metals [157]. 
The second goal of the work was more technology driven and focused on 
different method development areas to build upon the proteomics pipeline developed at 
Oak Ridge National Laboratory.  Improvements to two of the technologically challenged 
areas of proteomics (sample preparation for proteome analysis and computational 
analysis of MS/MS data) enhanced both the experimental design and the resulting 
information obtained from performing shotgun proteomics experiments.  Figure 1.4 
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Figure 1.3.  Flowchart diagram of the proteome studies of S. oneidensis Cr(VI) exposure.   
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Figure 1.4.  Representative shotgun proteomics experimental design. 
Outlined in the flow chart are the steps in a representative experiment from whole-cell 
lysate to the resulting data analysis of the acquired MS/MS data.  Improvements to the 
setup are highlighted and details are outlined in Chapters 5, 6, and 7.  
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depicts the steps involved in a conventional shotgun proteomics experiment and is 
representative of the pipeline used at Oak Ridge National Laboratory from cell lysis to 
data analysis.  Highlighted are the method development areas described in this 
dissertation that have been accomplished to improve on the design of the experimental 
setup.  Chapter 5 demonstrates a novel systematic study of mining shotgun proteomics 
data for PTMs.  This was accomplished by comparing the performance of three 
algorithms (DBDigger [44], InsPecT [40], and Sequest [39]) by searching MS/MS data 
from whole-cell lysates of S. oneidensis for PTMs.  Chapter 6 is not only about 
understanding chromate transformation in S. oneidensis, but comprises one of the first 
comprehensive proteome measurements from biological replicate cultures of a bacterium.  
In addition, Chapter 7 describes a novel single-tube lysis method that has been 
successfully applied in the results of Chapter 6.  The single-tube lysis method permits 
global proteome detection from a few milliliters of bacterial cell culture versus the 
traditional liters of cell culture.  This is a greater than 1000x reduction in the amount of 
cellular material needed for proteome detection and characterization.  All of the research 
described in this dissertation comprises both novel and thorough evaluations performed 
to understand acute and chronic chromate exposure as well as during chemical 
transformation of chromate at the molecular level utilizing methodologies in the systems 
biology area of shotgun proteomics.   
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Chapter 2 
Experimental Design of Shotgun Proteomics Experiments and Bioinformatic 
Platforms using Multidimensional Protein Identification Technology 
 
Introduction 
 The work presented in this dissertation utilized a mass spectrometry based 
platform for global protein characterization from microbial isolate cultures and a natural 
microbial community.  This chapter describes the experimental details and components of 
this platform utilized for large scale proteome measurements.  Each chapter summarizes 
the specific mass spectrometry method used (i.e. LCQ or LTQ), with this chapter 
describing the overall methodological approach explored and developed.  The 
instruments utilized during the course of the dissertation were a LCQ (liquid 
chromatography quadrupole ion trap, three-dimensional ion trap) and a LTQ (linear 
trapping quadrupole) coupled to an online two-dimensional chromatography method.  In 
addition to acquisition of mass spectrometry data, the lack of a feasible means of 
searching the data for post-translational modifications was addressed through optimizing 
the scoring filters from three bioinformatics platforms and adapting an in-house script. 
Microbial Cultures and Communities 
 Microbial cultures (Chapters 3-7) were obtained from isolates stored as glycerol 
stocks at -80 °C and were provided by Dr. Dorothea Thompson from Purdue University 
(Shewanella oneidensis MR-1) and Dr. Dale Pelletier from the Biosciences Division at 
Oak Ridge National Laboratory (Rhodopseudomonas palustris CGA0010).  The acid 
mine drainage biofilm microbial community used in Chapter 7 was a gift from Dr. Jillian 
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Banfield at University of Berkley.  S. oneidensis was cultivated in batch culture under 
aerobic conditions and R. palustris was cultivated under photoheterotrophic conditions.  
S. oneidensis was grown in 500 mL cultures for [147, 156, 158] or 100 mL cultures for 
[159] under aerobic conditions to mid-exponential phase (A600, 0.5) followed by 
continued monitored growth or the addition of K2CrO4 for a given period of time.  For 
cellular harvest, cells were pelleted by centrifugation (5,000 x g for 5 min), resuspended 
in ice-cold LB medium, washed two times in 50 mM Tris, 10 mM EDTA (pH 7.6), and 
centrifuged at 5,000 x g for 10 min. The cell pellets were stored at -80 °C until cellular 
lysis and digestion.  Details of microbial growth can also be found in [147, 156, 158-
160]. 
Preparation of Proteomes for HPLC-MS/MS Analysis 
All chemical reagents were obtained from Sigma unless stated otherwise.  
Modified sequencing grade trypsin (Promega, Madison, WI) was used in all digestions.  
The modified trypsin used for digestion was methylated on lysines and arginines, thereby 
reducing the autolytic behavior of the enzyme, which may interfere with detection of the 
peptides of interest [161].  HPLC grade water and acetonitrile were acquired from 
Burdick & Jackson (Muskegon, MI), and 99% formic acid was purchased from EM 
Science (Darmstadt, Germany).   
Lysis by Sonication and Tryptic Digestion 
For proteome analyses in Chapters 3, 4, 5, and 7, the S. oneidensis cells were 
placed on ice and lysed by sonication using a microprobe at high power with 30-s pulses 
five times with a 30-s cooling period between each sonication. R. palustris and the acid 
mine drainage biofilm in chapter 7 were also lysed by sonication, however due to the 
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invaginated membrane of R. palustris and the cellulose matrix structure of the biofilm, 
there were ten 30-s sonication pulses followed by the 30-s cooling period.  Cellular debris 
was removed by centrifugation at 5,000 x g for 10 min.  The supernatant was centrifuged 
at 100,000 x g for 60 min in an ultracentrifuge to separate a soluble fraction from a pellet 
for Chapters 3, 4, and 5.  The pellet (membrane fraction) was washed with 50 mM Tris, 
10 mM EDTA (pH 7.6) and centrifuged at 100,000 x g for 60 min; this fraction was then 
resuspended in 50 mM Tris, 10 mM EDTA (pH 7.6) by brief sonication.  Both proteome 
fractions were quantified using bicinchoninic acid (BCA) analysis [162], aliquoted, and 
stored at -80 °C until ready for digestion.  Approximately 2 mg of each proteome fraction 
(soluble and membrane) was denatured and disulfide bonds reduced in 6 M guanidine 
and 10 mM DTT (60 °C for 1 h).  The denatured/reduced proteome mixture was diluted 
6-fold with 50 mM Tris, 10 mM CaCl2 (pH 7.8), and sequencing grade trypsin was added 
at 1:100 [protease/protein (w/w)].  The digestions were run with gentle shaking at 37 °C 
for 18 h, followed by a second addition of trypsin at 1:100 and an additional 5 h 
incubation.  The samples were treated with 20 mM DTT for 1 h at 37 °C as a final 
reduction step to remove remaining disulfide bonds and then immediately desalted using 
Sep-Pak Plus C18 solid phase extraction (Waters, Milford, MA).  A second reduction 
step with DTT was performed instead of using the cysteine alkylation reagent 
iodoacetemide.  Iodoacetemide blocks the cysteine residues through the addition of a 
carboxymethyl group (57 Da), which will appear as a static modification in the resulting 
MS/MS searches.  The added complexity of this modification in the resulting data filter 
levels must be taken into consideration as described below for PTMs.  All samples were 
concentrated and solvent-exchanged into 0.1% formic acid in water by centrifugal 
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evaporation to ~10 µg/µl starting material, filtered, aliquoted, and stored at -80 °C until 
ready for LC-MS/MS analysis. 
Single-Tube Lysis and Tryptic Digestion 
For the proteome analyses presented in Chapters 6 and 7, a single-tube lysis 
method was employed.  This method differs from the above sonication method and was 
performed as follows.  Microbial cell pellets ranging in size from 1 mg to ~200 mg were 
lysed using 6 M Guanidine/10 mM DTT dissolved in 50 mM Tris/ 10 mM CaCl2 pH 7.6 
(Tris Buffer).  The Ca2+ ion is necessary to enhance activity by promoting autocatalytic 
activity converting trypsinogen into trypsin, the active enzyme [163].  In addition, the 
resulting protein content is denatured with the guanidine and the mixture was incubated 
overnight at 37 °C.  Following lysis, the samples were diluted 6-fold with the Tris Buffer 
and trypsin was added in an optimized amount for 6 hr at 37 °C with gentle rocking 
followed by a second trypsin aliquot overnight.  The optimized amount of trypsin was 
determined in order to obtain the fewest autolytic tryptic peptide identifications after the 
LC-MS/MS experiment.  When too much trypsin is added, the resulting proteome dataset 
will have greater than 50% sequence coverage of trypsin identified in the resulting 
dataset, in contrast to the ~20% sequence coverage observed if an optimized amount is 
used.  A final 20 mM DTT reduction step was performed following the proteolytic 
digestion for 2 hr at 37 °C with gentle rocking.  After lysis, proteolytic digestion, and the 
final reduction step a high speed centrifugal step was performed to pellet cellular debris.  
Samples were then desalted with a Sep-Pak C18 Lite or Plus cartridge and solvent 
exchanged into 100% H2O, 0.1% formic acid; followed by filtration using an Ultrafree-
MC centrifugal filter device (Millipore, Billerica, MA) and stored at -80 °C until LC/LC-
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MS/MS analysis.  The final filtration step is necessary to remove any aggregate cellular 
material that will clog the subsequent LC column. 
Lysis using Tetrafluoroethylene (TFE) was performed in the same manner as the 
Guanidine HCl method, except TFE was added initially at a concentration of 50:50 
TFE:Tris Buffer/10 mM DTT.  For the microbial community (acid mine drainage 
biofilm) discussed in Chapter 7, a different single-tube lysis method, freeze/grinding, was 
attempted.  The freeze/grinding method was accomplished by first flash-freezing the 
biofilm in liquid nitrogen, followed by mechanical grinding of the sample into a fine 
powder.  Then, the cell pellets were resuspended in 6 M Guanidine/10 mM DTT in Tris 
Buffer with the remaining steps being as above for the Guanidine lysis method.   
Small Sample Lysis by Bead-Beating 
 The bead-beating method of lysis [164] is not a single-tube lysis method, however 
bead-beating is similar in the respect that a smaller than traditional amount of biomass 
can be lysed with this method.  The bead-beating method used 0.5 mm glass beads 
(Biospec Products, Bartlesville, OK) first sterilized in HPLC-grade methanol (Burdick 
and Jackson) overnight.  Next, an approximately similar amount of glass beads as the cell 
pellet for lysis is transferred to a separate 2 mL eppendorf tube with a spatula cleaned 
with methanol.  About 250 µL of 6 M Guanidine/10 mM DTT is added to the glass beads 
and vortexed.  The biofilm (as in Chapter 7) is transferred to the glass beads and vortexed 
5 times for 30 s with a 30 s cooling period.  The biofilm/glass bead slurry is then 
incubated over night at 37 °C.  Following this step, the Guanidine is diluted to 1 M with 
50 mM Tris/10 mM CaCl2 and centrifuged to pellet the glass beads.  The supernatant is 
transferred to a separate eppendorf tube and 10-20 µg of trypsin was added for 5 hr at 37 
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°C with gentle rocking, and another aliquot of trypsin was added with an overnight 
incubation.  Finally, a final reduction step for 2 hr with 20 mM DTT, followed by 
centrifugation to pellet debris, and the samples were then desalted with a Sep-Pak C18 
Plus cartridge.  As described in Chapter 7, this method has not been optimized and the 
results for this method are worse than the other lysis methods due to the buoyancy of the 
biofilm floating on the top of the glass beads. 
Liquid Chromatographic Separation of Peptides 
 Separation of complex mixtures of peptides using an online two-dimensional 
liquid chromatographic separation has many advantages over other methods of 
separation.  In particular, the use of orthogonal separations such as strong cation 
exchange (SCX) and reverse phase (RP) provides coupled but independent separation 
dimensions.  An orthogonal separation method is defined as use of two or more 
chromatography types, which separate peptides based on two or more different chemical 
properties (i.e. hydrophobicity, size, ionic properties, etc.).  There are other methods of 
two-dimensional separation available (see Chapter 1 for discussion); however the 
coupling of SCX and RP online with mass spectrometry analysis of peptides has become 
the most successful implementation of two-dimensional orthogonal online separation of 
peptides.  SCX separates peptides based on their affinity for the negatively charged 
benzene sulfonic acid bonded resin and RP separates peptides based on their affinity for a 
highly hydrophobic 18-carbon chain bound resin.  The traditional method of SCX 
separation is not considered to be compatible with mass spectrometry due to the use of a 
strong salt (i.e. NaCl) for peptide elution.  However, the work demonstrated here utilizes 
the volatile salt ammonium acetate, which exhibits greater compatibility with MS 
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allowing for online separation.  In addition, the total capacity of the column must be 
considered prior to loading the peptides.  Overloading leads to diminished separation of 
the peptides, as well as a decreased confidence in the prediction of the elution time. 
The proteome fractions (soluble and membrane) prepared from control and 
chromate-treated samples were analyzed in duplicate for Chapters 3, 4, and 5 and from 
whole cell lysates in triplicate for samples in Chapters 6 and 7 via a 24-hr two-
dimensional (2-D) LC-MS/MS experiment using an Ultimate HPLC system (LC 
Packings, a division of Dionex, San Francisco, CA).  The HPLC pump provided a flow 
rate of ~100 µl/min that was split pre-column using a fused silica setup as shown in 
Figure 2.1 to achieve a final flow rate of ~300 nl/min at the nanospray tip. The flow at the 
tip was measured using a 5 µL capacity calibrated micropipet (Drummond Scientific 
Company, Broomall, PA) with 1 µL increments over at least a 3 min time frame.  This 
was chosen due to the flow rate variation over time and so an average flow rate is taken 
over the specified time period.  A split phase column (150 µm inner diameter fused 
silica) was packed via a pressure injection platform (New Objective, Woburn, MA) as 
follows:  first with ~3.5 cm of strong cation exchange (Luna SCX, 5 µm particle size, 100 
Å distance between particles when packed together; Phenomenex, Torrance, CA) 
followed by ~3.5 cm of C18 reverse phase (Aqua C18, 5 µm, 200 Å; Phenomenex).  
Subsequently, ~500 µg of proteolytic peptide sample was loaded onto the split phase 
column via the pressure injection platform.  The sample size of 500 µg was chosen in 
order to take advantage of the dynamic range capabilities of the ion trap mass 
spectrometers used.  This amount of protein slightly overloads the theoretical capacity of 
the column, but allows us to identify proteins that may be present at a concentration of
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Figure 2.1.  Schematic diagram of the two-dimensional column setup. 
The Ultimate pump is connected to the two dimensional nanocolumn via peek tubing 
connected to 100 µm fused silica by a metal fitting, which acts as a ground for the 
voltage.  The 50 µm waste line is depicted as well extending from the second micro tee 
connecting the mass spectrometer voltage to the nanocolumn. 
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nanograms per milliliter [165].  The loaded split phase column was then inserted behind a 
PicoFrit tip (100 µm inner diameter, 15 µm inner diameter at the tip; New Objective) 
packed via the pressure injection platform with ~15 cm of C18 reverse phase (Jupiter C18, 
5 µm, 300 Å or Aqua C18, 5 µm, 200 Å; Phenomenex).  The C18 reverse phase resin on 
the split phase column acts as a trapping cartridge for the peptides to initially bind to, 
with the first chromatographic step being a desalting step as described by McDonald et al 
[166].  This acts to remove impurities from the sample preparation process and move the 
peptides during the gradient [100% Buffer A (95% H2O, 5%ACN, 0.1% formic acid) to 
100% Buffer B (30% H2O, 70% ACN, 0.1% formic acid)] from the C18 resin to the SCX 
resin for subsequent separation based on charge affinity.   
Following the first chromatographic step (the desalting step), proteome fractions 
(Chapters 3, 4 and 5) or cell lysates (Chapters 6 and 7) were separated using the 
orthogonal methods of SCX followed by RP for 11 subsequent salt steps (a step 
gradient).  Table 2.1 depicts the time and amount of ammonium acetate added to dislodge 
peptides from the SCX resin for each salt step and subsequent organic phase separation.  
The chromatographic separation of each salt step is as follows:  2 min of Buffer A for re-
equilibration of the column followed by 2 min (steps 2-11) of the specified amount of salt 
or 10 min for step 12.  After the salt step, there was another Buffer A equilibration period 
of 5-10 min followed by the Buffer A to Buffer B RP separation.  The re-equilibration 
period with the second Buffer A step is critical; if this step is not performed the salt 
introduced will precipitate out of solution in the presence of organic solvent.  This RP 
separation method consisted of the gradient from 100% Buffer A to 50% Buffer B for 
steps 2-11 and 100% Buffer A to 100% Buffer B for step 12.  The goal of step 12 is to  
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Table 2.1.  The Consecutive LC Steps Employed in the Two-Dimensional Separation 
 
Chromatography Step Time (min) Ammonium Acetate Added (mM) 
1 60 0 
2 120 50 
3 120 75 
4 120 100 
5 120 125 
6 120 150 
7 120 175 
8 120 200 
9 120 225 
10 120 250 
11 120 300 
12 100 500 
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remove all peptides that may still be binding to the resin following step 11, which 
explains the longer salt step followed by the complete organic phase endpoint during the 
RP separation.  The complete organic phase acts to diminish carryover between LC-
MS/MS experiments due to peptides remaining bound to the 15 cm RP analytical column, 
which is used for multiple chromatographic separations.   
Typical total ion current (TIC) and base peak chromatograms are depicted in 
Figure 2.2 for chromatography steps 1, 6, and 12.  These steps were chosen as 
representatives of how the chromatograms should look for a LC separation.  Note how 
the relative intensity disappears during the injection of salt across the chromatography 
column.  The loss of intensity is a result of the greater conductivity of the salt raising the 
current of the nanospray tip causing cessation of electrospray.  Also, there is a notable 
difference in peptide elution between steps 6 and 12.  In step 12, elution of a majority of 
peptides occurs by 100 min into the chromatography step indicating complete elution of 
peptides from the analytical column, which leads to less carry over between sample 
analyses.  Originally, step 12 was 120 min in length; however as noted above, the 
peptides primarily elute by 100 min and so the gradient was shortened accordingly (See 
Table 2.1). 
Mass Spectrometry Experiments for the Detection of Peptides 
During the entire chromatographic process, the three-dimensional ion trap (LCQ) 
or linear trapping quadrupole (LTQ) was operated in a data-dependent MS/MS mode 
detailed below.  The chromatographic methods and HPLC columns were similar for all 
analyses.  The LC-MS/MS system was fully automated and under direct control of the 
Xcalibur software system (Thermo Scientific, San Jose, CA).  Operation of the mass 
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Figure 2.2.  TIC and base peak chromatograms from selected chromatography steps. 
The TIC chromatograms are on the top with the base peak chromatogram below for (A) chromatography step 1, (B) step 6, and 
(C) step 12 from Table 2.1.  Even though there appears in the TIC chromatogram to be an overwhelming amount of peptides 
eluting at any given time, the base peak chromatogram illustrates that there is actually respectable separation of the peptides.
A B C 
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spectrometer in a data-dependent mode allows for increased dynamic range through the  
use of dynamic exclusion.  Dynamic exclusion is used to reduce the sampling of 
abundant ions being triggered for MS/MS fragmentation; when an abundant ion is 
detected, it is subsequently placed on a list that prohibits that ion from being isolated for 
a set period of time (i.e. 3 min).  The data-dependent mode of operation is independent of 
operator control, where the control software (Xcalibur) is programmed such that during a 
set period of time, a full MS scan is acquired followed by a specified number of MS/MS 
scans.  This loop is repeated until the set period of time is completed (i.e. the liquid 
chromatographic separation).  The MS/MS scans are dependent on ion intensity in the 
respect that following the MS scan, the nth most intense ion is isolated and fragmented 
where n is equal to 1, 2, 3, etc.  Once the ion is chosen for fragmentation, the m/z value is 
placed on the dynamic exclusion list and is not isolated or fragmented until removed from 
the list.  Discussed below are the details of how each mass spectrometer was operated and 
the process by which ions are detected and isolated by each instrument. 
Operation of a three-dimensional ion trap (LCQ) 
The LCQ is a three-dimensional ion trap composed of a ring electrode in the 
middle and two end-cap electrodes acting to trap ions in the center of the ring electrode.  
This instrument was first developed in 1960 by Paul and Steinwedel and known as the 
Paul trap [167].  Advancements to the design leading to successful commercialization of 
the instrument came in 1984 by Stafford et al [29].  Ions are injected into the trap via 
focusing multipoles transferring the ions as a coherent packet from the electrospray 
ionization source operated at atmospheric pressure through a heated capillary for 
desolvation of the ions and into the vacuum of the mass spectrometer.  The ions become 
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energetically stable in the center of the trap according to the stability diagram represented 
in Figure 2.3 by applying DC (U) and AC (V) voltages as well as a frequency (cosΩt) to 
the ring electrode, thereby creating a dynamic trapping field over a specific mass to 
charge (m/z) range [29].  The dynamic trapping field is depicted mathematically with the 
following equations.  The DC voltage (usually kept at 0) is reflected by a=4zU/mr02Ω2, 
where a is a unitless value comprising:  U, DC voltage; z, charge of the analyte; m, mass 
of the analyte, r, radius of the ion trap; and Ω, rf frequency.  The AC voltage is shown 
mathematically by q=2zV/mr02Ω2, where q is a unitless value comprising:  V, voltage, 
and all other components are the same as above.  In addition, a dampening He gas is 
added to the trap to remove energy from the ions through collisions.  In order to eject and 
thereby detect the trapped ions, the RF voltage is linearly increased to destabilize the 
trajectory of the ions inversely proportional to m/z according to (m/z)eject=4V/0.908 r02Ω2.  
Therefore, ions lighter in mass will be ejected from the trap prior to the heavier ions.  
Once an ion is ejected from the trap, it impinges on a conversion dynode, which 
dislodges many electrons that in turn impinge on an electron multiplier giving an 
intensity signal for a particular m/z value.  The resulting mass spectrum displayed depicts 
the m/z values ejected from the ion trap and their resulting relative intensities.   
This process of trapping ions is known as mass selective instability [29] in 
contrast to the original design of the Paul trap [168] using mass selective detection.  The 
mass selective instability used in the Stafford ion trap [29] allows for faster scan speeds, 
which permits this instrument to function on liquid chromatographic separation time 
scales.  In addition, Stafford et al [29] found that the addition of a low molecular weight 
gas (i.e. helium) improves the resolution, sensitivity, and dynamic range of the LCQ.  By 
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Figure 2.3.  Instability diagram of the three-dimensional ion trap. 
Reprinted Figure 3 from Analytical Biochemistry, Vol. 244, K. R. Jonscher and J. R. 
Yates III, The quadrupole ion trap mass spectrometer--a small solution to a big challenge, 
pages 1-15, Copyright 1997, with permission from Elsevier. 
37 
the addition of He gas, the ions injected into the trap collapse towards the center 
minimizing field imperfections caused by structural errors of the ion trap.  Tandem mass 
spectrometry operates in a similar manner as above, where the AC voltage is set as a 
window of m/z values that destabilizes the trajectory of all other m/z values of either 
lower or higher values except the m/z of interest.  Fragmentation occurs through 
increasing the supplemental RF frequency causing the selected ions to be more energetic, 
colliding with the He gas molecules within the trap.  This creates higher vibrational 
energy states for the selected ion, leading to dissociation of the relatively weaker covalent 
bonds within that ion, yielding fragments of the original ion detected as m/z peaks in the 
MS/MS [169]. 
The following parameters were applied to the LCQ analyses:  nanospray voltage 
of 2.6 kV, heated capillary temperature of 200 °C, and a full mass scan range of 400-
1700.  MS/MS were acquired in a data-dependent mode as follows:  4 MS/MS were 
obtained following every full scan; 5 microscans were averaged for every full MS and 
MS/MS; a 5 m/z isolation width was employed; 35% collision energy was used for 
fragmentation, and the dynamic exclusion was set to 1 with the duration being 3 min in 
length.   
Operation of a linear trapping quadrupole (LTQ) 
The fundamental operation of the LTQ is very similar to the LCQ, especially 
considering both instruments are ion traps.  This instrument was developed by Jae 
Schwartz at Thermo Finnigan (now Thermo Scientific) in 2002 [30].  The principal 
difference between the LCQ (a three-dimensional ion trap) and LTQ (a two-dimensional 
ion trap) is improvements that were made to the mechanical design of the trap itself.  The 
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LTQ has a larger trapping volume for injected ions where the ring electrode has been 
extended in length and broken apart into 4 hyperbolic rods with slits in two for ion 
ejection and subsequent impingement on the conversion dynode.  This is in contrast to 
the LCQ design where the trapping ring electrode is a single piece.  The endcaps of the 
LCQ have been converted into smaller quadrupoles, in which RF and DC voltages are 
applied repelling the ions into the center quadrupole.  The primary advantage to this 
instrument is the increased ion storage space provided by the lengthened trap.  The design 
of the LCQ limited the storage capacity of the ion trap, thereby limiting the dynamic 
range of the instrument, as well as mass accuracy problems arising from space charging 
[30].  Space charging is defined as the effect of over-filling the ion trap with ions, causing 
a repulsive internal force on the ion packet.  This repulsive force leads to ions on the 
outer edges of the packet to eject at a different resonance frequency than the m/z value 
predicts [170].  In other words, the m/z that is detected has a wider ion peak and the m/z is 
higher than the true m/z value for that particular ion leading to lower mass resolution.  An 
example of the increased dynamic range of the LTQ is found in Figure 2.4, which depicts 
a low-abundant ion that could be misinterpreted as noise giving a m/z peak-rich MS/MS.   
The LTQ was operated with a nanospray voltage of 2.6 kV, heated capillary 
temperature of 200 °C, and a full scan m/z range of 400–1700. The data-dependent 
MS/MS mode was operated as follows. Five MS/MS were acquired following every full 
scan and two microscans were averaged for every full MS and MS/MS.  An isolation 
width of 3 m/z was used and 35% relative collision energy was used for fragmentation.  
The dynamic exclusion was set to 1 with an exclusion duration of 3 min.  
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Figure 2.4.  A MS/MS from a low-abundant peptide using the LTQ. 
The peptide, SLDDACIGFIQTK, is from SO3587 a putative transmembrane domain 
hypothetical protein in S. oneidensis.  This peptide was found as singly charged in the 
membrane fraction of a LC-MS/MS experiment.  The top panel is the base peak chrom-
atogram of chromatography step 2 from the experiment and the middle panel is the full 
MS spectrum with a zoomed-in region of the spectrum showing the corresponding intact 
peptide with an m/z value of 1411.78.  The ion was subsequently isolated and fragmented 
yielding the MS/MS of the bottom panel with the respective fragment ions labeled.
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Proteome Bioinformatics 
Due to the hundreds of thousands of MS/MS acquired during the LC-MS/MS 
experiments performed, there is a paramount necessity for the development and 
optimization of bioinformatics platforms to distinguish the identities of the peptide ions 
fragmented, and filter the resulting datasets acquired by removing false identifications, 
also known as false positives.  False identifications are the result of the misidentification 
of a MS/MS, which has a scored value that is greater than the threshold filters.  A false 
negative identification is the result of a true peptide identification that has not scored high 
enough to pass the threshold filters.  To this end, a number of search algorithms were 
assessed and filtering levels for identifications were optimized based on the 
characteristics of both the datasets (i.e. instrumentation platform) and the algorithm’s 
performance for searching MS/MS data. 
The Sequest algorithm 
 Sequest was the first algorithm written to identify peptides fragmented by MS/MS 
[39].  As the performance and speed of both mass spectrometers and liquid 
chromatographic separations increased, the bottleneck to be addressed was computational 
automation of MS/MS identification.  To this end, Sequest was written and published in 
1994 by Jimmy Eng at the University of Washington-Seattle.  This now is part of the 
Bioworks software licensed by Thermo Scientific.  First, Sequest “digests” the provided 
protein FASTA database in silico into peptides based on the enzyme specificity provided 
by the parameters file (i.e. fully tryptic, no enzyme specificity, etc.).  This creates a list of 
possible peptides that are represented in the experimental MS/MS.  Next, Sequest 
generates theoretical MS/MS using the provided digested peptides from the protein 
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database in order to determine identifications of the experimental spectra.  The scoring 
process first determines the number of matching peaks between the two spectra and 
increases the resulting score if the experimental peak identifications comprise a 
consecutive sequence for the peptide.  Next, a cross correlation score (Xcorr) is given 
based on a comparison of the top 500 scoring peptide identifications [39].  The highest 
Xcorr is then compared to the Xcorr of the second best identification and a DeltaCN 
value is given.  The DeltaCN (∆CN) value indicates a confidence in the identification of 
the MS/MS as belonging to the best scoring peptide from the database. 
Sequest is widespread in proteomics; therefore results found in Chapters 3, 4, 5, 6, 
and 7 were all published with this algorithm.  The database used in the searches 
performed in this dissertation can be found in the experimental section of the relevant 
chapter.  The MS/MS spectra from individual RAW files were first converted to 
.mzXML format by using ReAdW software written at the Institute for Systems Biology 
in Seattle, WA (www.systemsbiology.org) and can be downloaded from the SourceForge 
repository (sashimi.sourceforge.net).  Individual spectra were then converted to DTA 
files by mzXML2Other, also from the Institute for Systems Biology.  DTA files are the 
required format for input into Sequest (see Ref. [2]).  The parameters for searching the 
MS/MS data with Sequest are:  enzyme type, trypsin; Parent Mass Tolerance, 3.0; 
Fragment Ion Tolerance, 0.5; up to 4 missed cleavages allowed; and fully tryptic peptides 
only.  The following filter levels were applied to the Sequest search results using the 
algorithms DTASelect and Contrast [171]:  tryptic peptides only, ∆CN value of at least 
0.08, and Xcorr values of at least 1.8 (+1), 2.5 (+2), 3.5 (+3).  These values were chosen 
and described in Chapters 3 and 4 due to the acceptable false discovery rate (FDR) of 
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~2% at the 2-peptide level of protein identification that result from this filter level.  No 
chemical modifications were added to the Sequest searches for Chapters 3, 4, 6, and 7.  
As discussed in detail in Chapter 5, the addition of chemical modifications to a Sequest 
search is cumbersome. 
The DBDigger algorithm 
 The search algorithm DBDigger [44] was written by David Tabb at Oak Ridge 
National Laboratory to help alleviate some of the inflexibilities present in the Sequest 
algorithm.  In addition, the speed at which a search of MS/MS against a protein database 
can be performed using DBDigger on a desktop computer is greater than Sequest.  
DBDigger uses a similar method of scoring experimental MS/MS against a provided 
protein database to the algorithm Sequest.  However, the method of searching by creating 
a theoretical spectrum once for a given set of experimental MS/MS yields the enhanced 
speed provided by this algorithm.  DBDigger also allows for the additional flexibility of 
including an unlimited number of chemical modifications to the search parameters.  This 
permits the ability to start searching for post-translational modifications embedded in the 
MS/MS datasets.  However, there are a number of limitations to this algorithm that are 
discussed in detail in Chapter 5. 
 DBDigger was used as a search algorithm due to the advantages listed above for 
datasets presented in Chapters 5 and 7.  The resulting raw MS/MS files were first 
converted to .ms2 files using the algorithm RAW2MS2 [172] with simple charge state 
assignment accomplished by MS2ZAssign.  The resulting ms2 files were then searched 
against a provided protein database using DBDigger with the MASPIC scorer [173] with 
the following parameters:  digestion sites after K and R; two digestion ends; Parent Mass 
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Tolerance, 3.0; Fragment Ion Tolerance, 0.5; and any PTMs that were specified as 
described in Chapter 5.  DBDigger results files are in the form of .sqt files; which are 
imported into DTASelect for the following filtering rules for unmodified datasets:  2 
peptides required for protein identification, 25 for +1 peptides, 30 for +2 peptides, and 45 
for +3 peptides.  Chapter 5 has a discussion on the optimization of the filtering rules 
when considering DBDigger searches including PTMs.   
The InsPecT algorithm 
 InsPecT was specifically designed to search MS/MS datasets containing PTM 
information [40].  The Bafna group at University of California-San Diego developed this 
algorithm.  This algorithm takes a different approach for searching MS/MS data against a 
provided search database.  The first stage generates a set of three amino acids in length 
tags (25 were specified in the searches performed in this dissertation) using fragment ions 
in the experimental MS/MS and enables a relatively short list of peptides to be searched.  
A list of candidate peptides are scored based on seven different criteria:  the number of 
predicted (1) b and (2) y ions that match to the MS/MS, how well the intensity of the 
identified (3) b and (4) y ions match the predicted intensity, (5) trypsin specificity, (6) the 
length of the candidate matching peptide where the presence of PTM(s) indicates a 
shorter peptide, and (7) the fragment ion profile of the spectrum (presence of an isotope, 
higher fragment ion intensity in the middle of the spectrum, and properties of the 
neighboring residue) [40].  The resulting top score (MQScore) is then compared to the 
distribution of the lower scores (DeltaScore) and a p-value is calculated.  The p-value 
used by InsPecT is based on the p-value devised for the algorithm Peptide Prophet [174].  
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A p-value representing an ~2% FDR is chosen based on the p-value distribution for a 
particular MS/MS dataset as discussed in detail in Chapter 5. 
 An in-house perl script used to automate Sequest searches, gitrseq.pl, was adapted 
for automation of InsPecT searches and named gitrinspect.pl.  The perl script 
gitrinspect.pl operates in a similar manner to gitrseq.pl with a few notable exceptions as 
follows.  Figure 2.5 is a flow chart outlining the procedure of gitrinspect.pl from a 
Xcalibur raw file to a tab-delimitated results file.  The script automates the process from 
raw file to InsPecT results in four stages, creating a queue for each raw file to be searched 
sequentially.  First, the conversion of the .raw file to the .mzXML format is performed 
using the ReAdW software (Institute for Systems Biology), which is the proper file 
format for InsPecT input.  Next, the mzXML file is moved to a sub-folder named 
temp_dir.  Once the mzXML file is in temp_dir, searching and scoring the MS/MS using 
InsPecT is completed.  Finally, the mzXML and the .txt InsPecT results files are removed 
from temp_dir and placed in the directory above (inspect_searches).  Once these files are 
removed, temp_dir is deleted and the loop starts over again and repeated for each raw file 
present in the directory.  This process is necessary due to the limited memory availability 
of the InsPecT algorithm on a desktop computer.  InsPecT attempts to load all MS/MS 
spectra in a given folder to be searched, thus leading to over 100,000 MS/MS being 
loaded into memory.  Feasibly, only one raw file is searched at a time, leading to the 
above necessity of creating a sub-folder to perform the actual InsPecT search.   
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Figure 2.5.  Flow diagram outlining the scheme of the gitrinspect.pl perl script. 
The .RAW files are located in the inspect_searches folder.  Creating the temp_dir folder 
allows InsPecT to search one .mzXML file at a time without overwhelming 
computational capacity on a desktop computer. 
For each .RAW file in the
inspect_searches folder
Create temp_dir
Convert .RAW file to .mzXML format
Save .mzXML file in temp_dir
Search .mzXML file with InsPecT
Save .txt results file in temp_dir
Cut files from temp_dir
Paste files in inspect_searches folder
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Semiquantitation of protein abundance 
There are many different methods of quantifying MS/MS data available; where 
stable isotope labeling [175, 176], isotope-coded affinity tags (ICAT) labeling cysteine 
residues [177, 178], and isobaric tagging for relative and absolute quantification (iTRAQ) 
[178-180] are some of the common examples of relative quantification by changing the 
mass of a peptide from one growth state to compare to a separate growth conditions.  One 
method of absolute quantification is the use of AQUA peptides [181], which are synthetic 
peptides created with heavy isotopes that have the exact amino acid sequence as an 
endogenous peptide of interest.  However, the microbial samples utilized in this 
dissertation were not amenable to the aforementioned methods as discussed in detail in 
Chapter 3.  Thus, the semiquantitation method was used, which takes into account 
reproducible differences in spectra count, peptide count and sequence coverage.  Spectral 
count is the total number of MS/MS identified as encompassing amino acid sequence 
from a particular protein and can be a measurement for relative quantification [182, 183].  
The definition of peptide count is the total number peptides identified for a given protein 
and sequence coverage is the total percent of the protein sequence identified from the 
MS/MS data.  The use of dynamic exclusion does not bias spectra count measurement, 
because all ions that are isolated are placed on the dynamic exclusion list. 
Due to differences in dynamic range discussed in Chapter 4 of this dissertation, 
different quantification parameters are applied for the LCQ and LTQ datasets.  LCQ 
datasets require the following parameters:  >30% change in sequence coverage, >4 
unique peptides identified, and/or at least a 2x difference in spectra count between the 
treated and control samples (adapted from Refs. [184] and [97]).  LTQ datasets require 
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the following semi-quantitation rules applied:  >40% change in sequence coverage, >5 
unique peptides identified, and/or at least a 2x difference in spectra count [147, 158].   
Peptide and protein false discovery rates 
 The peptide false discovery rate (FDR) can be calculated from using a distracter 
database (an unrelated proteome database), a reversed database (all protein sequences 
have been reversed) or a shuffled database (all protein sequences are scrambled).  The 
most popular database types for calculating the peptide FDR are using a reversed 
database or a shuffled database.  The argument for using either one of these two database 
types is both contain nonsense sequences to calculate the FDR.  If the distracter database 
is used, caution must be taken that the homology of the sequences between the true 
database and the distracter database do not result in true identifications from sequences 
comprising the distracter database (i.e. ribosomal proteins, DNA polymerase, etc.).  A 
study by Peng et al [185] describe the formula used to determine the peptide FDR for a 
MS/MS dataset using a reversed database.  The formula is %FDR = 2 * (nrev/ntot * 100), 
where nrev is the number of peptides identified that match the reversed database and ntot is 
the sum of the peptides identified matching the reversed and forward databases [185].  
The basis for multiplying the end value by 2 is the assumption that if a peptide sequence 
score from the reversed database is large enough to pass the filter thresholds then there is 
an incorrect peptide sequence score from the forward database that also was large enough 
to pass the filter threshold. 
 The resulting FDR at the protein level can be much higher (~10-fold) than the 
corresponding peptide FDR, resulting from the MS/MS identification confidence level.  
The protein FDR can be calculated from the peptide FDR as a function of the probability 
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of the possibilities.  Illustrated in Figure 2.6 is the predicted FDR at the protein level 
based on a 2% FDR at the peptide level using the requirement of 2 and 3 peptides for a 
positive identification.  Figure 2.6 displays the equation that determines the FDR for the 
resulting proteins.  For example, the requirement of at least two peptides for protein 
identification leads to four different possibilities and eight total peptide possibilities.  
Applying a 2% peptide FDR corresponding to 98% true identifications, results in a 
protein FDR of 11.5%.  This value agrees with the experimental FDR values found in 
Chapters 3-5.  If a one-peptide requirement were applied to the Figure 2.6 equation, there 
would be two possibilities for both values x and z, yielding a FDR at the protein level to 
be 48%.  This is in agreement with the protein FDRs found in Chapter 4.  The ability to 
predict the protein FDR based on the value of the peptide FDR is helpful in determining 
proper threshold filters to be applied to a MS/MS dataset. 
 However, if for instance the cutoff was 5 or 6 peptides to be required for protein 
identification, the resulting FDR value at the protein level would be 0.9% and 0.64%, 
respectively.  This decreases the resulting protein FDR as a consequence of requiring a 
larger number of true peptide identifications, with the protein FDR no longer of much 
consequence.  These calculations only apply to results from one single MS experiment.  
If a protein is required to be identified from peptides from multiple MS experiments, the 
resulting FDR is even lower than as calculated above.  As an example, the two-peptide 
requirement protein FDR is calculated to be 11.5%, however if the two peptides are 
required to be identified in two MS experiments the resulting FDR is 1.3%.  If the one-
peptide requirement were to be applied to this same scenario leading to one peptide in 
each MS experiment, the resulting protein FDR is now 23%.  Therefore, using  
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Figure 2.6.  Predicted protein FDR based on the peptide FDR classification. 
The values in the equation represent the peptide true discovery rate (y), the total number 
of true and false identification possibilities for the peptide requirement (x), and the total 
number of true and false identification possibilities for a given peptide (z). 
2 peptides required
TT, TF, FT, FF
y = 0.98
x = 4
z = 8
3 peptides required
TTT, TFT, TTF, TFF, 
FTT, FFT, FTF, FFF
y = 0.98
x = 8
z = 24
(0.98)4
8
= 11.5%X 100 (0.98)8
24
= 3.5%X 100
(y)x
z
= protein FDRX 100
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a more stringent filter leads to a total protein FDR lower if the peptide requirements are 
from two MS experiments. 
Conclusions 
 By improving MS sample preparation methods and data mining filter thresholds, 
we achieved a more in-depth proteome that would not have been possible otherwise.  
Through the incorporation of two-dimensional liquid chromatographic separation and the 
improved dynamic range capabilities of the LTQ, the global proteome studies presented 
in this dissertation would not have yielded as much depth into the microbial life 
processes.  In addition, the increased dynamic range of the LTQ provided the ability to 
perform quantification comparisons between cultures of S. oneidensis MR-1 following 
acute and chronic Cr(VI) exposure yielding interesting information on differentially 
expressed proteins that otherwise would be overlooked using other technologies. 
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Chapter 3 
Understanding Global Chromate Response of Shewanella oneidensis MR-1 under 
Acute and Chronic Exposure Using Shotgun Proteomics 
All of the data presented below has been adapted from the following published journal 
articles’ Results and Discussion text sections 
 
Stephen D. Brown, Melissa R. Thompson, Nathan C. VerBerkmoes, Karuna Chourey, 
Manesh Shah, Jizhong Zhou, Robert L. Hettich, and Dorothea K. Thompson.  Molecular 
Dynamics of the Shewanella oneidensis Response to Chromate Stress.  Molecular and 
Cellular Proteomics, 2006; 5, 1054-1071.  Sample preparation, LTQ measurements, and 
data analysis for the proteomics portion of the manuscript were performed by Melissa R. 
Thompson with assistance from Nathan C. VerBerkmoes.  Supplemental material can be 
found at http://compbio.ornl.gov/shewanella_metal_stress/stress. 
 
Karuna Chourey, Melissa R. Thompson, Jennifer Morrell-Falvey, Nathan C. 
VerBerkmoes, Stephen D. Brown, Manesh Shah, Robert L. Hettich, Jizhong Zhou, 
Mitchel Doktycz, and Dorothea K. Thompson.  Global Molecular and Morphological 
Effects of 24-h Chromium Exposure on Shewanella oneidensis MR-1.  Applied and 
Environmental Microbiology, 2006; 72, 6331-6344.  Sample preparation, LTQ 
measurements, and data analysis for the proteomics portion of the manuscript were 
performed by Melissa R. Thompson with assistance from Nathan C. VerBerkmoes on data 
analysis.  Supplemental material can be found at http://compbio.ornl.gov/shewanella_ 
metal_stress/chronic. 
 
 
Introduction 
The global molecular response of Shewanella oneidensis MR-1 to chromate 
exposure was unexplored prior to this dissertation work.  The need to understand both the 
initial response and prolonged exposure to hexavalent chromium [Cr(VI)] in the form of 
chromate (CrO42-) for the purposes of using S. oneidensis as an agent for bioremediation 
has not been examined previously.  The goal of the work presented in this chapter was to 
determine the global protein response in the form of a mass spectrometry based proteome 
dataset to reveal novel proteins that are indicative of Cr(VI) response.  The proteome 
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studies described here impart a global insight into temporal alterations in protein content 
occurring in response to a toxic acute level (1mM) and following long term chronic 
exposure of a lower dosage of chromate (0.3 mM).  The overall protein expression 
pattern of an organism will not change a great deal in response to a particular stimulus; 
however this chapter identifies novel proteins found to be differentially expressed during 
the bacterial response to a sub-lethal dosage of chromate.  The responses identified will 
increase the understanding of possible protein expression mechanisms that allow Cr(VI) 
reduction, detoxification, and adaptation under aerobic growth conditions.  Alterations in 
protein expression were complemented results from the microarray analysis.  However, 
microarray analysis discussion is limited to only where it is relevant to the proteome 
results. 
Materials and Methods 
Preparation of Proteomes for HPLC-MS/MS Analysis 
For the acute chromate shock large scale proteomic characterization, 500-ml 
cultures of S. oneidensis MR-1 in 4-liter flasks (a total of 1 liter of culture for treatment 
and control) were grown to midexponential phase (A600, 0.5) under aerobic conditions and 
then either exposed to a final K2CrO4 concentration of 1 mM or allowed to continue 
growing in the absence of added chromate.  At time points of 45 and 90 min after 
treatment with K2CrO4, cells were harvested from each of the following conditions for 
HPLCMS/MS analysis: 1) Control 1 (untreated midlog phase cells after 45 min of further 
growth), 2) Treatment 1 (45 min post-Cr addition), 3) Control 2 (untreated midlog phase 
cells after 90 min of further growth), and 4) Treatment 2 (90 min post-Cr addition). For 
this, cells were pelleted by centrifugation (5,000 x g for 5 min), resuspended in ice-cold 
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LB medium, washed two times in 50 mM Tris, 10 mM EDTA (pH 7.6), and centrifuged 
at 5,000 x g for 10 min. For the chronic exposure large scale proteome characterization, 
S. oneidensis cells were first adapted for 24 h to chromate by growth in the presence of 
0.3 mM K2CrO4 in a starter culture.  An aliquot of the starter culture was used to 
inoculate fresh media with or without 0.3 mM K2CrO4.  Cells were then incubated for 24 
h and harvested by centrifugation for mass spectrometry analysis.  The S. oneidensis cells 
were then placed on ice and lysed by sonication as detailed in Chapter 2.  Approximately 
2 mg of each proteome fraction (soluble and membrane) prepared from all of the growth 
conditions was denatured and reduced in 6 M guanidine and 10 mM DTT.  Denaturation 
and reduction were followed by an overnight digestion (see Chapter 2).   
LC/LC-MS/MS Analysis 
The proteome fractions (soluble and membrane) prepared from control and 
chromate-treated samples were analyzed in duplicate via two-dimensional (2-D) LC-
MS/MS experiments using an Ultimate HPLC system (LC Packings, a division of 
Dionex, San Francisco, CA) coupled to a linear trapping quadrupole (LTQ) mass 
spectrometer (ThermoFinnigan, San Jose, CA). See Chapter 2 for details of 
chromatographic separation of peptides.  The multiphasic column system was positioned 
in front of the LTQ on a nanospray source (ThermoFinnigan).  All samples were 
analyzed via a 24-h 12-step 2-D analysis consisting of increasing concentration (0–500 
mM) salt pulses of ammonium acetate followed by 2-h reverse phase gradients (see 
Chapter 2 for details).  During the entire chromatographic process, the LTQ was operated 
in a data-dependent MS/MS mode detailed in Chapter 2.  
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Proteome Bioinformatics  
A protein database was created by combining the most recent version of the S. 
oneidensis MR-1 database (Version 8; www.tigr.org/) containing a total of 4,798 
predicted proteins with 36 common contaminants (trypsin, keratin, etc.).  The database 
can be downloaded from the website compbio.ornl.gov/shewanella_metal_stress/ 
databases/.  For all database searches, the MS/MS spectra were searched using Sequest 
(Ref. [39]; ThermoFinnigan) with the following parameters:  enzyme type, trypsin; parent 
mass tolerance, 3.0; fragment ion tolerance, 0.5; up to four missed cleavages allowed; 
fully tryptic peptides only.  The output data files were then filtered and sorted with the 
DTASelect algorithm [171] using the following parameters: fully tryptic peptides only 
with ∆CN of at least 0.08 and cross-correlation scores (Xcorrs) of at least 1.8 (+1), 2.5 
(+2), and 3.5 (+3).  These threshold scores have been tested rigorously in our laboratory 
and provide a high confidence of identification (see Refs. [184] and [65] for more 
discussion) with a maximum false-positive rate of 1–2%.  Post-translational 
modifications and other fixed modifications (i.e. due to addition of iodoacetamide) were 
not included in the search parameters.  DTASelect files are available on the analysis page 
(compbio.ornl.gov/shewanella_metal_stress/) under the corresponding acute shock or 
chronic dataset and are filtered at one peptide and two peptides per protein.  The files are 
presented in a text format or a viewable html version where every identified spectrum can 
be viewed by clicking on the spectral number (first column, labeled by filename).  The 
DTASelect results from all control and chromate-treated samples were then compared 
with the Contrast program [171] for each time point.  These results are located under the 
global contrast heading on the analysis page.  A list was made of all proteins showing a 
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reproducible significant change of at least 40% sequence coverage, five or more unique 
peptides, and/or a reproducible spectral count difference of 2x between the control and 
chromate-treated samples at each time point (adapted from Refs. [184] and [97]). The 
analysis page also contains inter-run contrast files (compares duplicate runs on same 
sample) as well as fractionation comparisons (compares replicate runs of the same 
proteome broken down by fraction).   
Results and Discussion 
Acute Shock Proteome Dataset 
Cellular fractions from each of the four S. oneidensis growth conditions (i.e. 
Control 1, Control 2, Treatment 1, and Treatment 2) were analyzed in duplicate using 2-
D LC-ES-MS/MS with a linear trapping quadrupole mass spectrometer (see Chapter 2 for 
details).  A total of 2,370 of the 4,931 total predicted genes in the S. oneidensis MR-1 
genome were identified with at least two peptides (Table 3.1), representing 48% of the 
theoretical proteome.  Due to the large number of false positives possible at the one-
peptide filter level [65], we present a rigorous analysis of the two-peptide dataset only.  
High stringency filtering was used in this study, giving a maximum false-positive rate of 
1–2%.  The reproducibility between duplicate protein analyses on the LTQ was as 
follows:  78.6% (chromate-shocked) and 78.4% (control) for the 45-min poststress time 
point and 77.7% (chromate-shocked) and 73.5% (control) for the 90-min time point.  This 
level of reproducibility is necessary for semiquantification. Variation is likely due to low 
abundance proteins identified with two peptides in one of the analyses and only one 
peptide in another, thereby being filtered out.  Although previous studies using 2-D 
PAGE and LC-MS/MS have been used for global S. oneidensis proteome studies  
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Table 3.1.  Proteome Analysis of Chromate-Shocked S. oneidensis MR-1 
 
Condition 
No. proteins identified 
1 pepa 
No. proteins identified 
2 pepb 
Av. Sequence 
coveragec 
45 min Control 2610 1911 37.24% 
45 min Shock 2644 1959 37.20% 
90 min Control 2595 1892 36.38% 
90 min Shock 2664 1992 36.45% 
Total 2954 2370  
aTotal proteins identified with at least 1 peptide per protein from duplicate runs.  bTotal proteins 
identified with at least 2 peptides per protein from duplicate runs.  cAverage sequence coverage 
per protein at the 2 peptide level. 
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[25, 97, 186] this study represents, to our knowledge, one of the largest measurement of 
the S. oneidensis proteome published to date.  The entire list of identified proteins with 
total sequence coverage, functional categories, pI, and molecular weight information is 
given in Supplemental Table S2.  No major biases were found between the pI and 
molecular weights of the predicted proteome from the genome and the observed 
proteome (Supplemental Table S2).  The identified proteins with their peptide count 
(number of identified peptides), spectral count (number of MS/MS spectra identified per 
protein), and percent sequence coverage (total percentage of the protein sequence covered 
by tryptic peptides) for the different growth conditions and individual analyses can be 
found in Supplemental Table S3.   
Proteins identified at the two-peptide level were grouped according to the 
functional categories assigned by the J. Craig Venter Institute annotation [formerly The 
Institute for Genomic Research (Ref. [69]; www.tigr.org, Comprehensive Microbial 
Resource)] (Table 3.2).  Proteins with assigned functions in amino acid biosynthesis, 
cellular processes, protein fate, protein synthesis, nucleotide metabolism, and 
transcription were found with greater than 70% identified.  More than 90% of the 
proteins comprising the functional classes of protein synthesis, nucleotide metabolism, 
and transcription were identified, representing an almost complete characterization of 
these categories at the proteome level.  Proteins generally thought to be of lower 
abundance, such as those with assigned functions in signal transduction and 
transcriptional regulation, were identified at levels of 64 and 52%, respectively, of the 
total number of proteins per category.  A total of 624 of the 2,039 predicted hypothetical 
proteins were identified.  Of the 624 proteins in this functional category, 209 were 
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Table 3.2.  Functional Categories of Identified Proteins with at Least Two Peptides  
 
Number Functional Category 
Observed 
Proteome 
Predicted 
Proteome Percent Identified 
1 Amino acid biosynthesis 70 91 76.92% 
2 
Biosynthesis of cofactors, 
prosthetic groups, and carriers 94 121 76.69% 
3 Cell envelope 121 180 67.22% 
4 Cellular processes 188 260 72.31% 
5 Central intermediary metabolism 28 51 54.90% 
6 DNA metabolism 97 144 67.36% 
7 Energy metabolism 199 308 64.61% 
8 
Fatty acid and phospholipid 
metabolism 48 65 73.85% 
9 Hypothetical proteins 624 2039 30.60% 
10 
Mobile and extrachromosomal 
element functions 34 317 10.73% 
11 Protein fate 137 185 74.05% 
12 Protein synthesis 131 141 92.91% 
13 
Purines, pyrimidines, nucleosides, 
and nucleotides 56 62 90.32% 
14 Regulatory functions 104 199 52.26% 
15 Signal transduction 39 61 63.93% 
16 Transcription 49 54 90.74% 
17 Transport and binding proteins 148 274 54.01% 
18 Unknown function 203 379 53.56% 
 Total 2370 4931 48.06% 
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annotated as hypothetical proteins, and 415 were annotated as conserved hypothetical 
proteins.  This represents one of the largest identifications of hypothetical protein 
expression for a microbial proteome to date. 
Although absolute quantification at the global proteome level was not feasible, 
semiquantification of differentially expressed proteins between the chromate-treated and 
control samples could be accomplished by using a combination of percent sequence 
coverage, number of unique peptides, and spectral count from the mass spectra [20, 97, 
184] (see Chapter 2 for details).  Other methods for relative quantification, such as ICAT 
[177], were considered before the method used here was selected.  ICAT labels the 
cysteine residues of a protein, and in S. oneidensis greater than 50% of the predicted 
proteins have two or fewer cysteine residues present.  Moreover almost 20% of the 
predicted proteome does not contain any cysteine residues.  This method would not detect 
almost 70% of the predicted proteome confidently; thus ICAT was not deemed 
appropriate for this study.   
Comparisons were made between the transcriptome and proteome data to 
determine the relationship between gene and protein expression.  However, in this 
dissertation, only the proteome data will be described in detail.  Both up- and down-
regulated proteins were measured by comparing the chromate-shocked cell samples to 
their respective control samples.  Using the semiquantitative criteria discussed above, we 
identified 78 proteins (Supplemental Table S4) as being differentially expressed in 
response to chromate (Tables 3.3 and 3.4, Supplemental Table S4).  Supplemental Table 
S4 divides the proteins identified at 45 min post-shock from the proteins identified at 90 
min post-shock.  We propose that reproducibility of at least 70% between replicate  
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Table 3.3.  Up-Regulated Proteins Identified in the 90 min Chromate-Shocked Sample 
 
Gene Transcriptome Control 1 Control 2 Chrom 1 Chrom 2 Category Description 
SO0343 No changea 20.8 18.3 43.3 45.7 7 aconitate hydratase 1 (acnA) 
SO0423   Inducedb 11.2 0.0 43.6 39.2 14 pyruvate dehydrogenase complex repressor (pdhR) 
SO0798 Induced 0.0 0.0 24.7 21.7 9 conserved hypothetical protein 
SO0934 No change 12.2 55.5 87.8 76.3 9 conserved hypothetical protein 
SO1045 No change 0.0 0.0 22.3 24.5 9 hypothetical protein 
 SO1114c Induced 0.0 0.0 28.3 55.2 18 DNA-damage-inducible protein P (dinP) 
SO1178 No change 11.7 11.3 45.7 41.6 17 magnesium and cobalt efflux (corC) 
 SO1190c Induced 39.0 20.2 55.5 51.8 9 conserved hypothetical protein 
 SO1482c Induced 30.2 28.8 82.7 80.5 17 TonB-dependent receptor, putative 
SO1576 No change 20.7 0.0 39.2 44.6 4 glutathione S-transferase family protein 
 SO1580c Induced 5.0 14.0 29.0 45.3 17 TonB-dependent heme receptor 
SO1755 Induced 22.3 10.6 34.6 49.6 7 
phosphoglucomutase/phosphomannomutase family 
protein 
SO2290 No change 24.9 17.4 49.8 48.0 18 rhodanese domain protein 
 SO2426c Induced 0.0 0.0 37.1 48.1 15 DNA-binding response regulator 
SO2577 No change 6.3 22.3 41.3 48.7 4 septum site-determining protein (minD) 
 SO2912c Induced 38.3 25.9 64.7 55.1 7 formate acetyltransferase (pflB) 
SO2915 Induced 15.5 12.3 49.4 43.6 5 acetate kinase (ackA) 
 SO3030c Induced 12.9 0.0 62.4 66.1 17 siderophore biosynthesis protein (alcA) 
 SO3032c Induced 5.7 0.0 31.4 32.3 17 siderophore biosynthesis protein, putative 
 SO3033c Induced 12.0 6.7 57.6 57.3 17 ferric alcaligin siderophore receptor 
SO3061 Induced 6.1 3.1 31.3 37.9 6 DNA topoisomerase III (topB) 
SO3407 Induced 9.3 8.8 24.7 19.1 9 conserved hypothetical protein 
 SO3462c Induced 0.0 6.0 35.1 34.1 6 DNA repair protein RecN (recN) 
 SO3585c Induced 0.0 0.0 20.1 23.0 4 azoreductase, putative 
 SO3586c Induced 0.0 0.0 60.1 20.3 18 glyoxalase family protein 
SO3599 Induced 12.8 18.5 68.7 64.8 17 sulfate ABC transporter, periplasmic protein (cysP) 
 SO3667c Induced 0.0 0.0 91.9 96.8 9 conserved hypothetical proteind 
SO3669c Induced 9.3 11.6 71.6 77.9 17 heme transport protein (hugA) 
 SO3670c Induced 0.0 0.0 13.5 18.6 17 TonB1 protein (tonB1) 
SO3671 Induced 0.0 0.0 20.4 26.5 17 TonB system transport protein (exbB1) 
 SO3673c Induced 0.0 0.0 63.1 61.2 17 hemin ABC transporter, periplasmic (hmuT) 
 SO3675c Induced 0.0 0.0 72.9 59.0 17 hemin ABC transporter, ATP-binding protein (hmuV) 
SO3723 Induced 0.0 0.0 50.2 29.8 5 adenylylsulfate kinase (cysC) 
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Table 3.3.  Continued 
 
Gene Transcriptome Control 1 Control 2 Chrom 1 Chrom 2 Category Description 
SO3726 Induced 22.1 7.8 49.7 49.3 5 sulfate adenylyltransferase, subunit 1 (cysN) 
SO3727 Induced 38.7 20.2 68.5 68.5 5 sulfate adenylyltransferase, subunit 2 (cysD) 
SO3737 Induced 30.8 22.1 62.1 73.3 5 sulfite reductase (NADPH) hemoprotein (cysI) 
SO3738 Induced 5.9 0.0 30.8 27.3 5 sulfite reductase (NADPH) flavoprotein (cysJ) 
SO3907 No change 0.0 0.0 48.1 60.0 9 conserved hypothetical protein 
 SO3913c Induced 0.0 0.0 27.2 32.6 9 conserved hypothetical protein 
 SO3914c Induced 18.5 15.8 68.1 67.8 17 TonB-dependent receptor, putative 
SO4077 Induced 14.5 14.0 36.7 37.1 17 TonB-dependent receptor, putative 
SO4516 Induced 0.0 8.8 37.7 32.6 17 ferric vibriobactin receptor (viuA) 
SO4523 Induced 39.4 50.5 70.8 74.4 17 iron-regulated outer membrane virulence (irgA) 
 SO4651c Induced 0.0 0.0 41.4 77.6 9 conserved hypothetical protein 
 SO4652c Induced 0.0 0.0 46.6 62.0 17 sulfate ABC transporter, periplasmic (sbp) 
 SO4655c Induced 0.0 0.0 54.5 55.1 17 sulfate ABC transporter, ATP-binding (cysA-2)  
SO4743 Induced 50.9 49.9 71.7 67.7 17 TonB-dependent receptor, putative 
SOA0042 No change 0.0 0.0 46.9 46.3 9 hypothetical protein 
aNo change in expression at the 90 min time point in the microarray analysis.  No change defines a gene that was found to not 
have an induction or repression of expression at any time point on the microarray.  bInduced defines a gene that exhibited at 
least two-fold induction at the 90 min time point.  cProteins also found to be up-regulated in the 45 min chromate-exposure 
samples.  dThe functional annotation of SO3667 was revised recently to a heme iron utilization protein, HugZ [187]. 
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Table 3.4.  Down-Regulated Proteins Identified in the 90 min Chromate-Shocked Samples 
 
Gene Transcriptome Control 1 Control 2 Chrom 1 Chrom 2 Category Description 
SO0398   Represseda 42.4 18.1 0.0 4.6 7 fumarate reductase flavoprotein subunit (frdA) 
SO0404 Repressed 78.8 77.9 55.4 57.2 9 hypothetical protein 
SO0548 Repressed 70.0 76.7 47.8 51.1 6 DNA-binding protein, HU family 
SO0847 Induced 45.9 28.7 0.0 0.0 7 iron-sulfur cluster-binding protein (napG) 
 SO0848b  Inducedc 73.2 52.9 43.8 46.1 7 periplasmic nitrate reductase (napA) 
SO0902 Repressed 49.8 37.5 26.5 18.4 7 NADH:ubiquinone oxidoreductase,  (nqrA-1) 
SO0970 Repressed 59.9 57.4 34.7 34.9 7 fumarate reductase flavoprotein subunit precursor 
SO1111 Repressed 75.8 70.1 35.7 42.7 17 bacterioferritin subunit 2 (bfr2) 
SO1405   No changed 40.1 31.4 11.1 0.0 18 transglutaminase family protein 
SO1429 No change 42.8 26.8 0.0 0.0 7 anaerobic dimethyl sulfoxide reductase, A (dmaA-1) 
SO1430 No change 31.2 36.2 0.0 0.0 7 anaerobic dimethyl sulfoxide reductase, B (dmsB-1) 
SO1490 Repressed 67.3 70.2 27.2 39.8 7 alcohol dehydrogenase II (adhB) 
SO1518 Repressed 80.4 81.5 48.1 52.4 9 conserved hypothetical protein 
SO1776 Repressed 48.5 41.9 25.7 31.0 3 outer membrane protein precursor (mtrB) 
SO1777 Repressed 8.7 6.9 0.0 0.0 7 decaheme cytochrome c MtrA (mtrA) 
SO1778 Repressed 43.4 55.1 25.0 25.2 7 decaheme cytochrome c (omcB) 
SO1779 Repressed 51.8 53.5 26.7 29.9 7 decaheme cytochrome c (omcA) 
SO2469 Repressed 22.1 24.7 10.0 12.1 18 conserved hypothetical protein 
SO2490 Repressed 51.8 66.9 33.5 28.9 14 transcriptional regulator, RpiR family 
 SO2929b Repressed 73.8 73.0 36.3 40.0 9 hypothetical protein 
 SO3538b Repressed 46.9 34.7 0.0 0.0 14 transcriptional regulator HlyU (hlyU) 
SO3565 Repressed 72.0 59.9 36.8 39.6 13 2,3-cyclic-nucleotide 2-phosphodiesterase (cpdB) 
SO3920 Repressed 21.7 27.6 0.0 0.0 7 periplasmic Fe hydrogenase, large subunit (hydA) 
SO3967 No change 71.6 56.4 23.0 24.5 17 molybdenum ABC transporter, periplasmic protein 
 SO4513b No change 44.3 36.2 3.3 3.5 7 formate dehydrogenase, alpha subunit 
SO4561 No change 37.7 47.4 0.0 0.0 9 conserved hypothetical protein 
aRepressed is a gene exhibiting at least two-fold repression at the 90 min time point.  bProteins down-regulated in both the 45 
and 90 min chromate-exposure experiments.  cInduced is a gene exhibiting at least two-fold induction at the 90 min time point.  
dNo change in expression at the 90 min time point in the microarray analysis. 
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analyses at the protein level is necessary for a successful determination of differentially 
expressed proteins where a protein must be detected in both of the replicate analyses to 
be included as a candidate for semiquantification.  For the 45-min chromate treatment 
analysis, a total of 24 proteins were found to be up-regulated with six additional proteins 
being down-regulated relative to the control sample (Supplemental Table S4).  The genes 
for 23 of these 24 up-regulated proteins showed corresponding induction levels at the 30- 
and 60-min time points based on microarray hybridization.  A putative formate 
acetyltransferase (encoded by pflB), which was identified as being up-regulated at the 
protein level, was found to be induced at the transcript level at the 30-min treatment time 
but repressed at the 60-min time point.  The subset of proteins identified as up-regulated 
were dominated by species (12 total) assigned to the functional category of transport and 
binding proteins and included TonB-dependent receptors, siderophore biosynthesis 
proteins, heme transport proteins, and TonB1.  Proteins classified as hypothetical were 
also dominant with a total of six conserved hypothetical proteins identified as up-
regulated.  For the six proteins down-regulated in the 45-min shocked sample relative to 
the control condition, five were found to be repressed at the mRNA level by microarray 
analysis, and the other protein, a hypothetical protein (SOA0141), revealed no change at 
the transcript level.  Proteins that were measured as being down-regulated in the 45-min 
chromate-shocked samples consisted of three hypothetical proteins (SO1124, SO2929, 
and SOA0141), a periplasmic nitrate reductase (NapA), a transcriptional regulator 
(HlyU), and the α subunit of formate dehydrogenase (SO4513).   
Proteomic analysis of the 90-min chromate treatment samples revealed 48 up-
regulated proteins and 26 down-regulated proteins relative to the control sample 
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(Supplemental Table S4 and Tables 3.3 and 3.4).  After 90 min of chromate exposure, 39 
of the 48 proteins up-regulated under Cr(VI) conditions also were induced at the 
transcript level as identified by microarray analysis.  Nine of the up-regulated proteins 
(AcnA, SO0934, SO1045, CorC, SO1576, SO2290, MinD, SO3907, and SOA0042) 
revealed no significant change (p <0.05) in expression at the transcription level, and two 
of the proteins (AcnA and SO2290) expressed at higher abundance levels under chromate 
stress conditions did not exhibit a change in their mRNA expression levels at the 90-min 
time point but did at earlier time points (5, 30, and 60 min).  Of the 48 up-regulated 
proteins, 19 proteins were from the transport and binding category, six proteins were 
from central intermediary metabolism, and 10 were annotated as hypothetical proteins.  
All of the transport and binding proteins identified as up-regulated in the 45-min 
chromate-shocked samples were also identified as up-regulated in the 90-min samples, 
whereas only four of the six conserved hypothetical proteins showed up-regulation at 
both postexposure time points.   
Eighteen of 26 proteins down-regulated 90 min after chromate addition were also 
repressed at the transcript level.  Of the remaining down-regulated proteins, five showed 
no change at the mRNA level, one protein of which was found to exhibit no mRNA 
change at the 90-min time point.  Two down-regulated proteins (NapG and NapA) were 
found to be induced at the transcript level.  Four of the six proteins down-regulated at the 
45-min time point were also repressed at 90 min.  The transcriptome data revealed an 
increase in the number of down-regulated energy metabolism genes over time in response 
to chromate.  This trend was also reflected in the proteomic data in which 13 proteins 
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with functions in energy metabolism were identified as repressed at the 90-min time point 
relative to the 45-min interval. 
Differences between the transcriptomic and proteomic responses of S. oneidensis 
to chromate shock are due to the stringency of filtering used in the proteome study and 
inherent measurement differences between microarray versus proteome technology.  
Supplemental Table S5 demonstrates the correlation of the identified and/or differentially 
expressed proteins to the top 100 mRNAs induced at each time point.  The list is 
composed of a total of 194 mRNAs, which is a concatenated list representing the top 100 
mRNAs at each time point (initial list was 400 genes in total before removal of redundant 
genes).  A total of 67% of the genes in Supplemental Table S5 did not meet the 
differential criteria at the protein level where 45% were not identified by mass 
spectrometry and another 22% were not considered differentially expressed.  The 67% of 
genes found not to meet differential expression criteria corresponds to 130 genes of 194, 
which is comparative in percentage to the total global analysis. 
As revealed by transcriptome and proteome analyses, a major feature of the 
molecular response of S. oneidensis MR-1 to acute chromate challenge was the 
differential regulation of the TonB1-ExbB1-ExbD1 complex, an integral inner membrane 
system for iron transport, as well as other genes involved in exogenous iron acquisition.  
Genes that were highly induced based on time series microarray experiments and were 
identified as up-regulated proteins at the 45- and/or 90-min chromate treatment 
conditions (Table 3.3) included two putative siderophore biosynthesis proteins (AlcA and 
SO3032), a ferric alcaligin siderophore receptor (SO3033), HugA heme transport protein 
(SO3669), TonB1 (SO3670), a putative TonB-dependent receptor (SO3914), a TonB-
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dependent heme receptor (SO1580), ViuA (SO4516), and HmuT (SO3673) and HmuV 
(SO3675) of the hemin ABC transporter.  Wang and Newton [188] demonstrated that 
mutants harboring a deletion of the tonB-trp region of the E. coli chromosome were 
sensitive to chromic ion (Cr3+) due to defective iron transport systems, and residual iron 
uptake by these strains was shown to be inhibited by chromic ion.  Regulation of iron 
homeostasis is primarily carried out by the Fur protein (for a review, see Ref. [189]).  It 
has been suggested previously that iron uptake regulation may not be the only function of 
Fur but that it may also serve to sequester iron to prevent the generation of highly 
reactive hydroxyl radicals via Fenton reactions [190].  The putative MR-1 ferritin genes, 
but not bacterioferritin genes, were induced in response to chromate, and these respective 
iron storage proteins have been suggested to have roles in short term iron flux and long 
term iron storage in E. coli [191].   
In addition to iron transport genes, our global analyses demonstrated that CysP, 
CysC, CysD, CysN, CysI, CysJ, Sbp, and CysA-2 are up-regulated at both the mRNA 
and protein levels in response to chromate treatment (Table 3.3).  The enhanced 
expression of genes encoding proteins involved in sulfate transport and assimilatory 
sulfate metabolism suggests the possibility of chromate-induced sulfur limitation in S. 
oneidensis, perhaps through competitive inhibition of sulfate uptake by chromate, as has 
been shown previously [149, 151].  Partial reduction of Cr(VI) to Cr(V) produces ROS 
[126, 140, 143], leading to chromate-mediated oxidative stress.  Researchers working 
with a number of different bacteria have observed induction of genes involved in sulfur 
and iron homeostasis following different oxidative stresses [192-195].  A variety of 
explanations have been proposed including disruption of intracellular redox cycling 
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leading to insufficient sulfite reduction, a reduction in cysteine biosynthesis correlated 
with cell envelope damage and subsequent leakage of sulfide [196], and increased 
demand for low molecular weight protective thiol-containing compounds such as 
glutathione [197].  Alternatively induction of genes involved in sulfur metabolism and 
iron sequestration might represent an adaptive response to sulfur and iron limitation in 
MR-1 following chromate exposure. 
One of the potentially interesting findings to emerge from this integrated global 
investigation was the co-regulated expression of a cluster of three genes (so3585, so3586, 
and so3587) at both the mRNA and protein levels.  All three genes are transcribed in the 
same direction on the MR-1 chromosome and show a similar transcriptional profile in 
response to chromate with the peak in up-regulated expression occurring at the 30-min 
time point.  The proteins encoded by two of these genes (so3585 and so3586) were 
detected in the chromate-treated samples only (Table 3.3), suggesting that expression of 
SO3585 and SO3586 were differentially regulated in response to chromate stress 
conditions.  By contrast, hypothetical protein SO3587 was found in both the control and 
chromate-shocked samples at the two-peptide level (Supplemental Table S3) even though 
the gene encoding this protein was shown to be up-regulated over the entire time course 
in response to chromate stress.  In addition, SO3587 was found only in the membrane 
fractions, and a hydrophobicity plot analysis using the computer program SOSUI [198] 
identified a putative transmembrane domain (IGIALIFADVSLYLAYFFVGLGV) in 
SO3587.  SO3585 and SO3586 were detected in both the soluble and membrane 
fractions.  Based on their proximity in genome location and co-regulated expression 
profile within the context of chromate stress, we predict that SO3585, SO3586, and 
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SO3587 function together as a protein complex associated with the cell membrane and 
play an important role in the response of the cell to chromate toxicity.   
S. oneidensis SO3585 and SO3586 are annotated as a putative azoreductase and 
glyoxalase family protein, respectively [69].  Glyoxalase systems are known to serve as 
key detoxification routes for preventing the intracellular accumulation of methylglyoxal, 
a natural metabolite with toxic electrophilic properties (for a review, see Ref. [199]).  
Azoreductases are responsible for the reductive cleavage of azo dyes, synthetic organic 
colorants used extensively in the textile, food, and cosmetics industries.  Synthetic azo 
dyes are not readily reduced under aerobic conditions and are considered pollutants.  
Protein database searches using BLAST Version 2.2.12 [200] with the derived SO3585 
primary sequence revealed ~28% sequence identity with P. putida ChrR and E. coli YieF, 
two soluble flavoproteins that have been demonstrated to exhibit chromate reductase 
activity [128, 138, 201].  Regions of conservation in the derived amino acid sequence of 
SO3585 included the characteristic signature, LFVTPEYNX 6LKNAIDX 2S (conserved 
residues in SO3585 are underlined), of the NADH_dh2 family of NAD(P)H 
oxidoreductases (Ref. [201]; results not shown).  Recently further investigation 
demonstrated that the P. putida ChrR functions as a quinone reductase and minimizes 
oxidative stress induced by intracellular H2O2, which is generated during the course of 
chromate reduction [202].  An MR-1 strain carrying an in-frame deletion mutation in the 
so3585 locus has been created, and future studies will characterize it to gain insight into 
the functional role of SO3585 and to assess the importance of azoreductase in the S. 
oneidensis response to chromate. 
69 
Nine proteins (SO0798, SO0934, SO1045, SO1190, SO3667, SO3907, SO3913, 
SO4651, and SOA0042) annotated as hypothetical or conserved hypothetical met our 
criteria of significance for differential expression and were identified as being up-
regulated in response to chromate exposure at the 45- and/or 90-min time points (Table 
3.3).  For four of these unknown or conserved unknown proteins (SO0934, SO1045, 
SO3907, and SOA0042), we observed no significant change in expression at the mRNA 
level, suggesting post-transcriptional regulation of these proteins in response to chromate.  
Our integrated transcriptome and proteome study implicates these differentially regulated 
proteins of unknown function in the initial response of MR-1 to toxic chromate, thus 
revealing gene candidates for future functional analysis. 
A recent study by Kolker et al. [187] analyzed expression for a subset of 538 
hypothetical proteins that were confidently identified in S. oneidensis MR-1 as a result of 
large scale microarray and proteomic analyses of cell samples generated under different 
growth conditions.  A total of 788 hypothetical proteins have been identified based on the 
study by Kolker et al. [187] and the present study: 368 of these functionally undefined 
proteins were found in both studies, 170 were found only by Kolker et al. [187], and 256 
were found only in this study (Supplemental Table S6).  The 368 hypothetical proteins 
identified independently by both studies should be considered as expressed proteins, and 
their annotations should be changed to unknown or conserved unknown [184].  Most of 
these proteins were found under all growth conditions and identified in most of the 
replicates.  Differences between the datasets revealed by this proteomic study and the one 
reported by Kolker et al. [187] are likely due to differences in the growth conditions 
used.   
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Chronic Exposure Proteome Dataset 
Proteome measurements using LC/LC-MS/MS were taken to characterize the 
response of S. oneidensis MR-1 at the 24-h time point following initial exposure to 0.3 
mM chromate.  At this time point of sampling the proteome for differentially expressed 
proteins, the bacterium is no longer in the presence of Cr(VI) and is now presumably 
resuming growth with cytoplasmic Cr(III).  Gene and protein expression profiles of cells 
exposed to chromate were compared to those of untreated control cells grown in parallel 
(see Chapter 2 for experimental details).  The microarray data will only be presented in 
this section if the dataset pertains to results obtained by the proteome measurements.  At 
the protein level, a total of 2,313 gene products, representing 47% of the predicted MR-1 
proteome, were identified at the two-peptide level in duplicate analyses of control 
samples and samples exposed to chromate for 24 h (Table 3.5).  A total of 3,051 proteins 
were identified using the less stringent one-peptide filter level; however, a one-peptide 
filter level for the identification of proteins results in a dramatically higher false-positive 
discovery rate [65], so a thorough analysis of only the two-peptide data is presented here.  
The levels of reproducibility between replicate analyses of the control proteome and the 
experimental (chromate-treated) proteome on the LTQ instrument were 75.6% and 
77.2%, respectively.  For the observed proteome identified in this study, 109 protein 
species were found to be differentially expressed under prolonged Cr(VI) exposure, with 
56 proteins displaying increased abundance and 53 showing decreased abundance (Table 
3.5).  Supplementary proteome data (i.e., a list of the complete raw and filtered proteome 
data and a list of differentially expressed proteins) can be accessed online at 
compbio.ornl.gov/shewanella_metal_stress/chronic/. 
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Table 3.5.  Functional Distribution of the Observed and Predicted MR-1 Proteomes 
 
Functional Category (no.) Observed Predicted Percentage 
Up-
regulated 
Down-
regulated 
Amino acid biosynthesis (1) 72 91 79.1% 4 0 
Biosynthesis of cofactors, prosthetic 
groups, and carriers (2) 95 121 78.5% 0 1 
Cell envelope (3) 115 180 63.9% 3 5 
Cellular processes (4) 175 260 67.3% 0 7 
Central intermediary metabolism (5) 28 51 54.9% 3 0 
DNA metabolism (6) 84 144 58.3% 5 0 
Energy metabolism (7) 205 308 66.6% 1 5 
Fatty acid and phospholipid 
metabolism(8) 45 65 69.2% 0 0 
Hypothetical proteins (9) 633 2039 31.0% 20 20 
Mobile and extrachromosomal element 
functions (10) 45 317 14.2% 14 0 
Protein fate (11) 131 185 70.8% 2 4 
Protein synthesis (12) 128 141 90.8% 0 1 
Purines, pyrimidines, nucleo-sides, and 
nucleotides (13) 58 62 93.5% 1 1 
Regulatory functions (14) 104 199 52.3% 0 2 
Signal transduction (15) 34 61 55.7% 0 0 
Transcription (16) 45 54 83.3% 0 0 
Transport and binding  (17) 126 274 46.0% 0 5 
Unknown function (18) 190 379 50.1% 3 2 
Total 2313 4931 46.9%   
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Proteins identified at the two-peptide level under the two different growth 
conditions were organized in Table 3.5 according to the functional categories assigned by 
the J. Craig Venter Institute [formerly The Institute for Genomic Research (see 
www.tigr.org; Comprehensive Microbial Resource)].  Using multidimensional HPLC-
MS/MS, we identified more than 75% of the predicted MR-1 proteins for the following 
five functional categories:  amino acid biosynthesis; biosynthesis of cofactors, prosthetic 
groups, and carriers; protein synthesis; purines, pyrimidines, nucleosides, and 
nucleotides; and transcription.  Under 24-h Cr(VI) exposure, more proteins were 
identified in the functional categories of amino acid biosynthesis; biosynthesis of 
cofactors, prosthetic groups, and carriers; purines, pyrimidines, nucleosides, and 
nucleotides; and protein synthesis than were found under the corresponding control 
condition (Table 3.5). 
Sequence analysis of the MR-1 genome revealed the presence of an integrated 
lambda-like phage (LambdaSo; 51,857 bp) and two phylogenetically distinct phages 
related to the E. coli mu (MuSo1 [34,551 bp] and MuSo2 [35,666 bp]) [69].  The 
lambdalike phage genome is also present in MR-1 in a nonintegrated form [69].  There 
are 75, 42, and 53 open reading frames (ORFs) annotated as LambdaSo, MuSo1, and 
MuSo2 genes, respectively [69].  A previous study focusing on S. oneidensis MR-1 
demonstrated the induction of a large number of prophage-related genes in response to 
UV radiation, particularly those genes from the integrated LambdaSo genome, and the 
presence of phage particles in UV-irradiated MR-1 cultures [192].  Based on 
transcriptome analysis, the genomic response of MR-1 to ionizing radiation (40 Gy) was 
found to be very similar to its response to UV radiation [203].  Similarly, we observed the 
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strong induction of numerous prophage-related genes in MR-1 cells exposed to chromate 
for 24 h (see supplemental Table S1 at compbio.ornl.gov/shewanella_metal_stress/ 
chronic/supplemental; Table 3.6), suggesting that prolonged Cr(VI) exposure and/or the 
accumulation of intracellular chromium may induce the lytic cycle of lysogenic 
bacteriophage in MR-1.  Overall, 16 (21%), 2 (5%), and 10 (19%) ORFs annotated as 
LambdaSo, MuSo1, and MuSo2 genes, respectively, were significantly induced (more 
than twofold; P < 0.05) in response to prolonged Cr(VI) exposure.  This molecular 
response was in striking contrast to the differentially expressed genes/proteins 
characterizing the cellular response to a 90-min acute 1 mM chromate challenge, during 
which a very small subset of predicted prophage genes (i.e., six) displayed a moderate 
two- to fourfold induction [147]. 
Gene products for 14 ORFs with annotations corresponding to mobile and 
extrachromosomal element functions were confidently identified as being up-regulated in 
response to prolonged Cr(VI) treatment based on both microarray analysis and 
multidimensional HPLC-MS/MS (Table 3.6).  Ten of these 14 proteins were encoded in 
the LambdaSo genome, whereas 1 and 2 gene products were annotated as prophage 
MuSo1 and MuSo2 proteins, respectively.  The majority of these genes encoded such 
prophage structural proteins as minor and major tail proteins, tail assembly components, 
and the major head subunit (Table 3.6).  Six additional ORFs (SO2941, SO2969, 
SO2973, SO2978, SO2985, and SO3006) with prophage LambdaSo-related functions 
displayed significant increases (more than twofold; P < 0.05) in mRNA expression (see 
Supplemental Table S1 at compbio.ornl.gov/shewanella_metal_stress/chronic/).  The 
corresponding proteins for those genes were detected only under Cr(VI) conditions by  
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Table 3.6.  Relative Expression of Up-regulated mRNA and Corresponding Proteins in Response to 24-h Chromate Exposure 
 
Control 24-h chromate exposure 
Gene Gene product (functional category no.e) 
Transcriptomics 
[Cr(VI)/ 
Con ratio]a 
% 
Coverageb 
No. of unique 
peptides/ 
proteinc 
Avg no. 
of 
spectrad 
% 
Coverage 
No. of unique 
peptides/ 
protein 
Avg no. 
of 
spectra 
SO0401 
Alcohol dehydrogenase, zinc containing 
(7) 1.2 0.0 0 0 45.1 9 11 
SO0644 
Prophage MuSo1 DNA transposition 
protein (10) 11.9 0.0 0 0 72.4 15 25 
SO0795 Conserved hypothetical protein (9) 0.80 5.9 2 1 49.7 16 16.5 
SO2654 Putative transposase (10) 1.5 0.0 0 0 36.9 19 16 
SO2655 
Prophage MuSo2 DNA transposition 
protein (10) 3.6 16.0 3 2 57.5 18 57.5 
SO2660 Conserved hypothetical protein (9) 14.1 32.5 5 6 83.5 24 145 
SO2663 Conserved hypothetical protein (9) 8.5 0.0 0 0 58.7 12 36 
SO2667 Conserved hypothetical protein (9) 19.7 0.0 0 0 48.0 8 10 
SO2673 Hypothetical protein (9) 10.8 0.0 0 0 55.4 8 7.5 
SO2685 
Putative prophage MuSo2 major head 
subunit (10) 24.5 22.7 3 2 51.8 12 17.5 
SO2688 Hypothetical protein (9) 24.5 0.0 0 0 42.0 10 6.5 
SO2834 
Anaerobic ribonucleoside-triphosphate 
reductase, NrdD (13) 1.9 16.6 8 8 37.2 20 30 
SO2940 
Prophage LambdaSo host specificity 
protein J (10) 5.4 3.7 2 1 49.6 49 107 
SO2942 Hypothetical protein (9) 42.4 0.0 0 0 59.6 11 19 
SO2944 Hypothetical protein (9) 44.7 0.0 0 0 65.3 26 96.5 
SO2945 Hypothetical protein (9) 129.8 26.6 4 6.5 67.8 15 78 
SO2946 Hypothetical protein (9) 37.2 0.0 0 0 58.0 10 65.5 
SO2948 
Prophage LambdaSo tail assembly 
protein K (10) 23.7 0.0 0 0 51.9 8 7.5 
SO2949 
Prophage LambdaSo minor tail protein L 
(10) 5.6 0.0 0 0 50.6 10 23.5 
SO2950 Hypothetical protein (9) 10.9 0.0 0 0 53.4 9 23.5 
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Table 3.6.  Continued 
 
Control 24-h chromate exposure 
Gene Gene product (functional category no.e) 
Transcriptomics 
[Cr(VI)/ 
Con ratio]a 
% 
Coverageb 
No. of unique 
peptides/ 
proteinc 
Avg no. 
of 
spectrad 
% 
Coverage 
No. of unique 
peptides/ 
protein 
Avg 
no. of 
spectra 
         
         
SO2951 Hypothetical protein (9) 48.5 16.9 5 4 69.2 41 172.5 
SO2952 
Prophage LambdaSo minor tail protein M 
(10) 28.6 0.0 0 0 82.0 6 14.5 
SO2953 
Prophage LambdaSo tail length tape 
measure protein H (10) 33.4 4.2 2 2 58.5 51 74 
SO2955 Conserved hypothetical protein (9) 74.9 14.0 1 1.5 46.3 7 20 
SO2956 
Prophage LambdaSo major tail protein V 
(10) 61.9 0.0 0 0 80.9 8 57.5 
SO2963 
Prophage LambdaSo major capsid protein, 
HK97 family (10) 168.0 36.6 12 13 80.8 32 183.5 
SO2964 ClpP protease family protein (11) 57.7 0.0 0 0 23.6 7 11 
SO2965 
Prophage LambdaSo portal protein, HK97 
family (10) 106.0 14.8 2 1 41.9 14 16 
SO2979 Hypothetical protein (9) 11.7 0.0 0 0 45.0 7 8.5 
SO2980 Hypothetical protein (9) 8.9 0.0 0 0 69.1 11 12.5 
SO2988 Conserved hypothetical protein (9) 4.2 69.2 7 6.5 95.3 23 84.5 
SO2993 
Putative prophage LambdaSo type II DNA 
modification methyltransferase (10) 3.3 0.0 0 0 67.2 19 42.5 
SO3001 Hypothetical protein (9) 8.4 0.0 0 0 80.6 9 28 
SO3004 
Putative prophage LambdaSo DNA 
modification methyltransferase (10) 2.4 0.0 0 0 68.2 21 51.5 
SO3008 Hypothetical protein (9) 2.0 0.0 0 0 56.2 6 10.5 
SO3013 
Site-specific recombinase, phage integrase 
family (6) 1.4 0.0 0 0 24.3 11 10.5 
SO3019 
Anthranilate synthase component I, TrpE 
(1) 1.3 5.9 2 1 45.6 19 32 
SO3020 Glutamine amidotransferase, TrpG (1) 2.5 0.0 0 0 51.0 6 8.5 
SO3022 Isomerase, TrpC/F (1) 1.6 13.0 5 2.5 45.2 19 33.5 
SO3061 DNA topoisomerase III, TopB (6) 1.3 8.0 3 3 37.9 18 16 
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Table 3.6.  Continued 
 
Control 24-h chromate exposure 
Gene Gene product (functional category no.e) 
Transcriptomics 
[Cr(VI)/ 
Con ratio]a 
% 
Coverageb 
No. of unique 
peptides/ 
proteinc 
Avg no. 
of 
spectrad 
% 
Coverage 
No. of unique 
peptides/ 
protein 
Avg 
no. of 
spectra 
SO3183 
Perosamine synthetase-related protein 
(18) 3.3 12.7 3 2.5 46.8 10 12.5 
SO3185 Polysaccharide biosynthesis protein (3) 3.4 9.5 2 1 55.9 12 14.5 
SO3189 Polysaccharide biosynthesis protein (3) 2.2 28.2 7 9 70.9 18 34.5 
SO3315 
Conserved hypothetical protein 
TIGR00048 (9) 0.80 0.0 0 0 36.5 10 9.5 
SO3726 
Sulfate adenylyltransferase, subunit I, 
CysN (5) 2.4 14.7 3 4 45.9 14 22.5 
SO3727 
Sulfate adenylyltransferase, subunit 2, 
CysD (5) 2.2 16.6 4 2.5 54.6 11 23.5 
SO3737 
Sulfite reductase (NADPH) hemoprotein 
beta component, CysI (5) 2.1 3.7 2 1 45.7 17 27 
SO3797 Peptidase, U32 family (11) 1.0 0.0 0 0 28.1 10 10.5 
SO4265 
Type I restriction-modification system, M 
subunit, HSdM-2 (6) 1.1 22.9 6 6.5 52.9 17 20.5 
SO4309 
Diaminopimelate decarboxylase, LysA 
(1) 0.70 11.1 3 2 46.4 11 16.5 
SO4343 Aminotransferase, class V (18) 1.7 0.0 0 0 59.3 14 24 
SO4686 
NAD-dependent epimerase/dehydratase 
family protein (3) 1.1 0.0 0 0 50.1 10 7 
SOA0003 
Putative type II restriction endonuclease 
(6) 0.70 16.7 3 1.5 50.9 17 23 
SOA0004 
Type II DNA modification 
methyltransferase (6) 0.90 13.0 4 4 54.9 24 44 
SOA0160 Putative esterase (18) 0.70 30.5 6 7.5 63.4 11 21 
aRelative gene expression (induction) is presented as the mean ratio of the fluorescence intensity of Cr(VI)-exposed cells to 
control cells.  bTotal sequence coverage from replicate analyses.  cTotal number of unique peptides identified per protein from 
replicate analyses.  dAverage number of spectra identified per protein from replicate analyses.  eFrom Table 3.5. 
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HPLC-MS/MS analysis but failed to meet our filtering criteria for determining 
differential expression (see Chapter 2 and Supplemental Table S2):   
SO2941 (~20% sequence coverage), SO2969 (protein not detected), SO2973 
(~8.2%), SO2978 (~20%), SO2985 (~15%), and SO3006 (~15%).  The genes encoded a 
putative LambdaSo-associated lysozyme (SO2973; 1,053.6-fold), tail assembly protein I 
(SO2941; 366.5-fold), a putative holin (SO2969; 49.2-fold), a sitespecific recombinase 
(SO2978; 23.8- fold), replication protein O (SO2985; 4.4-fold), and a type II DNA 
modification methyltransferase (SO3006; 3.8-fold).  Other up-regulated prophage-related 
genes had predicted functions in virion morphogenesis (SO2690; 65.6-fold), DNA 
transposition (SO0644; 11.9-fold; SO2655; 3.6-fold) and circulation (SO2698; 4.1-fold), 
positive regulation of late transcription (SO2668; 16.7-fold), baseplate (SO2700; 4.3-
fold) and tail assembly (SO2699, 10.3-fold; SO2704, 17.2-fold), and assembly of the 
major head subunit (SO0675; 5.9-fold; SO2685; 24.5-fold), as well as assembly of other 
structural components (SO2681, 6.2-fold; SO2684, 6.8-fold) (see supplemental Table 
S1). 
 Of the differentially expressed proteins determined as having increased 
abundance under Cr(VI) conditions, 36% corresponded to hypothetical or conserved 
hypothetical proteins (Table 3.6).  Five of these proteins (SO2660, SO2663, SO2667, 
SO2673, and SO2688) are encoded by genes from the prophage MuSo2 genome, which 
implied their potential function in prophage activation and synthesis.  The majority of the 
up-regulated hypothetical proteins (i.e., SO2942, SO2944 to -46, SO2950, SO2951, 
SO2955, SO2979, SO2980, SO2982, SO2988, SO3001, and SO3008) were derived from 
genes located in the LambdaSo genome, while no potentially MuSo1-related hypothetical 
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or conserved hypothetical proteins were measured as being differentially expressed under 
our experimental conditions (Table 3.6).  The gene and protein expression data strongly 
suggest that, similar to UV irradiation [192], prolonged exposure to chromate and its 
derivatives may activate the lytic cycles of some or all three of the MR-1 prophages, 
leading to prophage-mediated cell lysis.  At this point, it is not clear whether the 
induction of MR-1 prophage-related genes/structural proteins is a response to an 
extended Cr(VI) exposure per se or to the possible intracellular accumulation of 
chromium, particularly reduced Cr(III).  S. oneidensis MR-1 cells exposed to Cr(VI) have 
been shown to precipitate reduced chromium both extracellularly on the cell surface and 
as electron-dense globules inside cells [135].  Qiu et al. [192] suggested that prophage 
activation was the major lethal factor in S. oneidensis MR-1 following UV C or UV B 
irradiation.  Our results certainly point to prophage activation as a major contributor to 
the toxic effects of Cr under conditions of prolonged exposure and reduction.  The 
conditions of Cr(III) toxicity and UV irradiation may be similar mechanistically due to 
both being DNA damage inducing agents. 
The membrane response was characterized by changes in the expression of genes 
encoding outer membrane structural components and polysaccharide biosynthesis 
proteins.  Induced genes included those encoding putative outer membrane porins 
(encoded by SO0312 and SO1821), OmpW (encoded by SO1673), and three proteins 
with functions related to polysaccharide biosynthesis (encoded by SO3158, SO3181, and 
SO3185).  Proteomic analysis indicated increases in the synthesis of SO3185 and 
SO3189, both annotated as polysaccharide biosynthesis proteins, while four predicted 
lipoproteins (SO2570, NlpD, SOA0110, and SOA0112) and an OmpA family protein 
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(SO3969) belonging to the functional category of cell envelope proteins showed 
decreased abundance under Cr(VI) conditions (Tables 3.6 and 3.7).  Located immediately 
upstream of nlpD (SO3433) in the MR-1 chromosome is the gene pcm, which is 
predicted to encode protein-L-isoaspartate O-methyltransferase, an enzyme involved in 
protein modification and repair.  The ORF coding for the RNA polymerase sigma factor 
RpoS, which controls the expression of many stationary-phase-induced genes, is 
positioned just downstream of nlpD and is transcribed in the same direction as nlpD and 
pcm.  Proteomic analysis revealed that, in addition to the lipoprotein NlpD, expression of 
protein-L-isoaspartate O-methyltransferase was down-regulated under conditions of 24-h 
Cr(VI) exposure (Table 3.7).  This is of interest because, with age or under stress 
conditions, proteins are susceptible to various spontaneous or deleterious covalent 
modifications such as deamidation, the conversion of asparagines into aspartyls and 
isoaspartyls, which can result in loss of protein function.  Pcm functions in repairing 
damaged proteins by selectively methylating atypical L-isoaspartyl sites and converting 
them back to L-aspartyls [204, 205].  The enzyme was shown to enhance the survival of 
stationary-phase E. coli subjected to a secondary environmental stress [206].  The 
physiological significance of decreased synthesis of S. oneidensis Pcm under the Cr(VI) 
conditions used here is unclear. 
The vast majority of MR-1 proteins down-regulated under our experimental 
conditions are annotated as hypotheticals (Table 3.5).  Besides poorly characterized 
proteins, other down-regulated proteins belonged to the functional categories of cellular 
process proteins, transport and binding proteins, cell envelope proteins, and energy 
metabolism proteins.  The relative abundance levels of seven proteins were found to be
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Table 3.7.  Relative Expression of Down-regulated Proteins and Corresponding mRNA Levels after 24-h Exposure to Chromate 
 
Control 24-h chromate exposure 
Gene Gene product (functional category no.f) 
Transcriptomics 
[Cr(VI)/Con ratio]a 
% 
Coverageb 
No. of unique 
peptides/ 
proteinc 
Avg no. 
of 
spectrad 
% 
Coverag
e 
No. of unique 
peptides/ 
protein 
Avg no. 
of 
spectra 
SO0433 Regulator of sigma D, Rsd (14) 0.70 67.7 12 19 36.0 5 2.5 
SO0576 PhoH family protein (18) 0.80 58.6 19 22.5 0.0 0 0 
SO0902 
NADH:ubiquinone oxidoreductase, Na 
translocating, alpha subunit, NqrA-1 (7) 1.0 70.6 24 24 16.7 6 6 
SO1144 Methyl-accepting chemotaxis protein (4) 0.60 86.5 33 71.5 31.8 9 12.5 
SO1425 Hypothetical protein (9) 1.0 44.8 17 13 0.0 0 0 
SO1518 Conserved hypothetical protein (9) 0.60 85.7 14 39 39.7 7 8 
SO1689 Cation transport ATPase, E1-E2 family (4) 0.40 30.0 13 10 0.0 0 0 
SO1700 Hypothetical protein (9) 0.90 61.2 21 23.5 0.0 0 0 
SO2062 Conserved hypothetical protein (9) 0.50 63.8 12 29 44.0 3 5.5 
SO2247 Hypothetical protein (9) 0.40 38.4 12 12 0.0 0 0 
SO2304 
Alanine dehydrogenase, authentic point 
mutation, Ald (7) 0.40 67.7 20 62.5 23.5 4 10 
SO2469 Conserved hypothetical protein (9) 0.60 67.9 61 90.5 8.8 5 2.5 
SO2570 Putative lipoprotein (3) 1.0 58.3 34 54.5 26.5 10 6 
SO2682 Hypothetical protein (9) 2.5 54.5 3 7 0.0 0 0 
SO2766 Conserved hypothetical protein (9) 1.0 63.6 27 25.5 34.3 7 6 
SO2882 Conserved hypothetical protein (9) 0.80 75.2 51 91.5 43.8 21 23 
SO2893 Conserved hypothetical protein (9) 1.9 72.3 16 57 25.1 3 4.5 
SO2991 Conserved hypothetical protein (9) 0.70 55.0 5 10 0.0 0 0 
SO3030 
Siderophore biosynthesis protein, 
AlcA(17) 1.6 60.8 27 79.5 36.7 10 9.5 
SO3069 Conserved hypothetical protein (9) 1.6 31.2 30 44.5 10.8 7 7 
SO3103 AcrB/AcrD/AcrF family protein (4) 1.1 34.1 23 22.5 13.7 9 6.5 
SO3145 
Electron transfer flavoprotein, beta 
subunit, EtfB (7) 1.2 96.4 26 131.5 64.3 14 45.5 
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Table 3.7.  Continued 
 
Control 24-h chromate exposure 
Gene Gene product (functional category no.f) 
Transcriptomics 
[Cr(VI)/Con ratio]a 
% 
Coverageb 
No. of unique 
peptides/ 
proteinc 
Avg no. 
of 
spectrad 
% 
Coverage 
No. of unique 
peptides/ 
protein 
Avg no. 
of 
spectra 
SO3207 Chemotaxis protein (4) 1.5 54.9 44 127 46.7 24 32 
SO3235 Flagellar hook-associated protein FliD (4) 0.80 71.3 30 39 34.6 7 5.5 
SO3247 Flagellar hook protein FlgE (4) 0.90 66.0 14 36.5 31.1 6 10 
SO3314 
Putative fimbrial biogenesis and twitching 
motility protein(4) 1.0 53.1 10 10.5 0.0 0 0 
SO3343 Conserved hypothetical protein (9) 0.80 81.2 20 97.5 61.3 11 28 
SO3407 Conserved hypothetical protein (9) 0.80 28.6 16 16 0.0 0 0 
SO3422 
Ribosomal subunit interface protein, 
YfiA-2 (12) 1.0 89.8 8 28 17.8 2 1 
SO3433 Lipoprotein NlpD (3) 1.2 46.3 10 9.5 0.0 0 0 
SO3434 
Protein-L-isoaspartate O-
methyltransferase, Pcm (11) 0.80 64.0 9 7.5 0.0 0 0 
SO3442 MazG family protein (18) 1.6 66.3 13 26 18.6 3 3.5 
SO3468 
Riboflavin synthase, alpha subunit, RibE-
2 (2) 1.1 51.8 10 11 0.0 0 0 
SO3483 HlyD family secretion protein (17) 1.0 68.6 19 18.5 25.5 5 3 
SO3516 
Transcriptional regulator, LacI family 
(14) 1.2 49.1 13 14 15.7 3 3 
SO3539 Peptidase, M28D family (11) 0.50 72.7 26 40 30.7 9 5 
SO3550 Hypothetical protein (9) 1.0 57.4 9 7 0.0 0 0 
SO3560 Peptidase, M16 family (11) 0.30 65.0 45 50 33.7 20 19 
SO3565 
2,3-Cyclic-nucleotide 2-
phosphodiesterase, CpdB (13) 0.70 79.7 53 74.5 28.8 12 8.5 
SO3597 Conserved hypothetical protein (9) 1.0 78.7 13 48 0.0 0 0 
SO3683 Coniferyl aldehyde dehydrogenase (7) 0.50 55.1 24 33 21.1 6 6.5 
SO3720 Conserved hypothetical protein (9) 1.6 80.1 12 21.5 29.8 4 2.5 
SO3800 Serine protease, subtilase family (11) 0.50 19.7 11 7 0.0 0 0 
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Table 3.7.  Continued 
 
Control 24-h chromate exposure 
Gene Gene product (functional category no.f) 
Transcriptomics 
[Cr(VI)/Con ratio]a 
% 
Coverageb 
No. of unique 
peptides/ 
proteinc 
Avg no. 
of 
spectrad 
% 
Coverag
e 
No. of unique 
peptides/ 
protein 
Avg 
no. of 
spectra 
SO3936 Sodium-type flagellar protein MotX (17) 0.90 47.6 8 6 0.0 0 0 
SO3969 OmpA family protein (3) 1.5 61.8 14 19.5 20.6 2 1.5 
SO3980 Cytochrome c552 nitrite reductase (7) 1.2 49.5 27 49.5 20.3 7 6.5 
SO4319 HlyD family secretion protein (17) 1.3 46.7 20 23 25.0 7 6 
SO4329 Conserved hypothetical protein (9) 1.4 94.0 15 47 66.7 6 13 
SO4403 Hypothetical protein (9) 0.50 72.5 16 18 22.1 2 2 
SO4505 Conserved hypothetical protein (9) 0.50 80.7 8 11.5 0.0 0 0 
SO4523 
Iron-regulated outer membrane virulence 
protein IrgA (17) 0.60 78.9 55 169 48.3 23 36.5 
SOA0110 Putative lipoprotein (3) 0.50 43.3 10 (46) 147 16.4 1 (16) 32 
SOA0112 Putative lipoprotein (3) NAe 47.7 0 (52) 224.5 20.4 0 (17) 31.5 
aRelative gene expression (induction) is presented as the mean ratio of the fluorescence intensity of Cr(VI)-exposed cells 
experimental) to control (nonexposed) cells.  bTotal sequence coverage from replicate analyses.  cTotal number of unique 
peptides identified per protein from replicate analyses.  dAverage number of spectra identified per protein from replicate 
analyses.  eNA, not applicable; gene was not represented on the microarray.  fFrom Table 1.   
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decreased under 24-h Cr(VI) exposure compared to the control conditions:  two 
chemotaxis proteins (SO1144 and SO3207), a cation transport ATPase (SO1689), an 
AcrB/AcrD/AcrF family protein (SO3103), and three proteins involved in motility (FliD, 
FlgE, and SO3314) (Table 3.7).  Down-regulation of proteins involved in motility and 
chemotaxis was consistent with confocal laser scanning microscopy observations, which 
indicated a prevalence of nonmotile cells under prolonged Cr(VI) exposure (data not 
shown).   
Conclusions 
The proteome datasets presented here provide an in-depth analysis of the global 
response of S. oneidensis MR-1 to both acute toxic shock and chronic exposure to 
chromate.  Using 2D LC-MS/MS for the proteome measurements, the proteome datasets 
provided protein expression information on previously unknown proteins and revealed 
possible post-transcriptional regulation that is not possible to predict by microarray 
analysis.  Under the acute shock conditions, the proteins most commonly up-regulated 
were involved in iron uptake and assimilation as well as sulfate transport.  Many 
hypothetical proteins were also found to be up-regulated in response to acute chromate 
exposure.  In addition, a putative operon containing three genes (so3585-so3587) was 
detected up-regulated at the transcript and protein levels primarily under chromate 
exposure.   
After growth in the presence of chromium for 24-h, the differentially expressed 
proteins identified from S. oneidensis were unique in comparison to the acute shock 
proteome dataset.  Proteins corresponding to structural components and hypothetical 
proteins encoded within an integrated lambda-like phage (LamdaSo) were identified not 
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only highly up-regulated at the time of proteome sampling in the chromate-exposed 
culture, but was primarily detected in this sample as well.  A similar response was found 
for this bacterium after exposure to UV radiation [192].  The activation of the lysogenic 
phage may be the lethal cause that results from prolonged exposure to chromate.  Since 
the phage is activated after transformation of Cr(VI) to presumably Cr(III), understanding 
cellular response in the presence of Cr(III) may not be possible without first inactivating 
the lysogenic phage.  The use of global whole-cell proteomics allowed the detection and 
characterization of these novel responses to chromate by S. oneidensis. 
Since the purpose is to gain global understanding of the Cr(VI) response of S. 
oneidensis for the purposes of bioremediation, we chose to explore environmentally 
relevant scenarios of Cr(VI) exposure.  Therefore, the two proteome studies discussed 
here provided insight into both initial and long-term Cr(VI) exposure.  We found that 
after prolonged exposure, a high level of stress was demonstrated that may be detrimental 
to a long-term bioremediation strategy; however, without this work, the stress response 
would have remained unknown.  Due to the large differences between the two proteomes, 
this resulted in the exploration of the Cr(VI) dosage response, another relevant scenario. 
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Chapter 4 
Dosage-Dependent Proteome Response of Shewanella oneidensis MR-1 to Acute 
Chromate Challenge 
The work presented below has been published as the following journal article and 
adapted from the text 
 
Melissa R. Thompson, Nathan C. VerBerkmoes, Karuna Chourey, Manesh Shah, 
Dorothea K. Thompson, and Robert L. Hettich.  Dosage-Dependent Proteome Response 
of Shewanella oneidensis MR-1 to Acute Chromate Challenge.  Journal of Proteome 
Research, 2007; 6, 1745-1757.  Sample preparation, LCQ and LTQ measurements, and 
data analysis were performed by Melissa R. Thompson.  Supplemental material can be 
found at http://compbio.ornl.gov/shewanella_metal_stress/dosage. 
 
 
Introduction 
 Technological advances in the area of “shotgun” proteomics have substantially 
improved the quantity and quality of data that can be derived from diverse biological 
systems, including molecular descriptions of the growth states and environmental 
perturbation responses of various bacteria.  Areas that have seen improvements include 
liquid chromatographic separation of peptides, new and improved mass spectrometers, 
and advanced computational approaches to search the resulting raw data files.  In 2001, 
Washburn et al [33]  first introduced multidimensional protein identification technology 
(MudPIT), in which a multiphasic column was used to separate peptides online for direct 
injection into a nanoelectrospray mass spectrometer.  This design was enhanced by 
McDonald et al [166] in 2002 to incorporate a biphasic column that is connected 
upstream from the reverse-phase analytical column.  These improvements in online 
peptide separation have greatly improved sample handling and have reduced the 
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complexity of ions injected into the mass spectrometer, thereby allowing more ions to be 
analyzed by MS/MS.  Over the past 8 years, the quadrupole ion trap (QIT) has been the 
prevalent choice of instrumentation for this experimental approach [207-212].  However, 
advancements in instrumentation (i.e., the new linear trapping quadrupole LTQ [30] and 
LTQ-Orbitrap [23]) that can acquire full MS and MS/MS scans on greatly reduced time 
scales have become just as critical as improvements made in peptide separation.  All of 
these improvements have led to a greater depth of proteome coverage, yielding confident 
identifications of greater than 2000 proteins on a routine basis for many microbes [63, 65, 
147, 158].   
These technological advances have enabled the elucidation of microbial 
proteomes at a remarkably deep level, now permitting the extensive examination of how 
a microbe adjusts its molecular machinery as a function of diverse growth conditions.  
The focus of this work was to exploit this technology to characterize for the first time the 
dosage-dependent changes in the proteome of the metal-reducing bacterium Shewanella 
oneidensis MR-1 in response to chromate insult.  Hexavalent chromium [Cr(VI)], in the 
form of chromate (CrO42-) or dichromate (Cr2O72-), is a widespread environmental 
contaminant due to its prevalent use in industrial and defense applications [121].  
Microbially-catalyzed transformation of soluble Cr(VI) to less soluble Cr(III) hydroxides 
has been proposed as a potentially economical and environmentally friendly remediation 
strategy for Cr(VI)-contaminated subsurface environments [213].  Cr(III) hydroxides, for 
example, exhibit substantially reduced mobility, bioavailability, and toxicity.  Species of 
the γ-proteobacterial genus Shewanella have been shown to mediate both direct 
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enzymatic [86, 133, 134] and indirect chemical reduction [131, 136, 137] of Cr(VI) to 
Cr(III), thus suggesting their potential utility for in situ bioremediation.   
Under aerobic growth conditions, S. oneidensis preferentially uses oxygen as its 
terminal electron acceptor.  Chromate reduction by this organism has been reported under 
both aerobic and anaerobic conditions [86, 133, 135, 146].  Although S. oneidensis can 
generate energy for growth via respiratory-linked reduction of certain metals such as 
Fe(III) and Mn(IV) [79], there have been no reports to date of this organism’s growth on 
Cr(VI) as a sole terminal electron acceptor under anaerobic respiratory conditions [132].  
Current evidence suggests that Cr(VI) reduction mechanisms are likely associated with 
bacterial electron transport systems [86, 214] and that Cr(VI) reduction is dependent on 
the physiological state of the culture [133], but the details describing these mechanisms 
and the molecular components themselves are not understood in S. oneidensis.  Thus, the 
prediction and assessment of bioremediation performance is a difficult task, being 
compounded by the lack of fundamental knowledge on the molecular basis and regulation 
underlying bacterial metal reduction and cellular responses to metal toxicity. 
 This research builds upon and extends a previous study probing the temporal 
transcriptomic and proteomic changes in S. oneidensis MR-1 in response to a single 
exposure concentration of chromate [147] by investigating the Cr(VI) dosage-dependent 
proteome response.  The lethal dosage for S. oneidensis was found to be around 2 mM; 
however, at dosages of 0.5 and 1 mM, a reduction in growth of 50 and 66%, respectively, 
was observed [147].  Given the likelihood that microorganisms are exposed to a gradient 
of chromate levels in contaminated local microenvironments, it is important to 
understand changes in the molecular response to metal toxicity that are dependent on 
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concentration and, thus, gain insight into the level of resistance exhibited by a bacterium.  
The objective of this study was to identify proteins involved in the general response of 
the bacterium to chromate insult, in particular those that demonstrate a dosage-dependent 
alteration in abundance level.  The majority of proteins synthesized by this bacterium 
were expected to remain relatively constant, as this is the vital machinery that enables 
cell growth and survival maintenance.  However, a subset of proteins that play important 
roles in the stress response to chromate and ultimately for cell survival in toxic metal 
environments should exhibit measurable changes in abundance as a function of growth 
conditions, and thus would provide key information about how this microbe copes with 
acute exposures to Cr(VI).   
A component of this study was to evaluate the differences between the datasets 
obtained by the more conventional quadrupole ion trap technology as compared to the 
newer linear trapping quadrupole instrumentation.  These technological advances have 
the potential to increase the correlation of transcriptome and proteome measurements due 
to improved dynamic range of the LTQ, thereby increasing proteome coverage and 
improving confidence in the interpretation of results derived from global high-throughput 
techniques. 
Materials and Methods 
Preparation of Proteomes for HPLC-MS/MS Analysis 
Four independent cultures of wild-type S. oneidensis MR-1 were grown in Luria-
Bertani (LB) medium (pH 7.2) at 30 °C under aerobic conditions.  Aerobic conditions 
were maintained in batch cultures by growing both the control and treatment samples in 
the same-size Erlenmeyer flasks (with sufficient headspace) and continuously aerating 
89 
each culture by vigorous shaking at 200 rpm.  Batch cultures were grown to mid-
exponential phase (OD600, 0.5), followed by the addition of potassium chromate (K2CrO4) 
to three of the four cultures at a final concentration of 0.3, 0.5, or 1.0 mM, respectively.  
The culture receiving no chromate served as the control and was grown in parallel with 
the treated cultures.  Thirty minutes after chromate exposure, cells were harvested and 
lysed by sonication, as described in Chapter 2.  On the basis of initial growth response 
studies of S. oneidensis [147], the decision for sampling the resulting proteome during the 
initial transitional period (i.e., 30 min post-shock) from logarithmic growth toward 
adaptation to chromate would reveal key regulatory and structural proteins that respond 
to the initial signs of chromate stress (see Supplemental Figure S1, Supporting 
Information).  Each of the resulting four proteome samples (control and 0.3, 0.5, or 1.0 
mM chromate) were separated into two fractions (crude/soluble and membrane) by high-
speed centrifugation [147] and quantitated using BCA analysis (Pierce, Rockford, IL).  
Approximately 2 mg of each proteome fraction was then digested with trypsin, desalted 
and stored at –80 °C until HPLC-MS/MS analysis.   
LC-MS/MS Analysis  
Both the soluble and membrane-associated proteome fractions of the chromate-
treated and control samples were analyzed in duplicate via two-dimensional LC-MS/MS 
on both an LCQ Deca XP three-dimensional ion trap mass spectrometer (Thermo 
Electron) and an LTQ linear trapping quadrupole mass spectrometer (Thermo Electron).  
Both instruments were coupled to identical Ultimate HPLC pumps (LC Packings; a 
division of Dionex, San Francisco, CA), each of which had an initial flow rate of ~100 
µL/min that was split precolumn to obtain a flow rate of ~300 nL/min at the nanospray 
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tip.  See Chapter 2 for details of chromatographic separation of peptides for both 
instrument platforms.  The multiphasic column system was positioned in front of the 
LCQ or LTQ on a nanospray source (ThermoFinnigan).  All samples were analyzed via a 
24-h 12-step 2-D analysis consisting of increasing concentration (0–500 mM) salt pulses 
of ammonium acetate followed by 2-h reverse phase gradients (see Chapter 2 for details).  
During the entire chromatographic process, the LTQ was operated in a data-dependent 
MS/MS mode detailed in Chapter 2.  
Proteome Bioinformatics 
The S. oneidensis MR-1 protein database used in all MS/MS spectra searches 
consisted of 4798 open reading frames that were downloaded from the J. Craig Venter 
Institute (formerly TIGR) and concatenated with a list of common contaminants (trypsin, 
keratin, etc.); the entire database can be downloaded from compbio.ornl.gov/shewanella_ 
metal_stress/dosage/databases/.  All MS/MS spectra were searched with the Sequest 
Algorithm [39] as detailed in Chapter 2.  The Xcorr values used here have been tested in 
a rigorous manner in the laboratory and typically give a maximum false positive rate of 
1-2% for both bacterial isolates [184] and simple microbial communities [65].  All of the 
resulting DTASelect files from both the LCQ and LTQ datasets are available on the 
analysis page under the corresponding dataset and are filtered at 1 and 2 peptides per 
protein.  Spectra identified for each peptide can be viewed by clicking on the spectral 
number (first column, labeled by filename) in the html version of the DTASelect files.  
The algorithm Contrast [171] was used to compare DTASelect files and all of the 
resulting files are also found on the page.  Although there are a number of large-scale 
proteomics studies describing S. oneidensis MR-1 under various growth conditions, the 
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availability and accessibility of the entire datasets to the general scientific community is 
limited.  This precludes direct comparisons of the large dataset across different 
laboratories.  To assess the false identification rate of both the LTQ and LCQ, a database 
consisting of the protein sequences in reverse as well as the forward protein sequences 
was created.  The 1 mM Cr(VI) dataset from each instrument was searched against this 
database to determine the false identification rate of the filtering levels used in this study 
and the results were calculated according to the equation presented in ref [185].  Results 
in the form of DTASelect files are found at compbio.ornl.gov/shewanella_ 
metal_stress/dosage/. 
Label free quantitation was employed to determine those proteins that were 
differentially expressed under the Cr(VI) dosage conditions with respect to the control 
sample.  The criteria for label free quantitation are measurable differences in percent 
sequence coverage, peptide count, and spectral count, where two of the three criteria must 
be met for a protein to be identified as differentially expressed (see Chapter 2 for details).  
The use of more stringent criteria for the LTQ is due to the increase in the number of 
spectra acquired and identified.  The increase in the amount of spectra acquired results in 
a plateauing effect in determination of differential expression for many moderately 
abundant proteins as discussed below. 
Results and Discussion 
Global Proteome Analysis 
A total of 2406 out of 4931 predicted proteins from the annotation provided by 
TIGR were confidently identified with at least 2 peptides per protein using both the LCQ 
and the LTQ.  This constitutes 49% of the predicted S. oneidensis MR-1 proteome and 
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represents the largest proteome characterization of this bacterium to date from this 
laboratory [147, 158].  The total number of proteins identified under each treatment 
condition for the two instruments is provided in Table 4.1.  With the LTQ mass 
spectrometer, confident identification of 1883 proteins in the control sample was 
achieved, with a comparable amount detected in each of the dosage samples.  By 
contrast, the LCQ instrument yielded 809 proteins for the control, with comparable 
amounts in each of the dosage samples.   
The total number of proteins identified was organized into a list with the percent 
sequence coverage, functional category, isoelectric point (pI), and molecular weight 
information included (Supplemental Table S1, Supporting Information).  With respect to 
these factors, there were no major biases between the observed proteome in this study 
and the predicted proteome.  Proteins detected under the three chromate dosage 
conditions and the control condition are organized according to percent sequence 
coverage (the total percent of the protein sequence identified), peptide count (the number 
of peptides identified for a given protein), and spectral count (the number of spectra 
identified for a given protein) and can be accessed in Supplemental Table S2 (see 
Supporting Information) for both the LCQ and LTQ datasets. 
Biological variability with respect to independently grown cultures of S. 
oneidensis was assessed to determine if perturbation of the environment reveals a culture-
dependent proteome.  Independently grown cultures that were sampled previously [147] 
for proteomics analysis were compared to the current datasets, and gave very similar 
results.  These previous samples included a wild-type control culture grown in parallel 
with a 1 mM chromate-treated culture that was harvested 45 min after addition of the  
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Table 4.1.  Global Proteome Analysis of Chromate Dose on S. oneidensis. 
 
Condition Instrumenta 
Proteins Identified  
1 pepb 
Proteins Identified 
2 pepc 
Average 
Sequence 
Coveraged Reproducibility 
Control LCQ 1263 809 26.0% 78.6% 
0.3 mM K2CrO4 LCQ 1267 835 30.0% 72.8% 
0.5 mM K2CrO4 LCQ 1185 716 31.1% 81.8% 
1.0 mM K2CrO4 LCQ 1307 879 29.1% 74.5% 
Control LTQ 2574 1883 35.6% 79.4% 
0.3 mM K2CrO4 LTQ 2423 1752 38.9% 70.5% 
0.5 mM K2CrO4 LTQ 2425 1807 37.2% 81.3% 
1.0 mM K2CrO4 LTQ 2624 1953 37.5% 79.8% 
Total Non-Redundant 3239 2406   
aLCQ:  Thermo Electron NanoES-quadrupole ion trap.  LTQ:  Thermo Electron NanoES-
linear trapping quadrupole.  bNon-redundant proteins identified with at least 1 peptide per 
protein.  cNon-redundant proteins identified with at least 2 peptides per protein.  dAverage 
sequence coverage with at least 2 peptides per protein. 
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metal.  For these two datasets, the reproducibility at the protein level is 79% for the 30 
min 1 mM chromate dosage versus the 45 min 1 mM acute shock sample and for the 
control samples is 78%.  Therefore, even though there were differences in the chromate 
exposure times for these two separate experiments, there does not seem to be much 
measurable biological variation, even when chromate exposure is 15 min longer in the 
case of Brown et al [147]. 
Instrumentation Effects on Proteome Characterization 
The LCQ and LTQ datasets were compared to determine differences in 
informational content.  Under the control conditions (no added chromate), both 
instruments together identified a common list of 803 proteins at the two-peptide level.  A 
total of 5 proteins were uniquely identified using the LCQ, whereas approximately 1100 
proteins were only identified using the LTQ.  The 5 unique LCQ proteins were identified 
with only 2 peptides per protein.  For the 0.3 and 0.5 mM chromate-treated cells, 876 and 
777 proteins identified were common between the two instruments, respectively; a total 
of 5 proteins were unique to the LCQ under these dosages, whereas almost 1000 proteins 
were unique to the LTQ.  The unique LCQ proteins were investigated further and once 
again were found to consist of only 2 or 3 peptides identified for a given protein.  A 
different trend was observed for the 1 mM chromate-treated samples compared to the 
other three conditions.  All proteins identified using the LCQ were also identified using 
the LTQ mass spectrometer.  Overall, 99% of the proteins identified using the LCQ were 
also identified when using the LTQ, indicating that the performance of these two 
instruments is similar; however, the LTQ offered enhanced performance in terms of 
dynamic range, as discussed below.   
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Because of its slower scanning speed, the LCQ mass spectrometer is not able to 
trigger and conduct MS/MS on as many ions as the LTQ during a chromatographic run, 
thus resulting in a lower number of total protein identifications (for the LCQ).  The 
capability of the LTQ [30] instrument for not only higher duty cycle experiments but also 
a greater trapping efficiency of ions relative to the LCQ is already making LTQ 
technology the high-throughput instrumentation of choice for shotgun proteomics 
measurements.  This improved ion trapping efficiency is evident by the triggering of 
MS/MS acquisitions on low abundance ions that would be missed by the LCQ 
measurements (see Figure 4.1).  Due to the increased dynamic range offered by the LTQ 
linear trapping quadrupole, only the LTQ-derived datasets were analyzed in greater detail 
in the following discussion sections. 
The increased scanning speed of the LTQ instrument results in a concomitant 
increase in the number of false positive identifications of peptides [32, 215].  Generation 
of more spectra with the LTQ leads to more possible matches to spectra that are 
considered “noise” and do not contain “true” peptide spectra.  The 1 mM Cr(VI) dataset 
was used to test the false identification rate of both the LCQ and LTQ.  These datasets 
were searched against a protein database containing the forward sequence of the protein 
database (see above) with the reverse sequences of the database concatenated to the end.  
The false identification rates for the duplicate analyses were averaged to give the 
following results for each instrumentation platform (Table 4.2).  For the LCQ, a protein 
false identification rate of 10.5% was identified for the 1 peptide dataset and 0.1% for a 2 
peptide requirement.  For the LTQ, the protein false identification rate at the 1 peptide 
level was 33.3% and at the 2 peptide level 4.8%.  As expected, the false identification 
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Figure 4.1.  MS/MS from a peptide of SO3585 identified in the 0.3 mM dosage. 
The base peak chromatogram (top figure) from the 0.3 mM chromate sample illustrates a 
full LTQ-MS scan that contains a peak of very low abundance at m/z 638.8 (middle 
figure).  This peak was subsequently isolated and fragmented, giving the MS/MS 
spectrum (bottom figure), which contains the sequence of a peptide from the SO3585 
protein that was identified as up-regulated at the 0.5 mM and 1 mM chromate levels.   
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 Table 4.2.  False Peptide and Protein Identifications with a LCQ and a LTQ 
 
  Peptide Identifications Protein Identifications 
Instrument a Requirementb False Uniquec Total Uniqued Rate False Idse Total Idsf Rate 
LCQ Run 1 1 peptide 55 6041 1.8% 58 1157 10.0% 
 2 peptide 0 5666 0.0% 0 736 0.0% 
LCQ Run 2 1 peptide 65 6912 1.8% 73 1311 11.1% 
 2 peptide 2 6492 0.0% 1 835 0.2% 
LTQ Run 1 1 peptide 428 22014 3.8% 434 2735 31.7% 
 2 peptide 68 21153 0.6% 34 1808 3.8% 
LTQ Run 2 1 peptide 527 22476 4.6% 498 2854 34.8% 
 2 peptide 108 21531 1.0% 53 1844 5.8% 
a1 mM Cr(VI) Dataset on both instrumentation plaforms.  bRequirement is whether 
protein identification is based on at least 1 or 2 peptides for a given protein, respectively.  
cFalse Unique refers to the number of peptides identified using protein sequences from 
the reversed protein database.  dTotal Unique is the total number of unique peptides 
identified using the forward and reverse protein databases.  eFalse IDs are the proteins 
identified from the reverse database.  fTotal IDs are the total number of proteins identified 
from the forward and reverse databases.  
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LTQ is higher, especially at the 1 peptide level; however, with the 2 peptide requirement, 
rate for the the rate is low enough that ~95% of the protein identifications are true.  
Therefore, using more stringent filtering criteria is necessary in order to minimize the 
false positive identifications for LTQ datasets. 
 In order to further understand the contribution of peptides to protein 
identification, the distribution of the number of peptides identified for a given protein was 
calculated using the Control dataset as an example.  A protein identification is only made 
if at least two peptides are identified from one of the two MS analyses.  The protein 
identifications made by two replicate MS experiments comprising two peptides were 260 
(~14%) of the total proteins identified for the Control condition.  A total of 75 (~4%) 
proteins were identified with three peptides, while 103 (~5%) proteins were found with 
four peptides.  A majority of the protein identifications comprise at least five peptide 
identifications with 1443 (~77%) proteins.  Therefore, the false identification rate is 
maintained at a reasonable level with less than 30% of the protein identifications arising 
from proteins identified with four or fewer peptides. 
Semiquantitation was investigated on both the LCQ and LTQ datasets using the 
criteria described in Chapter 2.  Results generated using both instrumentation platforms 
are provided in Supplemental Table S3 (see Supporting Information).  Although there is 
reasonable agreement between the LCQ and LTQ datasets for the three chromate dosage 
samples, the different depth of protein identification and the distinct semiquantification 
criteria for each MS platform made it difficult to directly compare the results.  This is 
especially noticeable for the lower abundance proteins; they are likely to be missed in the 
LCQ analysis but found in the LTQ measurements.  Thus, whereas the LCQ 
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measurements often reveal large semiquantitative differences, such as proteins 
completely absent in the control sample but present with a few peptides detected in a 
dosage sample, the deeper measurements possible with the LTQ often reveal the presence 
of the protein in both control and sample, with some differences in abundance.  At the 
other end of the spectrum, the most abundant proteins also are somewhat difficult to 
quantify with the LTQ, because at least one of the semiquantitative metrics (percent 
sequence coverage) “saturates”, precluding determination of differences between 
samples.  Thus, these factors must be taken into account in the determination of 
semiquantification criteria for LTQ measurements.  Because of the increased depth of 
proteome coverage achieved by the LTQ measurements, all semiquantification 
determinations and discussions were focused on these datasets. 
LTQ-Based Global Proteome Characterization 
The proteins identified using the LTQ were organized according to the 18 
functional category assignments given in TIGR’s Comprehensive Microbial Resource 
(www.tigr.org) and were grouped according to their annotated subcellular roles (Figure 
4.2).  The functional categories of amino acid biosynthesis; biosynthesis of cofactors, 
prosthetic groups, and carriers; cell envelope; cellular processes; DNA metabolism; 
energy metabolism; fatty acid and phospholipid metabolism; and protein fate were all 
represented with at least 50% of their protein members identified for the control and each 
Cr(VI) dosage sample.  Furthermore, in the functional categories of protein synthesis, 
purines/pyrimidines/nucleosides/nucleotides, and transcription, identification of 80% of 
the members was achieved for each condition.   
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Figure 4.2  Functional category distribution for each dosage and the control condition. 
The total number of non-redundant proteins identified by LTQ-MS under each dosage 
condition organized according to the functional categories assigned by TIGR.  The 
number of proteins identified under each functional category is labeled by the slice in 
which it is located for each dosage condition and the control condition. 
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The Venn diagrams in Figure 4.3 illustrate the relationship of the proteins 
identified under the three chromate dosage treatments:  1,535 proteins were identified 
under all three dosage conditions using the LTQ, while relatively few proteins (ranging 
from 86 to 231 proteins) were unique to a specific chromate dose, thus suggesting that the 
majority of the proteome was not measurably altered in response to acute chromate 
exposure.  However, as detailed below, the actual proteins identified as putatively 
differentially expressed for each dosage treatment are for the most part unique for a given 
dose. 
Dosage-Dependent Response of Differentially Expressed Proteins 
The information in Supplemental Table S2 (see Supporting Information) (percent 
sequence coverage, peptide count, and spectral count) was used to identify those proteins 
from the three dosage treatments that were differentially expressed when compared to the 
control sample (as detailed in Chapter 2).  Semiquantitation or label free quantitation is 
important in cases where other methods of quantitation like isotope coded affinity tags 
(ICAT) [177] or metabolic labeling [175] are not feasible for sample characterization.  
The semi-quantitation method relies on the average between the two sample runs of the 
same treatment, as compared to the average of the two runs of the control condition 
(Table 4.1).  A previous study by our group [184] sampled technical replications from six 
growth conditions in Rhodopseudomonas palustris and established that a 70% 
measurement of reproducibility in replicated samples was readily and consistently 
achievable under optimal instrument conditions.  This criterion has become the standard 
in our laboratories and has enabled more confident determination of proteins changing  
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Figure 4.3.  Venn diagrams of dosage response proteome samples for the LTQ and LCQ. 
The Venn diagram on the left represents results using an LTQ mass spectrometer.  The 
Venn diagram on the right depicts results using an LCQ mass spectrometer.  The top left 
circle is the 0.3 mM K2CrO4 dosage sample, the top right circle is the 0.5 mM, and the 
bottom circle is the 1 mM.  The numbers are the total number of proteins shared between 
the respective samples.  For instance, 1535 proteins were identified in all three dosage 
conditions for the LTQ and 665 proteins were identified in all three doses with the LCQ. 
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86 96 
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abundance as a result of different biological growth conditions as opposed to varying 
sampling and instrumentation fluctuations. 
A total of 14 proteins were up-regulated under all three Cr(VI) doses, with 
representatives in bold in Tables 4.3-4.5.  In comparing the 0.3 mM chromate dosage 
with the other two higher doses, this dose appears to elicit a unique response in which 
only three up-regulated proteins are shared with the 0.5 mM dose.  The datasets for the 
0.5 and 1 mM chromate doses had 13 up-regulated proteins in common, suggesting that 
the toxicity of these two Cr(VI) concentrations may induce a similar molecular response.  
A greater variation was observed among the various chromate doses for proteins 
identified as down-regulated in contrast to up-regulated proteins, with only 10 proteins 
exhibiting decreased abundance levels across all three metal treatments.  The 0.3 and 0.5 
mM dosages were most similar with seven additional down-regulated proteins shared 
between the two; the down-regulated protein profiles for doses 0.3 and 1 mM shared a 
total of five proteins.  No additional proteins were identified that were solely shared 
between the 0.5 and 1 mM doses, indicating that down-regulated protein expression in 
response to chromate was much more varied and showed more instances of dose-
dependent patterns compared to the up-regulated expression profiles.  Proteins with 
annotated functions in transport and binding consistently displayed up-regulation, with 
representatives over the treatments remaining constant as well.  For down-regulated 
proteins, all three dosages displayed a large number of energy metabolism proteins with 
reduced expression. However, only a small subset of the proteins are conserved over the 
three treatment conditions.  In addition, the representative functional categories varied  
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Table 4.3.  Selected Differentially Expressed Proteins Identified after Treatment with 0.3 mM K2CrO4a 
 
0.3 mM Average Control Condition Average 
Locus % coverage peptide spectra % coverage peptide spectra 
Functional 
Categoryb Description 
Up-regulated        
SO1190 69.3% 25 75.5 48.0% 11 19 9 conserved hypothetical protein 
SO1482 78.2% 63.5 192.5 52.2% 26 35 17 TonB-dependent receptor, putative 
SO2426 31.7% 6.5 11 0.0% 0 0 15 DNA-binding response regulator 
SO3030 43.3% 20.5 37.5 4.0% 1 2 17 siderophore biosynthesis protein (alcA) 
SO3033 50.6% 38 112 27.5% 15 23 17 ferric alcaligin siderophore receptor 
SO3599 56.2% 16.5 49.5 42.0% 13 18 17 
sulfate ABC transporter, periplasmic sulfate-binding 
protein (cysP) 
SO3667 91.4% 24 88 25.2% 4 4 9 conserved hypothetical protein 
SO3669 76.1% 47 269 11.2% 4 4 17 heme transport protein (hugA) 
SO3914 62.4% 56 199.5 44.5% 30 49 17 TonB-dependent receptor, putative 
SO4077 42.9% 23.5 39.5 9.6% 4 5 17 TonB-dependent receptor, putative 
SO4523 65.8% 42.5 146.5 51.4% 28 47 17 iron-regulated outer membrane virulence protein (irgA) 
SO4743 74.6% 66 223 67.1% 46 100 17 TonB-dependent receptor, putative 
Down-regulated        
SO0004 24.6% 9 13.5 36.5% 23 42.5 3 inner membrane protein, 60 kDa  
SO0848 45.2% 31.5 45.5 66.4% 68 186.5 7 periplasmic nitrate reductase (napA)  
SO0947 28.0% 9.5 12.5 46.1% 19.5 32 16 ATP-dependent RNA helicase SrmB (srmB)  
SO0970 52.5% 27.5 51.5 55.9% 38.5 99 7 fumarate reductase flavoprotein subunit precursor  
SO1425 36.9% 9 12 45.2% 22 30.5 9 hypothetical protein  
SO1490 30.7% 7.5 11.5 55.9% 21 43 7 alcohol dehydrogenase II (adhB)  
SO1519 34.7% 18.5 23.5 54.9% 33.5 63 7 iron-sulfur cluster-binding protein  
SO1677 68.6% 22 60.5 74.9% 32.5 112.5 8 acetyl-CoA acetyltransferase (atoB)  
SO1679 36.6% 9.5 15.5 53.2% 18.5 28.5 8 acyl-CoA dehydrogenase family protein  
SO1776 11.6% 4 4 40.0% 30.5 35.5 3 outer membrane protein precursor MtrB (mtrB)  
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Table 4.3.  Continued 
 
0.3 mM Average Control Condition Average 
Locus % coverage peptide spectra % coverage peptide spectra 
Functional 
Categoryb Description 
SO1778 28.2% 15 25.5 43.3% 39 80 7 decaheme cytochrome c (omcB)  
SO2606 19.0% 11 16 51.6% 36.5 55 18 PqiB family protein  
SO2929 45.6% 15.5 22 69.6% 31 56 9 hypothetical protein  
SO4053 9.5% 3.5 3.5 38.4% 18 25.5 4 methyl-accepting chemotaxis protein  
SO4513 8.0% 6 8 42.3% 42 67.5 7 formate dehydrogenase, alpha subunit  
aProteins in bold are found differentially expressed under all three Cr(VI) dosage conditions.  bFunctional Category number 
refers to the designation in Figure 4.2 as an abbreviation for the category name.   
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Table 4.4.  Selected Differentially Expressed Proteins Identified after Treatment with 0.5 mM K2CrO4a 
 
0.5 mM Average Control Condition Average 
Locus % coverage peptide spectra % coverage peptide spectra 
Functional 
Categoryb Description 
Up-regulated        
SO0578 51.7% 36 68 29.6% 17 29 9 hypothetical protein  
SO1190 84.0% 33 118 48.0% 11 19 9 conserved hypothetical protein  
SO1482 71.0% 69 201 52.2% 26 35 17 TonB-dependent receptor, putative  
SO2426 22.4% 5 18 0.0% 0 0 15 DNA-binding response regulator  
SO2903 92.1% 59 617 82.3% 36 150 1 cysteine synthase A (cysK)  
SO3030 48.7% 22 47 4.0% 1 2 17 siderophore biosynthesis protein (alcA)  
SO3033 55.0% 38 100 27.5% 15 23 17 ferric alcaligin siderophore receptor  
SO3420 75.8% 23 100 54.4% 9 30 7 cytochrome c  
SO3509 40.5% 23 28 17.1% 10 12 7 beta-hexosaminidase b precursor (hex)  
SO3585 28.0% 6 8 0.0% 0 0 4 azoreductase, putative 
SO3599 80.0% 34 170 42.0% 13 18 17 
sulfate ABC transporter, periplasmic sulfate-
binding protein (cysP)  
SO3667 91.4% 33 281 25.2% 4 4 9 conserved hypothetical protein  
SO3669 69.6% 49 228 11.2% 4 4 17 heme transport protein (hugA)  
SO3914 61.7% 52 126 44.5% 30 49 17 TonB-dependent receptor, putative  
SO4743 74.1% 64 271 67.1% 46 100 17 TonB-dependent receptor, putative  
Down-regulated        
SO0441 41.3% 13 27 49.8% 23 70.5 13 phosphoribosylamine--glycine ligase (purD)  
SO1185 43.5% 10 28 38.2% 15 57 9 conserved hypothetical protein TIGR00092  
SO1519 30.9% 19 27 54.9% 33.5 63 7 iron-sulfur cluster-binding protein  
SO1776 17.0% 6 6 40.0% 30.5 35.5 3 outer membrane protein precursor MtrB (mtrB)  
SO1853 16.5% 6 7 29.3% 16 25.5 17 ABC transporter, ATP-binding protein  
SO2304 38.2% 10 27 47.6% 20.5 45 7 alanine dehydrogenase, authentic point mutation (ald)  
SO2590 16.3% 3 3 44.6% 16 23.5 18 GTP-binding protein  
SO2929 39.3% 10 14 69.6% 31 56 9 hypothetical protein  
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Table 4.4.  Continued 
 
0.5 mM Average Control Condition Average 
Locus % coverage peptide spectra % coverage peptide spectra 
Functional 
Category Description 
SO3783 12.6% 5 7 36.7% 14 16 16 ATP-dependent RNA helicase, DEAD box family  
SO3863 50.4% 11 22 68.6% 16.5 41 17 
molybdenum ABC transporter, periplasmic 
molybdenum-binding protein (modA)  
SO4053 13.5% 7 8 38.4% 18 25.5 4 methyl-accepting chemotaxis protein  
SO4066 20.3% 5 7 64.1% 25 36.5 13 
phosphoribosylaminoimidazole-succinocarboxamide 
synthase, putative  
SO4249 37.1% 6 11 47.1% 13.5 21.5 2 DNA/pantothenate metabolism flavoprotein (dfp)  
SO4513 19.8% 16 22 42.3% 42 67.5 7 formate dehydrogenase, alpha subunit  
aProteins in bold are found differentially expressed under all three Cr(VI) dosage conditions.  bFunctional Category number 
refers to the designation in Figure 4.2 as an abbreviation for the category name.   
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Table 4.5.  Selected Differentially Expressed Proteins Identified after Treatment with 1 mM K2CrO4a 
 
1.0 mM Average Control Condition Average 
Locus % coverage peptide spectra % coverage peptide spectra 
Functional 
Categoryb Description 
Up-regulated        
SO0343 48.0% 38 69 20.5% 14 14 7 aconitate hydratase 1 (acnA)  
SO0578 49.2% 32 68 29.6% 17 29 9 hypothetical protein  
SO1482 70.5% 60 160 52.2% 26 35 17 TonB-dependent receptor, putative  
SO2426 32.3% 8 13 0.0% 0 0 15 DNA-binding response regulator  
SO2903 90.7% 54 482 82.3% 36 150 1 cysteine synthase A (cysK)  
SO2912 62.7% 54 115 36.8% 26 57 7 formate acetyltransferase (pflB)  
SO3030 62.0% 30 77 4.0% 1 2 17 siderophore biosynthesis protein (alcA)  
SO3033 57.0% 46 158 27.5% 15 23 17 ferric alcaligin siderophore receptor  
SO3420 69.8% 20 66 54.4% 9 30 7 cytochrome c  
SO3577 58.8% 66 167 34.0% 33 51 11 clpB protein (clpB)  
SO3585 42.7% 10 32 0.0% 0 0 4 azoreductase, putative  
SO3599 81.4% 35 107 42.0% 13 18 17 
sulfate ABC transporter, periplasmic sulfate-
binding protein (cysP)  
SO3667 92.2% 34 241 25.2% 4 4 9 conserved hypothetical protein  
SO3669 72.4% 54 199 11.2% 4 4 17 heme transport protein (hugA)  
SO3737 67.0% 52 112 26.1% 14 20 5 
sulfite reductase (NADPH) hemoprotein beta-
component (cysI) 
SO3914 56.5% 53 217 44.5% 30 49 17 TonB-dependent receptor, putative  
SO4215 65.9% 31 90 45.9% 16 36 4 cell division protein FtsZ (ftsZ)  
SO4743 69.6% 61 266 67.1% 46 100 17 TonB-dependent receptor, putative 
SOA0048 45.6% 31 49 23.7% 12 15 11 prolyl oligopeptidase family protein  
Down-regulated        
SO0029 20.8% 7 12.5 30.7% 15 29 17 potassium uptake protein TrkA (trkA)  
SO0130 10.0% 4.5 5 29.6% 21 28 11 protease, putative  
SO0398 6.1% 2 2 28.5% 13 19 7 fumarate reductase flavoprotein subunit (frdA)  
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Table 4.5.  Continued 
 
1.0 mM Average Control Condition Average 
Locus % coverage peptide spectra % coverage peptide spectra 
Functional 
Categoryb Description 
SO0848 41.9% 34 60.5 66.4% 68 187 7 periplasmic nitrate reductase (napA)  
SO0902 24.8% 6.5 8 39.0% 16 22 7 
NADH:ubiquinone oxidoreductase, Na 
translocating, alpha subunit (nqrA-1)  
SO0907 11.9% 5 7 32.3% 15 19 7 
NADH:ubiquinone oxidoreductase, Na 
translocating, beta subunit (nqrF-1)  
SO1066 14.6% 6.5 6.5 36.9% 20 24 6 extracellular nuclease  
SO1424 23.0% 10 12.5 37.3% 25 29 9 hypothetical protein  
SO1776 9.0% 4 6 40.0% 31 36 3 outer membrane protein precursor (mtrB)  
SO1779 29.4% 17.5 25.5 47.9% 43 81 7 decaheme cytochrome c (omcA)  
SO2929 47.8% 14.5 21.5 69.6% 31 56 9 hypothetical protein  
SO3175 23.9% 13.5 15 40.3% 27 38 1 
asparagine synthetase, glutamine-hydrolyzing 
(asnB-2)  
SO4053 9.3% 6 19.5 38.4% 18 26 4 methyl-accepting chemotaxis protein  
SO4513 11.7% 8 11 42.3% 42 68 7 formate dehydrogenase, alpha subunit  
SOA0141 2.3% 1 1 51.4% 24 36 9 hypothetical protein  
aProteins in bold are found differentially expressed under all three Cr(VI) dosage conditions.  bFunctional Category number 
refers to the designation in Figure 4.2 as an abbreviation for the category name. 
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over the treatment conditions, with 9-13 categories represented in each dose (as outlined 
in detail below). 
Differentially Expressed Proteins After Exposure to 0.3 mM Cr(VI) 
Comparison of the 0.3 mM chromate-treated sample with the control sample 
revealed a total of 90 proteins that were differentially expressed in response to Cr(VI), 
with 26 proteins up-regulated and 64 proteins down-regulated.  Overall, representatives 
of transport and binding proteins dominated this subset of up-regulated proteins, with 
54% of the proteins annotated as such.  Twelve of the proteins had increased abundance 
levels only in response to the 0.3 mM chromate dose (dose-dependent expression) and 
included a conserved hypothetical protein (SO0564), TopB (DNA topoisomerase III), and 
a sigma-54 dependent response regulator (SO4718) (Supplemental Table S3).  The 
functional categories of hypothetical proteins with 12 members and cellular processes (in 
particular, chemotaxis and motility) with 8 members dominated the list of down-
regulated proteins with a total of 12 hypothetical and conserved hypothetical proteins 
unique to this dose.  The large proportion of repressed genes with unassigned cellular 
functions under this Cr(VI) dosage suggests that much remains to be explored in terms of 
the molecular response of MR-1 to chromate toxicity.  Of the two predominant functional 
classes, only SO2929 (a hypothetical protein) and SO4053 (a methyl accepting 
chemotaxis protein) consistently displayed down-regulated expression across all three 
chromate doses (Tables 4.3-4.5), indicating the greater influence of chromate 
concentration on the down-regulated protein expression profiles.  Interestingly, SO2929 
was also identified in another study [216] investigating S. oneidensis growth under 
aerobic conditions. 
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In response to the 0.3 mM chromate dose, 14 annotated transport and binding 
proteins were up-regulated and comprised members of a hemin ABC transporter complex 
(HmuT, HmuV), a heme transport protein (HugA), a TonB-dependent heme receptor 
(SO1580), siderophore biosynthesis proteins (AlcA, SO3032), a member (CysP) of a 
sulfate ABC transporter system, four putative TonB-dependent receptors (SO1482, 
SO3914, SO4077, SO4743), a ferric alcaligin siderophore receptor (SO3033), a ferric 
vibriobactin receptor (ViuA), and an iron-regulated outer membrane virulence protein 
(IrgA) (Tables 4.3-4.5 and Supplemental Table S3, Supporting Information).  The vast 
majority of these proteins have predicted functions in iron sequestration and transport, 
suggesting a possible linkage between chromate stress and iron transport and/or 
metabolism at the molecular level.  Interestingly, 10 of these putative transport and 
binding proteins (SO1482, AlcA, SO3032, SO3033, CysP, HugA, HmuT, HmuV, 
SO3914, SO4743) were identified as being up-regulated in response to all three chromate 
doses (Tables 4.3-4.5 and Supplemental Table S3, Supporting Information), whereas 2 
proteins (SO4077, IrgA) displayed a 0.3 mM chromate dose-dependent up-regulation 
(Table 4.3).  These proteomic results suggest that the 10 shared transport and binding 
proteins constitute part of the initial core molecular response to chromate exposure that is 
induced irrespective of environmental metal concentration.  Many of these initial 
responders are localized to the S. oneidensis outer membrane, periplasmic space, and the 
cytoplasmic membrane, all of which constitute cellular structures or compartments that 
are immediately impacted by metal stress and other environmental perturbations.  
SO1580 (a TonB-dependent heme receptor) and SO4516 (ViuA) were identified as being 
up- regulated upon challenge to 0.3 and 0.5 mM Cr(VI) but not to 1 mM, whereas, 
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SO3671 (TonB system transport protein ExbB1), SO4652 (sulfate ABC transporter Sbp), 
and SO4655 (sulfate ABC transporter CysA-2) were basically detected only in cells 
exposed to the higher Cr(VI) concentrations of 0.5 and 1 mM (Supplemental Table S3, 
Supporting Information).   
Certain proteins with predicted functions in transport and binding demonstrated 
dose-dependent down-regulation in response to 0.3 mM chromate.  For example, two 
proteins displaying decreased abundance in response to the 0.3 mM chromate dose were 
SO4598 and SOA0153, members of the CzcA family of heavy metal efflux pumps.  
However, these proteins were identified at low levels (2-4 peptides) under the other two 
Cr(VI) doses.  In bacteria, efflux pumps are a commonly employed metal resistance 
mechanism, with both plasmid and chromosomal systems, and active efflux of chromate 
appears to be a resistance strategy used by some microorganisms [126, 217].  At this 
point, it is not known what role, if any, efflux pumps are playing in the resistance of S. 
oneidensis MR-1 to chromate stress.  Perhaps these efflux pumps (SO4598 and 
SOA0153) are expressed only at higher (i.e., ≥ 0.3 mM) chromate concentrations or their 
expression is temporally controlled depending on the levels of accumulated intracellular 
chromate.  More detailed studies are needed to explore this efflux pump system down-
regulation, but are beyond the scope of this present study. 
In addition, proteins with annotated functions in chemotaxis (SO3052, SO3282, 
SO4454) and in the assembly of the flagellum (PomB, FliS, FlgH) were down-regulated 
only in response to the 0.3 mM chromate dose based on our analysis.  Two of these 
down-regulated proteins are the flagellar protein FliS, a chaperone, and the L-ring protein 
FlgH, a structural component of the flagellar apparatus.  FliS is the molecular chaperone 
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that ensures the prevention of premature folding and polymerization of FliC in the 
cytosol of the cell [218].  Under low dosage conditions as exhibited here, this protein is 
down-regulated, but the two encoded flagellum proteins (SO3237 and SO3238), which 
are structural components of the helical filament that extends outward from the cell, are 
not differentially expressed under the dosage conditions investigated here.  The down-
regulation of FliS has implications with respect to cytosolic polymerization of flagellin 
upon exposure to low doses of chromate.  Because assembly and rotation of the flagellum 
require an investment of energy by the cell, it seems reasonable that MR-1 might divert 
energy away from the production of flagella to cellular processes more directly involved 
in metal stress protection and detoxification. 
Differentially Expressed Proteins After Exposure to 0.5 mM Cr(VI) 
A total of 79 (40 up-regulated and 39 down-regulated) proteins were identified as 
being differentially expressed in cells challenged with 0.5 mM chromate for 30 min 
(Table 4.4 and Supplemental Table S3, Supporting Information) relative to the control 
culture.  The up-regulated proteins were distributed over 10 of the 18 functional 
categories, where the most prevalent category was transport and binding proteins 
(category 17).  Other notable functional categories represented in this dose response 
included hypothetical and conserved hypothetical proteins, with five members, and the 
unknown function category, with four members.  Transport and binding proteins were 
represented by 17 members, constituting 44% of the up-regulated proteins in this dose 
response group, with 12 also showing up-regulated expression under the 0.3 mM dose.  
Particularly noteworthy was the observation from these global proteomic studies that 
proteins involved in sulfate transport and sulfur metabolism displayed dose-dependent 
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up-regulation.  In Pseudomonas fluorescens, it was shown that chromate acts as a 
competitive inhibitor for sulfate uptake via sulfate active transport systems [149].  
Similarly, it is likely that chromate enters S. oneidensis MR-1 cells by energy-dependent 
sulfate transport mechanisms because of chromate’s structural similarity to sulfate [126, 
149, 154].  We hypothesize that the increase in abundance of sulfate transporters 
observed following chromate exposure could be the result of a decrease in intracellular 
sulfur due to competitive inhibition by chromate.   
Challenge with the 0.3 mM dose resulted in the up-regulation of only one protein 
involved in sulfate transport:  SO3599 (sulfate ABC transporter CysP) (Table 4.3).  
However, in response to 0.5 mM Cr(VI), we observed a substantial expansion in the 
number of up-regulated proteins detected for the sulfate transport and sulfur metabolism 
categories, with five additional representatives identified under this higher dose (Table 
4.4, Supplemental Table S3).  With the exception of SO3602 (CysA-1), six proteins with 
annotated roles in transport and binding and central intermediary metabolism [SO3599 
(CysP), SO3726 (CysN), SO3727 (CysD), SO3738 (CysJ), SO4652 (Sbp), and SO4655 
(CysA-2)] were also found to be up-regulated in response to 1 mM Cr(VI) treatment 
(Tables 4.4, 4.5 and Supplemental Table S3).  Three of these proteins are annotated as 
members of one of two sulfate ABC transporter systems found in the MR-1 genome and 
are located in gene clusters so3599-3602 or so4652-5.  With the reduction of Cr(VI) in 
the bacterium, the generation of an unstable Cr(V) intermediate produces reactive oxygen 
species and leads to an increase in oxidative stress[126, 140].  A possible explanation for 
the increased level of expression observed for certain sulfur metabolism proteins in this 
proteomic study may be due, in part, to an increased demand for protective thiol-
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containing compounds needed for coping with the oxidative stress imposed by sub-toxic 
metal exposures.   
 In addition, proteins with predicted functions in stress responses (IbpA) and DNA 
repair (RecN) showed increased abundance under 0.5 mM Cr(VI), indicating that this 
dose creates increased oxidative stress in the bacterium.  Two proteins, IbpA and RecN, 
were up-regulated at both the 0.5 and 1 mM Cr(VI) doses, while these same proteins 
were identified with a comparable number of peptides as the control under 0.3 mM 
Cr(VI) treatment, indicating no detectable differential expression.  However, both 
proteins exhibited greater abundance levels in response to the 1 mM dose compared to 
the 0.5 mM dose demonstrating an increased response with dosage.  With the 1 mM 
Cr(VI) dose, both the ATP-dependent ClpA and ClpB proteases were up-regulated.  Clp 
proteases have been shown to be involved in the cellular response to thermal and other 
types of cellular stress by working in conjunction with the chaperone proteins in 
Escherichia coli [219].  In addition, the expression of a putative azoreductase (SO3585), 
which is predicted to play a role in cellular detoxification, was detected only under 
chromate treatment, with an average of ~28 and ~43 % sequence coverage identified 
under 0.5 and 1 mM Cr(VI), respectively.  However, under the 0.3 mM dose treatment, 
SO3585 was not identified in the two analytical replicates, suggesting that this protein 
may be involved in metal detoxification mechanisms at higher chromate doses.  The 
increased expression levels of general stress response proteins, DNA repair proteins, and 
SO3585 indicate an elevated response to the Cr(VI) stress in the growth medium. 
Three members of the functional category energy metabolism were identified at a 
higher abundance level after exposing S. oneidensis to chromate.  One member (PrpC, a 
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methylcitrate synthase) is up-regulated under all three dosage conditions.  The second 
protein, Hex beta-hexosaminidase b precursor (SO3509), is only up-regulated in response 
to 0.5 mM chromate (Table 4.4), whereas SO3420 (cytochrome c) demonstrates 
increased abundance at higher levels of chromate (Tables 4.4 and 4.5).  This cytochrome 
c does not change its abundance under the control condition or the 0.3 mM chromate 
dose, with approximately 10 peptides identified under both conditions.  However, at a 
dosage of 0.5 and 1 mM chromate, the number of peptides identified increased to at least 
20 on average for cytochrome c, suggesting the possible involvement of SO3420 in the 
MR-1 response to chromate stress.  Previously, Myers et al [86] localized Cr(VI) 
reductase activity to the cytoplasmic membrane of anaerobically grown S. oneidensis.  
They concluded the possible involvement of cytochromes in the reductase activity, which 
is not inhibited by O2.  Also, Lovely and Phillips [214] identified the cytochrome c3 of 
Desulfovibrio vulgaris, a member of the δ-proteobacteria, as a Cr(VI) reductase.  Both 
studies either implicated or demonstrated the involvement of cytochromes in Cr(VI) 
reduction.   
Proteins identified as down-regulated using our semi-quantitation method totaled 
39 after cells were exposed to 0.5 mM chromate for 30 min, with the most dominant 
functional category being energy metabolism (category 7).  Most of the 8 energy 
metabolism proteins showing differential expression were annotated as dehydrogenases 
and reductases (Table 4.4 and Supplemental Table S3, Supporting Information).  With 
the exception of SO2304 and SO3546, all of the energy metabolism proteins down-
regulated under the 0.5 mM chromate condition were also down-regulated under the 0.3 
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mM dose.  There appears to be a similar response between the 0.3 mM and 0.5 mM 
doses; however, as detailed below, this is not the case with the 1 mM dose.  
Differentially Expressed Proteins After Exposure to 1 mM Cr(VI) 
The proteome response to 1 mM Cr(VI) was characterized by a total of 92 
proteins showing differential expression, with 66 proteins up-regulated and 26 proteins 
down-regulated (Table 4.5 and Supplemental Table S3, Supporting Information).  The 
functional category distribution among up-regulated proteins was similar to that elicited 
by the 0.3 mM dosage, where all but 5 of the functional categories were represented.  
There was a bias toward the following functional categories for up-regulated proteins:  
amino acid biosynthesis (7 proteins); cellular processes (4); central intermediary 
metabolism (6); energy metabolism (12); hypothetical and conserved hypothetical 
proteins (5); protein fate (7); and transport and binding proteins (14).  The subsets of 
transport and binding proteins that were differentially expressed in response to the three 
different chromate doses were very similar.  Exposure of cells to 1 mM Cr(VI) resulted in 
only one protein (SO1072, a putative chitin-binding protein) being unique to this dosage.  
The other two doses (0.3 and 0.5 mM) have a repertoire of more unique proteins in each 
category and share two other proteins not identified as up-regulated under the 1 mM 
chromate dosage (SO1580, a TonB-dependent heme receptor, and ViuA, ferric 
vibriobactin receptor).  The category of amino acid biosynthesis is only represented by 1 
member in the other two doses, whereas for the 1 mM Cr(VI)-treated sample there are 7 
members identified as up-regulated.  This same trend holds true for the functional classes 
of central intermediary metabolism, energy metabolism, and protein fate, which only 
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have up to 3 members in the other two Cr(VI) doses and 6-12 members with the 1 mM 
dose.   
Four proteins were identified as being up-regulated under the 1 mM dose and 
annotated as involved in cellular processes.  One of these proteins, a putative 
azoreductase (SO3585), demonstrates a dose-dependent response to Cr(VI) challenge and 
is up-regulated under the higher doses, as mentioned above.  There are two other proteins 
(SO3586 and SO3587) located immediately downstream of SO3585 in the MR-1 
chromosome that may be organized in an operon, as suggested previously [147].  SO3586 
encodes a glyoxalase family protein and SO3587 encodes a hypothetical protein with a 
putative transmembrane domain [147].  SO3586-87 have a reduced level of detection 
with respect to SO3585, where SO3587 is identified with no more than 4 peptides.  The 
predicted transmembrane-spanning domain of SO3587 comprises a 36 amino acid tryptic 
peptide (residues 38-73), which may contribute to the lack of identified peptides.  
SO3585-87 were identified solely under Cr(VI) challenge (Supplemental Table S2, 
Supporting Information).  This is in contrast to a previous study [147] in which SO3587 
was identified under both control and chromate treatments in response to temporally 
longer growth exposures (up to 90 min).  It is important to note that the previous study 
involved control samples grown for 45 and 90 min. prior to harvesting, whereas the 
current study has a control sample grown for 30 min.  After 90 min of exposure to 
Cr(VI), the growth rate of S. oneidensis decreased significantly with respect to control 
growth conditions (Supplemental Figure S1), whereas 30 and 45 min after introduction of 
Cr(VI) the difference is reduced.  Also, in the previous study, only two peptides were 
identified for SO3587 in the 45 min control with the difference between them resulting 
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from a missed cleavage.  However, since SO3587 is located at the terminus of the operon, 
the gene may not be translated to the same frequency perhaps due to the ribosome 
disengaging from the mRNA.  This has been shown in E. coli using a fabricated 
betagalactosidase hexamer transcriptional unit,where the ribosome disengaged from the 
mRNA approximately half of the time when reaching the third copy of the gene [220]. 
An important class of proteins involved in signal transduction consists of 
relatively low-abundance proteins, with only about 50 members confidently identified at 
the two-peptide level under a given growth condition using the LTQ (Figure 4.2).  Of 
these 50 proteins, two (SO2426, a DNA-binding response regulator, and SO4003, a 
response regulator) were up-regulated under doses 0.3 and 1 mM Cr(VI).  Only one of 
these proteins (SO2426) was also up-regulated in response to the 0.5 mM dose (Tables 
4.3-4.5).  SO2426 was exclusively detected in the Cr(VI) treatment samples under all 
three doses relative to the control sample, and a MR-1 strain harboring an in-frame 
deletion of this gene showed impaired growth and Cr(VI) reduction activity under metal 
conditions (K. Chourey and D. K. Thompson, unpublished data), thus suggesting that this 
signal transduction component plays a regulatory role in the cellular response to chromate 
stress.  Also, in a previous study [147], the transcript data for the so2426 gene was 
consistent with the corresponding protein expression data.  
As described above, proteins involved in general stress responses in the bacterium 
were up-regulated at a dosage of 0.5 mM Cr(VI).  In addition to IbpA (16 kDa heat shock 
protein A) and RecN (a DNA repair protein), ClpB, PrlC, and a prolyl oligopeptidase 
family protein (SOA0048) were all up-regulated in response to 1 mM Cr(VI) exposure.  
Jiang et al concluded that PrlC in E. coli functions as a molecular chaperone [221].  The 
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greater degree of oxidative stress imposed by the higher 1 mM Cr(VI) dose correlates 
with the increased number of up-regulated proteins involved in stress protective response 
and protein fate determination.   
A subset of 26 down-regulated proteins identified following acute exposure to 1 
mM Cr(VI) displayed a trend similar to the other two dosages.  The two dominant 
categories, energy metabolism and hypothetical/conserved hypothetical proteins, 
constituted almost 60% of the proteins down-regulated under 1 mM Cr(VI) challenge.  
Interestingly, a large number of energy metabolism proteins were also up-regulated under 
this dosage.  Of the 308 energy metabolism proteins predicted from the MR-1 genome 
annotation, 183 were identified confidently at the two-peptide level representing almost 
60% of the predicted total.  Of these 183 proteins, 21 were differentially expressed under 
the 1 mM dose.  Five of the down-regulated energy metabolism proteins are annotated as 
reductases, which might suggest a reconfiguration of energy metabolism by the cell in 
response to chromate stress. 
Conclusions 
The work presented here provides the first large-scale description (2406 proteins) 
of the proteome response of S. oneidensis to three different acute chromate concentration 
challenges.  Approximately 90% of the proteins identified did not demonstrate a change 
in abundance in response to chromate treatment; however, the remaining 10% of proteins 
that demonstrated an abundance change in response to chromate (Tables 4.3-4.5 and 
Supplemental Table S3, Supporting Information) provided some important insights into 
the molecular response to chromate insult.  Among the up-regulated proteins identified, it 
was clear that both general stress and specific chromate responses were elicited.  
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Primarily, the up-regulated sulfate transport system under higher chromate dosage (> 0.5 
mM) suggested an increased demand for sulfate uptake and metabolism, possibly due to 
sulfate deficiency in the bacterium.  Sulfate deficiency could lead to a decrease in the 
biosynthesis of certain amino acids (i.e., methionine and cysteine) and this may explain 
why there are many more down-regulated proteins under the lower dosage.  Out of the 11 
genes encoding members of the cytsteine metabolism pathway, none were differentially 
expressed subsequent to 0.3 mM Cr(VI) exposure and one protein (SO2903, CysK) was 
up-regulated at a dosage of 0.5 mM.  However, subsequent to the addition of a 1 mM 
Cr(VI) dosage, four proteins in the cysteine metabolism pathway were up-regulated:  
SO1095 (a putative O-acetylhomoserine (thiol)-lyase), SO2406 (AspC-2), SO2903 
(cysK), and SO3598 (cysM).  The methionine metabolism pathway is composed of 12 
protein-encoding genes and demonstrated one up-regulated protein in the 1 mM dosage 
sample, SO1095.  The 0.5 and 1 mM dosages may be compensating for sulfate deficiency 
with the apparent increased production of sulfate transport and metabolism protein 
complexes.  Also, during Cr(VI) reduction, a one-electron transfer can occur producing 
the metastable, highly reactive Cr(V) species [140] leading to an increase in reactive 
oxygen species within the cytoplasm.  Both of these response systems may lead to the 
observed proteome changes detected in this study.  There were at least three general 
stress response proteins up-regulated as well under each dose, indicating a general stress 
response similar to other stress-response proteome studies [222]. 
The functional category of transport and binding proteins, particularly those with 
annotated functions in iron and sulfate transport, dominated the group of up-regulated 
proteins.  Most of the TonB-dependent receptors and other iron acquisition proteins (e.g., 
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siderophore biosynthesis proteins) showed increased abundance under all three Cr(VI) 
dose exposures, indicating that expression of these proteins is an important feature of the 
MR-1 response to chromate.  In addition, proteins whose abundance levels behaved in a 
dose-dependent manner were identified by examining differences in peptide spectral 
counts between samples.  Most of these transport and binding proteins were highly up-
regulated under the 0.3 mM dosage and increased when challenged with 0.5 mM but 
remained the same between the 0.5 and 1 mM dosages (Figure 4.4).  This was the general 
trend for most differentially expressed proteins, as illustrated by binning and comparing 
the relative abundances of the proteins between the 0.3 mM and 1.0 mM dosage 
conditions (Figure 4.5).  Whereas more than 50 proteins that were up-regulated relative to 
the control showed no change between the 0.3 mM and 1.0 mM conditions, there were 
almost twice as many proteins up-regulated in the 1.0 mM condition relative to the 0.3 
mM condition.  Many fewer proteins were down-regulated in the 1.0 mM condition.   
Table S4 (see Supporting Information) lists the identities and spectral count ratios of all 
proteins shown in the bins of Figure 4.5. 
Recently, an instrumentation comparison study between the linear trapping 
quadrupole and the three-dimensional ion trap for the proteome of the model organism E. 
coli OP50 was published [31], with similar results to the study discussed here.  Our 
present study confirmed the substantially increased ability to identify proteins at the two 
peptide level in the LTQ datasets, with many proteins identified as being differentially 
expressed that were not even detected with the three-dimensional quadrupole ion trap.  
One objective of our present study was to conduct a direct comparison between the QIT 
and LTQ technology platforms to determine which would provide more extensive insight 
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Figure 4.4.  Proteins demonstrating dosage-dependent up-regulation. 
Proteins up-regulated under all dosages tested, but were at similar levels of up-regulation 
under 0.5 and 1 mM dosages.  SO0344:  methylcitrate synthase (prpC), SO2426:  a DNA-
binding response regulator, SO3032:  a putative siderophore biosynthesis protein, 
SO3673:  the periplasmic hemin-binding protein of the hemin ABC transporter (hmuT), 
and SO4743:  a putative TonB-dependent receptor. 
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Figure 4.5.  Dosage dependent abundance of proteins between 0.3 and 1 mM dosages. 
A comparison of the relative abundances of proteins identified as differentially expressed 
between the 0.3 and 1 mM Cr(VI) dosage datasets (Supplemental Table S3).  The x-axis 
represents the relative change in protein expression (1.0 mM / 0.3 mM), where the first 
two bins represent reduced abundance of proteins in the 1 mM dose, the third bin are the 
proteins that have the same concentration level in both dosages, and the last three bins 
represent proteins with increased abundance in the 1 mM dosage.  The y-axis represents 
the number of proteins found in each bin out of a total of 153 differentially expressed 
proteins.  Supplemental Table S4 contains the proteins identified under each bin. 
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into the molecular response of S. oneidensis to dosage-dependent chromate insult.  In 
addition to a substantially deeper level of proteome characterization, the LTQ datasets 
should provide a much better degree of correlation with differentially expressed 
transcriptome data determined with microarray measurements.  Furthermore, the LTQ 
datasets provided information about low-abundance proteins not identified by the three-
dimensional ion trap.  Proteins involved in transcription regulation are generally of low 
abundance, such as SO2426, a DNA-binding response regulator.  With LTQ technology, 
the detection of SO2426 and other proteins with regulatory functions was achievable.  In 
fact, SO2426 was identified only under chromate exposure and correlated with the results 
from a previous study [147], where the transcript levels were also up-regulated in 
response to acute chromate challenge. 
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Chapter 5 
Systematic Assessment of the Benefits and Caveats in Mining Microbial Post-
Translational Modifications from Shotgun Proteomic Data; Response of Shewanella 
oneidensis to Chromate Exposure 
Text and data presented below has been accepted for publication 
 
Melissa R. Thompson, Dorothea K. Thompson, and Robert L. Hettich.  Systematic 
Assessment of the Benefits and Caveats in Mining Microbial Post-Translational 
Modifications from Shotgun Proteomic Data; Response of Shewanella oneidensis to 
Chromate Exposure.  Journal of Proteome Research, Accepted, (2007).  Melissa R. 
Thompson performed all data analysis.  Supplemental material located at Journal of 
Proteome Research website.  
 
 
Introduction 
During the course of examining the global proteomic response of chromate 
exposure in Shewanella oneidensis, the need to obtain information on post-translational 
modifications (PTMs) involved in chromate response arose.  PTMs are enzymatically-
driven chemical changes to amino acids and constitute one mechanism used by microbes 
to regulate both protein synthesis and activity.  Therefore, we expect that PTMs will 
contribute to the response of S. oneidensis to Cr(VI) exposure.  This chapter outlines 
three algorithms evaluated for the purpose of providing a foundation for global PTM 
searches, which has to date been unexplored.   
Protein activity can be modulated via the addition and/or removal of PTMs, which 
act to repress or stimulate target protein function [223].  Some common PTMs include 
phosphorylations, methylations, acetylations, and oxidations.  Methylations and 
acetylations in bacteria typically occur on lysine and arginine residues [14, 223].  
 127 
Methylation modifications have been implicated in regulation of gene expression as well 
as protein-protein and protein-DNA interactions (i.e. the histone code) [14].  In bacterial 
chemotaxis, which is the response to a chemical gradient of attractant or repellent 
molecules, methylation is involved in the adaptive mechanism and short-term memory 
abilities of methyl-accepting chemotaxis receptor proteins (chemoreceptors) [54, 224].  
Two enzymes, a methyltransferase (CheR) and a methylesterase (CheB), function to 
covalently attach and remove a methyl group, respectively, from the chemoreceptor.  
Acetylations have also been shown to be involved in bacterial chemotaxis [53] and 
provide protein terminus stability in eukaryotes [50, 225] as well.  For example, the 
ability of the chemotactic response regulator CheY to activate the flagellar switch is 
enhanced upon acetylation [53].  In contrast to the above PTMs, modification via the 
oxidation of a protein can be due to either chemical [46, 47, 226] or in some cases 
biological [227, 228] mechanisms.  Free radicals formed during aerobic cellular 
metabolism are highly reactive and often damaging proteins abundant within the cytosol 
through oxidation [46, 47].  Detecting the level of chemically-induced oxidation of the 
proteome has been hypothesized as a way to determine oxidative stress levels in 
organisms [46].  In eukaryotes, a well studied enzymatically driven oxidation conversion 
of the protein ubiquinol to ubiquinone, a vital component of the electron transport chain 
in mitochondria, is mediated by the cytochrome bc1 complex [228]. 
 To date, most studies detecting PTMs in both prokaryotes and eukaryotes have 
been accomplished using targeted approaches [48, 50, 229, 230] by purifying protein(s) 
or enrichment of a specific PTM.  A study by MacCoss et al [51] was one of the first 
attempts at a more global approach by searching shotgun proteomic data for PTMs.  In 
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this study, the authors purified the Schizosacchromyces pombe Cdc2p complex as well as 
proteins from human lens tissue.  Using a three-dimensional ion trap, they were able to 
characterize a number of PTMs, including phosphorylations, methylations, and 
acetylations.  The tandem mass spectra (MS/MS) searches were accomplished with an 
initial search where no modifications were specified, followed by the creation of a sub-
database to re-search the data for PTMs [51].  The sub-database was created taking 
identifications made by an initial search specifying no modifications and the -98 Da loss 
common to phosphorylated peptides using the collision induced dissociation (CID) 
fragmentation method.  The building of a sub-database was necessary for this work in 
order to reduce the false discovery rate (FDR) of identified PTM-containing peptides due 
to the combinatorial increase in database search space generated by including PTMs. 
 In 2004, Strader et al [48] published a comprehensive characterization of the 70S 
ribosome from Rhodopseudomonas palustris.  The 70S ribosome was characterized using 
the top-down bottom-up technique, wherein PTM information was acquired from both 
the intact protein mass spectral data and peptide MS/MS data.  The term top-down refers 
to the measurement of the intact protein, while bottom-up corresponds to first digesting 
proteins followed by acquisition of fragmentation MS leading to sequencing information 
on the proteolytic peptides.  The authors were able to confirm and identify novel PTMs 
present on the constituent proteins of the complex.  One of the primary advantages of the 
top-down approach is the use of a high-resolution mass spectrometer (i.e. FT-ICR) to 
discern the difference between a trimethylation and an acetylation, which are isobaric on 
a lower resolution instrument (i.e. a 3-D or linear ion trap).  Nielsen et al [231] further 
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demonstrated the utility of a high-resolution instrument (LTQ-FT hybrid instrument) for 
reducing the FDR of PTM peptides. 
 Phosphorylations are prevalent PTMs in both eukaryotes and prokaryotes.  These 
PTMs play important roles in cell signaling cascades, specifically two-component signal 
transduction [232, 233], and in the regulation of cell cycle progression and cellular 
differentiation [223].  Phosphorylation sites play a critical role in both normal and 
diseased cell function, making them important targets for global studies.  Phosphorylation 
in prokaryotes usually targets histidine and aspartic acid residues, producing modified 
species which are known to be acid labile and often do not survive the sample handling 
process for subsequent MS analysis.  This usually precludes searching for 
phosphorylation in prokaryotic proteome studies.  In contrast, phosphorylation in 
eukaryotes usually targets threonine and serine residues; these modified species are much 
more stable and survive the sample handling process.  Unfortunately, most of these 
modified residues readily display phosphate neutral loss as the dominant fragmentation 
pathway when a low-energy, multiple collision fragmentation method is used [51, 233], 
thereby precluding information about the modification site.  Nevertheless, Olsen et al 
[55] were able to identify and quantitate 6600 phosphorylation sites in HeLa cells using 
an LTQ-FTICR.  To address the neutral loss problem, the authors performed MS/MS/MS 
to obtain more sequencing information on the modified peptide. 
All of the aforementioned studies were targeted, whether that target was a protein 
complex (Cdc2p [51] or 70S ribosome [48]), a subset of proteins [230], or an enrichment 
due to the presence of a specific modification [55, 56, 58, 234].  As such, none of these 
targeted studies provides guidance on performing a truly non-biased global analysis of 
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PTMs in eukaryotes or prokaryotes.  In addition, most PTM studies to date have focused 
on eukaryotic systems [46, 181, 223, 231, 234-236].  Since protein post-translational 
modifications also play a critical role in bacterial cellular processes, it is important to 
evaluate and optimize informatic methods which can accurately unravel this level of 
proteome detail.  The goal of the present work is to identify a robust and accurate method 
for performing global PTM searches of shotgun proteomics data for microbial isolates.  
To this end, we searched a previously acquired shotgun proteomics dataset [147] derived 
from control (non-stressed) and chromate-stressed S. oneidensis cells in order to examine 
the potential roles of PTMs in the cellular response to acute metal challenge. Three 
search algorithms (DBDigger [44], InsPecT [40], and Sequest [39]) were employed to 
test the feasibility of performing a PTM search on a proteome and determine the 
feasibility of each method to provide detailed PTM information at an acceptable false 
discovery rate.  Since the false discovery rate will increase with increasing search space, 
this work is a systematic attempt to compare different algorithmic tools on the same 
dataset for their efficacies in managing false positive rates.  In addition, the search results 
for each algorithm were compared for overlap in PTM identifications as a method of 
validation, the ease of conducting searches using a standard desktop computer, and the 
flexibility in specifying PTMs in the search parameters. Note that this study was focused 
on data mining of peptide MS/MS data, and did not attempt to provide PTM 
heterogeneity at the protein level. 
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Materials and Methods 
Experimental dataset 
The shotgun proteomics dataset used in the PTM searches was acquired 
previously [147].  Briefly, four separate cultures of S. oneidensis MR-1 were grown 
aerobically to mid-log phase followed by addition of a sub-lethal dose (1 mM) of K2CrO4 
to two of the cultures, which were exposed to chromate for 45 or 90 min and then 
harvested for proteome characterization.  The other two cultures served as controls and 
were grown in parallel under identical conditions excluding metal addition.  The goal of 
the previous work was to identify differentially expressed proteins implicated in the 
response to a sub-lethal, acute chromate exposure [147].  Cultures were lysed by 
sonication and fractionated into a crude/soluble and membrane-associated fraction by 
high-speed centrifugation.  Lysates were then digested with trypsin and analyzed via 
online two-dimensional liquid chromatography (strong cation exchange and reverse 
phase) coupled to a LTQ mass spectrometer (Thermo Scientific, Waltham, MA).  The 
LTQ was operated in a data-dependent mode for 24 h, and digested lysates were analyzed 
in duplicate.  
Computational searches and algorithms 
The above data (a total of 8 datasets) was searched using three separate search 
algorithms:  DBDigger [44], InsPecT [40], and Sequest [39].  The database(s) used for all 
searches performed can be downloaded from the project website compbio.ornl.gov/ 
shewanella_metal_stress/databases/.  A reverse database was used for estimating the FDR 
in this study by applying the equation from Peng et al [185].  The use of a reverse 
database is one method to estimate the FDR, where peptide(s) and/or protein(s) matching 
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nonsense sequences from the reverse database are considered incorrect identifications.  
The false negative rate is a more difficult number to quantify in shotgun proteomics 
datasets, because the exact number and identity of all true peptide identifications are 
unknown.  This number was qualitatively determined in the datasets presented here by 
comparing the total number of peptides or proteins identified in the unmodified searches 
to the searches specifying PTMs. 
In our lab, DBDigger has been the algorithm of choice for PTM searches, because 
it allows simultaneous evaluation of sequentially modified forms of individual amino 
acid residues in the same peptide.  DBDigger was used initially to develop proper 
filtering thresholds.  The following PTMs were specified in separate DBDigger searches:  
(1)mono-, (2)di-, and (3)trimethylations on lysines and arginines; (4)monomethylations 
on glutamate; (5)mono- and (6)diacetylations on lysines and arginines; and 
(7)monooxidations on methionines, cysteines, tyrosines, and tryptophan; dioxidation on 
methionines and cysteines; and trioxidation on cysteine residues.  Table 5.1 depicts the 
modifications and corresponding residue mass shifts that were targeted in the present 
study.  Due to the use of an LTQ mass spectrometer in this study, phosphorylations were 
not searched in the resulting datasets.  Results from DBDigger were stored in the form of 
.sqt files that were then filtered and sorted using DTASelect [171] with the following 
options:  -m 0 (extracts only modified peptides) and --DB (exports results in database 
format).  The resulting DTASelect output files were imported into Microsoft Access for 
storage and data analysis.   
Sequest searches were performed on a subset of mass spectra initially identified as 
PTM-containing by DBDigger as follows:  selected DTA files were extracted from one 
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Table 5.1.  Amino Acid Residues and Corresponding Post-translational Modifications 
 
Amino Acid PTMa Amino Acid Mass 
(Da) 
Amino Acid + PTM mass (Da) 
Lysine +CH2 128.09 142.11 
Lysine +C2H4 128.09 156.12 
Lysine +C3H6 128.09 170.14 
Lysine +COCH2 128.09 170.10 
Lysine +C2O2C2H4 128.09 210.11 
Arginine +CH2 156.10 170.12 
Arginine +C2H4 156.10 184.13 
Arginine +C3H6 156.10 198.15 
Arginine +COCH2 156.10 198.11 
Arginine +C2O2C2H4 156.10 238.12 
Glutamic Acid +CH2 129.04 143.06 
Methionine +O 131.04 147.03 
Methionine +O2 131.04 163.02 
Cysteine +O 103.01 119.00 
Cysteine +O2 103.01 134.99 
Cysteine +O3 103.01 150.99 
Tryptophan +O 186.08 202.07 
Tyrosine +O 163.06 179.05 
aEmpirical formula for post-translational modification 
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directory and placed into another directory using DTACopy (Vilmos Kertesz, Oak Ridge 
National Laboratory) and results were filtered and sorted using DTASelect as described 
above.  Since Sequest is only able to search three modifications at a time, the above DTA 
files were searched repeatedly until all of the above modifications had been specified in 
the sequest.params file (total of 8 searches for each dataset).  InsPecT searches were 
performed in one search where all 8 modification events on 7 amino acids were specified 
(Table 5.1).  A total of 3 modification events were allowed for each peptide.  The 
following filter levels were used for the InsPecT dataset:  a minimum of 2 peptides 
identified per protein and a p-value score that gives a FDR of 2% for the total peptide 
dataset (see InsPecT scoring optimization for post-translationally modified peptides for 
details).  The results were then imported into Access in order to compare the PTM 
identifications with the DBDigger results. 
Results and Discussion 
DBDigger scoring optimization for post-translationally modified peptides 
Initially, searches were performed using the DBDigger algorithm on the 45 min 
Control dataset in order to determine the correct filter thresholds for minimizing the FDR 
and false negative rate.  The 45 min Control Run1 dataset was searched using two 
methods:  (1) raising the scoring threshold levels and (2) creating a sub-database prior to 
PTM searches applying loose filtering criteria and no modifications.  As a comparison, 
all searches were performed either with no modifications specified or with 
monomethylations on lysines and arginines.  This particular PTM was chosen first due to 
the small mass shift in the amino acid residue by the addition of a methyl group, and 
preliminary searches demonstrated a high FDR through the use of a reverse database with 
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this modification.  Table 5.2 depicts the FDRs for a number of filter threshold levels 
tested and demonstrates a basic premise of data filtering in shotgun proteomics at present.  
This premise is that care must be taken in order to maximize the number of resulting 
peptide identifications made while minimizing the FDR of the filter threshold levels 
chosen.  As a control, the dataset was searched with no modifications using “normal” 
filtering levels that give a FDR of 2.6% at the two peptide threshold level corresponding 
to the minimum peptide score of 25 for +1 peptides, 30 for +2 peptides, and 45 for +3 
peptides using DBDigger.  Using these same scoring minima, the addition of a 
differential modification (monomethylation) to lysines and arginines raises the FDR to 
7.6%.  The increased FDR is expected and is caused by the combinatorial increase in 
database search space due to the modification.  Increasing the minimum peptide level for 
protein identification to four decreased the FDR to 1.7%; however, this also led to a 
dramatic decrease in the number of proteins identified.  Therefore, the decision was made 
to pursue increasing the minimum peptide score while retaining the minimum two 
peptides for protein identification.  Increasing the minimum scores to 29 (+1), 34 (+2), 
and 49 (+3) leads to a FDR of 1.9%, while maintaining a protein identification level 
similar to the non-modification search.  There was less of a reduction in protein 
identifications using stringent peptide scoring filters (283 proteins) than by increasing the 
minimum peptide count to four (585 proteins), demonstrating a relatively lower false 
negative rate for the stringent peptide scoring filters. 
The other option explored for retaining a FDR of 2%, while identifying at least a 
similar number of proteins compared to a non-modification search, is to construct a sub- 
database for subsequent PTM searching.  This was performed by MacCoss et al [51] on a 
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Table 5.2.  False Discovery Rates for 45min Control Run1 Dataset at Various Filter Threshold Levels 
 
 2 peptide filter level 4 peptide filter level 
No PTM Protein Peptide Protein Peptide 
25, 30, 45a 156b 2111c 14.8%d 333e 25943f 2.6%g 9 1443 1.2% 17 24390 0.1% 
27, 32, 47 68 1933 7.0% 136 24111 1.1% 7 1383 1.0% 8 22817 0.1% 
29, 34, 49 20 1816 2.2% 37 22643 0.3% 3 1326 0.5% 3 21482 0.0% 
             
 2 peptide filter level 4 peptide filter level 
Monomethylation Protein Peptide Protein Peptide 
25, 30, 45 427 2560 33.4% 1069 28112 7.6% 51 1526 6.7% 224 25690 1.7% 
27, 32, 47 215 2146 20.0% 503 25388 4.0% 21 1420 3.0% 75 23685 0.6% 
29, 34, 49 96 1924 10.0% 217 23330 1.9% 9 1343 1.3% 25 21952 0.2% 
31, 36, 51 50 1818 5.5% 106 21764 1.0%       
35, 40, 55 15 1689 1.8% 32 19089 0.3%       
aMinimum peptide scores for +1, +2, and +3 charged peptides, respectively.  Number of proteinsb or peptidese identified 
matching to reverse database sequences.  Total number of proteinsc or peptidesf identified from both the forward and reverse 
databases.  d,gFalse discovery rate value calculated as described in Peng et al [185]. 
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yeast protein complex and human lens tissue.  The sub-database in this study was 
constructed by using loose filtering criteria in an initial non-modification search.  The 
filtering criteria were as follows:  1 peptide minimum for protein identification and 
peptide scores of 25 (+1), 30 (+2), and 45 (+3).  These criteria were chosen since the 
minimum score will filter out 92.4% of the false peptide identifications, but retain a 
reasonable database size so that when the modification search is done, the identification 
of a protein with one modified and one unmodified peptide is possible.  The sub-database 
consists of 2,751 forward protein sequences plus their corresponding reversed sequences, 
thus yielding a total database size of 5,502 protein sequence entries.  The normal S. 
oneidensis proteome database size is 4,798 forward protein sequences; therefore, the sub-
database reduced the number of protein entries by approximately half.  After the sub-
database was created, a modification search for monomethylations on lysines and 
arginines was performed with the following threshold filters:  “normal” [2 peptides per 
protein, 25 (+1), 30 (+2), and 45 (+3)] and “stringent” [2 peptides per protein, 29 (+1), 34 
(+2), and 49 (+3)].  The “normal” filters yielded a FDR of 7.1% and the “stringent” filters 
1.8%.  These FDRs are similar to those above for the full-size database, and comparing 
the peptides identified with both strategies leads to an overlap in identification of 90% 
(Figure 5.1).  The use of a sub-database for PTM searches on bacterial species does not 
appear to be necessary based on the results obtained here.  The caveats of first creating a 
sub-database include the added complexity of performing two searches for each dataset, 
creating a separate database for each dataset, and a relatively insignificant decrease in 
overall search time.  Therefore, the decision was made for the remaining searches to use a 
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Figure 5.1.  A Venn diagram comparing peptide identifications. 
The results are from a search for monomethylations on lysines and arginines by two 
different search methods.  The circle on the left represents the modification search with 
the sub-database and the circle on the right represents the modification search with the 
full-size database and stringent filters.  The value in the middle (522) is the number of 
modified peptide identifications shared between the two methods and corresponds to a 
90% overlap between the two methods. 
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full-size database with the stringent filters [2 peptides per protein, 29 (+1), 34 (+2), and 
49 (+3)]. 
 Using the above threshold filters, many peptides with putative PTMs were 
identified with the search algorithm DBDigger [44].  DBDigger allows more flexibility in 
searching for differential PTMs than the search algorithm Sequest, because it generates a 
candidate sequence once for the collection of spectra rather than once for every spectrum 
and is much faster in searching complex datasets [44].  Therefore, initial searches with 
DBDigger were conducted in order to obtain a preliminary list of putative modified 
peptides.  There were a total of 8494, 7203, 9358, and 6588 non-redundant peptides, 
respectively, containing at least one post-translationally modified amino acid residue for 
the 45 min Control, 45 min Cr, 90 min Control, and 90 min Cr datasets.  Table 5.3 
displays the number of peptides identified in each dataset for the PTMs specified, and all 
modified peptides are listed in Supplemental Tables S1 and S2 (Supporting Information).  
However, as also depicted in Table 5.3, the FDR for modified searches is high (~50%) 
compared to the overall FDR described in Table 5.2.  This high FDR led to the testing of 
two other algorithms (InsPecT [40] and Sequest [39]) to determine if the FDR of a PTM 
search could be improved.  
Sequest scoring optimization for post-translationally modified peptides 
MS/MS in the form of DTA files (tab-delimited flat-files for each spectrum) 
identified as PTM-containing peptides from the above DBDigger searches were extracted 
using DTACopy (Vilmos Kertesz, ORNL) and interrogated with the algorithm Sequest.  
This algorithm was chosen in order to help validate the DBDigger results since Sequest is 
a widespread algorithm for searching shotgun proteomics data.  Only selected MS/MS 
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Table 5.3.  Number of Post-Translationally Modified Peptides Identified in Each Dataset Searched using DBDigger 
 
Modification Type 45 min Control FDRa 45 min Cr FDR 90 min Control FDR 90 min Cr FDR 
Monomethylation 1147b 53.9% 1167 62.4% 1356 45.7% 902 53.8% 
Dimethylation 1058 N/Ac 852 N/A 951 N/A 890 N/A 
Trimethylation 889 N/A 769 N/A 798 N/A 720 N/A 
Monoacetylation 709 62.1% 594 65.3% 619 59.0% 557 65.5% 
Diacetylation 779 N/A 669 N/A 667 N/A 620 N/A 
Oxidation 5567 8.0% 3940 8.6% 7068 4.2% 3209 9.3% 
aFDR:  false discovery rate.  bNumber of PTM peptides identified.  cN/A:  not available 
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first identified by DBDigger were searched due to the slower speed of Sequest on desktop 
computers.  The resulting OUT files were filtered and sorted with DTASelect [171].  The 
filtering thresholds used in the Sequest searches were a one-peptide requirement for 
protein identification and 1.8 for +1 charged peptides, 2.5 (+2), and 3.5 (+3).  Table 5.4 
gives the number of peptides identified using Sequest as well as the number of MS/MS 
searched (DTA files extracted). 
As apparent in Table 5.4, the number of MS/MS identified in the Sequest searches 
compared to the total number searched is much lower for all PTMs considered.  There are 
two possible reasons for this low identification rate using Sequest:  one is due to the high 
FDR of PTM-containing peptides obtained with DBDigger, and the other may be the 
result of the search algorithm itself.  Concerning the high FDR, the average for 
monomethylated peptides was 54% using DBDigger.  In addition, the Sequest searches 
were performed on all MS/MS spectra identified by DBDigger as containing a PTM 
including MS/MS identified from relevant reverse database searches and matching 
protein contaminant sequences.  Therefore, the MS/MS count is somewhat inflated with 
erroneous identifications (false-positives from the reverse database) and protein 
contaminant identifications.  The inflated MS/MS count may be an underlying cause of 
the low identification rate from Sequest.   
The second possible reason for the resulting low identification rate may lie in the 
fact that Sequest was not originally designed to search for differential PTMs.  The 
original design of the algorithm required that the PTM mass (i.e. 14 Da for 
monomethylation) be added to the amino acid mass [i.e. 14 Da + lysine (128.09 Da)] with 
the modification considered static or always present [39].  This search method is limiting, 
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Table 5.4.  Sequest Peptide Identifications from a Subset of MS/MS Spectra First Identified by DBDigger 
 
Monomethylation Dimethylation Trimethylation Monoacetylation Diacetylation Oxidation 
Dataset Spectra Identified Spectra Identified Spectra Identified Spectra Identified Spectra Identified Spectra Identified 
45 min Control 1363 314 967 172 776 123 887 123 749 73 6044 3480 
45 min Cr 1357 406 790 136 669 116 719 95 647 73 4371 2352 
90 min Control 1558 456 885 159 682 111 716 78 628 74 7388 4770 
90 min Cr 1059 248 808 140 628 89 680 74 580 70 3549 1896 
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resulting in both a decrease in peptide identifications and an increase in incorrect 
identifications.  A subsequent version of Sequest will only allow 3 differential 
modifications to be specified, while DBDigger allows an unlimited number of PTMs to 
be specified in the search parameters.  This limitation leads to reduced identifications, 
since different modifications can occur on the same peptide and result in a total of 32 
separate searches performed on the datasets.  This is a significant issue with the oxidation 
dataset (total of 7 modifications on 4 amino acids), where DBDigger completed the 
search in one round while Sequest required 3 separate rounds.  Therefore, the Sequest 
results were noted and can be found in Supplemental Tables S3-S6 but were not used for 
validation. 
InsPecT scoring optimization for post-translationally modified peptides 
Due to difficulties with Sequest and the high FDR of DBDigger when considering 
PTM-containing peptides only, the decision was made to search the datasets using the 
algorithm InsPecT [40].  Compared to DBDigger and Sequest, InsPecT uses a different 
approach to searching MS/MS for PTMs.  The first stage in filtering for InsPecT is to 
create a set of tags (25 were specified in the searches performed here) three amino acids 
in length using fragment ions in the experimental MS/MS.  This enables a relatively short 
list of peptides to be searched from the forward and reverse sequence database used here.  
The resulting candidate peptides are scored based on seven different criteria:  the number 
of predicted (1) b and (2) y ions that match to the MS/MS, how well the intensity of the 
identified (3) b and (4) y ions match the predicted intensity, (5) trypsin specificity, (6) the 
length of the candidate matching peptide where the presence of PTM(s) indicates a 
shorter peptide, and (7) the fragment ion profile of the spectrum (presence of an isotope, 
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higher fragment ion intensity in the middle of the spectrum, and properties of the 
neighboring residue) [40].  The resulting top score (MQScore) is then compared to the 
distribution of the lower scores (DeltaScore) and a p-value is calculated.  The p-value 
used by InsPecT is based on the p-value devised for the algorithm Peptide Prophet [174].  
A lower p-value and higher match score are indicative of a better match, which is in 
contrast to the limited evaluative parameters employed by the other two algorithms used 
in this study. 
To determine filtering parameters that would give at least an equivalent if not 
lower FDR for modified peptides, various filtering options were applied to the 45 min 
Control Run1 dataset.  The default parameters for InsPecT are a p-value of 0.1 and the 
requirement of at least one peptide for protein identification.  Using the default 
parameters yields a FDR of 0.7% (125 reverse peptides and 37,120 forward peptides).  
Therefore, the p-value was raised to 0.35, giving a FDR of 2.0% (428 reverse peptides 
and 42,200 forward peptides).  We then evaluated a p-value giving a 2% FDR and 
requiring two peptides for positive protein identification.  A p-value of 0.75 was chosen 
for the two-peptide dataset since this gave a FDR of 2.1% (499 reverse peptides and 
46,943 forward peptides).  A total of 97% of the proteins identified in the two-peptide 
dataset were identified in the one-peptide dataset as well.  However, the one-peptide 
dataset had only 77% overlap with an additional 472 proteins identified with only one 
peptide.  This observation raises an important issue of proteins identified solely by one 
peptide with the possibility of the identification coming from a modified peptide.  The 
FDRs when considering only peptides containing a putative PTM was 11.9% (420 
reverse peptides and 6668 forward peptides) for the one-peptide dataset and 10.8% (492 
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reverse peptides and 8634 forward peptides) for the two-peptide dataset.  When 
comparing the reverse peptide identifications for the PTM peptides and the total reverse 
peptide identifications for the datasets, ~99% of the reverse identifications came from a 
PTM peptide.  Therefore, all InsPecT datasets presented below had the following filtering 
criteria:  two peptides required for protein identification and a p-value cutoff that 
provides a 2±0.1% FDR for the total peptide dataset.  These criteria are more 
conservative and reduce the FDR of modified peptides by an average of 30% when 
compared to DBDigger’s modified peptide FDR. 
 The result files from the InsPecT search were filtered differently according to the 
p-value distribution for that dataset.  For the 45 min Control dataset, p-values of 0.75 
(Run1) and 0.73 (Run2) were used as cutoff scores, because this value gave a FDR of 
2.1% and 2.0%, respectively, for the total peptide dataset (both unmodified and modified 
peptide identifications) with 10.8% (Run1) and 9.1% (Run2) FDRs when considering 
only modified peptide identifications.  Table 5.5 depicts the FDRs and number of 
peptides (total and modified only) identified for the remaining datasets evaluated in this 
study.  All PTM peptides identified by InsPecT are located in Supplemental Tables S7 
and S8.  The reason for choosing a p-value that reflects a FDR value instead of one p-
value to be applied across all the datasets is due to the large variance in FDRs across the 
datasets for a given p-value.  For instance, if a p-value of 0.75 were chosen as the cutoff 
for all datasets, FDRs would range from 1.8-4.0% with an average of 2.3%.  This wide 
range skews the identifications between datasets and leads to some having a great deal 
more false or true identifications than others.  This variance was only pronounced in one 
dataset from the DBDigger searches (90 min Control oxidation versus 90 min Cr 
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Table 5.5.  FDRs for Total and PTM Peptide Identifications with InsPecT 
 
FDRa Total Peptide 
Identifications 
FDR PTM Peptide 
Identifications 
Dataset p-value Reverse IDs Total IDs % FDR Reverse IDs Total IDs % FDR 
45 min Control Run 1 0.75 499 47442 2.1 492 9126 10.8 
45 min Control Run 2 0.73 921 91769 2.0 857 18888 9.1 
45 min Cr Run 1 0.75 458 48057 1.9 449 8928 10.0 
45 min Cr Run 2 0.75 444 46475 1.9 378 8771 8.6 
90 min Control Run 1 0.75 482 48375 2.0 476 8671 10.4 
90 min Control Run 2 0.55 585 56904 2.1 530 18040 5.7 
90 min Cr Run 1 0.70 454 44784 2.0 444 9053 9.4 
90 min Cr Run 2 0.80 440 45736 1.9 381 7466 9.7 
aFDR:  false discovery rate 
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oxidation); and in general, DBDigger and Sequest do not have the FDR variation between 
datasets that was observed with InsPecT.  This variance is most likely due to differences 
in the p-value distribution in each dataset, which is in contrast to the charge-state 
dependant scoring of the other two algorithms. 
Post-translational modification results with DBDigger and InsPecT 
To illustrate the benefit of performing a search for PTMs, all modified proteins 
identified were compared according to their functional category.  Annotated genes of the 
S. oneidensis MR-1 genome were assigned to one of 18 functional categories by The 
Institute for Genomic Research (now the J. Craig Venter Institute).  Figure 5.2 depicts the 
functional distribution of the modified peptides identified using DBDigger and InsPecT 
according to the role categories.  As a comparison to the previously reported unmodified 
dataset [147], the categories of hypothetical proteins, energy metabolism, unknown 
function, cellular processes, and protein fate were the top five functional categories 
representing at least 55% of the unmodified protein identifications.  By contrast, the top 
five modified categories based on DBDigger analysis (Figure 5.2A) consisted of 
hypothetical proteins, energy metabolism, protein synthesis, protein fate, and cellular 
processes.  The category of protein synthesis is composed primarily of genes encoding 
components of the ribosome, which has been shown previously to contain a large number 
of modifications on the constituent proteins [48].  The cellular processes category also 
comprises a large number of proteins with putative PTMs (average of 570 PTM peptides) 
and some of these proteins are involved in the chemotactic response of S. oneidensis to 
environmental cues.  The identification of a number of modified proteins involved in 
chemotaxis is discussed below.  The functional category distribution of PTM peptides
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Figure 5.2.  Identification of PTM peptides using (A) DBDigger and (B) InsPecT.  
Assignment of a peptide into a category was according to the parent protein’s 
membership.  The functional category assignments are as follows:  (1) Amino acid 
biosynthesis; (2) Biosynthesis of cofactors, prosthetic groups, and carriers; (3) Cell 
envelope; (4) Cellular processes; (5) Central intermediary metabolism; (6) DNA 
metabolism; (7) Energy metabolism; (8) Fatty acid and phospholipid metabolism; (9) 
Hypothetical proteins; (10) Mobile and extrachromosomal element functions; (11) 
Protein fate; (12) Protein synthesis; (13) Purines, pyrimidines, nucleosides, and 
nucleotides; (14) Regulatory functions; (15) Signal transduction; (16) Transcription; (17) 
Transport and binding proteins; and (18) Unknown function. 
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based upon InsPecT analysis was similar to that observed with DBDigger.  The 
predominant categories containing PTM peptides were protein synthesis (~4600), energy 
metabolism (~3800), protein fate (~2700), hypothetical proteins (~2600), and cellular 
processes with ~1300 peptides on average (Figure 5.2B).  Some functional categories 
demonstrate a putative bias in modifications in the control versus chromate-shocked 
datasets (energy metabolism and hypothetical proteins).  At this time, however, the 
detailed understanding of this putative difference in control versus chromate-shocked 
PTM peptides is not known and is beyond the scope of the current work. 
A majority of the proteins comprising the functional categories of cellular 
processes and signal transduction are annotated as part of signaling cascades first 
activated by a PTM on the initiating protein, which responds to various environmental 
stimuli.  Signal transduction proteins are generally of low abundance, and identifications 
are usually confirmed by observing approximately two peptides per protein.  In a search 
that specifies no modifications on the proteins, less than 0.2% of the total spectra count 
are attributed to signal transduction proteins; where spectral count was used as a measure 
of protein abundance previously [182, 183, 237].  Out of the 61 proteins predicted to be 
involved in signal transduction in the S. oneidensis proteome, 53 of the proteins are 
annotated as members of two-component regulatory systems.  Two-component systems 
contain a sensor histidine kinase, which autophosphorylates in response to a specific 
environmental cue and then transfers the high energy phosphate group to a cognate 
response regulator, which effects a change in gene expression upon phosphorylation 
[232, 238, 239].  In our previous study [147], 39 members of two-component systems 
were identified without specifying PTMs in the search.  By including the option of 
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methylation, acetylation, or oxidation to seven different amino acids, there was an 
increase in the rate of identification for some members of this category using 
identifications from both DBDigger and InsPecT.  DBDigger was able to identify a total 
of 269 peptides containing at least one PTM from 41 proteins.  The signal transduction 
functional category yielded 47 protein identifications with at least two peptides using 
InsPecT.  A total of 253 unique PTM peptides annotated as involved in signal 
transduction were identified in the InsPecT dataset, with 101 of these peptides containing 
at least one methyl group.  Both algorithms identified more proteins than in our previous 
study solely by including PTMs in the search parameters.  All but two of the proteins 
identified previously [147] were identified by either DBDigger or  InsPecT.  Both 
algorithms identified 13 proteins as being post-translationally modified in this study.  
Interestingly, the control datasets yielded these shared peptides, while the chromate-
exposed cultures did not yield any shared modified peptides.   
Methylation has been implicated previously in changing DNA-protein interactions 
[238, 239].  The signal transduction group of proteins in bacteria may be phosphorylated 
in the activation domain, while DNA interaction occurs in the other domain [52].  The 
methylation could either perturb the domain preventing interaction with the phosphate 
backbone of the DNA or the phosphorylation event could cause a conformational change 
that leads to the methylation event.  The signal transduction proteins identified above 
were cross-referenced between DBDigger and InsPecT.  SO2541, a response regulator, 
was identified with various PTMs including methylation of various degrees up to 
trimethylation on multiple residues by both algorithms, but was identified in the Control 
dataset with InsPecT whereas DBDigger identified this protein in the Cr dataset for the 
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45 min time-point.  While DBDigger identified SO3196 and SO3688 in the 90 min 
dataset, InsPecT identified them in the 45 min Control dataset.  Both algorithms 
confirmed only one protein, SO2544, from the 90 min dataset.  However, each algorithm 
identified a different MS/MS and peptide.  This is not unexpected in complex proteome 
datasets, and illustrates the need to validate MS/MS from PTM identifications (especially 
since many modified peptides are of low abundance). 
Chemotaxis, part of the cellular processes functional category, plays an important 
role in enabling bacteria to identify and respond to small molecules (nutrients or toxins) 
in the surrounding environment.  The end result is a mechanical response that moves the 
organism either toward or away from the molecule concentration gradient.  Bacterial 
chemotaxis has been well-studied and largely elucidated mechanistically in the model 
bacterium E. coli [53, 54, 224, 240, 241].  In E. coli, methyl-accepting chemotaxis 
protein receptors (chemoreceptors) are encoded by five genes that detect amino acids 
such as serine (tsr) and aspartate (tar); dipeptides (tap); ribose and galactose (trg); and 
the redox potential (aer) [224] of the surrounding environment.  The level of stimulation 
of a particular chemoreceptor is controlled by two proteins CheR, a methyltransferase, 
and CheB, a methylesterase.  Therefore, the presence of a methyl group on the 
chemoreceptor is indicative of stimulation due to the binding of a specific molecule, this 
initiates a signaling cascade through the autophosphorylation of CheA and results in the 
activation of FliM (the protein subunit comprising the flagellar motor).  Activation of 
FliM results in the bacterium swimming in a tumbling motion either toward or away from 
the chemical gradient.  Methylation of the chemoreceptors is important in controlling the 
level of stimulation so that the bacterium is not constantly tumbling [54, 224].  
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Chemotaxis is not only indicative of stress (i.e. from chromate shock as described here), 
but rather is a response to the surrounding environment, so the presence of methylation 
on chemoreceptors from both the control and chromate-shocked datasets [88, 92, 242-
244] is not surprising. 
The chemotaxis system of S. oneidensis is more complicated and includes 
pathways responding to a number of anaerobic electron acceptors [88, 92], three separate 
signal cascades initiated by CheA, and 29 chemoreceptors.  The E. coli and S. oneidensis 
chemoreceptors were aligned and a dendogram (or sequence tree) was constructed to 
assess sequence similarity between S. oneidensis and E. coli chemoreceptors.  Figure 5.3 
depicts the relationship between the five chemoreceptors from E. coli along with 29 from 
S. oneidensis.  As shown, four of the E. coli chemoreceptors cluster tightly together in the 
middle of the tree and do not demonstrate sequence similarity with chemoreceptors from 
S. oneidensis.  Aer, which responds to redox potential, shows sequence similarity with 
three S. oneidensis chemoreceptors (SO1385, SO0584, and SO3404).  The lack of 
sequence similarity between the chemoreceptors in the two organisms is expected due to 
the differences of the natural habitats in which the bacteria are found.  S. oneidensis is a 
fresh water microbe, which must be ready to adapt to rapidly changing concentrations in 
nutrients and metals [88, 92, 242, 243].  A large number of chemoreceptors were 
identified with and without PTM peptides in the 45 and 90 min datasets both under 
control and chromate-shocked growth conditions (Table 5.6).  DBDigger was able to 
identify all but one (SO3510) of the chemoreceptors predicted.  While InsPecT identified 
SO3510 in the 90 min Control dataset, this algorithm did not identify a couple of low 
abundant receptors identified by DBDigger (SO1434 and SO2117).
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Figure 5.3.  A sequence tree (or dendogram) depicting sequence similarity. 
The sequence similarity is between E. coli and S. oneidensis chemoreceptors to determine 
if there is any sequence conservation between the two organisms.  MotA (motility protein 
A) and MotB (motility protein B) from both organisms served as outgroups for the 
alignment.  Circled are the four E. coli chemoreceptors that are not recognizably 
conserved with S. oneidensis.  The protein sequences were imported into and aligned 
using Clustal X (version 1.8, [245]).  A bootstrap Neighbor-Joining tree was created 
using Clustal X (bootstrap value of 10,000).  The resulting dendogram was visualized 
with TreeView (version 1.6.6, taxonomy.zoology.gla.ac.uk/rod/treeview.html). 
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Table 5.6:  Identification of Chemoreceptors using DBDigger and InsPecT from the 45 and 90 min Datasets 
 
DBDigger Identifications InsPecT Identifications 
Locus 45 min Control 45 min Cr 90 min Control 90 min Cr 45 min Control 45 min Cr 90 min Control 90 min Cr 
SO0500 2a 4 2 3 3 4 2 3 
SO0584 2 3 4 (2)b 2 4 (1) 2 (1) 5 (1) 0 
SO0987 32 24 (2) 39 (2) 28 (1) 29 (2) 20 (2) 36 (1) 25 (2) 
SO1056 44 (1) 37 (1) 45 (5) 37 (1) 57 35 (1) 74 (2) 26 
SO1144 31 (2) 29 24 (2) 24 19 18 19 (2) 15 
SO1278 5 10 11 (1) 9 2 6 3 3 
SO1385 11 13 (2) 8 12 9 (1) 7 5 8 
SO1434 4 3 4 4 0 0 0 0 
SO2083 7 8 7 8 6 2 3 2 
SO2117 4 3 4 4 0 0 0 0 
SO2123 0 3 2 0 6 (1) 4 (1) 4 (1) 2 
SO2240 17 (2) 20 (2) 25 (1) 17 19 (1) 17 27 9 
SO2317 2 2 3 3 0 2 (1) 3 (1) 5 (2) 
SO2323 11 11 6 6 8 13 7 5 
SO3052 13 (1) 14 13 21 8 8 7 16 
SO3207 38 36 40 (1) 39 43 (3) 27 27 33 
SO3282 16 8 25 14 14 (1) 0 24 6 
SO3396 4 4 4 5 (2) 2 (2) 3 (1) 2 (1) 0 
SO3404 4 2 5 3 0 3 2 0 
SO3510 0 0 0 0 0 0 2 0 
SO3582 17 (1) 15 (1) 14 20 (2) 9 8 (2) 8 6 
SO3642 43 (1) 38 (2) 38 (2) 42 (3) 45 (3) 34 (2) 41 (2) 35 (2) 
SO3838 21 (1) 32 (1) 24 (1) 25 (2) 19 25 (1) 31 (1) 15 (1) 
SO3890 7 (1) 7 7 9 8 7 4 9 (1) 
SO4053 20 11 24 12 12 6 25 9 
SO4454 22 (2) 24 (1) 24 24 (1) 12 15 (1) 22 (1) 14 
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Table 5.6.  Continued. 
 
DBDigger Identifications InsPecT Identifications 
Locus 45 min Control 45 min Cr 90 min Control 90 min Cr 45 min Control 45 min Cr 90 min Control 90 min Cr 
SO4466 5 (1) 2 3 4 2 0 4 0 
SO4557 30 37 30 33 40 (1) 37 (1) 52 (4) 31 (2) 
SO4635 4 5 4 4 0 0 2 2 
SOA0106 36 (2) 39 (2) 37 (3) 34 42 (2) 48 (3) 61 (1) 33 (2) 
aNumber of unique peptides both unmodified and containing a PTM identified for a given chemoreceptor.  bNumber of 
monomethylated glutamate residues found for a given chemoreceptor. 
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The S. oneidensis chemoreceptor SO3642 was identified consistently as having a 
methylated glutamate residue at the C-terminus of the protein.  A total of 9 MS/MS were 
identified using InsPecT and 16 were identified using DBDigger (Table 5.6).  An 
example MS/MS found in common between the two algorithms is depicted in Figure 5.4.  
The mass shift due to the addition of 14 Da is readily present and causes the fragment 
ions with the glutamate residue to be 14 Da heavier.  Using InsPecT, two spectra were 
identified and scored very well (p-values of < 4e-5) in the 45 min Control dataset.  
DBDigger did not score these MS/MS high enough to pass the filter thresholds.  In 
addition, InsPecT did not identify any modified MS/MS in the 45 min Cr datasets, but 
DBDigger found 3 spectra.  The 90 min Control Run 2 dataset was more consistent with 
4 MS/MS found by InsPecT and 9 by DBDigger.  Overall, the 90 min Cr dataset was the 
most consistent as both algorithms identified the MS/MS depicted in Figure 5.4.  As 
mentioned, chemoreceptors are a well-studied class of proteins, and information in the 
literature [54, 224, 246] was used to help confirm the physiological significance of this 
modification.  The SO3642 peptide was identified solely in the membrane fraction of cell 
lysates, which is consistent with a cytoplasmic membrane location of known 
chemoreceptors [224, 240].  Chemoreceptors have also been shown to be methylated on 
conserved C-terminal glutamate residues, as is the case with SO3642 demonstrated here 
[224, 240].  Therefore, based on our MS data and the extant literature, we conclude that 
SO3642 is methylated on residue E515.  However, the implication of this modification in 
terms of a response to chromate is not known at this time and was not evaluated in detail 
within the scope of this work.  While the present study delineates the computational data 
mining approach for identifying the range of protein post-translational modifications at 
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Figure 5.4.  A MS/MS for SO3642, a chemoreceptor, confirms a C-terminal peptide.   
The C-terminal peptide contains a monomethylated glutamate residue.  All major peaks 
of the MS/MS are labeled, and 12 fragment ions demonstrate a mass shift of 14 Da 
corresponding to the addition of a methyl group.  The MS/MS scored high for both 
algorithms:  DBDigger score of 75.73, DelCN of 0.46 and InsPecT MQScore 3.268, 
DeltaScore 0.65, p-value 0.151.
158 
the global level, thereby providing detailed information about the types of proteins 
modified and the range of modifications, future detailed studies will be required to fully 
unravel the biological details of PTM correlation with chromate exposure for S. 
oneidensis. 
Conclusions 
InsPecT and DBDigger are complementary algorithms that both identified a large 
number of putative post-translationally modified peptides.  However, the FDR for 
DBDigger was more than twice that for PTM peptides, and its search capabilities for 
large datasets was reduced, thereby limiting combinatorial PTMs.  Therefore, InsPecT 
was tested and resulted in a much lower FDR for PTM peptides.  If an identification 
resulting from the chemical addition of a methyl, acetyl, or hydroxyl group was made by 
both DBDigger and InsPecT for a particular peptide, this was taken as a positive 
confirmation of that modification.  The PTM peptide identifications between DBDigger 
and InsPecT were compared in this study.  For the 45 min Control Run1 dataset, a total of 
3219 modified peptides were shared between the two algorithms (Figure 5.5).  This 
corresponds to 69% of the peptides identified using DBDigger (a total of 4651 PTM 
peptides) and 37% from InsPecT.  The InsPecT overlap is much smaller due to the 
scoring scheme of the algorithm:  InsPecT allows high scoring MS/MS from non-tryptic 
and semi-tryptic peptides to pass the filtering thresholds.  The option of specifying a non-
tryptic cleavage was not used with DBDigger due to the increased time and search space, 
and thus higher FDRs.  Removing the non-tryptic and semi-tryptic identifications from 
the InsPecT dataset yields 4005 fewer peptides; this brings the overlap between 
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Figure 5.5.  A Venn diagram comparing DBDigger and InsPecT PTM peptides. 
The results represent the 45min Control Run1 dataset.  A total of 3219 peptide 
identifications were shared between the two algorithms.  DBDigger identified a further 
1432 unique tryptic peptides.  InsPecT identified 3996 semi-tryptic, 9 non-tryptic, and a 
further 1410 unique tryptic peptide identifications. 
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DBDigger and InsPecT to 70%.  Comparable results were found for the remaining 
datasets (Supplemental Figures S1-S7, pubs.acs.org/journals/jprobs/index.html).   
Even though an average of 3000 post-translationally modified peptides for each 
dataset were shared between the two algorithms, there is still room for improvement in 
performing PTM searches.  DBDigger and InsPecT search the MS/MS very differently.  
DBDigger uses the MASPIC [173] scoring algorithm to determine peptide identifications 
for the MS/MS.  MASPIC separates the MS/MS spectra into different intensity classes 
where the most intense class is restricted to a few fragment ions.  The score is weighted 
based on identification of intense peaks.  InsPecT is similar to MASPIC in the respect 
that there is a scoring factor for intensity.  However, InsPecT first discriminates whether 
an intense peak is identified as a b or y ion and then weights that intensity into the score, 
where the y ions derived from the lower energy CID as used in this study are more 
intense than their counterpart b ions.  This is more discriminatory than MASPIC and 
leads to more stringent filtering of false identifications.  The more stringent scoring of 
InsPecT is the reason for the 30% reduction in false identifications of modified peptides.  
Another advantage to using InsPecT is the incredible speed with which the algorithm 
searches shotgun proteomic data.  InsPecT was able to search over 240,000 MS/MS in 
approximately 84 hours specifying all PTMs in one search on a desktop computer for 
each dataset, while DBDigger took twice as long with seven different searches for each 
dataset.  The authors initially attempted to specify all methylations in one search, but due 
to the combinatorial increase in search space the computational memory was 
overwhelmed.  The ability to search for all modifications at one time is physiologically 
relevant, since a peptide can be methylated and oxidized at the same time.  However, 
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using both algorithms together increases the confidence and accuracy of identifications 
with the overlap between them composed of the top-scoring PTM peptides, which was a 
major goal of this work. 
As evident from other studies, the use of a higher performance mass spectrometer 
will undoubtedly provide more confident identifications of peptide PTMs, since 
improved mass accuracy will reduce ambiguities.  However, at present, many readily 
available algorithms, such as the three tested in this study, do not contain a scoring 
element which exploits mass accuracy of the parent peptide or resulting fragment ions as 
an additional metric.  Since medium resolution mass spectrometers are common in many 
research laboratories, and since many existing bioinformatic approaches do not utilize 
higher mass accuracies, we chose to focus on evaluating methodologies which would be 
readily available to the current field.  There are certainly efforts underway in many 
laboratories to incorporate high performance mass spectral datasets from Orbitrap, 
FTICRMS, and QTOF platforms into data mining schema.  This is already providing 
increased confidence in identification of peptide modifications, including the ability to 
discriminate between phosphorylation (79.980) and sulfonation (80.064) as well as 
trimethylation (42.03 Da) versus monoacetylation (42.01 Da). 
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Chapter 6 
Proteomic Comparison of Shewanella oneidensis MR-1 Wild-Type and a Response 
Regulator Deletion Strain under Conditions of Chromate Transformation 
Data presented below is in preparation for submission for publication 
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Introduction 
Our previous work with Cr(VI) exposure and S. oneidensis MR-1 identified over 
2400 proteins expressed from the MR-1 genome [147, 156, 158], with a subset 
demonstrating differential expression in response to Cr(VI).  Many of the differentially 
expressed proteins had annotated functions in metal ion transport and sulfate 
transport/metabolism.  Interestingly, a putative response regulator, SO2426, was also 
identified as being up-regulated under Cr(VI) conditions (5, 39).  Response regulators are 
part of two-component signal transduction systems that serve as a basic stimulus-
response coupling mechanism, allowing organisms to sense and respond to changes in 
many different environmental conditions [238].  For example, the redox sensing system 
pathway involves the ArcAB complex in Escherichia coli [247].  In fact, due to the 
extensive respiratory versatility in S. oneidensis, Gralnick et al [247] hypothesized that 
this bacterium must have an extensive regulatory system.   
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In our acute shock study [147], S. oneidensis was exposed to a sub-lethal 
concentration of 1 mM Cr(VI) for 45 and 90 min.  When compared to the control cultures 
(no Cr(VI) added), SO2426 was highly up-regulated.  The corresponding transcript was 
found to follow a trend of increasing expression level with increased exposure time [147].  
A Cr(VI) dosage study [156] also found SO2426 to be up-regulated under three different 
sub-lethal concentrations (0.3, 0.5, and 1 mM) of Cr(VI) exposure for 30 min.  Therefore, 
SO2426 appears to be activated under growth conditions where Cr(VI) is present, 
irrespective of the dosage.  In another study, so2426 was found to also be up-regulated 
after exposure to acute Strontium stress [248].  These observations led to the conclusion 
that SO2426 may be a response regulator for transition metal redox state.  This prompted 
further investigation of the role SO2426 may be playing in response to sub-lethal 
concentrations of Cr(VI) by “knocking out” the gene through an in-frame deletion, as 
described by Chourey et al [157].  The ∆2426 mutant strain demonstrates sensitivity to 
other transition metals besides Cr(VI) (Chourey et al, unpublished results). 
The use of shotgun proteomics of biological replicates to probe the functionality 
of global regulator proteins provides information not found with other methodologies.  
Also, the resulting variability between cultures consisting of a gene deletion mutant has 
not been explored in great detail.  Information about gene function can be probed 
utilizing shotgun proteomics, thus allowing for increased understanding of the global 
response [249] and possible compensatory pathways encoded in the bacterium’s genome.  
Most shotgun proteomics studies have been performed using technical replicates [19, 20, 
147, 211, 250] instead of biological replicates.  A technical replicate is defined as 
multiple LC-MS experiments on one sample (i.e. a cell culture, tissue sample, etc.) [251].  
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However, recently there has been a number of shotgun proteomics studies [210, 252, 253] 
and a review article [251] on both the informational value and necessity of biological 
replicates for quantitation of the measured proteins.  Most of the focus for the discussion 
between the use of technical replicates or biological replicates has been on the resulting 
statistical treatment of the dataset [182, 183, 251, 253].  The primary argument for the 
use of biological replicates is to reduce the background biological noise of the sample 
[251].  Available nutrients, temperature fluctuations, and light availability (relevant for 
phototropic bacteria) are factors considered biological noise and may play a significant 
role in the growth variability of a culture.  The resulting protein complement of the 
culture may vary based on these factors.   
The possible role of SO2426 as a global regulator of Cr(VI) response pathways is 
explored further through the comparison of a ∆2426 mutant to the wild-type strain of 
MR-1.  In this study, differentially expressed proteins solely from biological replicates of 
wild-type and a ∆2426 mutant in response to a sub-lethal concentration of Cr(VI) are 
identified.  Differential regulation of protein function through the identification of post-
translational modification sites on proteins present in the global dataset is also 
investigated.   
Materials and Methods 
Chemical reagents and culture growth 
Luria-Bertani (LB) medium, Guanidine HCl, Tris, EDTA, Ammonium Acetate, 
and CaCl2 were purchased from Sigma Chemical Co. (St. Louis, MO) and were used 
without further purification.  Modified sequencing grade trypsin was purchased from 
Promega (Madison, WI) and used for all protein digestions.  The 99% formic acid was 
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obtained from EM Science (Darmstadt, Germany) and HPLC-grade water and 
acetonitrile from Burdick & Jackson (Muskegon, MI). 
 Three independent cultures of wild-type S. oneidensis MR-1 and three 
independent cultures of strain ∆2426 (obtained from D. Thompson, Purdue University) 
were grown in a 250 mL flask with 100 mL of LB medium (pH 7.2) at 30°C under 
aerobic conditions with constant agitation at 200 rpm.  When the OD at 600 nm reached 
0.5 (mid-log phase), a 10-ml aliquot of each culture was taken as the 0 h time point and 
processed as described in Brown et al [147].  Afterwards, Cr(VI) in the form of K2CrO4 
was added to yield a final concentration of 0.3 mM in all six cultures.  Cr(VI) 
concentration in the media was monitored using the 1,5-diphenylcarbazide (DPC) method 
as described previously [138].  When the approximate concentration of Cr(VI) in the 
media of the control cultures (wild-type MR-1 strain) reached 0.25 (1 h), 0.15 (3 h), and 0 
(4 h) mM, 10 mL aliquots of culture were harvested.  Cell lysis and digestion 
The resulting frozen cell pellets from the 10 mL aliquots were weighed and then 
further distributed into 5 mg wet cell pellets for lysis.  The lysis protocol used is 
essentially as described in Thompson et al [160].  Briefly, 6 M Guanidine with 10 mM 
DTT were added to each sample and incubated at 37°C overnight after which the 
guanidine was diluted 6-fold with 50 mM Tris/ 10 mM CaCl2.  Then, 5 µg of trypsin was 
added, followed by a 6 h incubation period after which another aliquot of trypsin was 
added with an overnight incubation at 37°C.  A final reduction step for 2 h was 
performed with 20 mM DTT.  Protein digests were then spun at 10,000 x g for 10 min to 
remove cellular debris and then stored at -80 °C until the LC/LC-MS/MS experiment. 
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Global proteome LC/LC-MS/MS analysis 
The LC/LC-MS/MS experiments were performed as described in Brown et al 
[147].  Each lysis/digestion from each culture was a separate 24 h LC/LC-MS/MS 
experiment.  Samples were loaded onto a split phase column consisting of reverse phase 
(C18) and strong cation exchange (SCX) separation materials.  This column was placed 
behind a 15 cm C18 analytical column located directly in front of the mass spectrometer 
(LTQ, Thermo Scientific, San Jose, CA).  The LTQ was coupled with an Ultimate HPLC 
pump (LC Packings, a division of Dionex, San Francisco, CA).  The samples were 
analyzed with a 12-step 2D HPLC analysis by adding increasing concentrations (0 to 500 
mM) of ammonium acetate salt pulses followed by an aqueous (95% H2O, 5% ACN, 
0.1% formic acid) to organic (30% H2O, 70% ACN, 0.1% formic acid) gradient.  The 
LTQ was operated in the data-dependent mode during the chromatographic separations as 
detailed in Brown et al [147]. 
Proteome bioinformatics 
The protein database used for all MS searches consisted of Version 8 
(www.tigr.org) of the S. oneidensis MR-1 proteome (4,798 proteins) as well as 36 
common contaminant sequences (trypsin, keratin, etc.).  The database is available for 
download at the project website compbio.ornl.gov/shewanella_metal_stress/databases/.  
Initially, Sequest was used to search the resulting MS raw files for peptide/protein 
identifications.  Sequest searches were performed as detailed in Brown et al [147] with 
the following scoring cutoffs.  A minimum of 2 peptides were required for a positive 
identification of a protein with peptide charge state score minimums of 1.8 (+1), 2.5 (+2), 
and 3.5 (+3).  A delCN value of 0.08 was required for peptide identifications.  Sequest 
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results were then filtered and sorted according to the above criteria with DTASelect and 
Contrast [171], and all resulting data is available on the project website 
(compbio.ornl.gov/ shewanella_metal_stress/reduction).   
 For performing searches for post-translational modifications, the search algorithm 
InsPecT [40] was used.  For optimization of PTM searches with InsPecT on shotgun 
proteomics data, see reference [59].  The proteome database used in these searches 
consisted of the forward database (mentioned above) with the reversed sequences of all 
proteins concatenated to the end.  This database was used in order to estimate the false 
discovery rate of each individual search.  MS/MS spectra were extracted from the raw 
files using ReAdW.exe to create a .mzXML file.  The mzXML files were then searched 
with InsPecT [40] specifying the following PTMs.  An optional mass of 14 Da 
(monomethylation) was added to lysines, arginines, and glutamates; optional masses of 
28 (dimethylation), 42 (trimethylation/monoacetylation), 84 (diacetylation) Da were 
added to lysines and arginines; 16 Da (monooxidation) to methionines, cysteines, 
tryrosines, and tryptophans; 32 Da (dioxidation) to methionines and cysteines; and 48 Da 
(trioxidation) on cysteines.  The scripts Summary.py and Pvalue.py were used to filter the 
resulting output tab-delimited text files by p-value and peptide count.  A peptide count of 
two was required for all proteins, and the p-value was adjusted to give a false discovery 
rate of 2±0.2% for the total peptide dataset. 
Results and Discussion 
The gene so2426 encodes a putative DNA-binding response regulator and may 
regulate the transcriptional activation of genes involved in response to Cr(VI) in the 
bacterium.  so2426 contains two putative domains, a CheY-like domain and a putative 
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DNA-binding domain.  The CheY-like domain is ~50% similar to the other three CheY 
proteins predicted in the S. oneidensis genome.  However, the similarity extends only to 
residue 131, leaving 106 residues not aligning to CheY.  The 106 remaining residues are 
on the C-terminal end and constitute a putative DNA-binding domain.  SO2426 is also 
highly conserved at the amino acid level to a putative ortholog from fifteen other 
Shewanella genomes sequenced to date.  The C-terminal DNA-binding domain portion of 
the protein is annotated as a member of the Trans_reg_C family (PF00486) as described 
using the Pfam database [254].  The top-aligning proteins from the other Shewanella 
genomes are also annotated as part of the Trans_reg_c family.  Figure 6.1 is a dendogram 
(or sequence tree) tree depicting SO2426 clustering with a protein from the Sargasso Sea 
Shewanella genome [74].  CheY from S. oneidensis and Escherichia coli were used as an 
outgroup, further demonstrating SO2426 is not CheY, but rather a fusion protein with a 
CheY-like domain, that is conserved across the genus Shewanella.  Even though the top 
blast hit from Geobacter metallireducins GS-15 did not cluster with these Shewanella 
proteins, this protein is also identified in the same family with SO2426. 
Microbial growth during Cr(VI) transformation 
S. oneidensis strains MR-1 and ∆2426 were cultivated aerobically in LB medium 
(see Materials and Methods for details).  The strains were cultured for 4 h in the presence 
of Cr(VI) in the form of 0.3 mM K2CrO4.  Figure 6.2 depicts the transformation of Cr(VI) 
over the exposure period.  The arrows point to the time points of harvest for global 
proteome analysis.  The standard error bars for the strains are shown for triplicate 
cultures and the abiotic control, which demonstrated undetectable transformation of 
Cr(VI) during the 4-h period.  The standard deviation for the abiotic control ranged from  
169 
 
Figure 6.1.  A sequence tree aligning the protein sequences of SO2426 and SO4477. 
SO2426 and SO4477 (CpxR transcriptional regulator) are aligned against the top Blast hit 
for each species/strain of Shewanella for genomes sequenced to date.  SO2426 is at the 
bottom of the tree and most closely aligns with a protein sequence from a Shewanella 
strain from the Sargasso Sea[74].  The following proteins were used as an outgroup:  
from S. oneidensis MR-1 SO2318 (CheY-2); SO2120 (CheY-1); SO3209 (CheY-3); and 
SO0549 and SO4001 (chemotaxis protein CheY/response regulator receiver domain 
proteins) and b1882 (CheY) from E. coli.  The species/strains of Shewanella are as 
follows:  S. oneidensis MR-1 (SO4477), S. putrefaciens 200 (put_200_01 and 
put_200_02), Shewanella W3-18-1 (W3-18-1_01 and W3-18-1_02), Shewanella ANA-3 
(ANA-3_01 and ANA-3_02), S. woodyi ATCC 51908 (51908_01 and 51908_02),  
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Figure 6.1.  Continued. 
S. frigidimarina NCIMB400 (NCIM400_01 and NCIM400_02), Shewanella MR-4 (MR-
4_01 and MR-4_02), Shewanella MR-7 (MR-7_01 and MR-7_02), S. baltica OS195 
(OS195_01 and OS195_02), S. denitrificans OS217 (OS217_01 and OS217_02), S. 
putrefaciens CN-32 (CN-32_01 and CN-32_02), Shewanella SAR-1 environmental 
sequence (SAR-1_01 and SAR-1_02), Shewanella SAR-2 environmental sequence 
(SAR-2_01 and SAR-2_02), S.  loihica PV-4 (lo_PV-4_01 and lo_PV-4_02), S. baltica 
OS155 (OS155_01 and OS155_02), S. amazonensis SB2B (SB2B_01 and SB2B_02), 
and S. pealeana ATCC 700345 (700345_01).  There was no significant conservation 
found between proteins from Geobacter sulfurreducins GS-15 and S. oneidensis MR-1 
(data not shown).  Alignment and Neighbor-Joining tree (bootstrap value of 1000) was 
created by ClustalX [version 1.8, [245]].  The dendogram was visualized with njplot 
(pbil.univ-lyon1.fr/software/njplot.html). 
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Figure 6.2.  Transformation of 0.3 mM Cr(VI) in the form of K2CrO4.   
The Cr(VI) transformation is depicted for strains MR-1 and ∆2426 of S. oneidensis.  
There was no detectable reduction of Cr(VI) by an abiotic control (sterile LB medium) 
shown as black diamonds and the standard deviation of the triplicate measurements 
ranged between 9 x 10-5 to 0.02 mM.  This standard deviation is too small to be 
visualized in the figure.  Strain MR-1 (WT and squares in the figure) completely reduced 
the Cr(VI) during the 4 hour time period and only 1 culture of strain ∆2426 (2426 and 
triangles in the figure) completely reduced Cr(VI).  Error bars represent triplicate cultures 
for stains MR-1 and ∆2426.
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9 x 10-5 to 0.02 mM.  Strain MR-1 was able to completely transform the 0.3 mM 
Cr(VI)by the fourth hour, with 0.15 mM left by the third hour of exposure.  Strain ∆2426 
demonstrated comparable reduction as MR-1 during the first 3 hours of exposure.  In 
contrast, between 3 and 4 hours of Cr(VI) exposure, strain ∆2426 transformed the Cr(VI) 
incompletely for two of the three cultures.  The incompletely reduced cultures had 0.10 
and 0.26 mM Cr(VI) remaining after 4 hours of cultivation.  The incomplete 
transformation of Cr(VI) by ∆2426 for two of the three cultures indicates the possibility 
that SO2426 may be involved in response to Cr(VI) toxicity.  The reason as to why one 
culture from strain ∆2426 was able to transform Cr(VI) completely is not understood at 
this time and is beyond the scope of this work. 
Global proteomics profile of strains MR-1 and ∆2426 
A total of 5 mg of cell pellet were lysed, and the resulting protein content was 
digested with trypsin and analyzed by 2D-HPLC-MS/MS.  The resulting MS/MS spectra 
were searched with Sequest [39] for each culture during the 4 harvested time points.  A 
total of 2,121 proteins comprising 44% of the predicted proteome were confidently 
identified at the two peptide level for strains MR-1 and ∆2426.  Table 6.1 depicts the 
total proteins identified for strains MR-1 and ∆2426 for each time point harvested.  The 
molecular weight and isoelectric point distribution for the total dataset from each time 
point was plotted and demonstrated no discrepancy when compared to the predicted 
distribution of the proteome (data not shown).  The reproducibility at the protein level for 
each biological replicate was at least 60%.  Previously, the aim was to obtain a 
reproducibility of 70% for technical replicates [65, 147, 158, 184].  Achieving a  
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Table 6.1.  Total Proteins Identified by Strains MR-1 and ∆2426 at Each Time Point 
 
Time of harvest Amount of Cr(VI) present Strain MR-1a Strain ∆2426a 
0 hr 0.3 mM 1537 1398 
1 hr 0.3 mM 1583 1540 
3 hr ~0.2 mM 1535 1599 
4 hr 0.0 – 0.2 mM 1468 1687 
aTotal number of proteins identified by the three biological replicates. 
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reproducibility of at least 60% as demonstrated here is comparable since there is the 
added complexity of an additional proteome dataset represented by the third culture.
 All three replicates of each strain during each time point were grouped according 
to their functional category distribution annotated by the J. Craig Venter Institute 
(formerly The Institute for Genomic Research) and the results are presented in Figure 6.3.  
Overall, most of the functional categories did not fluctuate significantly between the first 
time point and the last or between the two strains.  However, proteins annotated in the 
functional categories biosynthesis of cofactors, prosthetic groups, and carriers; 
hypothetical proteins; transport and binding proteins; and proteins of unknown function 
demonstrated large fluctuations in protein expression between the two strains or over 
time within a particular strain.  Strain ∆2426 exhibited the most variation during the time-
course.  The number of proteins identified in a particular category was lower for the 
sample obtained at the 0 time point versus the last sample that was harvested at 4 h.  This 
may be due to the strain in general demonstrating deficient growth, where the starter 
culture required a longer time of incubation prior to inoculation for strain ∆2426 (data not 
shown).  The effects of removing a transcriptional regulator are known to cause growth 
deficiencies in bacteria [94, 255, 256].   
The large fluctuations of biosynthesis of cofactors, prosthetic groups, and carriers; 
hypothetical proteins; central intermediary metabolism; transport and binding proteins; 
and proteins of unknown function may be the result of perturbing regulation of the 
expressed genome through the knockout of so2426.  However, the hypothetical proteins 
category appears to fluctuate due to the presence of Cr(VI) in the growth media.  Prior to 
the addition to Cr(VI), there are comparable numbers of proteins identified by each  
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Figure 6.3.  Functional category distribution of proteins from strains MR-1 and ∆2426.  
Distribution for each strain (A) prior to Cr(VI) exposure, (B) after 1 hr of exposure, (C) 3 
hr exposure, and (D) 4 hr exposure.  The functional category numbers along the x axis 
are:  (1) Amino acid biosynthesis; (2) Biosynthesis of cofactors, prosthetic groups, and 
carriers; (3) Cell envelope; (4) Cellular processes; (5) Central intermediary metabolism; 
(6) DNA metabolism; (7) Energy metabolism; (8) Fatty acid and phospholipid 
metabolism; (9) Hypothetical proteins; (10) Mobile and extrachromosomal element 
functions; (11) Protein fate; (12) Protein synthesis; (13) Purines, pyrimidines, 
nucleosides, and nucleotides; (14) Regulatory functions; (15) Signal transduction; (16) 
Transcription; (17) Transport and binding proteins; and (18) Unknown function. 
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strain.  However, at the 1 h time point (equivalent to acute shock) where no significant 
Cr(VI) transformation has been detected, there is an increase by at least 20 proteins 
between the two strains.  The effect is much greater in strain ∆2426, with 48 proteins.  In 
strain MR-1, the resulting number counts for hypothetical proteins declines during the 3 
and 4 h time points.  In contrast, strain ∆2426 consistently continues to increase the 
number of hypothetical proteins detected to the 4 h time point.  The protein expression 
level implications of a number of hypothetical proteins are discussed further below. 
Protein expression effects due to deletion of so2426 
Within the S. oneidensis genome, so2426 is organized into a cluster with five 
other genes (so2422-2425 and so2427), which constitutes an approximately 5 kb region 
of the genome [69].  The gene cluster organization with respect to localization and 
transcriptional regulation is described in detail in Chourey et al [157].  Prior to Cr(VI) 
introduction into both strains, SO2424 and SO2427 were identified with the same number 
of peptides indicating there was no polar effect on expression of these proteins 
(Supplemental Table S1).  Following 1 and 3 h of Cr(VI) exposure, SO2424 and SO2427 
did not demonstrate a difference in protein expression level (Supplemental Table S2-S3).  
However, SO2422 was identified with 2 peptides in the mutant strain and not identified 
in the wild-type strain following Cr(VI) exposure for 1 h.  After 3 h of Cr(VI) exposure, 
SO2422 was identified in both the wild-type and mutant ∆2426 strains.  Following 
complete reduction of Cr(VI) in strain MR-1 at 4 h post-exposure, SO2422 was not 
identified as expressed, while SO2424 and SO2427 maintained the same relative protein 
expression level as prior to Cr(VI) introduction in both strains.  SO2423 and SO2425 
were not found in the MS/MS data presented here, however they were identified at 
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baseline levels (2-5 peptides) in previous work [147, 156].  Therefore, the expression of 
these two proteins may be repressed due to the deletion of so2426. 
Proteins differentially expressed between strains MR-1 and ∆2426 
Semiquantitation was employed as the method for determining proteins 
differentially expressed between the two strains.  This method takes into account 
reproducible differences of percent sequence coverage, peptide count, and spectral count 
between the knockout mutant strain ∆2426 and the wild-type strain MR-1.  Usually, 
semiquantitation compares the differences between technical replicates of a HPLC-
MS/MS experiment having a reproducibility of at least 70% between them.  In this study, 
the use of biological triplicates has reduced the reproducibility between the cultures to 
60%, so attempting the semiquantitation method is more difficult and the number of 
proteins differentially expressed is reduced compared to previous studies on S. oneidensis 
[147, 156, 158]. 
In light of this criteria, a number of proteins were identified as differentially 
expressed reproducibly across the cultures between each strain.  Table 6.2 comprises the 
differentially expressed proteins identified as down-regulated in the ∆2426 cultures.  A 
total of 22 proteins were found down-regulated in ∆2426 cultures at any given time point, 
with six of these proteins down-regulated under all of the time points.  Out of the total 22 
proteins down-regulated in ∆2426 cultures, 73% were annotated in the functional 
categories of hypothetical, transport and binding, and energy metabolism during the time-
course explored.  In addition, 23 proteins were identified as up-regulated in strain the 
∆2426 in comparison to strain MR-1, with only one protein (HugA, a heme transport 
protein) up-regulated prior to the addition of Cr(VI) to the cultures (Table 6.3).  The 
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Table 6.2.  Up-Regulated Proteins from MR-1 Cultures Versus ∆2426 Cultures 
 
Average ∆2426 Average MR-1 
Locus Time 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Peptide 
Count 
Spectra 
Count 
% 
Coverage Description (Number) 
SO0970 0 hr 25.3 55.0 46.8 39.0 105.3 61.4 fumarate reductase flavoprotein subunit precursor (7) 
SO1072 1 hr 4.0 5.3 18.2 9.3 14.3 24.9 chitin-binding protein, putative (17) 
SO1180 0 hr 5.0 5.0 18.4 10.7 11.7 34.1 PhoH family protein (18) 
SO1190 0 hr 0.0 0.0 0.0 11.0 13.0 43.0 conserved hypothetical protein (9) 
SO1190 1 hr 0.0 0.0 0.0 12.0 25.0 46.0 conserved hypothetical protein (9) 
SO1190 3 hr 0.0 0.0 0.0 18.7 40.7 58.3 conserved hypothetical protein (9) 
SO1190 4 hr 0.0 0.0 0.0 14.3 26.3 57.3 conserved hypothetical protein (9) 
SO1405 4 hr 0.7 0.7 3.5 5.7 8.0 23.2 transglutaminase family protein (18) 
SO1779 4 hr 6.0 7.7 13.2 12.0 18.3 19.3 decaheme cytochrome c (omcA) (7) 
SO1784 1 hr 2.7 3.7 7.2 7.7 14.0 14.6 ferrous iron transport protein B (feoB) (17) 
SO2492 1 hr 5.7 7.7 10.3 11.0 18.7 21.7 oxidoreductase, acyl-CoA dehydrogenase family (18) 
SO2796 1 hr 7.3 9.3 13.4 16.0 24.0 24.2 conserved hypothetical protein (9) 
SO2912 0 hr 13.3 18.7 21.3 21.7 38.0 36.9 formate acetyltransferase (pflB) (7) 
SO2916 0 hr 22.3 38.0 33.3 31.0 76.0 57.8 phosphate acetyltransferase (pta) (7) 
SO3030 1 hr 3.3 4.7 9.9 14.0 22.7 35.4 siderophore biosynthesis protein (alcA) (17) 
SO3030 3 hr 2.7 2.7 7.7 8.0 11.3 20.1 siderophore biosynthesis protein (alcA) (17) 
SO3032 1 hr 4.3 5.3 9.2 13.7 28.7 27.9 siderophore biosynthesis protein, putative (17) 
SO3032 3 hr 5.3 9.0 12.1 9.0 25.3 18.2 siderophore biosynthesis protein, putative (17) 
SO3032 4 hr 7.3 12.3 15.0 11.3 27.7 22.5 siderophore biosynthesis protein, putative (17) 
SO3033 1 hr 4.3 6.3 10.6 12.7 29.3 26.1 ferric alcaligin siderophore receptor (17) 
SO3637 1 hr 9.0 40.0 33.9 15.3 85.3 46.4 survival protein surA (surA) (11) 
SO3833 0 hr 5.7 7.7 26.3 11.7 17.0 44.5 peptide chain release factor 1 (prfA) (12) 
SO3863 0 hr 3.7 4.3 26.1 15.7 41.0 65.8 molybdenum ABC transporter (modA) (17) 
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Table 6.2.  Continued 
 
Average ∆2426 Average MR-1 
Locus Time 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Peptide 
Count 
Spectra 
Count 
% 
Coverage Description (Number) 
SO3863 3 hr 8.7 14.3 39.9 15.3 44.7 63.4 molybdenum ABC transporter (modA) (17) 
SO3863 4 hr 7.0 8.3 42.2 16.7 51.7 69.3 molybdenum ABC transporter (modA) (17) 
SO3967 0 hr 0.7 0.7 7.4 8.3 12.3 64.4 molybdenum ABC transporter, putative (17) 
SO3967 1 hr 1.3 2.0 7.3 12.3 20.3 64.2 molybdenum ABC transporter, putative (17) 
SO3967 3 hr 0.7 0.7 2.3 11.0 23.7 59.4 molybdenum ABC transporter, putative (17) 
SO3967 4 hr 1.7 1.7 6.5 13.0 29.7 55.0 molybdenum ABC transporter, putative (17) 
SO4509 0 hr 0.0 0.0 0.0 16.7 23.7 25.6 formate dehydrogenase, alpha subunit (7) 
SO4509 1 hr 0.0 0.0 0.0 12.3 15.7 19.3 formate dehydrogenase, alpha subunit (7) 
SO4509 3 hr 0.0 0.0 0.0 8.7 14.3 13.0 formate dehydrogenase, alpha subunit (7) 
SO4509 4 hr 0.0 0.0 0.0 9.7 14.7 15.8 formate dehydrogenase, alpha subunit (7) 
SO4513 0 hr 3.7 4.0 7.1 15.0 20.0 22.6 formate dehydrogenase, alpha subunit (7) 
SO4513 1 hr 0.0 0.0 0.0 6.0 7.3 9.2 formate dehydrogenase, alpha subunit (7) 
SO4513 3 hr 0.0 0.0 0.0 6.7 10.3 11.0 formate dehydrogenase, alpha subunit (7) 
SO4513 4 hr 0.0 0.0 0.0 6.3 8.7 8.8 formate dehydrogenase, alpha subunit (7) 
SO4719 0 hr 18.3 25.0 65.8 31.0 66.7 75.6 conserved hypothetical protein (9) 
SO4719 1 hr 22.3 35.3 74.1 32.3 89.0 78.7 conserved hypothetical protein (9) 
SO4719 3 hr 24.0 60.7 75.2 38.7 198.7 79.7 conserved hypothetical protein (9) 
SO4719 4 hr 22.0 35.3 71.6 38.3 118.3 78.2 conserved hypothetical protein (9) 
SO4743 0 hr 0.0 0.0 0.0 9.7 10.3 22.0 TonB-dependent receptor, putative (17) 
SO4743 1 hr 0.0 0.0 0.0 16.0 22.7 35.7 TonB-dependent receptor, putative (17) 
SO4743 3 hr 3.0 3.0 8.9 14.3 22.0 29.1 TonB-dependent receptor, putative (17) 
SO4743 4 hr 2.0 2.0 4.3 9.7 17.3 21.7 TonB-dependent receptor, putative (17) 
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functional category distribution for up-regulated proteins was more diverse compared to 
the down-regulated proteins, with 11 different categories represented and no proteins 
reproducibly up-regulated across the time course.  In addition, 14 of the up-regulated 
proteins were found at the 4 h time point, indicating that differential expression may be 
due to Cr response and not necessarily the role of SO2426 as a transcriptional regulator.   
 Proteins annotated under the functional role of hypothetical proteins were 
identified as being repressed in the ∆2426 mutant cultures.  Two conserved hypothetical 
proteins (SO1190 and SO4719) were consistently down-regulated during the entire time 
course.  SO1190 was not identified as being expressed in any of the ∆2426 cultures, 
while SO4719 was found with an average of ~21 ± 3 peptides corresponding to a steady 
expression level over the time course.  In addition, SO4719 behaved similarly in the MR-
1 cultures with an average peptide count of 70 ± 5 as well corresponding to a steady 
expression level during the time course.  The corresponding mRNA levels corroborated 
these results demonstrating an elevated induction of these genes during the Cr(VI) 
transformation period for strain MR-1 [157].  The predicted protein sequence of SO4719 
was aligned to the top blast hits from 16 other sequenced genomes of the genus 
Shewanella (Supplemental Figure S1).  SO4719 demonstrated good alignment with a 
predicted extracellular solute-binding protein (family 1) from eight of the species/strains.  
This group of proteins are members of the LysR substrate binding protein family, which 
is part of a larger clan of periplasmic binding proteins.  However, SO4719 is not 
annotated in the clan of periplasmic binding proteins, but rather the protein is located 
within the protein family of PfamB PB011652 according to the Pfam database 
[pfam.sanger.ac.uk, [254]].  This family was generated automatically from an alignment  
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Table 6.3.  Down-Regulated Proteins in MR-1 Cultures Versus ∆2426 Cultures 
 
Average ∆2426 Average MR-1 
Locus Time 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Peptide 
Count 
Spectra 
Count 
% 
Coverage Description (number) 
SO0343 1 hr 36.0 78.0 53.3 21.0 38.3 32.3 aconitate hydratase 1 (acnA) (7) 
SO0343 4 hr 45.3 116.7 62.4 26.7 53.0 40.3 aconitate hydratase 1 (acnA) (7) 
SO0344 4 hr 23.0 48.7 54.0 7.7 10.7 26.2 methylcitrate synthase (prpC) (7) 
SO0345 1 hr 18.0 98.3 58.8 13.0 46.0 48.7 methylisocitrate lyase (prpB)  (7) 
SO0346 4 hr 9.3 14.3 37.7 1.3 1.7 8.5 transcriptional regulator. GntR family (14) 
SO0575 4 hr 10.0 13.7 18.7 3.0 6.3 5.3 RNA polymerase-associated protein (hepA) (16)  
SO0798 3 hr 6.0 6.3 12.1 0.7 0.7 1.3 conserved hypothetical protein (9) 
SO0840 4 hr 45.0 72.0 40.6 19.0 34.0 19.8 acetyl-CoA carboxylase multifunctional enzyme accADC (8) 
SO0934 3 hr 6.0 8.3 27.2 0.0 0.0 0.0 conserved hypothetical protein (9) 
SO0958 4 hr 11.3 17.0 63.7 6.0 7.0 37.8 alkyl hydroperoxide reductase, C subunit (ahpC) (4)  
SO1484 4 hr 8.3 11.3 24.9 1.3 2.3 4.9 isocitrate lyase (aceA) (7) 
SO1551 1 hr 13.0 18.0 31.5 4.7 5.7 14.2 GGDEF domain protein (18) 
SO1551 4 hr 16.3 33.7 31.8 5.0 7.3 14.4 GGDEF domain protein (18) 
SO1898 4 hr 11.3 14.3 62.2 5.3 7.0 42.8 transcriptional regulator, putative (14)  
SO1930 4 hr 39.0 69.7 46.3 20.3 34.3 26.9 2-oxoglutarate dehydrogenase, E1 component (sucA) (7)  
SO2415 4 hr 16.7 24.7 28.5 7.7 12.3 14.0 ribonucleoside-diphosphate reductase, alpha subunit (nrdA) (8)  
SO3089 4 hr 5.7 8.3 23.9 0.0 0.0 0.0 fatty oxidation complex, beta subunit (8) 
SO3545 3 hr 25.3 99.3 49.1 14.7 39.0 28.6 OmpA family protein (3) 
SO3585 4 hr 8.3 14.0 39.1 0.7 0.7 1.8 azoreductase, putative (4) 
SO3669 0 hr 10.7 19.7 21.9 5.3 7.3 13.4 heme transport protein (hugA) (17) 
SO3669 3 hr 40.3 155.0 57.3 21.3 57.7 37.2 heme transport protein (hugA) (17) 
SO3669 4 hr 42.7 158.7 60.1 24.7 74.0 39.4 heme transport protein (hugA) (17) 
SO3681 1 hr 10.7 19.7 79.0 4.0 7.0 46.8 universal stress protein family (4) 
SO3914 3 hr 20.7 35.3 28.3 8.0 14.0 10.6 TonB-dependent receptor, putative (17) 
         
         
182 
Table 6.3.  Continued 
 
Average ∆2426 Average MR-1 
Locus Time 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Peptide 
Count 
Spectra 
Count 
% 
Coverage Description (number) 
SO3914 4 hr 22.0 30.7 31.8 7.3 10.3 12.3 TonB-dependent receptor, putative (17) 
SO4523 1 hr 27.3 58.7 49.7 9.0 16.0 21.5 iron-regulated outer membrane virulence protein (irgA) (17) 
SO4523 3 hr 29.0 67.0 45.9 7.0 14.3 18.1 iron-regulated outer membrane virulence protein (irgA) (17) 
SO4523 4 hr 34.3 84.3 58.7 11.7 19.0 27.7 iron-regulated outer membrane virulence protein (irgA) (17) 
SO4652 3 hr 14.0 32.3 35.4 8.0 19.0 20.8 
sulfate ABC transporter, periplasmic sulfate-binding protein 
(sbp) (17) 
SOA0048 1 hr 24.7 31.3 38.5 13.0 16.0 25.5 prolyl oligopeptidase family protein (11)  
SOA0048 3 hr 30.0 48.3 44.0 15.3 29.7 29.1 prolyl oligopeptidase family protein (11) 
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created by Prodom (prodom.prabi.fr) having the annotation of being a tungsten 
extracellular binding protein.  The protein sequence also aligned well with a sulfate 
substrate binding protein from five of the species/strains.  Therefore, SO4719 may be 
under transcriptional control of SO2426, but does not appear to demonstrate a Cr(VI) 
exposure-dependent regulation. 
SO1190 is located in a putative operon with two other genes (so1188 and 
so1189), which were identified as highly induced in the microarray work [157].  SO1190 
was found with an average of 14 peptides over the time course and demonstrates the 
highest expression level at the 3 h time point during Cr(VI) transformation.  SO1189 was 
identified solely in the MR-1 cultures during the 0, 1, and 3 h time points, with an 
average of 2 peptides, and SO1188 was not identified in this study.  Our previous study 
testing acute chromate shock in S. oneidensis [147] identified both SO1188 and SO1189 
expressed after 45 min of growth in the presence of 1 mM Cr(VI).  Both proteins were 
identified with 2-4 peptides, which is the minimum for positive protein identification 
according to the criteria in the study.  SO1188 was solely identified in the membrane 
fraction, where 2 peptides from SO1189 were identified in the crude fraction and the rest 
of the peptides in the membrane fraction.  Based on these observations, SO1188-SO1190 
may be under the transcriptional control of SO2426. 
Due to SO1188 and SO1189 appearing to associate with the membrane fraction of 
S. oneidensis cell lysates previously [147]; this may be the reason the shotgun proteomics 
results presented here identify SO1189 with the minimum peptide count.  The 
development of mass spectrometry proteome technology is not as mature with respect to 
sensitivity as microarray technology.  In addition, the lysis method utilized here does not 
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obtain the level of membrane protein coverage found previously through fractionation 
[147, 156, 158].  Factors such as protein solubility and, in the case of this study, trypsin 
specificity, reduce the peptide count of membrane embedded proteins.  These factors 
account for some of the discrepancy between microarray and proteomics technologies.  
For example, each protein contains 12 (SO1188) and 21 (SO1189) tryptic cleavage sites 
(lysines and arginines).  Using biological replicates instead of technical replicates reduces 
the biological background and increases the confidence level that a protein found up-
regulated reproducibly is actually responding to the condition presented to the culture.  
SO1189 is an example of a protein that was borderline up-regulated during the 3 h time 
point.  Each LC-MS experiment comprised a unique culture of either strain MR-1 or 
∆2426 (indicative of Culture 1, 2, and 3, respectively).  Cultures 2 and 3 identified the 
protein with 3 and 5 tandem mass spectra, respectively, which Culture 3 passes the 
criteria of spectral count in the semiquantitation method.  However, due to the absence of 
detection of SO1189 in Culture 1, this protein is not reproducibly up-regulated during the 
time point.  If only Culture 3 had been sampled for proteome analysis, this protein would 
have been identified as differentially expressed for that particular time point.   
The most prevalent category to demonstrate down-regulation of proteins was 
transport and binding.  Two transport and binding proteins were repressed during the 
entire time course in the ∆2426 cultures.  SO3967 encodes a putative molybdenum ABC 
transporter and was identified predominately in the MR-1 cultures (average of 18.5 
peptides) with an increased induction at the 3 and 4 h time points.  SO4743 encodes a 
putative TonB-dependent receptor and was predominantly found in the MR-1 cultures as 
well, with an average of 12.4 peptides during the time course.  SO4743 demonstrated a 
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different trend with an increased peptide count identified at the 1 and 3 h time points.  
The 4 h time point demonstrated a similar abundance to that found prior to the addition of 
Cr(VI) in the media.  The Cr(VI)-dependent regulation of this protein is implicated in the 
results presented here and may be one pathway in which Cr(VI) gains access into the cell.  
Previously, SO4743 was also found to be highly up-regulated following acute chromate 
shock [147] and appears to be induced irrespective of Cr(VI) concentration [156].  The 
repression of transport and binding proteins in strain ∆2426 during Cr(VI) transformation 
indicates that SO2426 may be a transcriptional regulator of these particular proteins and 
may operate in conjuction with Fur to regulate iron homeostasis.   
A total of six proteins were found to be repressed in strain ∆2426 cultures 
belonging to the functional category energy metabolism.  Included in the repressed 
proteins are two separate alpha subunits of a formate dehydrogenase complex (SO4509 
and SO4513).  There are a total of three formate dehydrogenase operons encoded in the 
S. oneidensis genome, so0102-so0104, so4509-so4511, so4513-so4515.  so0102-so0104 
encode a nitrate inducible formate dehydrogenase with the alpha subunit, so0102, 
containing a selenocysteine residue.  SO0102 was identified in both the wildtype MR-1 
strain and the mutant ∆2426 strain with two or three unique peptides, respectively.  The 
presence of SO0102 was identified solely prior to the introduction of Cr(VI) in the 
cultures.  Interestingly, this nitrate-inducible operon appears to demonstrate a low-level 
constitutive expression in the absence of Cr(VI).  One of the subunits of this operon 
possibly encodes a molybdenum center (SO0103) that coordinates with the 
selenocysteine containing alpha subunit (SO0102).  Therefore, Cr(VI) may be interfering 
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with molybdenum uptake, which is causing up-regulation of the molybdendum ABC 
transporter under Cr(VI) stress thereby allowing more molybdenum uptake into the cell. 
so4509-so4511 and so4513-so4515 are organized in tandem and appear to be 
constitutively expressed under wildtype conditions.  Formate dehydrogenase is a multi-
protein enzyme complex, which uses the electron donor formate for respiration and 
utilizes transition metals in the redox center [257].  Prior to the alpha subunit genes in 
both operons, there are small genes annotated within the genome, so4508 and so4512.  
There is no evidence found in the proteome datasets to suggest these proteins are 
expressed.  They may represent regulatory sequences, which have characteristics 
indicative of a protein-coding gene.  SO4509, alpha subunit of formate dehydrogenase, 
was solely identified in the MR-1 cultures over the entire time course.  The alpha subunit 
identified here is the only soluble member of the complex, which explains the ease of 
identification of this protein [257].  Formate dehydrogenase in MR-1 has been shown to 
be an important member of the electron transport chain to the terminal ferric reductase in 
anaerobically grown MR-1 using Fe(III) citrate [102].  Cr(VI) may be inhibiting the 
activity of formate dehydrogenase under the conditions tested here.   
Other energy metabolism proteins identified included a fumarate reductase 
flavoprotein subunit precursor (SO0970), PflB (formate acetyltransferase), and Pta 
(phosphate acetyltransferase), which were all found repressed in the ∆2426 cultures prior 
to chromate introduction.  The decaheme cytochrome c, OmcA, was found to be 
repressed in ∆2426 cultures after 4 h of exposure to Cr(VI).  This protein is known to 
play an important role in the reduction of Fe(III) and Mn(IV) in S. oneidensis MR-1 [107, 
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113, 258].  During the other time points sampled for proteome analysis, there is no 
change in the level of expression between strain MR-1 and ∆2426 cultures for OmcA.   
As mentioned, 11 of the functional categories were represented as up-regulated in 
∆2426 cultures over the time points sampled for proteome analysis.  These categories 
included proteins involved in energy metabolism and iron transport.  For the most part, 
the proteins repressed in ∆2426 cultures were members of two molybdenum ABC 
transporters.  The proteins up-regulated in ∆2426 were involved in transport of iron 
(HugA and IrgA).  IrgA was up-regulated during Cr(VI) exposure and transformation in 
∆2426 cultures and was borderline up-regulated prior to Cr(VI) introduction.  HugA was 
up-regulated in the control (0 h) and during active transformation, but borderline up-
regulated during the 1 h time point.  The up-regulation of these proteins during active 
Cr(VI) transformation indicates a possible intracellular iron deficiency more pronounced 
in the ∆2426 cultures versus wild-type cultures.  
A putative operon involved in energy metabolism and comprising genes so0344-
so0346 was identified as up-regulated in strain ∆2426 (Table 6.3).  so0346 encodes a 
transcriptional regulator from the GntR family and is at the beginning of the operon.  
so0344 (prpC) and so0345 (prpB) are located directly downstream of so0346.  prpBC 
encode methylisocitrate lyase and methylcitrate synthase, respectively, which are 
required for growth on propionate in Salmonella enterica [259].  SO0346 does share over 
90% sequence similarity to other members of the genus Shewanella, indicating this is a 
conserved putative transcriptional regulator (data not shown).  In addition, the operon 
structure also appears to be conserved with other Shewanella species as well.  The GntR 
family of transcriptional regulators contain a N-terminal helix-turn-helix DNA-binding 
188 
domain with one of four subtypes of a C-terminal signaling domain [260, 261].  For 
SO0346, the C-terminal domain belongs to the FadR subtype, featuring an all alpha-
helical structure [260], which are usually involved in regulating activity of proteins 
involved with amino acid metabolism pathways.  This is in contrast to the structural 
organization of SO2426 and may indicate interaction between these two proteins.  The 
GntR family of transcriptional regulators are known to dimerize with one another [260], 
the up-regulation of SO0346 may be a consequence of the protein dimerizing with itself 
in the absence of SO2426.   
SO0346 was only detected in strains MR-1 and ∆2426 upon Cr(VI) introduction 
to the growth media (Supplemental Tables S1-S4).  The level of expression for the other 
two members of the operon did not demonstrate any change in regulation prior to 
chromate introduction, indicating that SO0346 is not necessary for transcriptional 
activation of so0344 and so0345.  After 1 h in the presence of Cr(VI), SO0346 was 
identified in both strains, with only one of the triplicate cultures of strain MR-1 detecting 
this protein and all three cultures of strain ∆2426 having a similar detection level for this 
protein.  After 3 h of Cr(VI) exposure, three peptides from SO0346 were found in two of 
the replicates from strain MR-1 cultures.  SO0346 in strain ∆2426 cultures was 
borderline up-regulated at this time point with 5, 10, and 12 peptides, respectively 
identified in the replicate cultures.  When approximately half of the Cr(VI) had been 
transformed in strain ∆2426, SO0346 was detected up-regulated and only one of the 
replicate cultures of strain MR-1 detected any peptides at this point corresponding to 
complete transformation of Cr(VI) (Table 6.3).  The transcriptomic data indicates that the 
gene is up-regulated only after 24 h of exposure in strain ∆2426 [157].  Based on results 
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from previous studies [147, 156, 158, 248], SO0346 has not been found to be up-
regulated in wild-type cultures exposed to various concentrations and intervals of 
chromate exposure.  At this time, the exact mode of regulation of SO0346 with respect to 
the proposed function of SO2426 is not clear.  Further investigation will be needed in 
order to decipher the relationship between SO2426 and SO0346 if indeed a relationship 
exists. 
Proteins differentially expressed during Cr(VI) transformation in strain MR-1 
Wild-type cultures of strain MR-1 prior to and following exposure to Cr(VI) were 
compared to identify proteins that are differentially expressed during acute shock and 
transformation of Cr(VI) (Tables 6.4 and 6.5).  A total of 42 proteins were found to be 
up-regulated following addition of Cr(VI) with two primary functional categories 
represented (energy metabolism and transport and binding proteins).  In contrast, 13 
proteins were down-regulated following exposure to Cr(VI) in MR-1 cultures.  There was 
a greater variety of functional categories represented in the down-regulated proteins; 
however energy metabolism dominated with five members down-regulated.  Relatively 
few proteins identified as down-regulated indicated that the MR-1 cultures had not begun 
to be stressed by the transformation of Cr(VI) [158]. 
A number of the proteins found differentially expressed in MR-1 compared to 
∆2426 were also found to demonstrate a Cr(VI) dependent response.  For instance, 
AcnA, aconitate hydratase 1, was found to be up-regulated in response to Cr(VI) 
exposure in MR-1 cultures, but up-regulated in the ∆2426 cultures.  AcnA and AcnB are 
well characterized in E. coli [262] with a role in the TCA cycle by catalyzing the 
isomerization of citrate to isocitrate.  This important step in the TCA cycle is one reason 
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Table 6.4.  Proteins Identified as Up-Regulated upon Cr(VI) Exposure in MR-1 Cultures 
 
Average 0hr MR-1 culture Average Cr(VI) exposed MR-1 culture 
Locus 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Time 
point Description (Number) 
SO0343 8.7 14.7 12.9 21.0 38.3 32.3 1 aconitate hydratase 1 (acnA) (7) 
SO0343 8.7 14.7 12.9 26.0 53.3 39.5 3 aconitate hydratase 1 (acnA) (7) 
SO0343 8.7 14.7 12.9 26.7 53.0 40.3 4 aconitate hydratase 1 (acnA) (7) 
SO0345 6.7 18.3 37.0 13.0 46.0 48.7 1 methylisocitrate lyase (prpB) (7) 
SO0345 6.7 18.3 37.0 16.0 45.0 53.1 3 methylisocitrate lyase (prpB) (7) 
SO0429 15.3 19.3 31.5 20.7 41.7 41.0 1 peptidase, M13 family (3)  
SO0429 15.3 19.3 31.5 24.3 55.3 45.2 4 peptidase, M13 family (3) 
SO0518 1.7 1.7 5.6 6.7 9.7 23.3 4 outer membrane efflux family protein, putative (17) 
SO0519 4.0 4.0 15.3 9.0 18.7 31.9 3 cation efflux protein, putative (4) 
SO0519 4.0 4.0 15.3 9.7 20.3 34.0 4 cation efflux protein, putative (4) 
SO0554 4.0 5.3 26.6 9.3 17.3 50.4 3 hypothetical protein (9) 
SO0554 4.0 5.3 26.6 10.3 16.0 45.8 4 hypothetical protein (9) 
SO1072 2.7 4.7 11.2 9.3 14.3 24.9 1 chitin-binding protein, putative (17) 
SO1072 2.7 4.7 11.2 8.7 10.3 27.8 3 chitin-binding protein, putative (17) 
SO1075 11.3 12.0 18.3 17.3 24.3 29.5 1 conserved hypothetical protein (9) 
SO1482 5.0 5.3 10.7 10.7 18.0 23.2 1 TonB-dependent receptor, putative (17)  
SO1490 23.0 46.7 59.2 29.7 107.3 65.2 4 alcohol dehydrogenase II (adhB) (7) 
SO1677 24.3 57.7 64.5 31.0 138.3 73.8 1 acetyl-CoA acetyltransferase (atoB) (8)  
SO1678 1.3 2.0 3.1 8.0 19.0 22.6 4 methylmalonate-semialdehyde dehydrogenase (mmsA) (7) 
SO1679 11.3 20.7 34.6 18.0 44.0 54.8 3 acyl-CoA dehydrogenase family protein (8) 
SO1679 11.3 20.7 34.6 20.0 49.3 52.6 4 acyl-CoA dehydrogenase family protein (8) 
SO1755 10.0 15.3 23.7 15.7 34.3 36.7 4 phosphoglucomutase/phosphomannomutase family (7)  
SO1816 6.0 7.7 28.6 12.7 30.0 45.9 3 conserved hypothetical protein (9) 
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Table 6.4.  Continued 
 
Average 0hr MR-1 culture Average Cr(VI) exposed MR-1 culture 
Locus 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Time 
point Description (Number) 
SO1894 13.0 18.0 29.5 22.7 42.3 40.4 4 acetyl-CoA carboxylase, biotin carboxylase, putative (8) 
SO2903 33.3 214.0 86.6 45.0 482.7 91.9 1 cysteine synthase A (cysK) (1) 
SO2903 33.3 214.0 86.6 47.7 474.0 93.5 3 cysteine synthase A (cysK) (1) 
SO2903 33.3 214.0 86.6 46.3 526.7 91.2 4 cysteine synthase A (cysK) (1) 
SO3030 0.7 0.7 2,2 14.0 22.7 35.4 1 siderophore biosynthesis protein (alcA) (17)  
SO3030 0.7 0.7 2,2 8.0 11.3 20.1 3 siderophore biosynthesis protein (alcA) (17) 
SO3032 4.3 6.0 8.5 13.7 28.7 27.9 1 siderophore biosynthesis protein, putative (17) 
SO3032 4.3 6.0 8.5 11.3 27.7 22.5 4 siderophore biosynthesis protein, putative (17) 
SO3033 4.0 7.7 8.1 12.7 29.3 26.1 1 ferric alcaligin siderophore receptor (17) 
SO3033 4.0 7.7 8.1 13.3 33.3 24.6 3 ferric alcaligin siderophore receptor (17) 
SO3033 4.0 7.7 8.1 9.3 22.0 17.7 4 ferric alcaligin siderophore receptor (17) 
SO3145 8.3 22.7 43.7 13.3 46.3 61.2 4 electron transfer flavoprotein, beta subunit (etfB) (7)  
SO3237 6.7 13.7 38.2 11.7 43.0 48.3 3 flagellin (4) 
SO3238 5.3 12.0 35.0 10.7 37.3 53.7 4 flagellin (4) 
SO3430 16.3 23.3 47.4 35.3 133.7 77.1 1 recA protein (recA) (6) 
SO3430 16.3 23.3 47.4 37.3 129.3 75.2 3 recA protein (recA) (6) 
SO3430 16.3 23.3 47.4 36.7 122.0 85.3 4 recA protein (recA) (6) 
SO3462 0.0 0.0 0,0 7.7 10.7 17.1 1 DNA repair protein RecN (recN) (6) 
SO3462 0.0 0.0 0,0 11.0 14.0 28.6 3 DNA repair protein RecN (recN) (6) 
SO3462 0.0 0.0 0.0 8.0 12.0 19.4 4 DNA repair protein RecN (recN) (6) 
SO3599 14.0 28.3 56.5 24.0 88.7 71.9 1 
sulfate ABC transporter, periplasmic sulfate-binding (cysP) 
(17) 
SO3599 14.0 28.3 56.5 22.7 90.7 67.1 4 
sulfate ABC transporter, periplasmic sulfate-binding (cysP) 
(17) 
SO3667 4.0 4.3 40.6 20.0 87.7 85.8 1 conserved hypothetical protein (9) 
SO3667 4.0 4.3 40.6 16.0 69.3 74.6 3 conserved hypothetical protein (9) 
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Table 6.4.  Continued 
 
Average 0hr MR-1 culture Average Cr(VI) exposed MR-1 culture 
Locus 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Time 
point Description (Number) 
SO3667 4.0 4.3 40.6 17.3 64.7 76.6 4 conserved hypothetical protein (9) 
SO3669 5.3 7.3 13.4 27.0 78.3 46.9 1 heme transport protein (hugA) (17) 
SO3669 5.3 7.3 13.4 21.3 57.7 37.2 3 heme transport protein (hugA) (17) 
SO3669 5.3 7.3 13.4 24.7 74.0 39.4 4 heme transport protein (hugA) (17) 
SO3673 1.7 3.0 9.1 15.3 35.0 54.1 1 
hemin ABC transporter, periplasmic hemin-binding  
(hmuT) (17) 
SO3673 1.7 3.0 9.1 15.7 43.0 52.6 3 
hemin ABC transporter, periplasmic hemin-binding  
(hmuT) (17) 
SO3673 1.7 3.0 9.1 16.3 37.3 55.3 4 
hemin ABC transporter, periplasmic hemin-binding  
(hmuT) (17) 
SO3726 1.7 2.3 6.3 8.0 13.7 31.6 1 sulfate adenylyltransferase, subunit 1 (cysN) (5) 
SO3727 3.7 4.7 18.8 13.0 19.0 43.4 1 sulfate adenylyltransferase, subunit 2 (cysD) (5) 
SO3727 3.7 4.7 18.8 12.0 22.7 45.6 3 sulfate adenylyltransferase, subunit 2 (cysD) (5) 
SO3737 10.0 11.7 22.5 20.7 39.7 35.7 1 
sulfite reductase (NADPH) hemoprotein beta-component  
(cysI) (5) 
SO3737 10.0 11.7 22.5 23.3 47.3 42.3 3 
sulfite reductase (NADPH) hemoprotein beta-component  
(cysI) (5) 
SO3914 5.3 9.0 11.1 12.3 17.0 19.2 1 TonB-dependent receptor, putative (17) 
SO4134 1.3 1.7 18.6 8.0 13.3 50.0 4 conserved hypothetical protein (9) 
SO4215 13.7 20.0 41.3 23.7 46.0 52.9 4 cell division protein FtsZ (ftsZ) (4) 
SO4476 0.7 0.7 3.7 7.7 14.3 27.2 4 spheroplast protein y precursor, putative (18)  
SO4480 0.0 0.0 0.0 7.3 10.3 14.2 3 aldehyde dehydrogenase (aldA) (18) 
SO4652 1.3 2.7 6.3 10.0 32.7 28.8 4 sulfate ABC transporter, periplasmic sulfate-binding (sbp) (17) 
SO4655 0.7 0.7 1.9 5.0 11.7 26.2 4 sulfate ABC transporter, ATP-binding protein (cysA-2) (17) 
SO4692 9.0 11.3 11.9 14.0 25.3 19.9 1 AcrB/AcrD/AcrF family protein (4) 
SO4743 9.7 10.3 23.1 16.0 22.7 35.7 1 TonB-dependent receptor, putative (17) 
SOA0100 9.7 15.0 21.4 18.7 35.0 40.9 4 conserved hypothetical protein (9) 
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Table 6.5.  Proteins Identified as Down-Regulated upon Cr(VI) Exposure in MR-1 Cultures 
 
Average 0hr MR-1 culture Average Cr(VI) exposed MR-1 culture 
Locus 
Peptide 
Count 
Spectra 
Count 
% 
Coverage 
Peptide 
Count 
Spectra 
Count 
% 
Coverag
e 
Time 
point Description (Number) 
SO0575 10.0 25.7 15.7 3.0 6.3 5.3 4 RNA polymerase-associated protein (hepA) (16) 
SO0848 27.3 41.7 38.0 8.0 13.3 15.2 1 periplasmic nitrate reductase (napA) (7) 
SO0848 27.3 41.7 38.0 4.3 5.0 9.8 3 periplasmic nitrate reductase (napA) (7) 
SO0848 27.3 41.7 38.0 5.0 7.7 9.7 4 periplasmic nitrate reductase (napA) (7) 
SO1519 9.0 10.3 21.1 3.3 3.7 9.1 4 iron-sulfur cluster-binding protein (7) 
SO1602 20.0 26.7 14.5 10.0 13.3 7.9 3 multi-domain beta-ketoacyl synthase (18) 
SO1602 20.0 26.7 14.5 11.3 16.0 8.3 4 multi-domain beta-ketoacyl synthase (18) 
SO1631 10.0 23.0 49.2 4.3 8.3 21.9 4 uridylate kinase (pyrH) (13) 
SO2218 14.0 21.0 31.2 8.3 19.7 24.5 4 asparaginyl-tRNA synthetase (asnS) (12) 
SO2248 8.0 12.0 17.4 3.7 5.7 12.1 3 L-serine dehydratase 1 (sdaA) (7) 
SO2427 26.7 54.0 39.0 20.3 35.0 30.3 4 TonB-dependent receptor, putative (17) 
SO2705 20.7 26.0 30.6 9.0 12.0 12.4 3 DNA topoisomerase I (topA) (6) 
SO3565 10.7 11.7 19.5 3.0 3.3 6.7 1 2,3-cyclic-nucleotide 2-phosphodiesterase (cpdB) (13) 
SO3565 10.7 11.7 19.5 2.3 3.0 5.3 4 2,3-cyclic-nucleotide 2-phosphodiesterase (cpdB) (13) 
SO3980 20.7 42.3 36.1 9.0 12.7 20.0 1 cytochrome c552 nitrite reductase (7) 
SO3980 20.7 42.3 36.1 5.0 7.3 12.4 3 cytochrome c552 nitrite reductase (7) 
SO3980 20.7 42.3 36.1 6.7 7.7 15.4 4 cytochrome c552 nitrite reductase (7) 
SO4513 15.0 20.0 20.6 6.0 7.3 9.2 1 formate dehydrogenase, alpha subunit (7) 
SO4513 15.0 20.0 20.6 6.7 10.3 11.0 3 formate dehydrogenase, alpha subunit (7) 
SO4513 15.0 20.0 20.6 6.3 8.7 8.8 4 formate dehydrogenase, alpha subunit (7) 
SO4659 6.0 8.7 21.2 0.0 0.0 0.0 3 conserved hypothetical protein (9) 
SO4659 6.0 8.7 21.2 0.0 0.0 0.0 4 conserved hypothetical protein (9) 
194 
why the isozyme AcnB has a compensatory pathway.  AcnB has been found to be 
constitutively expressed, but easily inactivated due to demetallation [262].  AcnA is 
characterized as a compensatory counterpart to AcnB and is resistant to oxidative stress.  
This resistance is unusual for this type of [4Fe-4S] cluster enzyme.  The presence of 
AcnA is generally as a minor component (i.e. no Cr(VI) added equals ~13 spectra 
identified); however, during Cr(VI) transformation the prevalence of AcnA increases up 
to 50 MS/MS spectra identified at the 4 h time point.  This result is expected due to the 
transformation of Cr(VI) to Cr(III), which can proceed through the unstable redox active 
species Cr(V) [86, 126, 140, 146].  The fact that AcnA demonstrated increased 
expression in the ∆2426 cultures compared to MR-1 provides further evidence of the 
increased oxidative stress in strain ∆2426 cultures.  In addition, the AcnB product was 
found not to (1) change expression level following Cr(VI) exposure and (2) was not 
down-regulated in the ∆2426 cultures.  This is expected based on the known role of 
AcnB in E. coli as a house-keeping protein [262]. 
The alpha subunit of formate dehydrogenase (SO4513) demonstrated a 
contrasting expression pattern to AcnA.  As described above, SO4513 was found to be 
highly up-regulated in MR-1 cultures and to be expressed in ∆2426 cultures only in the 
absence of Cr(VI).  This protein was further found to be down-regulated following 
exposure to Cr(VI) in the MR-1 cultures.  All three time points sampled following Cr(VI) 
introduction revealed approximately the same level of expression (~6 peptides on average 
identified) in contrast to prior to Cr(VI) introduction (15 peptides on average identified).  
This result indicates a perhaps complex control mechanism for expression of SO4513. 
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A number of proteins involved in sulfate uptake and metabolism were also 
identified as up-regulated upon exposure to Cr(VI) in the MR-1 cultures.  CysK, CysP, 
CysN, CysD, CysI, Sbp, and CysA-2 were all found to be up-regulated post Cr(VI) 
introduction to MR-1 cultures.  In fact, a majority of these proteins were identified as up-
regulated during the initial shock time point (1 h post Cr(VI) introduction), indicating an 
initial up-take of Cr(VI) perhaps through the sulfate system thereby creating an 
intracellular sulphate deficiency, as has been implicated elsewhere [141].  CysK encodes 
the enzyme cysteine synthase A, which catalyzes the final synthesis step by condensing 
sulfide with O-acetyl-L-serine to yield cysteine [263].  In Bacillus subtilis, CysK was 
shown to negatively regulate the sulfur metabolism genes similar to the nitrogen 
metabolism regulatory system [263].  Therefore, the up-regulation of CysK under the 
conditions presented here implicates a possible deficiency of intracellular sulfur in 
response to the presence of Cr(VI) or oxidative stress.  The possible regulatory role of 
CysK in S. oneidensis is not clear at this time.  Two sulfate ABC transporters are encoded 
in the MR-1 genome (so3599-so3602 and so4652-4655) with three members from these 
operons up-regulated following exposure to Cr(VI).  CysP, the periplasmic sulfate-
binding protein, is a member of the first operon and was found up-regulated during the 1 
and 4 h time points, but demonstrated an equal expression level at the 3 h time point.  Sbp 
is the periplasmic protein of the second operon and was found up-regulated following 
complete Cr(VI) transformation at the 4 h time point in addition to member CysA-2, the 
ATP-binding protein.  Since Cr(VI) has been demonstrated as an inhibitor of sulfate 
uptake [141], there may be a deficiency within the cytoplasm of sulfide leading to the 
activation of genes necessary for sulfur acquisition and metabolism. 
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Post-translational modifications of strain MR-1 during Cr(VI) transformation 
The 0, 1, 3, and 4 h MR-1 datasets were searched using InsPecT to determine 
MS/MS containing post-translational modifications (PTMs) overlooked during the initial 
Sequest search.  Thompson et al [59] discusses the optimization of the scoring scheme 
used here, where the p-value threshold chosen for each dataset demonstrates a false 
discovery rate (FDR) of 2.0±0.2%.  Therefore, each dataset will have a unique p-value 
cutoff due to the scoring distribution of that dataset.  Table 6.6 contains the p-value cutoff 
chosen for each dataset with the corresponding FDRs observed.  The p-value distribution 
was from 0.45 to 0.83 for the four time points of the MR-1 cultures sampled.  The 
resulting FDR when considering PTM-containing peptides only was 12.0-19.0%.  For 
example, the MR-1 culture harvested prior to Cr(VI) addition had a FDR of 2.1% with 
the p-value cutoff score of 0.45 and a total of 10,871 PTM peptides identified.  All PTM 
peptide identifications can be accessed in Supplemental Table S5.  Prior to Cr(VI) 
introduction into the cultures (0 h), many more PTM peptides were identified.  This is in 
contrast to the non-modifications searches, where a comparable number of total proteins 
and peptides were identified under all of the time points (Table 6.1).  The resulting 
optimization of the filtering threshold for identification of PTM peptides to a specific 
FDR leads to a more accurate comparison across the information in the datasets. 
The most prevalent PTM in the 0 h dataset was oxidation of methionines, 
cysteines, tryosines, and tryptophan residues, followed by diacetylation of lysines and 
arginines.  In contrast, there was approximately the same amount of monomethylations as 
diacetylations in the 4 h dataset and much fewer dimethylations identified.  Relative to 
the total number of PTM peptides identified for the two respective datasets (Table 6.6), 
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Table 6.6.  InsPecT p-value Thresholds and Corresponding FDRs for Strain MR-1 PTMs 
 
Total Peptide Identifications PTM Peptide Identifications Culture 
Time point p-value Reverse IDs Total IDs % FDR Reverse IDs Total IDs % FDR 
0 hr 0.45 733 68640 2.1 694 11565 12.0 
1 hr 0.70 670 74244 1.8 621 8166 15.2 
3 hr 0.83 759 71248 2.1 745 8736 17.1 
4 hr 0.75 712 65193 2.2 706 7415 19.0 
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there were more oxidized peptides found at the 4 h time point relative to the 0 h control.  
The oxidation identifications for both datasets primarily consisted of monooxidations.  In 
addition, the other two Cr(VI) exposure time points, 1 and 3 h, exhibited the same overall 
distribution of PTMs characteristic of the 4 h time point.  Even though phosphorylations 
are common signaling PTMs, this modification was not searched in the resulting datasets.  
In bacteria, most phosphorylations occur on histidine or aspartic acid residues consisting 
of temporally rapid events that are difficult to detect [52, 236, 264].  In addition, the 
method of fragmentation utilized in this study (collision induced dissociation) is not 
amenable for retaining the location of the phosphorylation site on the peptide resulting in 
a neutral loss of 98 Da as the primary fragment ion [59]. 
 Due to the global differences in PTM characteristics for the time course, the 
PTM-containing peptides identified for each time point were organized according to the 
functional category role of the parent protein.  Figure 6.4 depicts the category distribution 
of the peptides from each time point.  The protein synthesis role category predominates 
across all time points as containing the greatest number of post-translationally modified 
peptides.  This is expected due to the proteins encoding the ribosome comprising this role 
category, which have been shown previously to be highly modified [48].  Peptides with a 
role in amino acid biosynthesis demonstrated increased modifications indicative of 
increased control over this process (Figure 6.4).  In addition, as exposure to Cr(VI) 
progresses, proteins involved in cellular processes become gradually more modified 
indicating a change in the level of regulation.  However, a majority of the categories do 
not change over Cr(VI) transformation time, but rather the constituents that are modified 
vary.
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Figure 6.4.  Post-translationally modified peptides identified by InsPecT for strain MR-1. 
Each slice represents a functional category and comprises the percent of peptides for the 
category identified out of the total PTM peptides for each time point (i.e. 0 hr, 1 hr, 3 hr, 
and 4 hr). 
PTM Peptides 0 hr PTM Peptides 1 hr PTM Peptides 3 hr PTM Peptides 4 hr
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 The functional category of signal transduction comprises proteins involved in 
gene expression regulation, namely the 53 two-component response regulators annotated 
in this group.  SO2426, which has been knocked out in this study, is an orphan response 
regulator in this category demonstrating a number of PTMs over time.  Over the time 
course presented here, signal transduction proteins identified as unmodified comprised 8-
14 protein identifications.  This is expected due to these members having a low copy 
number within a bacterial cell.  By including differential chemical modifications for the 
InsPecT search, the identification rate of signal transduction proteins increased to at least 
11-18 proteins identified over the time course.   
 A number of signal transduction proteins demonstrated Cr(VI)-dependent 
modifications during the time course evaluated here.  Three proteins demonstrated 
differential modification states over the time course:  SO2426, SO2742, and SO4472.  
SO2426 is a putative Cr(VI) transcriptional regulator shown here to be involved in 
controlling gene expression of a number of proteins.  SO2742 is an orphan sensor 
histidine kinase/response regulator similar to SO2426, while NtrC (SO4472) is a nitrogen 
regulatory protein.  Supplemental Figures S2-S4 are the annotated MS/MS of all the 
modified peptides documented for SO2742.  There were a total of seven amino acids 
found to be chemically modified after 1 and 4 h of exposure to Cr(VI).  An oxidized 
methionine was identified after Cr(VI) exposure for 1 h.  After 4 h, two dioxidized 
methionines, a triply oxidized cysteine, a monomethylated lysine residue, and two 
arginines were dimethylated and diacetylated, respectively.  Interestingly, one of these 
peptides included the monomethylated lysine, dioxidized methionine, and the 
dimethylated arginine would not have been identified with previous methods of PTM 
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search methods [51, 59], due to restrictions in both the computational requirements of 
algorithms and the flexibility in specifying PTMs in the algorithm parameters.  However, 
the PTMs present on SO2742 are interesting and may point to a level of control for this 
protein after Cr(VI) transformation has occurred. 
 SO2426 is a response regulator that has been implicated to specifically respond to 
Cr(VI) exposure previously [147, 156].  Due to the importance of this protein in response 
to chromate exposure, understanding possible regulation by PTMs is necessary to 
decipher both regulation and function within the bacterium.  Prior to Cr(VI) addition to 
the strain MR-1 cultures, the presence of SO2426 was not detected with PTMs and 
without any proteomic evidence from the non-modifications searches to suggest that the 
protein had even been translated at that time.  Following addition of Cr(VI) to strain MR-
1 cultures, SO2426 was identified in the proteome samples acquired, present with and 
without modified peptides.  According to the identifications made by the algorithm 
InsPecT, a total of five putative spectra were identified as comprising a PTM peptide 
with two spectra found to be incorrect identifications after manual inspection.  SO2426 
was identified with 2-3 peptides for all three MR-1 cultures after exposure to Cr(VI) for 1 
h.  Following 3 h of exposure to Cr(VI), a total of six peptides passed the filter thresholds 
used for InsPecT.  The 4 h time point yielded a total of 3 peptides for cultures 2 and 3 
only.  The identification of one modified peptide was found in culture 3 as well as the 
unmodified counterpart.  The modification consisted of a methionine oxidation that may 
or may not be due to the sample preparation procedures used in this study.  This same 
methionine residue was found to be oxidized after culture 2 was exposed to Cr(VI) for 4 
h.  The identification of a diacetylated arginine was found in culture 2 at the 3 h 
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timepoint.  At this time, there is active transformation of Cr(VI) to presumably Cr(III) 
(Figure 6.2).  The dicetylation was confidently identified by four fragment ions in the 
MS/MS and corresponds to R13 of SO2426 (Figure 6.5).  This peptide also contains a 
triply oxidized cysteine and a doubly oxidized methionine.  The acetylation may be 
regulatory in nature; however, the significance of this modification is unknown at this 
time.  The regulation is possibly due to the relative proximity of the diacetylated arginine 
(R13) to an aspartic acid that is putatively phosphorylated aspartic acid (D57) [232]. 
Conclusions 
 Although this global proteomic study has provided a great deal of valuable 
information as to the response of S. oneidensis to chromate exposure during the 
transformation period, much more effort is needed in order to fully appreciate the 
physiological response to Cr(VI) exposure and stress.  The deletion mutant strain ∆2426 
demonstrated a deficiency in Cr(VI) transformation during the time course examined in 
this study.  The deficiency may be due to genes that are involved in chromate 
transformation being under the control of SO2426.  In regards to possible gene control of 
SO2426, a number of proteins were found to be heavily down-regulated in strain ∆2426 
when compared to the wild-type strain MR-1 during parallel time points.  Out of the 
differentially expressed proteins identified, the presence of a chromate reductase protein 
was not clear.  However, as suggested by Viamajala et al [265], there may not be a 
dedicated chromate reductase encoded in the genome of S. oneidensis, but rather a 
number of reductase enzymes may recognize chromate as a substrate. 
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Figure 6.5.  A peptide MS/MS from SO2426 with confirmed modifications.   
The N-terminal peptide from SO2426 (MILILVWC+48LEM+32SR+84) has two oxidation 
events and a diacetylation event.  Fragment ions y4, y7, y8, and y10 confirm the 
diacetylated arginine residue, while fragment ions b8, b9, and b*10 confirm the triply 
oxidized methionine.  All three modifications are present in fragment ions y7, y8, and 
y10.  
b3
b5
b6 b7
b8
b9
b*10
y4
y8
y7
y10
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Chapter 7 
An Experimental Approach for Large-Scale Proteome Measurements from Small-
Scale Amounts of Microbial Cultures and Communities 
Portions of the data presented is in preparation for submission for publication 
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Introduction 
 A foremost consideration in shotgun proteomics experiments has been the amount 
of biomass needed for deep proteome characterization by LC-MS.  With many different 
methods of lysing microorganisms available to choose from, the most common methods 
utilize a manual disruption of the membrane to release the protein complement of the 
cell.  Research in mass spectrometry-based proteomics has focused both method 
development and application efforts on microorganisms that are readily cultured in a 
laboratory.  The limited range of organisms that can be cultured and studied with this 
technique is one of the many disadvantages to limiting the scope of investigation with 
these approaches.  In addition, many tissue samples available from more complex 
organisms may be limiting as well [266].   
 In general, the amount of starting microbial cellular material has been a limiting 
factor in shotgun proteomics experiments.  A relatively large quantity of biomass has 
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been the standard for an in-depth analysis of the protein complement in a given organism.  
Investigations published as recently as 2006 demonstrate the large amounts of cellular 
biomass (greater than 1 g) needed for an evaluation of the resulting proteome [63, 97, 
267-269].  In 2003, Corbin et al [267] investigated the relationship between the 
transcriptome and the proteome of Escherichia coli MG1655.  In order to obtain enough 
material for the proteome analysis, cultivation of ~3 x 109 cells in a 100 mL culture was 
necessary.  Furthermore, a recently published study by Ding et al [63] on various growth 
conditions of the dissimilatory metal-reducing bacterium Geobacter sulfurreducens also 
exploited large culturing conditions (a 1.5 L culture volume) to obtain a suitable quantity 
of starting cellular material.  The significant quantity of starting material needed is also 
due to the considerable losses inherent to the sample processing steps, which involve 
lysis, fractionation, digestion, and cleanup.  In addition to lysis, proteome experiments 
usually involve the fractionation of protein into a membrane-associated and a soluble 
fraction [63, 147, 156, 270].  Fractionation of cellular lysate requires greater amounts of 
starting material (at least 750 mg) due to the inherent losses caused by centrifugal 
separation and splitting the sample.  However, fractionation was necessary previously, in 
order to routinely identify low-abundant proteins.  The use of technical replicates also 
requires an increase in the amount of starting biomass.  Developing a method where lysis 
and digestion occur in the same tube reduces the number of surfaces proteins/peptides 
come in contact with, thereby reducing sample losses, while maintaining a level of 
proteome coverage similar to the traditional lysis method. 
 The ability to efficiently rupture the cellular membrane of an organism, whether it 
is of macro- (mammalian tissue) or micro-size (bacteria) has been at the forefront of 
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biological research.  In 1970, Coleman et al first described the enzyme lysozyme as an 
efficient agent to disrupt the cellular membrane of bacteria exposing the nucleic acid 
inside [271].  However, this technique is unsuitable for gram-positive bacteria, which 
have a different membrane composition [272].  Van Huynh et al described a method of 
lysing gram-positive bacteria using DMSO instead of a lytic enzyme [272].  Both of these 
methods are not suitable for shotgun proteomics experiments due to the use of excessive 
amounts of an enzyme for the lysozyme method [271] and employment of  SDS detergent 
for the DMSO method [272].  The lysozyme protein would suppress the signal of 
endogenous proteins and SDS interferes with the activity of the commonly used protease 
trypsin [273] as well as the resulting LC-MS/MS analysis [274] in a shotgun proteomics 
experiment.  Therefore, a new method of lysis had to be developed to alleviate these 
inherent problems associated with shotgun proteomics.  Two methods of manual 
disruption, sonication and French press, of microbial cells have been used extensively 
[275, 276], and have been shown to be efficient in lysing bacterial cells [276].  The 
disadvantage of these lysis methods is their requirement for milliliter volumes of sample.  
As discussed below for microbial ecology studies, there will most likely not be that much 
starting material available.  Designing a method of lysis that does not require a large 
volume for the suspended cells is critical in order to fully utilize the capabilities offered 
by shotgun proteomics experiments.  To address this issue, Wang et al in 2005 developed 
a method of lysis that utilizes trifluroethylene (TFE) as a lysing agent followed by urea as 
the protein denaturant [266].  The disadvantage of this method is the increased dilution 
needed after the denaturing step to minimize trypsin inhibition in urea [277].  The method 
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described in this study uses Guanidine HCl as both a lysis agent and denaturant yielding 
in-depth proteome coverage. 
 To date, the number of microbial species that are cultivable has been estimated to 
be less than 1% [278-280].  In fact, the estimate for genome complexity in soil is 
equivalent to ~6000-10,000 E. coli genomes, but the complexity that is actually 
recovered through cultivation is equivalent to 40 E. coli genomes [281].  This creates a 
bias in the characterization and understanding of microbes with respect to both their 
evolutionary role and their metabolic role in the natural world [280].  Many ecologists 
and population geneticists understand the need for utilizing a proteomics approach for 
classifying metapopulation structures and the adaptive processes at work in the natural 
environment [282].  Micoorganisms play key metabolic roles in natural settings like 
degradation and transformation of metal and organic pollutants in the soil [71, 121, 129, 
283] and are utilized in the treatment of sewage wastewater [284, 285].  A few studies on 
the proteome characterization of natural microbial communities have been published to 
date.  Wilmes and Bond [284, 285] utilized two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) to characterize proteins present in a laboratory-scale 
activated sludge system.  Powell et al [286] in 2005 used a similar yet distinct approach 
to characterize the dissolved organic matter (DOM) of marine environments utilizing 
SDS-PAGE LC-MS and MudPIT [33].  Recent work in our laboratory has demonstrated 
the comprehensive characterization of a natural microbial community found in acid mine 
drainage [65].  This microbial community thrives in the mine drainage, and was 
characterized by LC/LC-MS/MS.  All of these studies discuss the critical need for better 
sample preparation methods, in particular for processing small samples for characterizing 
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natural microbial communities.  A comprehensive approach to the lysis of the microbes, 
chromatographic separation of the digested peptides, and analysis of shotgun proteomics 
data from microbial communities will greatly expand knowledge in microbial ecology. 
Materials and Methods 
Reagents, Sample Acquisition, and Sample Preparation 
Chemical reagents (i.e. Guanidine HCl) were acquired from Sigma Chemical Co. 
(St. Louis, MO) and were used as supplied without further purification.  Modified 
sequencing grade trypsin (Promega, Madison, WI) was used for all protein digestions.  
Trifluoroethylene (TFE) was purchased from Fluka (Buchs, Switzerland).  HPLC-grade 
water and acetonitrile were obtained from Burdick & Jackson (Muskegon, MI), and 99% 
formic acid was purchased from EM Science (Darmstadt, Germany).  Wild-type 
Shewanella oneidensis MR-1 was cultivated under aerobic conditions as described in 
Brown et al [147] and was a gift from Dr. D. Thompson.  Wild-type Rhodopseudomonas 
palustris CGA0010 was cultured under photoheterotrophic conditions and was a gift 
from Dr. D. Pelletier of Oak Ridge National Laboratory.  The AMD biofilm was sampled 
from the Richmond Mine as described [65] and was a gift from Dr. J. Banfield of the 
University of California at Berkley.  
 Five separate lysis techniques were tested during the course of this study:  
sonication, Guanidine HCl, TFE, freeze-grinding, and bead-beating.  Figure 7.1 depicts a 
flow diagram of the experimental differences (sample size, preparation steps) between the 
lysis techniques of sonication and the two single tube (Guanidine HCL and TFE) 
methods described here.  Sonication was performed on S. oneidensis and R. palustris as a 
control lysis technique and is described in detail in [147] for S. oneidensis, with the only 
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Figure 7.1.  Schematic of the traditional sonication versus the single tube lysis method. 
In a traditional sonication lysis, this requires approximately 4 L of culture to obtain ~4 g 
of wet cell pellet.  While, the single tube lysis method requires much less ~0.3 to 5.0 mL 
of culture for down to 1 mg of wet cell pellet. 
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modification for R. palustris being 10-30 s sonication pulses.  The Guanidine HCl lysis 
method was performed by lysing and simultaneously denaturing the resulting protein 
content with 6 M Guanidine/10 mM DTT dissolved in 50 mM Tris/ 10 mM CaCl2 pH 7.6 
(Tris Buffer) overnight at 37 °C with details described in Chapter 2.  Lysis using TFE 
was performed in the same manner as the Guanidine HCl method except TFE was added 
initially at a concentration of 50:50 TFE:Tris Buffer/10mM DTT.  For the AMD biofilm, 
two other methods were attempted in addition to guanidine-lysis and TFE.  The freeze-
grinding method was performed by first flash-freezing the biofilm with liquid N2 
followed by pulverization of the biofilm for subsequent cellular lysis and digestion as 
described in Chapter 2.  A bead-beating method was also attempted for the AMD biofilm 
to determine if this method would destroy the biofilm structure and is also described in 
Chapter 2.  Details of the tryptic digestion following lysis can be found in Chapter 2. 
Protein Yield Quantification 
Wet cell pellets of 1, 5, and 10 mg from R. palustris; 1, 5, and 10 mg from S. 
oneidensis were lysed overnight in 6 M Guanidine HCl/ Tris Buffer.  Lysates were then 
centrifuged to pellet cellular debris and BCA analysis (Pierce, Rockford, IL) was 
performed according to the manufacturer’s instructions.  A total of eight replicate cell 
lysates were analyzed for the 1 & 5 mg R .palustris and 1, 5, & 10 mg S. oneidensis 
samples, with the Biofilm samples and 10 mg R. palustris sample having two replicates.  
The average protein yield with standard deviation error bars was plotted in Excel 
(Microsoft, Redmond, WA).  The working absorbance range for the samples was 0.2 to 
2.0.  Due to interfering chromophores present in the AMD biofilm, the BCA 
quantification was not performed. 
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LC/LC-MS/MS Analysis 
All resulting lysis samples were analyzed via two-dimensional on-line liquid 
chromatography using identical Ultimate pumps (LC Packings; a Division of Dionex, San 
Francisco, CA) coupled to a LCQ ion trap (Thermo Electron, Waltham, MA) or a LTQ 
linear trapping quadrupole (Thermo Electron).  The flow rate of the Ultimate pump at 
~100 µL/min was split pre-column to achieve a final flow rate at the nanospray tip of 
~300 nL/min.  The samples were loaded onto a split-phase column (packed in-house with 
C18 reverse phase and SCX chromatographic resin) as described in [147].  The split-phase 
column was placed behind a 15 cm C18 analytical column (packed in-house [147]) and 
both were situated in front on a Thermo Electron nanospray source for the LCQ and a 
Proxeon nanospray source (Odense, Denmark) for the LTQ.  The liquid chromatographic 
method used here for analyses with the LCQ and LTQ consisted of increasing step pulses 
of (0-500 mM) ammonium acetate salt, followed by a 2 hr 100% aqueous (95% H2O, 5% 
ACN, 0.1% formic acid) to 50% organic (30% H2O, 70% ACN, 0.1% formic acid) 
gradient.  During the liquid chromatographic separation both the LCQ and LTQ were 
operated in a data-dependent mode [147, 156] and under the control of the Xcalibur 
software (Thermo Electron). 
Proteome Bioinformatics 
The following databases were used to search resulting MS/MS spectra with the 
algorithm Sequest [39] or DBDigger [44].  For the S. oneidensis dataset, the database 
(4,798 open reading frames) was downloaded from TIGR (www.tigr.org, Comprehensive 
Microbial Resource) and concatenated with a list of common contaminants (trypsin, 
keratin, etc.).  The R. palustris dataset used the database annotated at Oak Ridge National 
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Laboratory and can be accessed at compbio.ornl.gov/rpal_proteome/databases.  The 
AMD biofilm database used was from Tyson et al [67].  The following parameters were 
used for all searches:  enzyme type, trypsin; Parent Mass Tolerance, 3.0; Fragment Ion 
Tolerance, 0.5; up to 4 missed cleavages allowed, and fully tryptic peptides only.  Output 
files were then sorted with DTASelect [171] with the following filtering criteria for the 
Sequest searches:  tryptic peptides only, delCN value of at least 0.08, and Xcorr values of 
at least 1.8 (+1), 2.5 (+2), 3.5 (+3).  For the DBDigger searches the following criteria 
were applied using DTASelect [171]:  tryptic peptides only, delCN of 0.08, and MASPIC 
[173] scores of at least 25 (+1), 30 (+2), and 45 (+3).  The criteria used here have been 
tested in our laboratory [59, 65, 156, 184, 287] and give a false positive identification rate 
between 1-2% for bacterial isolates as well as simple microbial mixtures and 
communities.  A comprehensive list of all proteins identified for a given sample size was 
created using the algorithm Contrast [171]. 
Results and Discussion 
Lysis Efficiency 
In order to determine the efficiency of Guanidine HCl as a lysing agent with 
respect to bacterial cells, control lysing experiments (sonication) of R. palustris and S. 
oneidensis were performed (Figure 7.2), and protein was quantified using the BCA 
analysis.  The results for a R. palustris cell pellet of 1 mg yielded 85.6 ± 18.9 µg/mL 
protein (equates to 94.16 µg of total protein) and the 5 mg pellet 286 ± 45.6 µg/mL 
protein (equates to 343.2 µg of total protein).  The S. oneidensis 1 mg cell pellets yielded 
276 ± 52.4 µg/mL protein and the 5 and 10 mg protein yields were initially above the 
working absorbance range, so a second set of replicates were diluted 2-fold and yielded  
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Figure 7.2.  BCA protein quantification assay for different amounts of wet cell pellets. 
Protein quantification was performed with 1, 5 or 10 mg of R. palustris lysed by adding 6 
M Guanidine or 1, 5, or 10 mg of S. oneidensis by the addition of 6 M Guanidine.  Error 
bars represent triplicate measurements and values within the bar graph are the average 
protein measured for each cell pellet mass for the respective bacterial species. 
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2274 ± 102 and 3353 ± 241 µg/mL protein, respectively.  As apparent from above, this 
method lyses S. oneidensis more efficiently than R. palustris, which is due to their 
respective membrane compositions.  The membrane of R. palustris grown 
photoheterophically contains many infoldings [288] that are not present in S. oneidensis; 
which makes penetrating the membrane for lysis more difficult.  Therefore, a way to 
improve the lysing efficiency of R. palustris is to add more denaturant (Guanidine HCl) 
to the cell pellets.   
Bacterial Isolates Characterization 
S. oneidensis wet cell pellets were lysed using sonication and Guanidnine HCl in 
order to assess the proteome coverage identified with both methods of lysis.  From a total 
of ~6 g of wet cell pellet harvested, ~4 g was lysed by sonication to yield ~82.5 mg of 
crude protein.  The other 2 g of wet cell pellet was resuspended at a concentration of 1 
g/mL, and then aliquoted into the smaller samples accordingly.  Using a LCQ ion trap 
mass spectrometer, the number of proteins identified for each of the different cell pellet 
sizes was similar to the 4 g sonication lysis sample, when the samples were desalted 
offline by solid phase extraction (Table 7.1).  There is a marked decrease in identification 
from samples desalted online, suggesting interference of the samples with the 
chromatography system.  The Comprehensive Microbial Resource at TIGR 
(www.tigr.org) organizes the S. oneidensis MR-1 predicted proteome into 18 functional 
category assignments.  By examining the proteins identified in each category, the 
distribution of the observed proteome is inferred.  According to this metric, lysing 1 and 
5 mg of wet cell pellet provides a more comprehensive identification rate (more proteins 
identified) versus sonication in eight of the 18 functional categories including the signal  
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Table 7.1.  Protein Identifications Made Using the LCQ Ion Trap 
 
Organism Biomass Size Number of Proteins 
S. oneidensis 4 g 754 
S. oneidensis 50 mg 700 
S. oneidensis 25 mg 782 
S. oneidensis 10 mg 698 
S. oneidensis 10 mg 502* 
S. oneidensis 5 mg 791 
S. oneidensis 5 mg 567* 
S. oneidensis 1 mg 820 
S. oneidensis 1 mg 515* 
* Online desalting of peptide mixture. 
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transduction category (Supplemental Table S1).  Proteins involved in signal transduction 
are of low abundance normally and in the sonication lysis sample, no proteins were 
identified at the two-peptide level belonging to this category.  However, from a cell pellet 
of 1 mg, a response regulator (SO4003) was identified with two peptides and the 5 mg 
cell pellet sample yielded the identification of a sensor histidine kinase (SO4173) with 
two peptides as well.  These proteins are of low abundance, as evident by their level of 
detection here, but they are of great importance to cellular function.  Identification of low 
abundance proteins is vital to understanding cellular responses to growth perturbations. 
In order to determine if the resulting identifications were biased against 
membrane fraction proteins, the following samples were compared against identifications 
found in membrane fraction proteomes [147, 158].  For the control sonication sample, 
60% of the membrane fraction proteins identified in previous studies was identified.  The 
1 and 5 mg samples did better, with 65-67% of the membrane fraction proteins being 
identified.  However, using the LCQ ion trap without fractionating the samples into 
soluble and membrane fractions results in a loss of around 40% of the protein 
identifications.  This method of lysis is not well suited for the LCQ ion trap 
instrumentation platform. 
 The LTQ linear trapping quadrupole has been described extensively as a more 
high-throughput instrument [31, 32, 156, 215].  Therefore, the S. oneidensis samples were 
also analyzed by this instrumentation platform (Table 7.2 and Supplemental Table S2).  
For the control sonication samples, a total of five sample analyses were conducted, 
yielding from 1229-1333 proteins identified under a single sample analysis and the total 
number of proteins identified was 1,831.  Table 7.2 depicts the combined list from the top  
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Table 7.2.  Functional Category Distribution for S. oneidensis MR-1 LTQ Dataset 
 
Number Functional Category 4 g 5 mg 1 mg 
1 Amino Acid Biosynthesis 58 52 40 
2 Biosynthesis of Cofactors, Prosthetic Groups, and Carriers 86 82 63 
3 Cell Envelope 94 94 73 
4 Cellular Processes 148 143 122 
5 Central Intermediary Metabolism 26 27 21 
6 DNA Metabolism 64 67 47 
7 Energy Metabolism 189 182 161 
8 Fatty Acid and Phospholipid Metabolism 38 37 35 
9 Hypothetical Proteins 375 373 250 
10 Mobile and Extrachromosomal Element Functions 106 100 93 
11 Protein Fate 119 115 92 
12 Protein Synthesis 124 116 106 
13 Purines, Pyrimidines, Nucleosides, and Nucleotides 55 55 52 
14 Regulatory Functions 65 71 47 
15 Signal Transduction 16 16 5 
16 Transcription 41 41 35 
17 Transport and Binding Proteins 70 79 43 
18 Unknown Function 151 155 115 
 Total 1825 1805 1400 
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three MS experiments.  The 5 mg lysis was analyzed in triplicate and yielded protein 
identifications from 1282-1472, with a total of 1,805 proteins identified from the three 
analyses.  The 1 mg lysis was analyzed once and detected 1308 proteins.  Note that the 
number of proteins identified by the LTQ is more than twice that of the LCQ, therefore it 
is reasonable to assume there would be less bias with this instrumentation platform.   
 Indeed, when analyzing the functional category distribution between the 5 mg 
lysis and the control sonication samples (Supplemental Table S2), nine of the eighteen 
functional category assignments for the 5 mg sample are represented by equal or greater 
number of proteins when compared to the control sonication sample.  In fact, the category 
of signal transduction contains 16 members for the LTQ dataset.  Thirteen of the protein 
members are shared between the two lysis techniques, indicating a similar performance 
between the two analyses.  Proteins localizing to membrane fractions in the previous 
studies described above were also analyzed with the LTQ dataset.  The results indicate 
for the 5 mg lysis sample an overlap of 82% of membrane fraction proteins identified 
from previous experiments were found.  For the control sonication sample, between 45 
and 47% of proteins were identified in the control sonication that localized to the 
membrane fraction in previous experiments.  The 1 mg lysis sample was intermediate, 
with 66-68% of the membrane fraction proteins identified.  Therefore, the smaller 
biomass (1 and 5 mg) samples performed better with the LTQ than the LCQ with respect 
to membrane fraction protein identification, but also performed better than the control 
sonication sample for both instrumentation platforms. 
 The metabolically diverse bacterium R. palustris was also utilized to test the 
ability of Guanidine HCl as both a lysis and reducing agent.  As above, one aliquot was 
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sonicated while the other was used to test Guanidine HCl and TFE (results below).  The 
LTQ mass spectrometer was utilized in assessing the R. palustris sample with a total of 
three control sonication samples and three 1 mg Guanidine HCl lysates to be compared.  
A total of 1,897 proteins were identified in the 2 g sonicated R. palustris cell pellet, and 
the 1 mg Guanidine HCl cell lysate yielded 1,797 proteins (Supplemental Table S3).  As 
above with S. oneidensis, there is not a significant difference in protein identifications 
with sonication versus Guanidine HCl.  However, the significant advantage of Guanidine 
HCl appears to be the chemical’s ability to efficiently lyse cells and simultaneously 
denature the protein complement in a single tube experiment for tryptic digestion and 
subsequent mass spectrometry analysis.  The R. palustris predicted proteome is divided 
into 16 functional category assignments, and these are used to compare the bias in 
sampling between the two methods.  First, the sonicated sample identified 39.4% of the 
total predicted proteins in the genome, with unknowns and unclassified, lipid metabolism, 
translation, amino acid metabolism, metabolism of cofactors and vitamins, and purine 
and pyrimidine metabolism dominating with over 60% of the constituent members being 
confidently identified.  The 1 mg Guanidine HCl lysates performed similarly, with 37.3% 
of the predicted proteins identified and the same functional categories dominated the 
identifications.   
Therefore, lysing 1-5 mg bacterial isolates with Guanidine HCl gives comparable 
and less biased coverage of the resulting proteome, as compared to a 2-4 g control 
sonication lysate.  The results presented here suggest a new era in “shotgun” proteomics 
experiments, where small < 10 mL of culture can be sampled and the subsequent 
proteome analyzed.  Sampling of a cell culture with a lower cell density leads to 
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understanding microbial processes and relationships in the environment.  Plus, this leads 
to the ability to analyze environmental samples where the limiting factor will most likely 
be the amount of starting material present.  In order to assess Guanidine HCl as a method 
for lysing environmental samples, the following acid mine drainage biofilm was tested. 
Comparison of Guanidine HCl versus Trifluoroethylene 
Recently, a similar small-scale approach has been published, highlighting the use 
of trifluoroethylene (TFE) as a lysing agent for mammalian tissue preparations [266].  
TFE has been used in the past for stabilizing bacterial membrane proteins [289]; therefore 
its use as a lysing agent would be compatible with the system presented in this study.  
Instead of further denaturing the resulting proteins present in the cell lysates, TFE was 
added in a higher concentration initially and then diluted 6-fold to minimize interference 
with trypsin.  In our study, R. palustris was lysed by sonication, Guanidine HCl, or TFE.  
A 1 mg wet cell pellet was used in the small sample lysing studies.  These samples were 
analyzed in triplicate on the LTQ mass spectrometer, and the following results were 
obtained.  For the Guanidine HCl lysate, 1334-1467 proteins were identified by mass 
spectrometry, with a total of 1797 found in the three replicate experiments.  The TFE 
lysate identified between 1566-1635 proteins, with a total of 1992 found in three 
replicates.  
These results were further analyzed in order to determine whether or not a bias in 
protein identification was present.  The experimental reproducibility for these samples 
was determined; however, due to the nature of the lysing methods (both as lysing agent 
and denaturant), bias should not be present.  Experimental reproducibility is defined as 
the percentage of proteins from the total list (i.e. 1797) that are identified in each 
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replicate experiment.  Here, the replicate experiment is a technical replicate, since only 
one data-dependent LC/LC-MS/MS experiment can be performed for each lysate.  For 
the Guanidine HCl lysate, the reproducibility was 58.2% and for the TFE lysate, 60.2%.  
This demonstrates that reproducible lysing, digestion, and mass spectrometric analysis of 
the resulting peptides occurs at a similar level between the two lysing methods.  
Furthermore, as depicted in Table 7.3, comparable identification across all 16 functional 
categories in the predicted proteome was achieved with these lysing techniques.  Using 
either Guanidine HCl or TFE results in a similar proteome dataset for bacterial isolates.   
Proteome analysis of the AMD biofilm with the single-tube methods 
The Guanidine HCl, TFE, and freeze-grinding single-tube lysis methods as well 
as the bead-beating method were tested for the AMD biofilm.  The community consists 
of five dominant members from both the bacterial and archeal domains found in a rigid 
matrix [65].  Table 7.4 illustrates the proteome measurement from various cell pellet 
sizes with all lysis methods using the algorithm DBDigger for searching.  DBDigger was 
chosen for searching this dataset due to the increased speed of the algorithm for searching 
MS/MS data against large predicted protein databases [44].  A total of 527 proteins were 
identified from less than 20 mg of biofilm using the Guanidine HCl method and 391 from 
a comparable biofilm size with TFE.  When a subsequent biofilm (C75) was tested with 
Guanidine HCl, freeze-grinding, and bead-beating with sample sizes from ~60-250 mg as 
well as a sonication control of 7.5 g, this resulted in even fewer protein identifications.  
The average identification rate for the Guanidine HCl method was 14 proteins for the two 
samples analyzed.  The bead-beating was even worse with only up to 9 proteins 
identified.  Freeze-grinding with liquid nitrogen seemed the most promising with an  
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Table 7.3.  Functional Category Distribution for R. palustris LTQ Dataset 
 
Number Functional Category 2 g Sonication 1 mg Guanidine 1 mg TFE 
1 Hypothetical 30 44 45 
2 Unknowns and Unclassified 269 284 278 
3 Replication and Repair 53 30 40 
4 Energy Metabolism 130 122 148 
5 Carbon and Carbohydrate Metabolism 81 64 78 
6 Lipid Metabolism 110 95 115 
7 Transcription 76 65 70 
8 Translation 140 133 131 
9 Cellular Processes 250 236 279 
10 Amino Acid Metabolism 125 110 122 
11 General Function Prediction 206 172 184 
12 Metabolism of Cofactors and 110 87 100 
13 Conserved Hypothetical 77 62 71 
14 Transport 121 176 193 
15 Signal Transduction 76 77 95 
16 Purine and Pyrimidine Metabolism 43 40 43 
 Total 1897 1797 1992 
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Table 7.4.  AMD Biofilm Proteome Measurements using DBDigger with the LTQ 
 
Biofilm Mass Biofilm Lysis Method Protein IDs Peptide IDs Spectra 
Count 29.1 mg AB TFE 391 6767 10477 
401.2 mg AB TFE 158 1292 2197 
16.5 mg AB Guanidine 527 8681 21113 
97.9 mg AB Guanidine 551 7950 20886 
386.2 mg AB Guanidine 95 2514 9995 
69.3 mg C75 Guanidine column clogged no information available 
176.67 mg* C75 Guanidine 15 26 87 
248.54 mg* C75 Guanidine 13 23 91 
59.5 mg C75 Freeze-grinding 21 34 50 
178.43 mg* C75 Freeze-grinding 29 55 145 
249.88 mg* C75 Freeze-grinding 29 55 162 
59.7 mg C75 Bead-beating 1 2 4 
172.49 mg* C75 Bead-beating 2 3 34 
256.72 mg* C75 Bead-beating 9 9 160 
7.5 g Run 1 C75 Sonication 2328 13197 25985 
7.5 g Run 2 C75 Sonication 2097 11372 22769 
7.5 g Run 3 C75 Sonication 2038 10945 19695 
*Used SCX material on the back column only. 
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average of 26 proteins detected.  Initially, the LC column was found to completely clog 
with the C75 biofilm.  A modified method was used where only SCX was loaded on the 
back column.  The goal was to obtain ~2000 proteins out of the approximately 14,000 
predicted from the genome annotation [67], which had been identified in previous 
proteome measurements with larger starting sample [65, 290] as well as for the 7.5 g 
sonication lysis of the C75 biofilm (Table 7.4).  A possible explanation as to why this 
microbial community did not yield a comprehensive proteome measurement similar to 
the bacterial isolates for the small scale method is due to the strong cellulose composition 
of the surrounding matrix (P. Wilmes, personal communication).  The rigidity of the 
biofilm matrix creates a formidable challenge for the lysis procedure, which will require 
further investigation.  One solution would be to enzymatically digest the matrix, thereby 
releasing the microbial cells.  The disadvantage to this method is that the resulting 
proteome may be different after the incubation period is completed.  In addition, by 
removing the scaffold during this incubation period, the microbial cells may go into 
shock due to the loss of the supporting structure.  This would not allow for identification 
of low-abundant proteins of metabolic significance. 
Conclusions 
 The need to sample complex environmental or biomedical samples with limited 
biomass has prompted the development of lysis methodologies that are unbiased and can 
be easily coupled with mass spectrometry-based proteomics as described here and 
elsewhere [266].  The method described here differs from other lysis techniques as being 
a true single-tube lysis method.  From wet cell pellet to tryptically digested proteins, all 
steps are performed in the same eppendorf tube.  In addition, there is no deleterious effect 
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on the tryptic digestion step with, as long as the Guanidine HCl is diluted to 1 M or less.  
The work presented here demonstrates both the ease and utility of performing a novel 
single-tube lysis method for the proteome-level characterization of bacterial isolates.  An 
advantage to this lysis method is the unbiased means by which an equal coverage of 
transmembrane-domain and soluble cytosolic proteins can be achieved in the resulting 
LC-MS experiment.  In addition, there is very little difference in the number of proteins 
identified utilizing 5 mg or less of wet cell pellet, in comparison to 2 g by a traditional 
sonication lysis technique.  The single-tube lysis method must now be optimized further 
for the AMD biofilm, which illustrates the challenges of the transition from bacterial 
isolates to complex microbial communities within proteomics.  Recently, a study by 
Wang et al [266] described the TFE single-tube lysis method for mouse brain samples in 
the range of 4.5-5.0 mg in size.  Using the accurate mass and time (AMT) tag approach, 
the authors were able to confidently identify 491 proteins from three replicate lysates 
[266].  Our results show similar total proteins identified with one of the AMD microbial 
communities, indicating a possible stoichiometric limitation for single-tube lysis.  
Stoichiometric limitation as indicated here is specific for complex mixtures, where only 
the most abundant proteins will be identified from the sample leaving the low-abundant 
proteins undetectable with current methodologies.  For example, far less than the mass 
weighed for the microbial community is actual biomass, but rather the bulk of the 
material is the supporting matrix. 
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Chapter 8 
Conclusions 
 
 
Proteomics serves as one of the key lynch-pins for systems biology studies, and 
has progressed dramatically from its humble beginnings with 2D-PAGE gels.  Many labs 
around the world are employing MS-based proteomic measurements to study biological 
problems ranging from simple bacteria to complicated human systems.  Even with these 
remarkable advancements and applications of proteomics, there are still many challenges 
for enhancing this approach to comprehensively characterize biological systems.  For 
example, consider the simple bacteria S. oneidensis, which is the focus of this dissertation 
work.  This bacterium has a genome consisting of  ~5000 annotated open-reading frames 
that could be translated into proteins.  Our proteome measurements have revealed the 
presence of ~1800 non-redundant proteins under any single growth condition.  The 
question then arises as to how many proteins are actually translated under a single growth 
condtion, and whether these proteins can be comprehensively detected by the MS 
technology employed here.  Clearly, the dynamic range of protein expression is large, 
possibly reaching 105 in bacterial systems, reflecting the range from highly abundant 
house-keeping proteins (such as ribosomal proteins) to low abundance (< 10 copies per 
cell) transcription factors.  The complexity and dynamic range of the proteome samples 
provide an enormous analytical challenge to the shotgun MS technique.  However, the 
advancements of on-line multidimensional LC-MS/MS based approaches have almost 
kept up with these challenges.  Returning to our example with S. oneidensis, other 
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evidence indicates that this organism may only express about 40% of its proteome under 
a single growth condition, thereby maintaining a reserve of untapped proteins for other 
environmental scenarios.  This would imply that of the ~2000-2500 proteins expressed 
under a single condition, our MS-based technology can detect roughly 75-90% of the 
proteins.  This clearly demonstrates that this approach is not merely skimming the surface 
of the most abundant (and possibly uninteresting) house-keeping proteins, but rather is 
digging quite deep into the proteome.  This provides strong hope for reconstructing 
detailed pathways and networks of the protein machinery that is operational for a 
bacteria’s life processes.  
One interesting aspect of these shotgun proteomics experiments is the detection of 
a large number of unknown proteins resulting from expression of hypothetic genes.  This 
direct measurement of definitive proteins strongly validates the validity of the genome 
annotation and aids in helping resolve the realities of gene expression.  Without these 
non-targeted MS-based proteomics experiments, the realities and possible functional 
roles of these unknown proteins would be completely absent.   
Within a shotgun proteomics experiment, many proteins are found to be expressed 
constitutively; albeit at varying levels under various growth or stress conditions.  
Therefore, quantitative proteomics allows for the determination of either relative or 
absolute abundance levels for proteins identified from a whole-cell lysate experiment.  
These differentially expressed proteins are typically used to compare two different 
growth conditions for the organism.  Quantification allows for the identification of 
proteins which may be induced or repressed in response to a specific stimulus.  For 
example, a central objective of this dissertation was to explore wild-type S. oneidensis 
228 
versus chromate-exposed cultures, to identify differentially expressed proteins that would 
provide insight into how this organism deals with metal stress.  The measured protein 
abundances using shotgun proteomics is challenging due to the amino acid distribution 
within the peptides, the confidence in the calculated abundance value for a given protein, 
and the labeling method used for a peptide/protein.  For this bacterium, most proteins will 
not vary significantly in abundance, since they are necessary for critical life functions and 
may not be influenced by the presence of chromate.  However, the more interesting 
proteins will be sensitive to this metal shock, which will impact their abundances.  The 
confidence in abundance measurements is challenging for proteins having a 2-3 fold 
change in expression level in response to growth changes.   
For bacterial systems, there are three standard methods of protein quantification:  
iTRAQ [1], isotopic labeling, and semiquantitation (or unlabeled quantification).  iTRAQ 
labels the N-terminal amine and the ε-amino group of lysines with one of four tags of the 
same mass, which works well for bacteria.  The resulting MS/MS will contain sequencing 
information identifying the peptide as well as quantification information from the 
reporter group giving relative abundances.  However, at the time of the studies described 
here, iTRAQ was not available for general use.  Isotopic labeling requires providing an 
isotopically “heavy” nutrient during growth in order for subsequent quantification of the 
intact peptide.  This method is not amenable for growth conditions chosen for S. 
oneidensis here due to the requirement in using a minimal medium for isotopic labeling 
of proteins.  Therefore, semiquantitation was chosen as the method of quantification here.  
Its benefits include:  no additional sample preparation or special media growth 
considerations, no requirement for a dedicated mass spectrometry method, and a clear 
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identification of those proteins that have dramatic changes in expression level.  As 
discussed below, the FDR for these proteins is below 1%, which allows for a confident 
conclusion that the protein is actually differentially expressed.  Ultimately, additional 
improvements must be made in order to extract meaningful information from smaller 
changes in protein abundance. 
The most important consideration of any aspect of a shotgun proteomic dataset is 
how the resulting FDR will affect the conclusions drawn.  The FDR for the work 
presented here was set to ~2.0% for peptides, which reflects a calculated protein FDR of 
~11.5% at the two-peptide level.  However, only ~14% of the total protein identifications 
in a given proteomics dataset arise from a two-peptide identification.  A majority (~77%) 
of proteins are identified from five or more peptides, which have a calculated FDR of 
0.9% for the protein identification.  These conservative filter levels increase the 
confidence of the resulting dataset for proteins identified and the resulting quantification 
performed.  However, more attention must be drawn to the issue of false identifications in 
shotgun proteomics datasets, because there are a large number of proteins that are 
subsequently identified and in many cases quantified. 
Understanding the role of PTMs in cell cycle control and signaling pathways is 
critical for providing a complete representation of the Cr(VI) stress response in S. 
oneidensis.  In order to predict the presence and location of a PTM, there are a number of 
principles that must first be understood.  In light of the previous drawbacks for 
investigating PTMs in shotgun proteomics datasets (detailed in Chapter 5), one of the 
aims in the research performed in the dissertation was the assessment of three separate 
algorithms which provide the option of searching for PTMs.  The FDR for PTM-
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containing peptides was found to be ~10% when searching the dataset with InsPecT, 
which is in contrast to the 50% found utilizing DBDigger.  In addition, InsPecT was 
found to search the shotgun proteomics dataset in approximately half the time required by 
DBDigger using a desktop computer.  Another metric to gauge the success of a PTM 
search is identifying an increased number of proteins.  However, there is not an increase 
in the total number of proteins identified by adding the option of including PTMs.  There 
is a slight decrease in the total number of peptides and spectra that are identified by 
specifying PTMs corresponding to an elevated false negative rate.  The increased 
thresholds necessary to compensate for the increased FDR in the PTM searches cause an 
elevation in the false negative rate (a decrease in peptide and spectral count).  A better 
metric may be to determine if information on the relative modification level of a protein 
is changed based on the growth condition.  However, much more work is needed in order 
to better understand how to search and interpret the resulting datasets.   
All of the methods development performed in this dissertation played a role in 
understanding chromium exposure in S. oneidensis at the molecular level.  A total of four 
large-scale proteome studies were performed to assess at the molecular level the response 
of S. oneidensis to chromium exposure during various times and dosages of exposure. 
Both technical and biological replicate measurements were made.  The first study 
performed involved acute chromate exposure in S. oneidensis to a sub-lethal 
concentration for a brief period of time (up to 90 min).  This study was followed by the 
molecular level characterization of the response of S. oneidensis to chromium exposure 
after complete transformation of Cr(VI) (at the 24 h time point).  Based on proteins found 
differentially expressed following acute and chronic exposure at fixed Cr(VI) 
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concentrations, a dosage-response study was undertaken.  The final study involved 
characterizing both wild type strain MR-1 and a gene knockout mutant strain (∆2426) 
during transformation of Cr(VI) to presumably Cr(III).  so2426 was chosen for deletion 
due to the protein and transcript identified as up-regulated following acute shock 
exposure under various Cr(VI) dosages.   
The first study performed involved understanding acute chromate exposure in S. 
oneidensis to a sub-lethal concentration.  Prior to this study, very little was known about 
how S. oneidensis responded to chromate exposure in culture.  Previous work focused on 
extremely low concentrations of chromate, which neither caused a stress response nor 
were an accurate representation of Cr(VI) concentration in contaminated sites [2-8].  The 
first study examined the response of S. oneidensis MR-1 to 1 mM of Cr(VI) for 45 or 90 
min.  A concentration of 1 mM Cr(VI) was chosen based on the growth response curves 
of S. oneidensis as a function of chromate concentration [9].  No Cr(VI) was reduced in 
the acute study; rather the goal of the study was to identify the initial transcriptome and 
proteome response of S. oneidensis.  Semi-quantification was performed on the resulting 
proteome dataset, taking into account reproducible differences in sequence coverage, 
peptide count, and spectral count.  The sulfur metabolism pathway predicted from the 
genome sequence of S. oneidensis is depicted as a KEGG map in Figure 8.1, where the 
protein components highlighted in blue within the pathway were found up-regulated and 
the green pathway components were not differentially expressed.  However, semi-
quantification is instrument-dependent, where the increased dynamic range of the LTQ 
requires a more stringent level of filtering for quantification of proteins detected with this 
instrumentation.  The benefit of the increased dynamic range of the LTQ allowed for the 
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Figure 8.1.  The sulfur metabolism pathway of S. oneidensis MR-1. 
Depicted is the KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway of sulfur 
metabolism (www.genome.jp/kegg/pathway.html).  Proteins shaded in blue were found 
up-regulated during Cr(VI) shock, shaded in green were not differentially expressed, and 
shaded in pink was not identified in the proteome dataset. 
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detection and quantification of a putative transcriptional regulator (SO2426) that 
appeared to respond overwhelmingly to Cr(VI) in the transcriptome data.  Previously, this 
level of detection was not possible with the older instrumentation (LCQ).  Now, detection 
and quantification of low abundance proteins, such as transcriptional regulators, is 
possible.  The more sensitive detection level leads to a greater corroboration with the 
transcriptome data, which in general has a much more sensitive level of detection 
If S. oneidensis is to be utilized for bioremediation purposes, then understanding the 
effects of long-term exposure to environmental factors such as chromate is necessary 
prior to implementation of S. oneidensis as an agent of bioremediation in contaminated 
sites.  Therefore, a proteome study was undertaken where S. oneidensis was exposed to 
0.3 mM Cr(VI) for 24 h correlating to a chronic exposure.  This concentration was 
chosen based on the growth results of the acute exposure study [9].  The concentration of 
1 mM demonstrated a biphasic growth pattern, where there was a long lag period of ~40 
h before growth resumed.  Whereas a 0.3 mM Cr(VI) concentration would allow the 
bacterial cells to recover and resume growth after a lag period between 20-30 h, thus 
allowing enough biomass to be produced for the proteome experiments.  The proteome 
results from the chronic exposure study were very surprising.  The assumption prior to 
data analysis was that a similar proteome profile to the acute exposure study would be 
observed.  However, when data analysis was complete, a unique proteome profile was 
obtained.  The results indicated a high level of stress response in S. oneidensis in addition 
to the presumable activation of a lytic phage based on up-regulated phage related 
proteins.  Out of the 76 proteins identified up-regulated after chronic Cr(VI) exposure in 
S. oneidensis, 36 proteins up-regulated corresponded to regions of the genome known to 
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harbor phage insertion sites.  The chronic exposure work was the first integrated 
transcriptomic and proteomic study to comprehensively evaluate chronic Cr(V) exposure 
in S. oneidensis. 
S. oneidensis was exposed to Cr(VI) concentrations of 0, 0.3, 0.5, and 1 mM for 
30 min.  These doses were also chosen based on growth response curves found in the 
acute exposure study [9].  In addition, Cr(VI) contaminated sites are known to comprise 
many different concentrations of Cr(VI), with a gradient ranging from low to highly 
contaminated regions within a particular site.  Understanding whether or not S. oneidensis 
will respond to and reduce Cr(VI) at various concentrations is critical before use of the 
bacterium as an agent for bioremediation.  The use of S. oneidensis at sites where the 
Cr(VI) contamination is minimal would not be useful if the bacterium does not respond to 
lower concentrations.  The time period of exposure response for the dosage-response 
study and the acute exposure study were comparable, creating the assumption that the 
proteome profiles for the two studies should be comparable (at least for the shared 
dosage).  This indeed was the case when the profiles were compared.  In addition, the 
overall response for each dosage demonstrated a number of similarities as well.  The 
overall profile indicated that a number of transport and binding proteins, as well as a 
putative transcriptional regulator (SO2426), were highly up-regulated for all dosages 
tested.  However, a number of proteins were found to demonstrate a dosage-dependent 
response to Cr(VI) as well.  These proteins were found to increase in their relative 
abundance with increasing dosage and included examples such as transporter proteins 
and the putative transcriptional regulator (SO2426).  The results of the dosage-response 
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study indicated a dosage dependent activation for SO2426, which was chosen for 
evaluation further as a positive regulator of Cr(VI) gene activation. 
Due to results from previous studies involving acute Cr(VI) exposure and the 
dosage-dependent response of S. oneidensis, a proteome study of Cr(VI) transformation 
was performed.  This study sampled time periods during Cr(VI) transformation of both 
wild-type strain MR-1 and a deletion mutant derived from strain MR-1.  The SO2426 
putative transcriptional regulator was knocked out in order to test how S. oneidensis 
would respond to Cr(VI) exposure during the transformation period of 4 h in length.  
SO2426 was chosen for deletion based on the previous studies, which indicated a clear 
activation of this gene in response to Cr(VI) exposure.  SO2426 previously was found to 
either not be expressed prior to Cr(VI) introduction or displayed a minimal level of 
expression (~2 peptides identified).  Therefore, we knew that SO2426 must play a key 
role in regulation of protein activation in response to Cr(VI) if this protein is indeed a 
transcriptional regulator as the genome annotation provided states.  Another aspect to this 
study was the use of biological triplicate cultures for proteome analysis.  Very few 
proteome studies published to date have utilized biological replicates for measurements 
or for quantification of protein abundance.  There is more difficulty in determining 
protein abundance from biological replicates versus technical replicates.  However, the 
differentially expressed proteins found in a biological replicate are more significant.  One 
caveat of using biological replicates is the overall decrease in reproducibility of proteins 
identified in comparison to using technical replicates.  However, the Cr(VI) 
transformation study confirmed the hypothesis of the importance of SO2426 in response 
to Cr(VI) exposure.  The ∆2426 cultures demonstrated an impaired ability to transform 
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Cr(VI) and a number of proteins were identified that indicate importance in Cr(VI) 
transport across the S. oneidensis outer and inner membranes.  Conclusions drawn from 
these proteome experiments indicate (1) that Cr(VI) may be a competitive inhibitor of 
sulfate, (2) Cr(III) may be more toxic to S. oneidensis than Cr(VI), (3) proteome results 
demonstrated a dosage-dependent stress response to Cr(VI), and (4) the characterization 
of a putative metal response regulator (SO2426), which appears to be a global regulator 
of not only Cr(VI), but a number of other transition metals. 
The evidence for competitive inhibition of sulfate by chromate arises from the 
induction of proteins annotated as involved in sulfate uptake and metabolism.  In the 
acute shock study, three of the nine sulfur metabolism pathway components were 
identified up-regulated (Figure 8.1).  The functions of the up-regulated components 
within in the pathway are enzymes that catalyze production of sulfate from other sulfur-
containing compounds, which indicates an intracellular sulfate deficiency.  In addition, 
there are two sulfate ABC transporters annotated in the S. oneidensis genome (so3599-
so3602 and so4652-so4655) and members of both transporters are found up-regulated 
during exposure to Cr(VI).  Finally, four members of the cysteine biosynthesis pathway 
were found up-regulated following exposure to 1 mM Cr(VI).  If sulfate deficiency were 
not an issue, S. oneidensis would not need to increase the production of these proteins.  
There may also be similarities between the hydration radius of chromate and sulfate, 
which leads to the chromate interacting with the sulfate transporters.  Competitive 
inhibition of sulfate could be caused by more Cr(VI) present in the media, which 
outcompetes sulfate for binding at the ABC transporters.  By increasing the sulfate 
concentration, one may be able to rescue S. oneidensis from chromate shock. 
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Prior to the studies presented here, the consensus in the field of microbiology was 
that the Cr(VI) species led to the toxicity phenotype observed when microbes are exposed 
to chromium [6, 10-18].  After S. oneidensis was grown in the presence of Cr for 24, all 
Cr(VI) was presumably transformed to Cr(III).  Cr(VI) and Cr(III) are the two stable 
forms of chromium commonly found in the environment [12].  The conclusion drawn 
from the chronic study is that Cr(III) may in fact be more toxic than Cr(VI).  In this 
study, the proteome profile observed was unique in comparison to the other Cr(VI) 
exposure proteome studies reported.  The activation of two lytic prophages appeared to 
be the signature response of S. oneidensis after the transformation of Cr(VI) to 
presumably Cr(III).  The presence of Cr(III) was not tested; as well as there was not a 
noticeable precipitate reported in the media.  The proteome dataset allowed for the 
confirmation of the lytic phage cycle by providing confirmation of translation of these 
genes by seizing the host cell’s translation apparatus.  The results of this chronic 
exposure study were similar to the transcriptome results reported for S. oneidensis 
exposure to both ionizing radiation and artificial UV radiation [19, 20].  The actual 
response of S. oneidensis towards long-term exposure to Cr could be deciphered by 
inactivation of the integrated phages or the use of a strain that does not have an integrated 
phage.  Also, one could test the mutagenesis rate of intracellular Cr(III) by a whole 
genome microarray as shown for E. coli [21].  This could detect the mutation rate of the 
S. oneidensis chromosome, thereby determining if critical house-keeping genes have 
nucleotide sequence changes following long-term exposure to Cr(III)-containing 
products.  In addition, O’Brian et al [22] demonstrated that Cr interacts with the 
phosphate backbone of double-stranded DNA molecules.  This interaction will cause the 
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DNA replication machinery to stall, with DNA replication arrest in cells that are actively 
reducing Cr(VI).  The stalled replication machinery may be one of the reasons as to the 
observed phenotype of elongated, filamentous bacterial cells at the 24 h sampling point. 
 In addition to the physiological responses just described, we found that upon 
Cr(VI) exposure there was evidence of stress response from the expressed proteome 
datasets.  Characteristic proteins found activated in response to Cr(VI) intracellular stress 
include RecN, TopB, SO1648 (cold shock domain family protein), IbpA, and ClpB.  
There was a dosage-dependent response found for stress response proteins (see Chapter 4 
for details).  The dosage-dependence of stress response-related proteins indicates a 
possible tolerance level to Cr(VI), which upon increased concentrations of Cr(VI) there is 
a trigger that indicates increased intracellular stress.  However, at this time there is not an 
indication as to the identity of the protein(s) responsible for activating the stress response 
demonstrated in the acute shock or dosage response studies. 
Finally, the characterization of a putative DNA-binding response regulator, 
SO2426, as a metal response regulator was the culmination of the proteome studies on Cr 
exposure.  Prior to the acute Cr(VI) shock study, there was no evidence that SO2426 was 
translated into protein or was induced at the transcriptome and proteome level under 
Cr(VI) conditions.  Further work determined that SO2426 putatively controlled gene 
expression at the transcript level of genes involved with sulfate metabolism and iron 
homeostasis after creation of a knockout of so2426 [23].  The same proteins identified as 
down-regulated in the mutant cultures both prior to and following Cr(VI) addition were 
found up-regulated during acute Cr(VI) shock; indicating that the gene expression is 
controlled by an actively expressed and translated so2426.  This work demonstrates the 
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utility and value of performing global non-targeted proteome studies to identify putative 
roles for proteins expressed under given growth conditions.  In addition, the expectation 
is that information gleaned from the Cr(VI) proteome studies will provide fodder for 
future proteome studies in environmental microbiology to better understand the complex 
role of Cr(VI) biogeochemical cycling in the environment. 
Measurements using mass spectrometry based proteomics have enhanced the 
scientific knowledge on microbial and eukaryotic systems.  Research in the areas of 
microbial ecology and human disease would not have progressed as quickly without 
global proteome studies.  First, comprehensive proteome studies provide novel non-
targeted biochemical information on protein presence and abundance.  In addition, the 
area of shotgun proteomics is helping to validate genome annotation.  The large number 
of hypothetical genes annotated led many individuals to question the validity of genome 
annotation.  Therefore, with the advent of shotgun proteomics, the identification and in 
some cases tentative functional assignments can be given to hypothetical proteins.   
The research to date is very helpful, but also can be overwhelming.  Repositories 
for MS/MS data must be created to organize, standardize, and increase the availability of 
information obtained from the large-scale proteome studies.  HUPO, the human proteome 
project, has begun the process of providing guidelines for proteome datasets [24].  The 
organizers were visionary, because they realized both the value of the proteome data and 
the need for community wide availability of the information.  In the future, other areas 
must following the HUPO example, otherwise the field of proteomics will suffer the 
same problems as faced when nucleotide sequencing of the human genome was 
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completed [25-28].  Some of these issues include organizing the large amount of 
sequencing information and dissemination of the genome sequence. 
 Since the induction of routine proteome measurements, the scientific questions 
posed have become more complex.  Previously, measurements on pure microbial cultures 
and human cell lines were considered to be significant studies.  However, as shotgun 
proteomics experiments have become more routine, there is an increasing interest in 
investigating microbial environmental communities [29-31] and complex mammalian 
tissues [32-35].  The current platform is limited to relatively abundant members within a 
particular community; therefore there is an increased concern of the overall dynamic 
range capabilities of the experimental platform.  In order to compensate for the current 
dynamic range limitations, improvements in chromatographic separation and the mass 
spectrometry instruments will be needed.  The mass spectrometer duty cycle is more 
efficient now than five years ago; however, many peptides/proteins are still not sampled 
during the experiments.  Low abundant peptides/proteins sampling will improve by 
adding a third dimension of separation.  Without dramatic advancements to the 
instrumentation, the goal of detecting proteins found at reduced expression levels is not 
possible.  In the end, an enrichment of low-abundant community members will be 
necessary to understand their contribution. 
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Appendix A1:  All Peptides Identified in Cr-Shocked S. oneidensis MR-1 using an LTQ Mass Spectrometer 
45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO0002     2    proton/peptide symporter family protein 
SO0003 2 4    3 2 3 tRNA modification GTPase TrmE (trmE) 
SO0004 26 18 19 18 24 15 20 16 inner membrane protein, 60 kDa 
SO0005  2    3  2 conserved hypothetical protein TIGR00278 
SO0006 2 3 3 3 2 3 2 2 ribonuclease P protein component (rnpA) 
SO0007  2       ribosomal protein L34 (rpmH) 
SO0008 10 12 9 13 13 14 13 14 chromosomal replication initiator protein DnaA (dnaA) 
SO0009 6 8 10 12 8 7 9 11 DNA polymerase III, beta subunit (dnaN) 
SO0010  2  2  2   DNA replication and repair protein RecF (recF) 
SO0011 44 49 48 55 56 44 56 66 DNA gyrase, B subunit (gyrB) 
SO0012    2   2  glutathione S-transferase family protein 
SO0014 32 42 37 40 34 35 34 44 glycyl-tRNA synthetase, beta subunit (glyS) 
SO0015 3    3  2 4 glycyl-tRNA synthetase, alpha subunit (glyQ) 
SO0016        2 DNA-3-methyladenine glycosidase I (tag) 
SO0017 7 8 2 2 4 8  4 conserved hypothetical protein 
SO0018 2 3 2 2   3 2 conserved hypothetical protein 
SO0019  5  3   2 3 conserved hypothetical protein 
SO0020 23 21 19 20 21 24 13 22 fatty oxidation complex, beta subunit (fadA) 
SO0021 43 53 45 48 43 40 47 52 fatty oxidation complex, alpha subunit (fadB) 
SO0022  3 2 2   4 4 prolidase (pepQ) 
SO0025 2 3   2 2  3 conserved hypothetical protein 
SO0026    2   3  transcriptional regulator, ArsR family 
SO0027 3    3 5   protoporphyrinogen oxidase, putative 
SO0029 9 16 5 9 11 17 6 9 potassium uptake protein TrkA (trkA) 
SO0030 10 8 4 7 4 2 4 8 sun protein (sun) 
SO0031 7 10 5 7 7  4 7 methionyl-tRNA formyltransferase (fmt) 
SO0032 3 6 6 7 8 2 5 6 polypeptide deformylase (def-1) 
SO0033 3 4 5 3 2  5 3 LysM domain protein 
SO0037  2 2     2 Sua5/YciO/YrdC/YwlC family protein 
SO0038 2 3 2 2 2   3 coproporphyrinogen III oxidase, aerobic (hemF) 
281 
45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO0039 3 3 3 2 4  3 4 conserved hypothetical protein 
SO0042 3 3    2   carbonic anhydrase, family 3 
SO0045 2   4 2    Rrf2 family protein 
SO0048 15 15 8 14 17 7 11 12 peptidase, M23/M37 family 
SO0049 16 9 12 12 9 9 14 14 
phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent 
(gpmA) 
SO0050 10 11 9 9 10 9 9 10 rhodanese domain protein 
SO0052 9 16 20 16 17 14 18 17 protein-export protein SecB (secB) 
SO0053 5 7 8 9 4 3 8 7 glycerol-3-phosphate dehydrogenase (NAD(P)+) (gpsA) 
SO0054 2        conserved hypothetical protein TIGR00275 
SO0055    2   3 3 conserved domain protein 
SO0060  2       sensor histidine kinase 
SO0061 3   2  2   lipoprotein, NLP/P60 family 
SO0062 6 5 3 4 4 3 4 3 hypothetical protein 
SO0063   3 2 3  2 2 conserved hypothetical protein 
SO0065 9 6 7 3 3 4 2  molybdenum cofactor biosynthesis protein Mog (mog) 
SO0066 23 28 22 27 28 27 24 31 conserved hypothetical protein 
SO0067        2 penicillin-binding protein 1C, putative 
SO0069 3 3 4 4 5 2 5 6 transport protein, putative 
SO0070 5 8 6 9 6 8 9 5 ATP-binding transport protein NatA (natA) 
SO0071 9 9 10 12 10 6 11 12 hydrolase, alpha/beta hydrolase fold family 
SO0072  4    3   transcriptional regulator, GntR family 
SO0073 7 9 8 9 5 5 5 8 ABC transporter, ATP-binding protein 
SO0075 12 19 11 11 14 18 9 9 AMP-binding family protein 
SO0076 38 51 44 50 42 26 27 38 hypothetical protein 
SO0080    2     conserved hypothetical protein 
SO0084 3 8 10 10 7 7 13 10 HAD-superfamily hydrolase, subfamily IA, variant 1 family protein 
SO0095 12 11 7 7 6 8 5 4 imidazolonepropionase (hutI) 
SO0096 5 2 3  2    histidine utilization repressor (hutC) 
SO0097 23 25 25 25 24 21 20 20 urocanate hydratase (hutU) 
SO0098 15 22 13 9 20 10 13 12 histidine ammonia-lyase (hutH) 
SO0102 7 12 6 10 6 7 5 5 formate dehydrogenase, nitrate-inducible, iron-sulfur subunit (fdnH) 
SO0104 3 4 2 5 4  3 5 fdhE protein (fdhE) 
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SO0105 7 6 2 4 10 4 3 4 L-seryl-tRNA selenium transferase (selA) 
SO0106 6 5 4 5 9 5 6 7 selenocysteine-specific translation elongation factor (selB) 
SO0108   2 2     conserved hypothetical protein 
SO0109    2 2 2 2 2 conserved hypothetical protein 
SO0110 6 6 2 4 8 6 7 4 conserved hypothetical protein 
SO0112 4 3 3 4  6 5 5 conserved hypothetical protein 
SO0113        2 conserved hypothetical protein 
SO0114  2 2 2   2 2 conserved hypothetical protein 
SO0118 3  2  3 3 2 2 hypothetical protein 
SO0119   2      conserved hypothetical protein 
SO0120 2 2 3   2 3 4 hypothetical protein 
SO0121 12 10 9 13 10 9 11 12 conserved hypothetical protein 
SO0123   3 2 2  2  acyltransferase family protein 
SO0130 13 11 3 7 4 5  5 protease, putative 
SO0131  2       conserved hypothetical protein 
SO0132 2   2  2   flagellar protein FliL, putative 
SO0135 7 7 6 6 8 5 7 6 hemolysin protein, putative 
SO0137  2  3 2    molybdopterin biosynthesis MoeB protein (moeB) 
SO0138 4 3 5 3 5    molybdopterin biosynthesis MoeA protein (moeA) 
SO0139 5 9 10 10 5 5 9 10 ferritin (ftn) 
SO0141 5 4 3 4 6 6 3 2 sensory box protein 
SO0142 2 3 2     3 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB) 
SO0144 12 19 13 17 15 13 9 12 protease II (ptrB) 
SO0148  2 2     3 hypothetical protein 
SO0152 17 15 13 17 12 10 8 13 conserved hypothetical protein 
SO0162 22 29 24 25 28 15 24 30 phosphoenolpyruvate carboxykinase (ATP) (pckA) 
SO0163 3    2  2  chaperonin HslO (hslO) 
SO0164       2  heat shock protein 15 (hslR) 
SO0165 10 17 10 10 10 15 10 15 general secretion pathway protein C (gspC) 
SO0166 25 31 33 38 24 31 35 43 general secretion pathway protein D (gspD) 
SO0167 17 21 14 17 21 18 14 15 general secretion pathway protein E (gspE) 
SO0168 6 11 6 10 9 7 6 9 general secretion pathway protein F (gspF) 
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SO0169 6 10 8 9 6 9 7 7 general secretion pathway protein G (gspG) 
SO0171 2 2       general secretion pathway protein I (gspI) 
SO0172  2 3 2 3 6 3 3 general secretion pathway protein J (gspJ) 
SO0173 2  2  2  2  general secretion pathway protein K (gspK) 
SO0174 12 14 13 8 8 7 9 12 general secretion pathway protein L (gspL) 
SO0175 4 5 2 3 6 3 5 5 general secretion pathway protein M (gspM) 
SO0176 7 12 10 8 7 6 10 9 general secretion pathway protein N (gspN) 
SO0190  2  2   2 2 MutT/nudix family protein 
SO0191  2  2   5 6 cysQ protein (cysQ-1) 
SO0194  2 2  2 3   acyltransferase family protein 
SO0196 6 10 6 9 9 4 4 9 selenide, water dikinase (selD) 
SO0197 5 10 4 6 11 13 6 4 fatty acid desaturase, family 1 
SO0198 5 6 6 5 5 5 5 2 transcriptional regulator, TetR family 
SO0203   2      hypothetical protein 
SO0206 4 5 6 4 2  2 6 tRNA (uracil-5-)-methyltransferase (trmA) 
SO0208 5 9 8 5 6 6 7 9 RNA-binding protein 
SO0215   2  2  2  pantothenate kinase (panK) 
SO0217 63 72 65 68 62 65 61 66 translation elongation factor Tu (tufB) 
SO0218    2     preprotein translocase, SecE subunit (secE) 
SO0219 22 20 14 18 16 18 10 18 transcription antitermination protein NusG (nusG) 
SO0220 15 16 18 17 16 22 14 16 ribosomal protein L11 (rplK) 
SO0221 47 53 42 47 44 57 43 46 ribosomal protein L1 (rplA) 
SO0222 38 41 34 40 39 48 35 34 ribosomal protein L10 (rplJ) 
SO0223 17 18 21 18 19 18 21 24 ribosomal protein L7/L12 (rplL) 
SO0224 166 194 153 166 170 172 155 175 DNA-directed RNA polymerase, beta subunit (rpoB) 
SO0225 121 153 128 134 143 138 142 144 DNA-directed RNA polymerase, beta subunit (rpoC) 
SO0226 13 18 15 17 14 12 17 17 ribosomal protein S12 (rpsL) 
SO0227 32 37 33 38 38 42 30 33 ribosomal protein S7 (rpsG) 
SO0228 44 62 50 46 42 34 29 42 translation elongation factor G (fusA-1) 
SO0229 60 70 63 66 60 63 59 64 translation elongation factor Tu (tufA) 
SO0230 16 17 17 18 17 18 15 14 ribosomal protein S10 (rpsJ) 
SO0231 28 34 29 31 30 34 18 29 ribosomal protein L3 (rplC) 
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SO0232 25 24 24 28 24 27 22 24 ribosomal protein L4 (rplD) 
SO0233 14 12 13 13 12 22 11 10 ribosomal protein L23 (rplW) 
SO0234 35 39 41 40 43 38 39 42 ribosomal protein L2 (rplB) 
SO0235 11 14 11 13 10 11 12 12 ribosomal protein S19 (rpsS) 
SO0236 23 25 22 24 21 23 22 24 ribosomal protein L22 (rplV) 
SO0237 42 47 39 42 38 50 40 42 ribosomal protein S3 (rpsC) 
SO0238 19 21 21 20 22 23 20 20 ribosomal protein L16 (rplP) 
SO0239 11 11 12 15 11 15 11 10 ribosomal protein L29 (rpmC) 
SO0240 16 16 15 15 15 16 14 18 ribosomal protein S17 (rpsQ) 
SO0241 19 21 20 23 17 18 19 19 ribosomal protein L14 (rplN) 
SO0242 21 25 25 25 21 29 26 24 ribosomal protein L24 (rplX) 
SO0243 37 40 38 40 33 42 37 40 ribosomal protein L5 (rplE) 
SO0244 13 12 10 15 13 10 13 10 ribosomal protein S14 (rpsN) 
SO0245 19 16 15 18 17 26 11 15 ribosomal protein S8 (rpsH) 
SO0246 28 33 29 30 28 34 26 28 ribosomal protein L6 (rplF) 
SO0247 26 27 23 23 20 31 20 22 ribosomal protein L18 (rplR) 
SO0248 28 29 29 24 21 30 22 25 ribosomal protein S5 (rpsE) 
SO0249 7 11 9 9 7 9 5 7 ribosomal protein L30 (rpmD) 
SO0250 24 26 23 26 23 26 21 21 ribosomal protein L15 (rplO) 
SO0251 7 11 6 7 5 12 4 5 preprotein translocase, SecY subunit (secY) 
SO0253 26 22 24 25 22 26 24 21 ribosomal protein S13 (rpsM) 
SO0254 22 25 23 22 22 22 21 20 ribosomal protein S11 (rpsK) 
SO0255 31 40 32 35 34 54 28 39 ribosomal protein S4 (rpsD) 
SO0256 42 42 42 46 39 36 41 43 DNA-directed RNA polymerase, alpha subunit (rpoA) 
SO0257 17 22 19 21 17 24 19 18 ribosomal protein L17 (rplQ) 
SO0259 2  2 2  4 3 4 cytochrome c biogenesis protein CcmE (ccmE) 
SO0261     3    heme exporter protein CcmC (ccmC) 
SO0263 6 7 9 10 9 7 8 8 heme exporter protein CcmA (ccmA) 
SO0264 7 6 4 3 4 7 3 3 cytochrome c (scyA) 
SO0265 30 27 22 28 36 28 24 31 conserved hypothetical protein 
SO0266 8 11 11 7 11 11 9 13 cytochrome c-type biogenesis protein CcmF (ccmF-1) 
SO0267 13 21 18 9 17 18 16 15 thiol:disulfide interchange protein DsbE (dsbE) 
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SO0268 9 9 6 4 6 10 6 9 cytochrome c-type biogenesis protein CcmH (ccmH) 
SO0272 2 6 8 9 9 4 10 14 competence/damage-inducible protein CinA (cinA) 
SO0273 4 8 9 4 8 4 6 7 conserved hypothetical protein 
SO0274 17 14 13 14 19 15 16 19 phosphoenolpyruvate carboxylase (ppc) 
SO0278  5 3 5 5  7 6 argininosuccinate synthase (argG) 
SO0280 29 31 34 31 28 27 26 25 penicillin-binding protein 1A (mrcA) 
SO0281  5 2 4 4 3   type IV pilus biogenesis protein PilM 
SO0282 5 7 3 5 5 6 3 2 type IV pilus biogenesis protein PilN 
SO0283 2 4   5  3 4 type IV pilus biogenesis protein PilO 
SO0284 3 3 2 4  5 3 2 type IV pilus biogenesis protein PilP 
SO0285 2 4 4 7 4 9 5 4 type IV pilus biogenesis protein PilQ 
SO0286 6 8 7 6 6 8 6 10 shikimate kinase (aroK) 
SO0287  2 2      3-dehydroquinate synthase (aroB) 
SO0288 2 5 4 6 2 2 3 4 damX domain protein 
SO0289 2 3  2   3 3 DNA adenine methylase (dam) 
SO0292 7 7 5 6 7 5 6 7 ribulose-phosphate 3-epimerase (rpe) 
SO0293 2        phosphoglycolate phosphatase (gph) 
SO0294 8 9 13 13 9 8 4 10 tryptophanyl-tRNA synthetase (trpS) 
SO0295      2   transcriptional regulator, LysR family 
SO0297 6 6 7 8 6 7 10 8 lipoprotein, putative 
SO0298 6 5 4 10 7 4 4 6 phosphoheptose isomerase (gmhA) 
SO0300 19 25 15 19 21 16 24 26 lipoprotein, putative 
SO0301 5 8 3 6 6 2 3 6 conserved hypothetical protein TIGR00096 
SO0302   2    2 2 hypothetical protein 
SO0311 4 16 3 8 7 6 4 7 conserved hypothetical protein 
SO0314 11 17 5 6 37 16 3 11 ornithine decarboxylase, inducible (speF) 
SO0316   2      conserved hypothetical protein TIGR00481 
SO0322  2       hypothetical protein 
SO0323        2 hypothetical protein 
SO0325  2  2 3 2   dsrE-related protein 
SO0326 5 4 5 8 7 7 5 4 hypothetical protein 
SO0330        2 conserved hypothetical protein 
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SO0333 8 11 16 17 11 8 13 16 thiol:disulfide interchange protein DsbA (dsbA) 
SO0335 8 8 8 7 6 8 6 7 conserved hypothetical protein 
SO0340 6 9 8 12 11 3 10 13 branched-chain amino acid aminotransferase (ilvE) 
SO0341 4 6   3 5  4 sensory box protein 
SO0342   3 4 2 5 2 6 conserved hypothetical protein 
SO0343 13 9 21 32 11 10 28 27 aconitate hydratase 1 (acnA) 
SO0344 3 10 18 24 19 3 21 29 methylcitrate synthase (prpC) 
SO0345 8 9 13 16 11 9 15 17 methylisocitrate lyase (prpB) 
SO0346 2  3 5  3 4 5 transcriptional regulator. GntR family 
SO0347 6 5 6 6 5 3 5 9 acyltransferase family protein 
SO0348 12 17 15 15 16 11 16 18 acyltransferase family protein 
SO0350  2 2 4   3  hypothetical protein 
SO0352      2  2 sensor histidine kinase, putative 
SO0355 16 16 17 15 18 13 18 19 AMP-binding protein 
SO0356 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO0358 3 3 5 3 2 4 2  endoribonuclease L-PSP, putative 
SO0359 7 11 4 14 13 9 16 14 guanosine-3,5-bis(diphosphate) 3-pyrophosphohydrolase (spoT) 
SO0360 7 8 11 8 7 4 10 10 DNA-directed RNA polymerase, omega subunit (rpoZ) 
SO0361 2 2 2 2 2 2 2  guanylate kinase (gmk) 
SO0362 15 18 18 27 20 18 23 23 hypothetical protein 
SO0364  2  3   2 3 conserved hypothetical protein 
SO0367        2 conserved hypothetical protein 
SO0368   2      helicase 
SO0369   3 4  2 2 2 transcriptional regulator, LysR family 
SO0374    2     ISSo1, transposase OrfB 
SO0375 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO0378 15 22 15 15 16 18 15 15  
SO0379      2   conserved hypothetical protein 
SO0380    2    2 type I restriction-modification system, R subunit (hsdR-1) 
SO0382 2 3 2 3 3 3 3 2 type I restriction-modification system, S subunit (hsdS-1) 
SO0383 4 7 2 3 4 3 4 6 type I restriction-modification system, M subunit (hsdM-1) 
SO0388 5 3 3 4 5 2 3 3 site-specific recombinase, phage integrase family 
287 
45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO0391     2    hypothetical protein 
SO0393 8 9 10 10 7 11 5 8 DNA-binding protein Fis (fis) 
SO0394  4      2 conserved hypothetical protein 
SO0395 6 4 2 6 3  8 6 ribosomal protein L11 methyltransferase (prmA) 
SO0398 11 5 2  23 11  2 fumarate reductase flavoprotein subunit (frdA) 
SO0401    3   5 2 alcohol dehydrogenase, zinc-containing 
SO0402 2 4 2 6 3 2  2 transcriptional regulator, LysR family 
SO0403 2   3 2 3 2 2 hypothetical protein 
SO0404 101 128 98 99 128 125 68 71 hypothetical protein 
SO0405 46 48 44 47 41 43 43 42 transcription termination factor Rho (rho) 
SO0406 15 15 14 14 12 21 10 11 thioredoxin 1 (trxA) 
SO0407 26 28 21 23 27 18 25 16 ATP-dependent RNA helicase, DEAD box family 
SO0409   2 2 2  3 3 hypothetical protein 
SO0414     3 4   type 4 prepilin-like proteins leader peptide processing enzyme (pilD) 
SO0415 2 3  3 4 3 6 5 type IV pilus biogenesis protein PilC 
SO0416 2 6 5 3 5  6 6 type IV pilus biogenesis protein PilB 
SO0417 3 4 4 5 3 2 3 5 pilin, putative 
SO0421       2 2 AmpD protein (ampD) 
SO0423  5 3 3 2  6 6 pyruvate dehydrogenase complex repressor (pdhR) 
SO0424 82 96 103 110 93 78 115 114 
pyruvate dehydrogenase complex, E1 component, pyruvate 
dehydrogenase (aceE) 
SO0425 31 38 33 36 30 35 31 31 
pyruvate dehydrogenase complex, E2 component, dihydrolipoamide 
acetyltransferase (aceF) 
SO0426 56 64 50 56 51 56 60 52 
pyruvate dehydrogenase complex, E3 component, lipoamide 
dehydrogenase (lpdA) 
SO0427   2 2  2 2 2 sensory box protein 
SO0428 9 7 10 5 11 13 7 13 conserved hypothetical protein 
SO0429 80 93 79 80 79 80 89 92 peptidase, M13 family 
SO0430  2  3     conserved hypothetical protein 
SO0431  2 2 2    3 HAD-superfamily hydrolase, subfamily IA, variant 3 protein family 
SO0432 78 87 67 74 75 62 63 74 aconitate hydratase 2 (acnB) 
SO0433 3 2 3 6 2  4 3 regulator of sigma D (rsd) 
SO0435 8 13 8 10 8 8 7 10 uroporphyrinogen decarboxylase (hemE) 
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SO0437 3 4 4 6  4 4 6 sensory box protein 
SO0438 2 4  3 4 3 6 6 oxidoreductase, short chain dehydrogenase/reductase family 
SO0439     2    hypothetical protein 
SO0440 3 6 4 4 3 5 2 6 conserved hypothetical protein 
SO0441 14 22 16 16 16 16 8 12 phosphoribosylamine--glycine ligase (purD) 
SO0442 23 31 23 26 21 16 13 20 
phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP 
cyclohydrolase (purH) 
SO0443   2 2     transcriptional regulator, MerR family 
SO0444 7 6 11 13 6  10 7 hypothetical protein 
SO0445     4 4   hflC protein, putative 
SO0449 8 10 8 7 4 4 9 7 conserved hypothetical protein 
SO0452 6 3 5 9 3 3 7 7 thioredoxin 2 (trxC) 
SO0453 9 8 8 8 6 2 5 8 peptidyl-prolyl cis-trans isomerase FkbP (fkbP-1) 
SO0456 8 8 9 9 7 5 7 10 immunogenic-related protein 
SO0459  3 2  3 2 2 2 conserved hypothetical protein 
SO0463   2      conserved hypothetical protein 
SO0466        2 hypothetical protein 
SO0467 8 11 3 4 6 2 3 7 DNA helicase II (uvrD) 
SO0470    2     hypothetical protein 
SO0471  2   2    conserved hypothetical protein 
SO0474  2 2 3 5 2 2  conserved hypothetical protein 
SO0481    2     peptidyl-prolyl cis-trans isomerase, FKBP-type 
SO0490 2 4   9 6 4  transcriptional regulator 
SO0491 32 46 36 32 36 33 31 34 peptidase, M13 family 
SO0492  2  2  2  2 conserved hypothetical protein 
SO0494 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO0495    2     ISSo1, transposase OrfB 
SO0496   3  2 2   conserved hypothetical protein 
SO0500 4 3 2 4 2 3 2 2 methyl-accepting chemotaxis protein 
SO0501 17 19 22 23 18 17 20 24 conserved hypothetical protein 
SO0502       2  transcriptional regulator, ArsR family 
SO0506 8 8 11 10 13 8 9 12 conserved hypothetical protein TIGR00148 
SO0508 2 3 4 3 3 3  3 hypothetical protein 
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SO0510    2     oxidoreductase, short-chain dehydrogenase/reductase family 
SO0511  2       acetyl-CoA carboxylase, biotin carboxyl carrier protein (accB) 
SO0513 2     2   prokaryotic and mitochondrial release factors family protein 
SO0514     2    hypothetical protein 
SO0515 2 2 3    2 2 hypothetical protein 
SO0518 9 13 15 14 9 16 15 19 outer membrane efflux family protein, putative 
SO0519 3 5 9 6 4 2 9 9 cation efflux protein, putative 
SO0520 10 18 11 11 14 12 17 18 heavy metal efflux pump, CzcA family 
SO0521 2 2 4  4  2 4 conserved hypothetical protein 
SO0526        2 acetyltransferase, GNAT family 
SO0527  4 3 4 4  4 3 conserved hypothetical protein 
SO0528 2  2  2  2 3 conserved hypothetical protein 
SO0532 3        arsenical resistence operon repressor (arsR) 
SO0538 4 2 5 6 5 3 8 6 glyceraldehyde 3-phosphate dehydrogenase (gapA-1) 
SO0541       2  metallo-beta-lactamase family protein 
SO0542 4 3 4  5  4 5 conserved hypothetical protein 
SO0543        2 hypothetical protein 
SO0544       2  sensory box histidine kinase 
SO0546     3 2 2  ribosomal protein S6 modification protein (rimK-1) 
SO0548 7 14 5 10 14 13 4 5 DNA-binding protein, HU family 
SO0549      2   chemotaxis protein CheY/response regulator receiver domain protein 
SO0551    2   2  conserved hypothetical protein 
SO0554 2 5 5 5 3 2  4 hypothetical protein 
SO0555 2        conserved hypothetical protein 
SO0556     3   2 hypothetical protein 
SO0558 2 4 2 2 2   2 smtA protein (smtA) 
SO0559  3 2 3 3  3 3 MaoC domain protein 
SO0560 3    5    formate--tetrahydrofolate ligase (fhs) 
SO0564  3 2   2 5 3 conserved hypothetical protein 
SO0565 2 3 2 2 2 3  3 adhesion protein, putative 
SO0567 4 7 2 8 4 3 2 5 1-acyl-sn-glycerol-3-phosphate acyltransferase (plsC) 
SO0568  3 2 2   3 4 conserved hypothetical protein 
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SO0570        2 response regulator 
SO0572    2     enoyl-CoA hydratase/isomerase family protein 
SO0575 27 27 18 22 21 12 19 17 RNA polymerase-associated protein HepA (hepA) 
SO0576       5 2 PhoH family protein 
SO0577 14 17 8 11 12 10 16 20 sensory box histidine kinase/response regulator 
SO0578 24 27 32 30 26 26 29 35 hypothetical protein 
SO0583    2     bacterioferritin-associated ferredoxin (bfd) 
SO0584 3 2 2 2 4 2 2 2 methyl-accepting chemotaxis protein 
SO0585       2  D-isomer specific 2-hydroxyacid dehydrogenase family protein 
SO0588 15 22 20 21 15 26 18 20 transporter, putative 
SO0591 10 12 9 11 9 5 11 18 conserved hypothetical protein TIGR00157 
SO0592  5 4 4 3   3 oligoribonuclease (orn) 
SO0595 3 2 2 3 3    hypothetical protein 
SO0596 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO0598     3    yjeF protein (yjeF) 
SO0600 10 9 9 6 8 10 7 5 N-acetylmuramoyl-L-alanine amidase (amiB) 
SO0601 3 4 3 4 4 3 4 4 DNA mismatch repair protein MutL (mutL) 
SO0602 6 10 9 7 8 3 6 12 tRNA delta(2)-isopentenylpyrophosphate transferase (miaA) 
SO0603 7 8 8 9 7 6 8 6 host factor-I protein (hfq) 
SO0604 3 4 3 3 2  5 5 GTP-binding protein HflX (hflX) 
SO0605 29 43 40 37 29 31 35 43 hflK protein (hflK) 
SO0606 42 57 46 46 41 43 51 52 hflC protein (hflC) 
SO0608 14 19 16 14 11 18 14 15 ubiquinol-cytochrome c reductase, iron-sulfur subunit (petA) 
SO0609 4 6 5 4 6 4 5 5 ubiquinol-cytochrome c reductase, cytochrome b (petB) 
SO0610 13 15 12 11 13 9 14 15 ubiquinol-cytochrome c reductase, cytochrome c1 (petC) 
SO0611 5 4 4 5 3 5 6 6 stringent starvation protein a (sspA) 
SO0612 6 4 5 3 4 2 3 3 stringent starvation protein b (sspB) 
SO0614 23 24 20 14 18 21 16 17 dipeptidyl peptidase IV, putative 
SO0617 19 22 15 13 14 18 16 19 acetylornithine aminotransferase (argD) 
SO0618 4 3 4 4 8 2 3 4 arginine N-succinyltransferase (astA) 
SO0619 13 13 9 11 10 12 9 11 succinylglutamic semialdehyde dehydrogenase (astD) 
SO0620        2 conserved hypothetical protein 
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SO0621   2  2  2 5 sensor histidine kinase 
SO0622     4   3 DNA-binding response regulator 
SO0624 13 17 16 17 18 13 12 21 catabolite gene activator (crp) 
SO0625   3 2  2   conserved domain protein 
SO0630 3  4 5  2 4 7 TonB-dependent receptor (nosA) 
SO0632     4  2  ATP-dependent helicase HrpB (hrpB) 
SO0633 25 27 20 17 28 12 23 20 penicillin-binding protein 1B (mrcB) 
SO0635 2 2 2 2 3 7 6 7 peptidyl-prolyl cis-trans isomerase C (ppiC-1) 
SO0636   2 2 2  2 2 acetyltransferase, GNAT family 
SO0640 4 3 2 3 4 3 3 3 alcohol dehydrogenase, zinc-containing 
SO0641 2  3  3    prophage MuSo1, transcriptional regulator, Cro/CI family 
SO0643        2 transposase, putative 
SO0644    2    2 prophage MuSo1, DNA transposition protein, putative 
SO0646    2   2  hypothetical protein 
SO0653    2     hypothetical protein 
SO0655   2 2     hypothetical protein 
SO0656 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO0657    2     ISSo1, transposase OrfB 
SO0667 2        conserved hypothetical protein 
SO0670 3  3 2 4  2 6 hypothetical protein 
SO0672   2      hypothetical protein 
SO0673 4 2  3 3  3 4 hypothetical protein 
SO0680  3  2  4 2 3 hypothetical protein 
SO0684    2     ISSo1, transposase OrfB 
SO0685 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO0688       2  hypothetical protein 
SO0691 9 15 12 12 10 15 8 10 hypothetical protein 
SO0693    4    2 aldose 1-epimerase (galM) 
SO0694        2 galactokinase (galK) 
SO0695 8 9 11 10 8 4 8 8 glutathione-regulated potassium-efflux system protein KefC, putative 
SO0696 7 9 6 6 10 6 8 9 thiol:disulfide interchange protein DsbD (dsbD) 
SO0698  2    2  4 fxsA protein (fsxA) 
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SO0701   3  2 2  2 transcriptional regulator, LysR family 
SO0703 13 15 18 18 14 19 16 15 chaperonin GroES (groES) 
SO0704 122 125 129 133 114 140 132 135 chaperonin GroEL (groEL) 
SO0708    2     transposase, mutator family 
SO0709   2      hypothetical protein 
SO0719 22 27 26 28 21 19 27 29 TonB-dependent receptor, putative 
SO0728 2        conserved hypothetical protein 
SO0730 2 2  3 6 2  3 hypothetical protein 
SO0733  3  3 3 3  2 cold shock domain family protein 
SO0740 3 4 5 5 3 4 6 6 melanin biosynthesis protein TyrA, putative 
SO0741  7   2    gamma-glutamyltranspeptidase (ggt-1) 
SO0742  2 4 4   4  iron(III) ABC transporter, ATP-binding protein 
SO0744 6 5 5   2 2 2 iron(III) ABC transporter, periplasmic iron(III)-binding protein 
SO0746       2  glutathione S-transferase family protein 
SO0747  2       ferredoxin--NADP reductase (fpr) 
SO0749       2 2 conserved hypothetical protein 
SO0750 4 8 5 6 8 7 6 4 glutamate synthase, putative 
SO0752 2   3    2 hypothetical protein 
SO0754 2 3 2 3  3 4 4 ABC transporter, ATP-binding protein 
SO0756 12 13 14 12 16 10 14 14 phospho-2-dehydro-3-deoxyheptonate aldolase, phe-sensitive (aroG) 
SO0764 2 5 7 5 2  6 2 hypothetical protein 
SO0768 2 3  2  3 4  conserved hypothetical protein 
SO0769 7 10 7 7 6 9 6 5 arginine repressor (argR) 
SO0770 34 30 31 38 26 29 30 33 malate dehydrogenase (mdh) 
SO0775 5 4  4 3  2 2 conserved hypothetical protein 
SO0777 2 4 2 2 4 2 2 2 2-octaprenyl-6-methoxyphenol hydroxylase (ubiH) 
SO0778 8 10 7 8 10 8 2 7 oxidoreductase, FAD-binding, UbiH/Coq6 family 
SO0779 12 19 18 22 15 13 14 18 glycine cleavage system T protein (gcvT) 
SO0781 24 39 27 42 40 21 39 41 glycine cleavage system P protein (gcvP) 
SO0783 4 7 9 14 10 4 8 12 hypothetical protein 
SO0788 5   2 2  3  conserved hypothetical protein 
SO0789  2 2    2  conserved hypothetical protein 
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SO0795 3 12 3 8 10  11 12 conserved hypothetical protein 
SO0798 3 2 6 12   11 13 conserved hypothetical protein 
SO0801  2     2  conserved hypothetical protein 
SO0804  2       hypothetical protein 
SO0805 7 5 7 5 4 3 5 9 CBS domain protein 
SO0807 5 8 6 5 5 3 3 5 hypoxanthine-guanine phosphoribosyltransferase (hpt-1) 
SO0808 2 4 2 3 3  2 2 conserved hypothetical protein 
SO0809 2 2 3 3  2 2 3 azurin (azu) 
SO0810 2 3 3 2 3 3 4  ribokinase (rbsK) 
SO0811 4 2 2 7 4 2 2 5 inosine-uridine preferring nucleoside hydrolase family protein 
SO0812     2    hypothetical protein 
SO0813 16 17 12 11 14 12 15 18 hypothetical protein 
SO0815 28 36 28 33 29 25 43 41 TonB-dependent receptor C-terminal domain protein 
SO0816 2 2 3 3 2 2 2 3 hypothetical protein 
SO0818      2   
5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase (metE) 
SO0820    2   4  HlyD family secretion protein 
SO0821   3 2  2 3 3 ABC transporter, ATP-binding/permease protein 
SO0822    2     outer membrane efflux family protein 
SO0823    3 2 3 3  conserved hypothetical protein 
SO0828 4 5 2 3 3 2 2 5 conserved hypothetical protein 
SO0830 2 6 4 8 3 4 5 4 alkaline phosphatase 
SO0831 9 12 8 13 11 3 9 12 glutathione synthetase (gshB) 
SO0832 8 9 7 9 6 4 5 7 conserved hypothetical protein TIGR00046 
SO0833  3   2    endonuclease I (endA) 
SO0834 2 2 2 2 2 2   sprT protein, putative 
SO0835  3 2 2     conserved hypothetical protein 
SO0837    2   2 2 beta-lactamase, putative 
SO0839    2 2    transcriptional regulator, LysR family 
SO0840 148 154 133 136 166 139 156 159 
acetyl-CoA carboxylase multifunctional enzyme accADC, carboxyl 
transferase subunit alpha/carboxyl transferase subunit beta/biotin 
carboxylase 
SO0842 71 82 71 79 70 57 85 81 translation elongation factor G (fusA-2) 
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SO0845 6 6 3 3 6 6 4 3 cytochrome c-type protein NapB (napB) 
SO0846  2    3   iron-sulfur cluster-binding protein napH (napH) 
SO0847 4 2   8 6   iron-sulfur cluster-binding protein NapG (napG) 
SO0848 49 59 33 45 74 66 23 34 periplasmic nitrate reductase (napA) 
SO0853       2  pilin, putative 
SO0855  2   3 2  2 conserved hypothetical protein 
SO0856     2    conserved hypothetical protein 
SO0859 2 4 9  4 5 3 9 sensory box histidine kinase/response regulator 
SO0860  2     4 2 response regulator 
SO0861  2 2 2    2 conserved hypothetical protein 
SO0862 11 15 17 16 17 11 15 15 D-3-phosphoglycerate dehydrogenase (serA) 
SO0864        3 transcriptional regulator, LuxR family 
SO0869 6 6  3 3  5 2 pantoate--beta-alanine ligase (panC) 
SO0870 5 6 3 3 4 4 4 5 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) 
SO0871  3 3 4 2  2 2 
2-amino-4-hydroxy-6-hydroxymethyldihydropteridine 
pyrophosphokinase (folK-1) 
SO0872 12 13 11 17 18 11 11 16 polyA polymerase (pcnB) 
SO0874 8 12 8 11 10 9 5 9 DnaK suppressor protein (dksA) 
SO0876 10 9 7 10 12 4 10 10 peptidase B (pepB) 
SO0880 2        conserved hypothetical protein 
SO0881 2        conserved hypothetical protein 
SO0882 4 5 2 2 5 6 4 3 oxidoreductase, GMC family 
SO0885 2 4 2 4 2 2 3 2 ABC transporter, ATP-binding protein 
SO0887 16 15 14 13 7 11 7 18 conserved hypothetical protein 
SO0888 11 19 10 20 8 6 12 17 amidase family protein 
SO0891 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO0892    2     ISSo1, transposase OrfB 
SO0897 11 11 3 2 7 8 7 6 ATP-dependent RNA helicase DbpA (dbpA) 
SO0899    3     glyoxalase family protein 
SO0900 5 5 3 6 8 3 8 10 oxidoreductase, aldo/keto reductase family 
SO0902 19 24 10 8 23 18 7 4 
NADH:ubiquinone oxidoreductase, Na translocating, alpha subunit 
(nqrA-1) 
SO0904 2 4 2 5 7 6 3 4 NADH:ubiquinone oxidoreductase, gamma subunit (nqrC-1) 
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SO0907 12 13 7 9 16 11 9 9 
NADH:ubiquinone oxidoreductase, Na translocating, beta subunit 
(nqrF-1) 
SO0912       3 3 hypothetical protein 
SO0915   2     2 ankyrin domain protein 
SO0916 2   2   3  transcriptional regulator, MarR family 
SO0918 11 11 7 7 7 15 5 4 aculeacin A acylase (aac) 
SO0919 2 3 2  2  2 2 serine transporter, putative 
SO0923 13 10 13 12 12 9 12 11 conserved hypothetical protein 
SO0929 21 21 21 21 13 17 15 27 S-adenosylmethionine synthetase (metK) 
SO0930 28 36 29 33 32 21 32 36 transketolase (tkt) 
SO0931 3 5 2 3  2 5 6 D-erythrose-4-phosphate dehydrogenase (epd) 
SO0932 25 21 21 23 17 19 11 16 phosphoglycerate kinase (pgk) 
SO0933 21 34 29 27 23 33 31 32 fructose-bisphosphate aldolase, class II, Calvin cycle subtype (fba) 
SO0934 9 10 12 14 2 12 22 24 conserved hypothetical protein 
SO0940     2    transcriptional regulator-related protein 
SO0942  2  2 2 2  3 conserved hypothetical protein 
SO0943 6 9 6 5 5 5 6 6 sensory box protein, putative 
SO0945  2     2  AcrB/AcrD/AcrF family protein 
SO0946 2 3   2    conserved hypothetical protein 
SO0947 17 19 12 14 15 11 11 10 ATP-dependent RNA helicase SrmB (srmB) 
SO0951 10 8 13 11 4 4 9 8 thiol:disulfide interchange protein DsbC (dsbC) 
SO0952       3  single-stranded-DNA-specific exonuclease RecJ (recJ) 
SO0956 4  2 4  2 2 7 alkyl hydroperoxide reductase, F subunit (ahpF) 
SO0958 14 19 18 19 15 11 12 14 alkyl hydroperoxide reductase, C subunit (ahpC) 
SO0959 22 20 23 18 13 18 17 15 cytosol aminopeptidase (pepA-1) 
SO0961  2 3 3     conserved hypothetical protein 
SO0968 2 3 2 4 3   3 D-lactate dehydrogenase (ldhA) 
SO0970 24 22 31 27 39 37 14 18 fumarate reductase flavoprotein subunit precursor 
SO0976      2   organic hydroperoxide resistance protein (ohr) 
SO0977   2 3 2   5 transcriptional regulator, MarR family 
SO0978      2   FAD-dependent glycerol-3-phosphate dehydrogenase, family protein 
SO0980  2       RNA methyltransferase, TrmA family 
SO0982 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
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SO0983    2     ISSo1, transposase OrfB 
SO0987 21 23 10 16 24 24 17 21 methyl-accepting chemotaxis protein 
SO0988 3 2   6 3 2  formate dehydrogenase, alpha subunit 
SO0992 11 18 9 20 9 11 14 16 lysyl-tRNA synthetase (lysS) 
SO0994 11 10 9 11 14 6 7 11 conserved hypothetical protein 
SO0996 2 3 5 4 2  2 3 glyoxalase family protein 
SO1002 2 3    3  2 hypothetical protein 
SO1003 7 13 8 9 13 21 12 8 hypothetical protein 
SO1004 17 26 25 17 21 26 25 22 hypothetical protein 
SO1006       2  dienelactone hydrolase family protein 
SO1014 9 14 16 10 12 9 16 11 NADH dehydrogenase I, I subunit (nuoI) 
SO1016 16 29 20 24 23 18 29 29 NADH dehydrogenase I, G subunit (nuoG) 
SO1017 21 25 23 22 22 19 20 14 NADH dehydrogenase I, F subunit (nuoF) 
SO1018 4 2 3  2  2 3 NADH dehydrogenase I, E subunit (nuoE) 
SO1019 23 34 19 20 27 22 19 22 NADH dehydrogenase I, C/D subunits (nuoCD) 
SO1020 7 9 5 7 7 7 4 6 NADH dehydrogenase I, B subunit (nuoB) 
SO1021  3      2 NADH dehydrogenase I, A subunit (nuoA) 
SO1024    2     ISSo1, transposase OrfB 
SO1025 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO1026 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO1030  5  4 4  7 3 5-methyltetrahydrofolate--homocysteine methyltransferase (metH) 
SO1033     2    iron-compound ABC transporter, ATP-binding protein, putative 
SO1035   3 3   4 4 
nicotinate-nucleotide--dimethylbenzimidazole 
phosphoribosyltransferase (cobT) 
SO1037 2        cobinamide kinase/cobinamide phosphate guanylyltransferase (cobU) 
SO1038  4 2      cobyric acid synthase CobQ (cobQ) 
SO1039   2 2     cob(I)alamin adenosyltransferase (cobO) 
SO1042        2 amino acid ABC transporter, ATP-binding protein 
SO1043       2  amino acid ABC transporter, permease protein 
SO1044   2      amino acid ABC transporter, periplasmic amino acid-binding protein 
SO1045    3   5 5 hypothetical protein 
SO1051 35 41 34 37 37 27 35 36 periplasmic glucan biosynthesis protein, putative 
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SO1052 3 3 2 2 2    low-affinity inorganic phosphate transporter (pit) 
SO1056 27 31 21 20 31 16 25 25 methyl-accepting chemotaxis protein 
SO1059 14 31 16 22 13 21 14 12 aminopeptidase N 
SO1060 15 20 19 20 22 13 24 24 conserved hypothetical protein 
SO1061 10 17 12 12 10 13 14 11 TPR domain protein 
SO1062 3  3 3 2  3 2 polypeptide deformylase (def-2) 
SO1063 2        slyX protein (slyX) 
SO1065 33 40 29 32 37 43 39 38 FKBP-type peptidyl-prolyl cis-trans isomerase FkpA (fkpA) 
SO1066 11 8 8 5 19 24 7 17 extracellular nuclease 
SO1068   2 3   2 2 conserved hypothetical protein 
SO1070     3   2 catalase (katB) 
SO1072 5 6 12 12  2 4 4 chitin-binding protein, putative 
SO1075 24 23 17 23 20 24 14 20 conserved hypothetical protein 
SO1079    2     ISSo1, transposase OrfB 
SO1080 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO1082 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO1083    2     ISSo1, transposase OrfB 
SO1093   2 3    3 ISSo7, transposase 
SO1094   2      conserved hypothetical protein 
SO1095 3 6 8 11 10 3 9 14 O-acetylhomoserine (thiol)-lyase, putative 
SO1096  3 3  2 2 2 2 hypothetical protein 
SO1097 2   2 2    conserved hypothetical protein 
SO1099  2 2  2   2 bolA protein (bolA) 
SO1101 9 8 6 8 5 4 5 8 autoinducer-2 production protein LuxS (luxS) 
SO1103 44 55 47 42 45 48 49 55 
NADH:ubiquinone oxidoreductase, Na translocating, alpha subunit 
(nqrA-2) 
SO1104 3 2 2  2 2 2  
NADH:ubiquinone oxidoreductase, Na translocating, hydrophobic 
membrane protein NqrB (nqrB-2) 
SO1105 16 27 18 21 18 16 15 14 
NADH:ubiquinone oxidoreductase, Na translocating, gamma subunit 
(nqrC-2) 
SO1108 43 42 36 37 42 31 44 43 
NADH:ubiquinone oxidoreductase, Na translocating, beta subunit 
(nqrF-2) 
SO1109 15 15 12 12 13 11 15 12 thiamin biosynthesis lipoprotein ApbE (apbE) 
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SO1111 5 5 2 5 8 12 3 4 bacterioferritin subunit 2 (bfr2) 
SO1112 4 7 3 2 8 10 3 3 bacterioferritin subunit 1 (bfr1) 
SO1114  2 6 11   5 13 DNA-damage-inducible protein P (dinP) 
SO1115 7 10 9 10 10 5 16 12 aminoacyl-histidine dipeptidase (pepD) 
SO1117 16 16 15 17 22 16 15 20 cytosol aminopeptidase, putative 
SO1121 7 3 4 3 6 5 4 4 glutamate 5-kinase (proB) 
SO1122 5 3 4 4 2 4 4 5 gamma-glutamyl phosphate reductase (proA) 
SO1124 3 3    3  3 conserved hypothetical protein TIGR00011 
SO1126 108 121 138 147 114 125 137 131 chaperone protein DnaK (dnaK) 
SO1127 39 44 42 50 51 39 47 56 chaperone protein DnaJ (dnaJ) 
SO1129    2     ISSo1, transposase OrfB 
SO1130 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO1133 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO1134    2     ISSo1, transposase OrfB 
SO1136 2 3 3 2 2  2 2 ATP-dependent RNA helicase, DEAD box family 
SO1137 8 7 13 6 7 6 13 11 conserved hypothetical protein 
SO1139 7 10 8 8 7 7 6 9 peptidyl-prolyl cis-trans isomerase FklB (fklB) 
SO1140 5 4 7 6 5 5 9 8 dihydrodipicolinate reductase (dapB) 
SO1141 25 25 21 23 21 28 14 16 carbamoyl-phosphate synthase, small subunit (carA) 
SO1142 71 66 52 44 67 47 43 44 carbamoyl-phosphate synthase, large subunit (carB) 
SO1144 15 13 16 15 15 12 13 16 methyl-accepting chemotaxis protein 
SO1149 5 7 4 5 5 6 6 6 conserved hypothetical protein 
SO1150 9 8 7 8 8 10 8 7 ribose 5-phosphate isomerase (rpiA) 
SO1154 2        hypothetical protein 
SO1156      2   TonB-dependent receptor 
SO1158 2   2     Dps family protein 
SO1161 14 19 12 20 14 15 17 17 lipoic acid synthetase (lipA) 
SO1162    5 5  6 6 lipoate-protein ligase B (lipB) 
SO1163 7 8 9 12 8 2 9 10 conserved hypothetical protein 
SO1164 51 61 56 46 51 41 50 50 D-alanyl-D-alanine carboxypeptidase (dacA-1) 
SO1165 10 6 7 6 7 2 8 7 rare lipoprotein A 
SO1166 3 4 4 7 4 2 4 7 membrane-bound lytic transglycosylase, putative 
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SO1168 9 15 18 11 15 23 15 11 penicillin-binding protein 2 (mrdA) 
SO1169 3 3 5 2 4  2  conserved hypothetical protein TIGR00246 
SO1170  3 4 8 3 4 6 6 iojap domain protein 
SO1173  2 4 5   2 2 rare lipoprotein B 
SO1174 32 29 26 24 24 14 21 24 leucyl-tRNA synthetase (leuS) 
SO1175 2  2 3 2 2 3 2 conserved hypothetical protein 
SO1177  4  2 3 5  4 apolipoprotein N-acyltransferase (cutE) 
SO1178 4 7 11 10 4 2 8 7 magnesium and cobalt efflux protein CorC (corC) 
SO1180 23 25 34 32 27 22 33 39 PhoH family protein 
SO1181 9 17 13 13 16 6 11 17 tRNA-i(6)A37 modification enzyme MiaB (miaB) 
SO1183 5 5 2 4 5 4  5 oxidoreductase, FAD-binding 
SO1184 7 5 6 8 3 8 3 5 peptidyl-tRNA hydrolase (pth) 
SO1185 8 15 11 10 11 8 6 10 conserved hypothetical protein TIGR00092 
SO1188   3 2     conserved hypothetical protein 
SO1189   4 3   3 4 conserved hypothetical protein 
SO1190 17 14 28 28 9 6 24 22 conserved hypothetical protein 
SO1191 8 13 10 12 12 12 6 11 transcription elongation factor GreA (greA) 
SO1193 5 7 3 4 3 2 7 4 protein-export membrane protein SecD (secD-1) 
SO1194  2       protein-export membrane protein SecF (secF-1) 
SO1195     3   2 conserved hypothetical protein TIGR00253 
SO1196 12 13 15 15 10 12 16 21 ribosomal RNA large subunit methyltransferase J (rrmJ) 
SO1197 54 67 63 71 66 42 72 84 cell division protein FtsH (ftsH) 
SO1198  7 2 5 4 2 3 2 dihydropteroate synthase (folP) 
SO1199 8 10 9 10 14 6 14 17 phosphoglucosamine mutase (glmM) 
SO1200 22 20 17 16 17 22 18 15 triosephosphate isomerase (tpiA) 
SO1201  3 4   3 5 7 preprotein translocase, SecG subunit (secG) 
SO1202 7 3 4 7 8 6 2 4 conserved hypothetical protein 
SO1203 35 45 35 43 38 43 33 32 N utilization substance protein A (nusA) 
SO1204 82 109 82 90 87 91 74 83 translation initiation factor IF-2 (infB) 
SO1205 12 8 5 4 7 7 4 3 ribosome-binding factor A (rbfA) 
SO1206 11 12 6 5 9 7 4 9 tRNA pseudouridine synthase B (truB) 
SO1207 12 12 13 15 14 10 14 17 ribosomal protein S15 (rpsO) 
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SO1208 4 4 2 2 8 2 6 7 GGDEF domain protein 
SO1209 73 76 66 76 81 67 66 81 polyribonucleotide nucleotidyltransferase (pnp) 
SO1210 4 6 5 5 7 4 4 2 TPR domain protein 
SO1214 2 2   2  2 2 NupC family protein 
SO1215 8 7 11 10 7 10 16 13 outer membrane protein OmpK, putative 
SO1217 9 14 11 10 8 9 13 12 deoxyribose-phosphate aldolase (deoC) 
SO1218 13 11 13 12 15 8 12 12 thymidine phosphorylase (deoA) 
SO1219 7 12 6 6 12 13 7 12 phosphopentomutase (deoB) 
SO1221 17 21 19 22 21 16 19 24 purine nucleoside phosphorylase (deoD-2) 
SO1222 4 5 3 5 5 2 11 11 hypothetical protein 
SO1223    2   2  phosphoserine phosphatase (serB) 
SO1224   2     2 conserved hypothetical protein 
SO1225  2       conserved hypothetical protein 
SO1226 4 4  2  5 2 2 DNA repair protein RadA (radA) 
SO1230 2  3  3  2 2 sensor histidine kinase/response regulator TorS (torS) 
SO1236     2    xanthine/uracil permease family protein 
SO1242 2 2   2   3 hypothetical protein 
SO1250      2   conserved hypothetical protein 
SO1252 9 19 18 8 19 7 5 17 peptidase, U32 family 
SO1254     2    conserved hypothetical protein 
SO1255        2 cyclic nucleotide phosphodiesterase, putative 
SO1258 7 8 5 3 6 4 2 3 adenylosuccinate synthetase, putative 
SO1259       2 2 transcriptional regulator, LysR family 
SO1262      2   hypothetical protein 
SO1264 5 3  3 8 2 2 2 conserved hypothetical protein 
SO1265 4 4 2 3 2 4   transcriptional regulator, putative 
SO1267 2 2       conserved hypothetical protein 
SO1268  4 2  4  4 2 glutamine synthetase 
SO1269 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO1270 3 3 10 5 5 5  5 polyamine ABC transporter, periplasmic polyamine-binding protein 
SO1271 9 9 9 8 8 5 6 6 polyamine ABC transporter, ATP-binding protein 
SO1274 3  5 6 6 3 4 6 conserved hypothetical protein 
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SO1275 5 7 3 2 4 3 6 8 succinate-semialdehyde dehydrogenase (gabD) 
SO1276 8 13 10 6 9 7 8 6 4-aminobutyrate aminotransferase (gabT) 
SO1278 4 5 5 7 7 5 8 9 methyl-accepting chemotaxis protein 
SO1284 22 25 25 31 23 17 18 36 RNA polymerase sigma-70 factor (rpoD) 
SO1286  5  4 2 4 3 7 DNA primase (dnaG) 
SO1287 4 4 6 4 3 6 2 4 conserved hypothetical protein 
SO1288 13 17 13 15 11 16 11 14 ribosomal protein S21 (rpsU) 
SO1289 4 6 5 5 4 3 2 8 O-sialoglycoprotein endopeptidase (gcp) 
SO1295 9 15 11 10 12 15 18 17 major outer membrane lipoprotein, putative 
SO1297 10 12 12 4 11 7 10 11 general secretion pathway protein a (gspA) 
SO1298 3 3 4 3 2 6 4 4 general secretion pathway protein B (gspB) 
SO1300 16 22 12 15 18 15 8 11 glutamate-1-semialdehyde-2,1-aminomutase (hemL) 
SO1301 5 14 12 11 13 4 10 15 aspartate carbamoyltransferase (pyrB) 
SO1303 9 10 10 7 12 5 11 12 hypothetical protein 
SO1304 6 6 7 6 5 5  2 HesB/YadR/YfhF family protein 
SO1306    2    2 conserved hypothetical protein 
SO1309    2     conserved hypothetical protein 
SO1313  4 3    2 3 conserved hypothetical protein 
SO1314  5 2 2 2 2   peptidase, M23/M37 family 
SO1315 23 28 28 31 27 15 24 22 tyrosyl-tRNA synthetase (tyrS) 
SO1322 2 2 2      
5-methylthioadenosine nucleosidase/S-adenosylhomocysteine 
nucleosidase (pfs) 
SO1324 4 3 2  5 4   glutamate synthase, small subunit (gltD) 
SO1325  4  2 2 2 2  glutamate synthase, large subunit (gltB) 
SO1327 4 5 4 6 7  6 12 sensor histidine kinase-related protein 
SO1328 6 7 7 6 9 4 2 7 transcriptional regulator, LysR family 
SO1329 5 2 3 3 4  2  adenylate cyclase-related protein 
SO1330     2  2  DNA mismatch repair protein MutH (mutH) 
SO1332 4 6 4 5 7 3 4 2 phosphoenolpyruvate-protein phosphotransferase PtsP (ptsP) 
SO1334     2 2  2 prolipoprotein diacylglyceryl transferase (lgt) 
SO1335 4   4 2 2   thymidylate synthase (thyA) 
SO1339 4 2 2 2 2 2   conserved hypothetical protein 
SO1341 8 8 7 7 8 4 9 9 L-aspartate oxidase (nadB) 
302 
45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO1342 3 4 4 5 4 7 8 6 RNA polymerase sigma-24 factor (rpoE) 
SO1343 2 4 3 3 3   4 sigma-E factor negative regulatory protein (rseA) 
SO1344 4 5 3 7 5 5 2 2 sigma-E factor regulatory protein RseB (rseB) 
SO1345   2 4     sigma-E factor regulatory protein RseC (rseC) 
SO1346 9 11 6 12 17 8 17 14 GTP-binding protein LepA (lepA) 
SO1347 21 29 25 19 22 23 23 19 signal peptidase I (lepB) 
SO1348 3 6  2 5 4 4 4 ribonuclease III (rnc) 
SO1349 8 12 10 10 6 6 11 9 GTP-binding protein Era (era) 
SO1351 7 7 6 4 5 7 7 7 pyridoxal phosphate biosynthetic protein PdxJ (pdxJ) 
SO1353  2  3 2 3   conserved hypothetical protein 
SO1354 2 4 3 4 3 9 4 3 hemolysin protein, putative 
SO1356 36 52 39 46 38 39 38 42 signal recognition particle protein Ffh (ffh) 
SO1357 8 11 11 10 10 12 9 10 ribosomal protein S16 (rpsP) 
SO1358 5 5 2 3 3   3 16S rRNA processing protein RimM (rimM) 
SO1359  3 2      tRNA (guanine-N1)-methyltransferase (trmD) 
SO1360 23 22 20 17 19 23 18 19 ribosomal protein L19 (rplS) 
SO1361  3  2     phospho-2-dehydro-3-deoxyheptonate aldolase, tyr-sensitive (aroF) 
SO1362    2    2 chorismate mutase/prephenate dehydrogenase (tyrA) 
SO1366      2   sodium/hydrogen exchanger family protein 
SO1367 4 4 2 4 4 2  3 chorismate mutase/prephenate dehydratase (pheA) 
SO1368 26 28 23 21 27 19 22 21 cytosol aminopeptidase (pepA-2) 
SO1369 6 7 4 5 3 4 6 6 conserved hypothetical protein 
SO1370 3 4  5 4 2 2 2 conserved hypothetical protein 
SO1371 2   2     conserved hypothetical protein 
SO1372 2  2  3  3 2 conserved hypothetical protein 
SO1375  4 5 3 4 2 9 3 carboxypeptidase 
SO1377 35 46 40 41 46 50 41 54 conserved hypothetical protein 
SO1378       2 3 ThiJ/PfpI family protein 
SO1380      2   conserved hypothetical protein 
SO1383 20 22 10 11 17 23 11 13 ATP-dependent RNA helicase, DEAD box family 
SO1385 5 8 3 9 4 6 6 8 methyl-accepting chemotaxis protein 
SO1388 15 24 13 12 15 14 11 10 aminopeptidase P, putative 
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SO1389 2    2    ROK family protein 
SO1390 12 11 10 6 11 12 8 7 peptidyl-prolyl cis-trans isomerase, FKBP-type 
SO1401 13 12 9 8 14 13 11 15 hypothetical protein 
SO1402 6 3 2  3 4  2 conserved hypothetical protein 
SO1403  2 2      conserved hypothetical protein 
SO1404 4 7 4 4 4 3 2 3 endoribonuclease L-PSP, putative 
SO1405 3 4 4 2 10 7 2  transglutaminase family protein 
SO1407     2    mercuric transport periplasmic protein MerP, putative 
SO1408 2 5 2 2 2    helicase, putative 
SO1410 2 2  4 3 3   hypothetical protein 
SO1412   3     2 conserved hypothetical protein 
SO1417 2  2  3    sensor histidine kinase 
SO1424 18 27 7 20 21 26 16 23 hypothetical protein 
SO1425 13 18 13 20 19 14 17 12 hypothetical protein 
SO1429 2 3  4 24 23   anaerobic dimethyl sulfoxide reductase, A subunit (dmaA-1) 
SO1430 2    8 7   anaerobic dimethyl sulfoxide reductase, B subunit (dmsB-1) 
SO1434 3 4 3 3 4 3 3 4 methyl-accepting chemotaxis protein 
SO1438 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO1441  2 4 3 3  4 4 hypothetical protein 
SO1457 13 15 15 14 15 8 17 18 type I restriction-modification system, M subunit, putative 
SO1458  2       hypothetical protein 
SO1460 17 16 14 10 16 12 14 12 type I restriction-modification system, S subunit, putative 
SO1461 10 8 11 11 14 11 12 13 protein kinase, putative 
SO1462 6 2 4  5 4 2 2 hypothetical protein 
SO1463 2 3 4   2   hypothetical protein 
SO1464 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO1465    2     ISSo1, transposase OrfB 
SO1468   2   2   conserved hypothetical protein 
SO1471 2 3 4 4 7 2 5 6 site-specific recombinase, phage integrase family 
SO1473 8 8 9 11 10 7 4 6 SsrA-binding protein (smpB) 
SO1474 2   2     conserved hypothetical protein 
SO1475 7 10 5 4 8 8 4 4 conserved hypothetical protein 
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SO1476 6 11 7 8 8 9 8 8 small protein A (smpA) 
SO1481 2 3 2 2 5 4 5 6 glutathione-regulated potassium-efflux system protein 
SO1482 34 36 66 61 14 16 87 88 TonB-dependent receptor, putative 
SO1483    5   2 5 malate synthase A (aceB) 
SO1484 5 6 12 12 12 3 9 16 isocitrate lyase (aceA) 
SO1487 3    3 4 2 3 hypothetical protein 
SO1489 3 5 4 7 10 5 4 4 hypothetical protein 
SO1490 16 16 9 10 23 27 5 11 alcohol dehydrogenase II (adhB) 
SO1496   2      glycogen phosphorylase family protein 
SO1500 3   3 3  4  sensory box protein 
SO1501 2 2     2 3 ATP-dependent RNA helicase, DEAD box family 
SO1502 4 3 2 3 2 3 3 3 cobalamin synthesis protein/P47K family protein 
SO1507 8 6 11 11 5 2 4 7 hypothetical protein 
SO1511      2   transposase, IS91 family, putative 
SO1512 2   2  2   hypothetical protein 
SO1514 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO1515    2     ISSo1, transposase OrfB 
SO1518 12 14 13 13 16 15 7 8 conserved hypothetical protein 
SO1519 35 39 23 27 36 36 21 27 iron-sulfur cluster-binding protein 
SO1520 8 7 6 9 13 5 4 9 conserved hypothetical protein 
SO1521 89 95 80 78 99 92 71 70 iron-sulfur cluster-binding protein 
SO1522     2    L-lactate permease, putative 
SO1523 2        conserved hypothetical protein 
SO1524 22 21 25 26 18 25 21 26 heat shock protein GrpE (grpE) 
SO1525 8 10 10 11 13 2 10 6 deoxyxylulose-5-phosphate synthase (dxs) 
SO1526  2       geranyltranstransferase (ispA) 
SO1529 6 6 6 2 3 2  4 chemotaxis motA protein (pomA) 
SO1530 5 3 2 6 3 5 3 7 sodium-driven polar flagellar protein PomB (pomB) 
SO1531 14 10 9 9 16 11 10 10 thiamine biosynthesis protein ThiI (thiI) 
SO1533 2  2  2    glycine cleavage system transcriptional activator, putative 
SO1536 9 13 11 6 10 7 7 12 conserved hypothetical protein 
SO1538 13 13 15 17 13 7 17 19 isocitrate dehydrogenase, NAD-dependent 
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SO1539 11 21 15 22 19 15 21 22 conserved hypothetical protein 
SO1548 4 3  4 5 5 3 7 hypothetical protein 
SO1549 4 3 5 6   4 5 exodeoxyribonuclease IX (xni) 
SO1550 5 10 11 5 7 5 8 5 conserved hypothetical protein 
SO1551 12 10 9 12 17 12 15 7 GGDEF domain protein 
SO1552 7 9 5 6 8 9 6 7 TPR domain protein 
SO1556 19 29 18 18 21 9 13 23 conserved hypothetical protein 
SO1559 4 7 5 5 7 6 4 5 phosphate regulon sensor protein PhoR (phoR) 
SO1560 2   2     phosphate-binding protein 
SO1563    2   2  glutathione peroxidase, putative 
SO1565  2 3  4  2 2 magnesium transporter, putative 
SO1568 7 11 10 9 5 6 11 10 hypothetical protein 
SO1571 3 10 4 5 10 4 11 12 hypothetical protein 
SO1575 5   3 2   2 NOL1/NOP2/sun family putative RNA methylase 
SO1576 2 5 7 6 3  6 11 glutathione S-transferase family protein 
SO1579     2   3 conserved hypothetical protein 
SO1580 11 13 22 21 3 7 19 26 TonB-dependent heme receptor 
SO1581 7 6 6 5 4  3 4 phnA protein (phnA) 
SO1582 2 3  2 2    transcriptional regulator, MarR family 
SO1589 4 3 3 3 5 2 2 4 hypothetical protein 
SO1595        2 hypothetical protein 
SO1597 3 3 4 6 3  3 3 conserved hypothetical protein 
SO1599 18 14 24 19 18 5 12 17 beta-ketoacyl synthase 
SO1602 37 35 44 49 35 33 29 36 multi-domain beta-ketoacyl synthase 
SO1603   2      transcriptional regulator, putative 
SO1605 2   2   3 2 lipoprotein, putative 
SO1606 2  3 3 2   6 metallo-beta-lactamase superfamily protein 
SO1608 3 7 4 4 5 2 3 4 conserved hypothetical protein 
SO1610 4 6 4 3 2 2 5 4 conserved hypothetical protein 
SO1611 3 6 2 4 2 3 4 4 hypothetical protein 
SO1616 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO1617 3        conserved hypothetical protein 
306 
45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO1620     2  2  RNA pseudouridylate synthase family protein 
SO1624     2    formyltetrahydrofolate deformylase (purU) 
SO1625 10 9 15 18 10 9 18 15 
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase 
(dapD) 
SO1626 7 4 4 5 7 5 6 4 protein-P-II uridylyltransferase (glnD) 
SO1627 15 17 13 17 11 12 10 12 methionine aminopeptidase, type I (map) 
SO1629 36 43 39 42 39 41 44 41 ribosomal protein S2 (rpsB) 
SO1630 44 43 40 49 37 47 29 34 translation elongation factor Ts (tsf) 
SO1631 12 17 15 17 15 9 8 10 uridylate kinase (pyrH) 
SO1632 22 18 17 24 14 19 11 19 ribosome recycling factor (frr) 
SO1633 2     2 2 2 undecaprenyl diphosphate synthase (uppS) 
SO1635 2 2 2 2 3   3 1-deoxy-D-xylulose 5-phosphate reductoisomerase (dxr) 
SO1636 2 6 6 3 5 2 4 5 membrane-associated zinc metalloprotease, putative 
SO1637 46 55 47 55 38 42 46 46 bacterial surface antigen 
SO1638 22 21 25 21 17 25 19 22 outer membrane protein OmpH (ompH) 
SO1639 5 6 6 7 6 10 7 7 
UDP-3-O-(3-hydroxymyristoyl) glucosamine n-acyltransferase 
(lpxD) 
SO1641 8 10 5 7 8 5 4 5 
acyl-(acyl-carrier-protein)--UDP-N-acetylglucosamine O-
acyltransferase (lpxA) 
SO1642 6 7 4 8 8 3 13 10 lipid A disaccharide synthase (lpxB) 
SO1643 2 2 3 4 2 2 2 2 ribonuclease HII (rnhB) 
SO1644 2 3 4 6 6 4 4 9 DNA polymerase III, alpha subunit (dnaE) 
SO1648 5 7 4 5 5 5 4 3 cold shock domain family protein 
SO1651 2 5 5 2 3  4 3 Snf2 family protein 
SO1652 2  2 2 4  3 2 conserved hypothetical protein 
SO1655 2 2 3 4   4 4 cysQ protein (cysQ-2) 
SO1656  3 3 5 2 2 3 8 ROK family protein 
SO1657 4 3 3 2 3 4 3 2 conserved hypothetical protein 
SO1659  3 2      decaheme cytochrome c 
SO1662 2 3 3 2 2 3 3 4 conserved hypothetical protein 
SO1664 5 8 7 6 4 2 8 7 UDP-glucose 4-epimerase (galE) 
SO1665 24 22 21 22 18 22 18 25 UTP-glucose-1-phosphate uridylyltransferase (galU) 
SO1669 12 12 9 10 15 9 9 11 transcriptional regulatory protein TyrR (tyrR) 
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SO1670 9 9 6 7 8 7 10 10 fumarylacetoacetate hydrolase family protein 
SO1674 6 13 4 5 8 5 4 8 oxidoreductase, short chain dehydrogenase/reductase family 
SO1675 14 15 12 12 13 9 9 11 conserved hypothetical protein 
SO1676 2 3 2 2   3 4 homoserine O-succinyltransferase (metA) 
SO1677 29 38 36 38 32 31 28 33 acetyl-CoA acetyltransferase (atoB) 
SO1678 8 10 11 11 17 10 11 16 methylmalonate-semialdehyde dehydrogenase (mmsA) 
SO1679 19 18 24 22 31 23 19 21 acyl-CoA dehydrogenase family protein 
SO1680 10 17 14 15 17 19 15 16 enoyl-CoA hydratase/isomerase family protein 
SO1681  3 3 5 4  2 2 enoyl-CoA hydratase/isomerase family protein 
SO1682 4 6 3 6 4 2 2 3 3-hydroxyisobutyrate dehydrogenase (mmsB) 
SO1683 11 11 9 7 13 21 10 13 3-oxoacyl-(acyl-carrier-protein) reductase, putative 
SO1686 3 4 3  2 6 3 4 prolyl oligopeptidase family protein 
SO1689 4 2 2 8 3 2 4 3 cation transport ATPase, E1-E2 family 
SO1690 17 18 21 15 16 12 23 16 ABC transporter, ATP-binding protein 
SO1691 3 3 3 4 2 2 3 5 lipoprotein Blc (blc) 
SO1700 5 9 12 15 4 5 9 8 hypothetical protein 
SO1701   5  3 2 3 2 hypothetical protein 
SO1717 3 5 6 7 6  7 9 hypothetical protein 
SO1718 2   2 2 2  5 conserved hypothetical protein 
SO1723 4 5 3 3 2 4 2 2 phosphate ABC transporter, permease protein, putative 
SO1724 6 6 8 3 4 4 6 3 phosphate ABC transporter, permease protein, putative 
SO1725 10 12 16 19 12 7 11 18 phosphate ABC transporter, ATP-binding protein (pstB-1) 
SO1726 3 4  4 3 2 2 3 phosphate transport system regulatory protein PhoU (phoU) 
SO1732  3  3 3   2 cold shock domain family protein 
SO1734   2     3 glyoxalase family protein 
SO1738       4  conserved hypothetical protein 
SO1742    4 2   3 conserved hypothetical protein 
SO1743 6 9 3 4 5 6 4 5 hydrolase, alpha/beta hydrolase fold family 
SO1744 4 2  2 4 4 2 3 AMP-binding protein 
SO1745 7 6 5 4 6 5 3 5 3-beta hydroxysteroid dehydrogenase/isomerase family protein 
SO1750 22 25 20 20 25 20 20 23 ABC transporter, ATP-binding protein 
SO1751 12 12 9 9 19 15 11 13 membrane protein, putative 
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SO1755 7 16 12 14 6 4 16 21 phosphoglucomutase/phosphomannomutase family protein 
SO1756    2    3 glyoxalase family protein 
SO1767 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO1769  2     3 2 glutamate decarboxylase, putative 
SO1770  2       glycerate kinase, putative 
SO1776 13 20 14 9 32 26 12 18 outer membrane protein precursor MtrB (mtrB) 
SO1777  2  2 4 3   decaheme cytochrome c MtrA (mtrA) 
SO1778 30 34 29 29 42 44 14 12 decaheme cytochrome c (omcB) 
SO1779 35 39 21 29 56 55 18 18 decaheme cytochrome c (omcA) 
SO1783 7 7 8 8 2 3 2 8 ferrous iron transport protein A (feoA) 
SO1784 20 19 21 20 14 13 23 26 ferrous iron transport protein B (feoB) 
SO1786 11 18 11 17 21 6 21 13 glutaminyl-tRNA synthetase (glnS) 
SO1788       4  tRNA-(MS[2]IO[6]A)-hydroxylase (miaE) 
SO1790 12 12 11 7 9 11 8 11 peptidyl-prolyl cis-trans isomerase B (ppiB-1) 
SO1791 7 13 6 12 9 4 13 9 cysteinyl-tRNA synthetase (cysS) 
SO1792 4 2 4 4 4 4 5 5 
methylenetetrahydrofolate dehydrogenase/methylenetetrahydrofolate 
cyclohydrolase (folD) 
SO1793 69 76 78 77 69 81 70 70 trigger factor (tig) 
SO1794 5 9 7 6 6 2 6 9 ATP-dependent Clp protease, proteolytic subunit (clpP) 
SO1795 19 20 24 25 13 14 18 22 ATP-dependent Clp protease, ATP-binding subunit ClpX (clpX) 
SO1796 51 65 60 71 56 48 69 74 ATP-dependent protease La (lon) 
SO1797 22 23 22 23 23 31 23 21 DNA-binding protein, HU family 
SO1798 88 112 100 95 77 99 85 100 peptidyl-prolyl cis-trans isomerase D (ppiD) 
SO1800 18 29 26 23 19 12 19 22 conserved hypothetical protein 
SO1801 9 10 8 8 10 8 8 5 peptide ABC transporter, ATP-binding protein (sapF) 
SO1802 7 9 7  10 7 6 6 peptide ABC transporter, ATP-binding protein (sapD) 
SO1805 8 10 7 5 4 3 6 8 peptide ABC transporter, periplasmic peptide-binding protein (sapA) 
SO1806 2      2 2 psp operon transcriptional activator (pspF) 
SO1807 36 39 33 40 39 33 41 40 phage shock protein A (pspA) 
SO1808 2 2 2 3 3 2 2 2 phage shock protein B (pspB) 
SO1809  4 3 5 4 5 4 2 phage shock protein C (pspC) 
SO1810   2  2 3 2  conserved hypothetical protein 
SO1811 3 4 4 4 6 3 8 11 conserved hypothetical protein 
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SO1812   2 2    2 methionine gamma-lyase (mdeA) 
SO1816 8 10 8 10 7 5 5 9 conserved hypothetical protein 
SO1817  4 3 3 3   3 primosomal replication protein n, putative 
SO1819 4 3  4 3  3 2 ATP-dependent helicase DinG (dinG) 
SO1821 10 14 16 19 14 18 22 22 outer membrane porin, putative 
SO1824 49 61 52 51 51 51 52 52 conserved hypothetical protein 
SO1825 92 119 87 93 97 120 97 112 MotA/TolQ/ExbB proton channel family protein 
SO1826 5 6 4 4 6 6 2 4 TonB system transport protein ExbB2 (exbB2) 
SO1827 12 10 13 11 10 8 11 11 TonB system transport protein ExbD2 (exbD2) 
SO1828 14 18 13 17 17 12 15 15 TonB2 protein (tonB2) 
SO1829 74 85 73 66 77 64 70 72 TPR domain protein 
SO1831 34 44 30 28 38 21 33 31 conserved hypothetical protein 
SO1832 2 5 7 4 4 3 5 8 peptidyl-prolyl cis-trans isomerase C (ppiC-2) 
SO1833   2 3    3 ISSo7, transposase 
SO1839  2   2    hypothetical protein 
SO1844  4  4 4 4 2 3 extracellular nuclease, putative 
SO1846        3 hypothetical protein 
SO1848 6 5 6 5 4 3 4 5 hypothetical protein 
SO1849 7 8 4 3 6 2 2 5 hypothetical protein 
SO1850 2 3 2 3 2 2 3 4 DnaJ domain protein 
SO1851 7 5 6 6 8 2 3 6 conserved hypothetical protein 
SO1853 10 15 6 9 6 10 7 13 ABC transporter, ATP-binding protein 
SO1854 27 37 29 29 29 29 32 36 hypothetical protein 
SO1855   2    3 2 ribosome modulation factor (rmf) 
SO1856 9 5 3 5 4 2 4 3 3-hydroxydecanoyl-(acyl-carrier-protein) dehydratase (fabA) 
SO1857 7 9 3 7 6 6 4 9 conserved hypothetical protein 
SO1860 5 3 3 6 4 2 7 7 DNA-binding response regulator, LuxR family 
SO1861 2 2 3 2 4 2  4 excinuclease ABC, C subunit (uvrC) 
SO1863 4 6 3 2 3 2  2 DNA-binding protein, HU family 
SO1865 8 3 5 8 5 4 6 4 ABC transporter, ATP-binding protein 
SO1867 7 6 5 5 6 3 2 7 conserved hypothetical protein 
SO1868 3 7  4 4  4 3 conserved hypothetical protein 
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SO1870 19 18 15 15 19 9 17 21 biosynthetic arginine decarboxylase (speA) 
SO1875 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO1877 6 8 3 7 9 3  3 bacterioferritin comigratory protein (bcp) 
SO1878 3  2 3 3  2 2 glycine cleavage system transcriptional repressor, putative 
SO1879 13 17 11 13 11 10 11 11 dihydrodipicolinate synthase (dapA) 
SO1880 18 36 26 28 24 29 25 30 lipoprotein-34 NlpB (nlpB) 
SO1881 7 11 6 6 3 4 2 6 HlyD family-related protein 
SO1882 5 2 4 3 4 2 2 2 AcrB/AcrD/AcrF family protein 
SO1891 5 11 10 9 8 6 8 14 3-oxoadipate CoA-succinyl transferase, beta subunit 
SO1892 9 6 6 6 9 10 6 8 acetate CoA-transferase, subunit A (atoD) 
SO1893 11 6 5 5 11 10 3 8 hydroxymethylglutaryl-CoA lyase (mvaB) 
SO1894 34 39 34 33 49 32 32 33 acetyl-CoA carboxylase, biotin carboxylase, putative 
SO1895 7 3 3 5 8 5 6 7 enoyl-CoA hydratase/isomerase family protein 
SO1896 23 24 14 21 28 35 19 25 3-methylcrotonyl CoA carboxylase, beta subunit (pccB-1) 
SO1897 20 19 19 27 28 26 20 24 isovaleryl-CoA dehydrogenase (ivd) 
SO1898 7 9 11 8 7 7 9 11 transcriptional regulator, putative 
SO1899    2 3   2 conserved hypothetical protein 
SO1902 6 7 4 3 8 6 3 2 6-phosphogluconate dehydrogenase, decarboxylating (gnd) 
SO1904    2     ISSo1, transposase OrfB 
SO1905 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO1912 2 3 2 4 3 2 3 3 acyl-CoA thioesterase II (tesB) 
SO1913 3 4 3 4  5 4 3 conserved hypothetical protein 
SO1915 3 2    2   serine protease, subtilase family 
SO1916 2 2 2  2    transcriptional regulator, LysR family 
SO1921 3 5 2 2 3 3 4 2 hypothetical protein 
SO1923  3   2    AcrB/AcrD/AcrF family protein 
SO1924  2     3  AcrB/AcrD/AcrF family protein 
SO1925   2      HlyD family secretion protein 
SO1926 34 33 29 34 42 19 40 41 citrate synthase (gltA) 
SO1928 67 69 66 73 63 56 55 59 succinate dehydrogenase, flavoprotein subunit (sdhA) 
SO1929 32 32 29 27 31 27 28 35 succinate dehydrogenase, iron-sulfur protein (sdhB) 
SO1930 63 76 68 67 75 61 92 91 2-oxoglutarate dehydrogenase, E1 component (sucA) 
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SO1931 45 48 45 38 42 44 43 39 
2-oxoglutarate dehydrogenase, E2 component, dihydrolipoamide 
succinyltransferase (sucB) 
SO1932 41 49 38 46 34 43 27 40 succinyl-CoA synthase, beta subunit (sucC) 
SO1933 17 25 17 16 19 18 14 18 succinyl-CoA synthase, alpha subunit (sucD) 
SO1935 3 2 3 2 3  3 2 regulator of nucleoside diphosphate kinase (rnk) 
SO1936    2   2  acetyltransferase, GNAT family 
SO1937 6 13 12 12 9 8 9 12 ferric uptake regulation protein (fur) 
SO1940     2    hypothetical protein 
SO1941  2 2 2 2 2 3  magnesium and cobalt transport protein CorA (corA) 
SO1942    2     HDIG domain protein 
SO1945 5 10 5 6 7 7 7 8 sensor protein PhoQ (phoQ) 
SO1946  2  3 2  4 3 transcriptional regulatory protein PhoP (phoP) 
SO1948 3 4 3 2 2 4   sodium:dicarboxylate symporter family protein 
SO1949 18 29 13 16 26 32 10 18 invasin domain protein 
SO1952 3 6 5 10 2  5 2 gamma-glutamyltranspeptidase (ggt-2) 
SO1959   2      ABC transporter, periplasmic substrate-binding protein, putative 
SO1961        3 maltose O-acetyltransferase (maa) 
SO1962   2 2 4   2 4-hydroxyphenylpyruvate dioxygenase 
SO1966  2 6 2 3 4 4 2 conserved hypothetical protein TIGR00266 
SO1968     2    hypothetical protein 
SO1970    2     hypothetical protein 
SO1975        2 Zinc carboxypeptidase-related protein 
SO1980        2 phosphoribosyl transferase domain protein 
SO1981 2   5 2 2 2  conserved hypothetical protein 
SO1986  2     2  RNA polymerase sigma-70 factor, ECF subfamily 
SO1988        2 conserved hypothetical protein 
SO1989    2 2  2 2 chemotaxis protein CheV (cheV-1) 
SO1994 16 17 15 16 17 17 18 18 membrane-bound lytic transglycolase-related protein 
SO1995 7 8 4 4 9 6 6 7 peptidyl-prolyl cis-trans isomerase, FkbP family 
SO2001 45 47 48 44 55 60 39 44 5-nucleotidase (ushA) 
SO2006 2 2  2    2 NifR3/Smm1 family protein 
SO2007        2 conserved hypothetical protein 
SO2008  4       conserved hypothetical protein 
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SO2012 2 2 2 2  2  2 adenine phosphoribosyltransferase (apt) 
SO2013 9 8 2 6 5 5 4 7 DNA polymerase III, gamma and tau subunits (dnaX) 
SO2014 8 9 12 11 9 11 6 8 conserved hypothetical protein TIGR00103 
SO2015  2  3     recombination protein RecR (recR) 
SO2016 63 75 92 100 82 72 113 124 heat shock protein HtpG (htpG) 
SO2017   4 5 3  6 8 conserved hypothetical protein 
SO2018 24 32 27 26 25 19 18 22 adenylate kinase (adk) 
SO2019 4 5 2 2 6 7 3 3 ferrochelatase (hemH-1) 
SO2020 4 6 2 2 7 2 4 2 inosine-guanosine kinase (gsk) 
SO2021 6 7 5 9 3 4 3 7 NH(3)-dependent NAD(+) synthetase (nadE) 
SO2025 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO2026    2     ISSo1, transposase OrfB 
SO2027 3 4 3 2 2 2 5 2 hypothetical protein 
SO2031    2     ISSo1, transposase OrfB 
SO2032 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO2034   2    4  hypothetical protein 
SO2035      2   transposase, putative 
SO2037  2       site-specific recombinase, phage integrase family 
SO2040 6 6 5 13 8 5 10 9 soluble lytic murein transglycosylase, putative 
SO2041 14 24 19 25 21 26 20 26 conserved hypothetical protein 
SO2042    3 2   2 conserved hypothetical protein 
SO2044 2 4 2 4 2   4 lactoylglutathione lyase (gloA) 
SO2045 2 5   3 3 3  cation efflux family protein 
SO2046    2   2  transcriptional regulator, MarR family 
SO2047 3  4 4   2 3 prolyl oligopeptidase family protein 
SO2048 9 9 8 2 10 11 6 7 membrane protein, putative 
SO2052  2   2  2  conserved hypothetical protein 
SO2056    2     ISSo1, transposase OrfB 
SO2057 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO2062 4 8 6 6 3 13 7 8 conserved hypothetical protein 
SO2064   2  2  4  conserved domain protein 
SO2067       2 2 
phosphoribosyl-ATP pyrophosphatase/phosphoribosyl-AMP 
cyclohydrolase (hisI) 
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SO2069    2     
phosphoribosylformimino-5-aminoimidazole carboxamide ribotide 
isomerase (hisA) 
SO2071       2 2 
imidazoleglycerol-phosphate dehydratase/histidinol-phosphatase 
(hisB) 
SO2072        2 histidinol-phosphate aminotransferase (hisC) 
SO2074  3       ATP phosphoribosyltransferase (hisG) 
SO2078 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO2082  5 3 4 3 2 2 2 rod shape-determining-related protein 
SO2083 5 6 5 5 5 7 5 6 methyl-accepting chemotaxis protein 
SO2085 24 26 21 24 27 23 16 18 phenylalanyl-tRNA synthetase, alpha subunit (pheS) 
SO2086 35 37 28 30 37 31 33 38 phenylalanyl-tRNA synthetase, beta subunit (pheT) 
SO2087 12 16 13 16 13 12 16 13 integration host factor, alpha subunit (ihfA) 
SO2088 13 8 8 5 11 10 5 9 lipid A biosynthesis acyltransferase, putative 
SO2098     4 2   quinone-reactive Ni/Fe hydrogenase, large subunit (hyaB) 
SO2099     2    quinone-reactive Ni/Fe hydrogenase, small subunit precursor (hoxK) 
SO2107 5 12 11 11 8 6 10 10 periplasmic glucans biosynthesis protein MdoG (mdoG-1) 
SO2108 14 17 8 13 19 17 14 16 periplasmic glucans biosynthesis protein MdoH (mdoH) 
SO2110   2      conserved hypothetical protein 
SO2112 4 5 3 3 3 4 7 4 ribosomal protein L25 (rplY) 
SO2113 11 11 10 4 15 18 6 10 conserved hypothetical protein 
SO2114 5 4 3 4 5 5 7 4 conserved hypothetical protein 
SO2116 3 3  5 4  5 2 acetyltransferase, GNAT family 
SO2117 3 4 3 4 4 3 3 4 methyl-accepting chemotaxis protein 
SO2123    2 3    methyl-accepting chemotaxis protein 
SO2130    2     ISSo1, transposase OrfB 
SO2131 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO2133 2        hypothetical protein 
SO2134 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO2135    2     ISSo1, transposase OrfB 
SO2136  4      2 aldehyde-alcohol dehydrogenase (adhE) 
SO2147 2        exodeoxyribonuclease V, alpha subunit (recD) 
SO2148 2  2  2  2  exodeoxyribonuclease V, beta subunit (recB) 
SO2149 3 2   2   2 exodeoxyribonuclease V, gamma subunit (recC) 
314 
45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2150 2     2  2 transglutaminase family protein 
SO2151 2 3 3  2 2 2 3 conserved hypothetical protein 
SO2165      2   transposase, IS91 family, putative 
SO2168 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO2169    2     ISSo1, transposase OrfB 
SO2171    2     ISSo1, transposase OrfB 
SO2172 5 3 7 7 10 2 8 12 ISSo1, transposase OrfA 
SO2175 7 8 9 8 8 3 11 8 conserved hypothetical protein 
SO2176    2   2  conserved hypothetical protein 
SO2177 10 14 5 13 8 13 10 12 conserved hypothetical protein 
SO2178 2 2 4 3 3 3   cytochrome c551 peroxidase (ccpA) 
SO2180 4 5 9 7  3  4 peptidase, M23/M37 family 
SO2183 2 3 3 3 3  3 2 conserved hypothetical protein 
SO2189 2 5  3 3    conserved hypothetical protein 
SO2190 3 3 4  3 5 3 2 creA protein (creA) 
SO2191  2 2 4 2  2 2 cystathionine beta-lyase (metC) 
SO2192 5 4 3  2 3 2 4 sensor histidine kinase 
SO2193     2    DNA-binding response regulator 
SO2195      2   inter-alpha-trypsin inhibitor domain protein 
SO2197        2 GGDEF family protein 
SO2198 4 6 7 6 6  2 6 conserved hypothetical protein 
SO2200 4 5 2 5 4 5 2  ribosomal protein S6 modification protein, putative 
SO2201    4   4 3 conserved hypothetical protein 
SO2202       2  transcriptional regulator, LysR family 
SO2212      2   transposase, IS91 family, putative 
SO2215 8 13 5 5 7 7  6 sun protein, putative 
SO2217 2 2 2 2 2  2 2 D-alanine--D-alanine ligase (ddlA) 
SO2218 17 21 24 24 22 9 21 33 asparaginyl-tRNA synthetase (asnS) 
SO2220        2 MutT/nudix family protein 
SO2221   2    2 2 para-aminobenzoate synthase, component I (pabB) 
SO2222 26 38 26 30 25 17 23 22 fumarate hydratase, class I, anaerobic, putative 
SO2223 11 14 14 14 15 9 19 10 peptidase, putative 
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SO2228       2  CBS domain protein 
SO2229 11 14 9 5 9 8 5 12 ATP-dependent helicase HrpA (hrpA) 
SO2236 3   3    3 PTS system, glucose-specific IIA component (crr) 
SO2237   3  3   2 phosphoenolpyruvate-protein phosphotransferase (ptsI) 
SO2240 12 12 13 12 19 12 10 12 methyl-accepting chemotaxis protein 
SO2244 2        transcriptional regulator, LacI family 
SO2247  4 5 9 5 5 6 7 hypothetical protein 
SO2248 5 16 13 14 11 3 12 15 L-serine dehydratase 1 (sdaA) 
SO2250 2  2  2 2 2 2 beta-hexosaminidase (nagZ) 
SO2251     4 2   conserved hypothetical protein 
SO2254 11 11 14 11 13 7 9 12 conserved hypothetical protein 
SO2255 3 8 5  5 4 6 8 transcription-repair coupling factor (mfd) 
SO2257 2 5  2 3 4 5 4 lipoprotein releasing system transmembrane protein LolE (lolE) 
SO2258 6 8 5 11 7 3 8 5 lipoprotein releasing system ATP-binding protein LolD (lolD) 
SO2259 4 4 3 3 4 2 3 5 lipoprotein releasing system transmembrane protein LolC, putative 
SO2260 16 17 14 15 15 10 15 10 extragenic suppressor protein SuhB (suhB) 
SO2261 7 4 7 5 5 3 2 5 RNA methyltransferase, TrmH family, group 1 
SO2262 15 19 20 16 17 20 18 22 serine acetyltransferase (cysE) 
SO2263 6 4 10 6 3  8 9 Rrf2 family protein 
SO2264 27 35 38 40 29 29 36 39 cysteine desulfurase (iscS) 
SO2265 8 10 11 13 5 6 10 13 NifU family protein 
SO2267 2 5 4 3 3  4 6 co-chaperone Hsc20 (hscB) 
SO2268 12 16 16 14 15 9 19 20 chaperone protein HscA (hscA) 
SO2269 4 3 3 2 2 3   ferredoxin, 2Fe-2S 
SO2270 9 9 4 5 6 5  7 ribosomal protein S6 modification protein (rimK-2) 
SO2272 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO2274 13 16 16 16 17 16 16 16 nucleoside diphosphate kinase (ndk) 
SO2277 11 12 20 19 10 14 18 19 16 kDa heat shock protein A (ibpA) 
SO2278 4 2    3   acetolactate synthase III, small subunit (ilvH) 
SO2279 5 4 4 4 6 3 8 8 acetolactate synthase III, large subunit (ilvI) 
SO2286 4 5 4 2 5 2 3 7 sulfate permease family protein 
SO2290 6 10 12 13 5 3 17 14 rhodanese domain protein 
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SO2292 15 19 13 13 15 16 14 14 ISSo4, transposase 
SO2299 18 23 19 22 29 9 30 28 threonyl-tRNA synthetase (thrS) 
SO2300 15 19 18 14 16 23 13 13 translation initiation factor IF-3 (infC) 
SO2301 4 5 3 4 4 2   ribosomal protein L35 (rpmI) 
SO2302 19 20 16 20 19 25 16 18 ribosomal protein L20 (rplT) 
SO2303 11 17 14 17 15 14 14 14 thioredoxin reductase (trxB) 
SO2304 20 21 11 9 13 18 10 10 alanine dehydrogenase, authentic point mutation (ald) 
SO2305 11 13 10 6 10 12 8 9 leucine-responsive regulatory protein (lrp) 
SO2306 20 25 24 21 28 21 27 31 cell division protein FtsK, putative 
SO2307  3  2   2  outer membrane lipoprotein carrier protein LolA (lolA) 
SO2308 3   2 3 5 6 4 ATPase, AAA family 
SO2310 22 28 22 20 26 26 20 21 seryl-tRNA synthetase (serS) 
SO2317 2 2 3 3 2 3 3 3 methyl-accepting chemotaxis protein, truncation 
SO2320        2 chemotaxis protein CheA, interruption-N 
SO2321 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO2323 6 6 7 7 7 3 3 7 methyl-accepting chemotaxis protein 
SO2328 14 15 13 14 14 13 16 14 translation elongation factor P (efp) 
SO2330 3 5 3 7 5 3 5 6 flavodoxin 
SO2331 5  2      conserved hypothetical protein 
SO2333  2  2 3 2 4 2 hydrolase, alpha/beta fold family 
SO2335 4 7 6 3 7 5 2 3 seqA protein (seqA) 
SO2336 4 4 4 5 6 2 4 5 phosphoglucomutase, alpha-D-glucose phosphate-specific (pgm) 
SO2338 8 6 8 8 9 5 5 5 succinylglutamate desuccinylase (astE) 
SO2339 45 54 43 47 50 53 45 50 
alpha keto acid dehydrogenase complex, E1 component, alpha 
subunit 
SO2340 30 31 25 28 33 36 24 27 alpha keto acid dehydrogenase complex, E1 component, beta subunit 
SO2341 35 33 35 36 34 33 36 33 alpha keto acid dehydrogenase complex, E2 component 
SO2342 4 6 5 6 9 3 2 4 quinolinate synthetase complex, subunit A (nadA) 
SO2344 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO2345 22 26 29 29 24 21 25 25 glyceraldehyde 3-phosphate dehydrogenase (gapA-2) 
SO2346      3  3 conserved hypothetical protein 
SO2347 37 43 34 42 34 31 33 37 glyceraldehyde 3-phosphate dehydrogenase (gapA-3) 
SO2350 15 14 8 16 18 4 6 13 aspartate aminotransferase (aspC-1) 
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45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2352  3 2 2 2 4   bax protein, putative 
SO2353 2 4  4 2 2  2 hypothetical protein 
SO2354  2  3 2 2   conserved hypothetical protein 
SO2355 4 9 7 7 9 4 3 7 universal stress protein family 
SO2356 2       2 electron transport regulator A (etrA) 
SO2359 6 4 6 5 6 9 6 3 cation transport ATPase, E1-E2 family 
SO2360 6 10 6 6 6 10 6 6 conserved hypothetical protein 
SO2361 32 38 28 31 31 27 24 29 cytochrome c oxidase, cbb3-type, subunit III (ccoP) 
SO2363 17 24 18 20 24 11 16 20 cytochrome c oxidase, cbb3-type, subunit II (ccoO) 
SO2365   3 3   2 2 conserved hypothetical protein 
SO2366        2 response regulator 
SO2374 5 4 2  4 3 4 4 transcriptional regulator, LysR family 
SO2379     2    conserved hypothetical protein 
SO2380     3 2  3 RecQ domain protein 
SO2387  2       conserved hypothetical protein 
SO2388  2 3 3   3 2 beta-lactamase 
SO2390 8 8 8 6 12 6 13 14 CDP-diacylglycerol--serine O-phosphatidyltransferase (pssA) 
SO2392 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO2394       2  penicillin-binding protein 4 (dacB) 
SO2395 6 12 7 8 10 3 6 7 acyl-CoA dehydrogenase family protein 
SO2396 3 3 5 3 4 4 5 4 conserved hypothetical protein 
SO2398 11 12 9 12 7 7 7 9 orotidine 5`-phosphate decarboxylase (pyrF) 
SO2399 4 4 9  4 3 4 8 conserved hypothetical protein 
SO2400      2   conserved hypothetical protein 
SO2401 9 6 8 8 6 9 9 6 integration host factor, beta subunit (ihfB) 
SO2402 83 119 96 110 97 99 100 108 ribosomal protein S1 (rpsA) 
SO2403 8 9 8 9 7 7 10 8 cytidylate kinase (cmk) 
SO2404 6 7 5 5 5  5 4 3-phosphoshikimate 1-carboxyvinyltransferase (aroA) 
SO2406 12 11 15 16 16 4 6 13 aspartate aminotransferase (aspC-2) 
SO2407 2 2 3 2 3 2   conserved hypothetical protein 
SO2410 3      3 3 phosphoserine aminotransferase (serC) 
SO2411 42 49 37 48 39 38 33 42 DNA gyrase, A subunit (gyrA) 
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45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2413 7 11 9 8 4 9 8 13 3-demethylubiquinone-9 3-methyltransferase (ubiG) 
SO2415 24 37 24 21 32 31 37 35 ribonucleoside-diphosphate reductase, alpha subunit (nrdA) 
SO2416  4 3 3 2  4 7 ribonucleoside-diphosphate reductase, beta subunit (nrdB) 
SO2418 3  3  2 3 2 2 ISSo5, transposase 
SO2419 25 33 30 17 25 22 19 27 2,4-dienoyl-CoA reductase, putative 
SO2420 10 17 10 13 13 10 9 15 signal peptide peptidase SppA, 67K type (sppA) 
SO2421 3        L-asparaginase I (ansA) 
SO2422   2 5   3  conserved hypothetical protein 
SO2423        5 hypothetical protein 
SO2424 6 6 5 8 8 4 5 7 zinc carboxypeptidase domain protein 
SO2426  4 9 9   9 12 DNA-binding response regulator 
SO2427 55 62 56 59 51 50 51 51 TonB-dependent receptor, putative 
SO2429 3 7 3 5 2 5 5 7 Holliday junction DNA helicase RuvB (ruvB) 
SO2430    2     Holliday junction DNA helicase RuvA (ruvA) 
SO2431 2        crossover junction endodeoxyribonuclease RuvC (ruvC) 
SO2432  4 2 2  5  2 conserved hypothetical protein TIGR01033 
SO2433 34 50 32 30 39 23 42 39 aspartyl-tRNA synthetase (aspS) 
SO2434     2    
extracellular solute-binding proteins, family 3/GGDEF domain 
protein 
SO2435  3 3    2 3 methyltransferase, putative 
SO2436 3 3 5  6 4 9 9 methyltransferase, putative 
SO2437 5 9 10 12 10 11 3 4 hypothetical protein 
SO2438 2   3    2 transcriptional regulator, LysR family 
SO2441  2      2 thiG protein (thiG) 
SO2446   2    2  hypothetical protein 
SO2453  2   3  2 2 N-ethylmaleimide reductase, putative 
SO2460 2    3    hypothetical protein 
SO2469 5 8 7 5 17 16 4 7 conserved hypothetical protein 
SO2470   2  4 2 2 4 conserved hypothetical protein 
SO2471 2 5   2   3 succinyl-diaminopimelate desuccinylase (dapE) 
SO2474 2 3 7 4 2  5 7 carbonic anhydrase family protein 
SO2476 17 20 18 22 15 15 20 22 polysaccharide biosynthesis protein 
SO2477 11 9 12 9 8 4 12 9 alcohol dehydrogenase, iron-containing 
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Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2478 5 2 2 2 3 2  2 3-deoxy-D-manno-octulosonate cytidylyltransferase (kdsB) 
SO2479      2  2 hypothetical protein 
SO2481      2   conserved hypothetical protein 
SO2483 19 13 8 14 18 9 12 15 aspartate aminotransferase, putative 
SO2484 3  3 4   3  conserved hypothetical protein 
SO2485 2  3 4 5  3 3 deoxyguanosinetriphosphate triphosphohydrolase, putative 
SO2486 12 13 5 7 6 5 8 8 
2-deydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-
oxoglutarate aldolase (eda) 
SO2487 14 19 14 17 10 4 12 15 6-phosphogluconate dehydratase (edd) 
SO2488 7 4 3 4 2 3 2 5 6-phosphogluconolactonase (pgl) 
SO2489 6 18 12 9 11 3 10 18 glucose-6-phosphate 1-dehydrogenase (zwf) 
SO2490 14 13 11 17 12 20 6 7 transcriptional regulator, RpiR family 
SO2491 21 24 24 26 25 15 16 24 pyruvate kinase II (pykA) 
SO2492 43 36 43 40 45 24 28 40 oxidoreductase, acyl-CoA dehydrogenase family 
SO2493 4 2 2 3  3 2 3 transcriptional regulator, TetR family 
SO2494 23 35 28 24 24 26 19 31 zinc-dependent metallopeptidase 
SO2495  2 2 5   3 3 Smr domain protein 
SO2497   2  2    conserved hypothetical protein 
SO2501  3  3 3   2 radical activating enzyme 
SO2503   2  2    exsB protein (exsB) 
SO2506  3 2 4 6 2 6 5 excinuclease ABC, B subunit (uvrB) 
SO2507 4 4 4 7 5 4 5 7 GGDEF domain protein 
SO2509 5 4 4 3 3 2 3 2 iron-sulfur cluster-binding protein 
SO2510 24 27 15 24 21 21 18 22 iron-sulfur cluster-binding protein 
SO2512 8 7 4 4 5 10 12 8 conserved hypothetical protein 
SO2514    2   3 4 Endonuclease III (nth) 
SO2525 4 3 3 3 5 3 3 3 ABC transporter, ATP-binding protein 
SO2527      2   transposase, IS91 family, putative 
SO2529 4 7 3 3 6 7 5 8 hypothetical protein 
SO2530        2 polypeptide deformylase (def-3) 
SO2533 3 4 9 7 4 2 4 9 conserved hypothetical protein 
SO2535   2      conserved hypothetical protein 
SO2536 28 30 30 29 36 27 34 35 oxidoreductase, acyl-CoA dehydrogenase family 
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45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2537 4 6 5 6 7 10 7 11 sodium/hydrogen exchanger family protein 
SO2540  2       response regulator 
SO2543    2     sensor histidine kinase 
SO2553        2 conserved hypothetical protein 
SO2557  4  2 2 4 3 6 conserved hypothetical protein 
SO2559  2 4 4 3 2 3 3 DNA polymerase III, epsilon subunit (dnaQ-2) 
SO2560  3 2      ribonuclease HI (rnhA) 
SO2564 6 10 6 3 8 4 3 2 transglycosylase, Slt family 
SO2566 12 19 22 23 25 27 38 33 asmA protein (asmA) 
SO2567 3 2 2 3 2    
S-adenosylmethionine:2-demethylmenaquinone methyltransferase 
(menG-1) 
SO2569 3 5 6 9 5 7 7 7 hypothetical protein 
SO2570 17 22 15 18 17 21 18 19 lipoprotein, putative 
SO2571 14 10 10 9 12 12 6 5 ATP-dependent RNA helicase, DEAD box family 
SO2572    2 2   2 peptidyl-prolyl cis-trans isomerase B (ppiB-2) 
SO2573     2    conserved hypothetical protein 
SO2575   2      conserved hypothetical protein 
SO2576        2 septum site-determining protein MinC (minC) 
SO2577 3 6 8 10 4 4 12 12 septum site-determining protein MinD (minD) 
SO2578 5 2 6 3 4   4 cell division topological specificity factor MinE (minE) 
SO2580 2 2 3 7 4   2 ribonuclease D (rnd) 
SO2581 24 20 22 27 31 28 27 20 long-chain-fatty-acid--CoA ligase (fadD-1) 
SO2583 9 9 10 15 8 3 6 9 hypothetical protein 
SO2587 8 10 8 10 19 13 10 11 delta-aminolevulinic acid dehydratase (hemB-1) 
SO2588  4 2  2 2 2 2 protein-methionine-S-oxide reductase, PilB family 
SO2589     2    oxidoreductase, iron/ascorbate family 
SO2590 10 9 6 11 4 7 3 6 GTP-binding protein 
SO2592 24 21 24 25 22 23 17 24 dihydroorotate dehydrogenase (pyrD) 
SO2593 80 99 80 99 101 71 79 100 conserved hypothetical protein 
SO2594  2   2 2   conserved hypothetical protein 
SO2596 2 2  3 2  2  conserved hypothetical protein 
SO2600 3 3 3 6 4  3 6 aminopeptidase N (pepN) 
SO2601 20 26 26 30 22 15 18 25 carboxyl-terminal protease 
321 
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Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2602 13 19 10 15 9 17 12 13 conserved hypothetical protein 
SO2603        3 conserved hypothetical protein 
SO2604 2  2 2 2   2 conserved hypothetical protein 
SO2606 29 39 32 31 29 31 26 24 PqiB family protein 
SO2610  8 7 9 4  3 7 hydrolase, TatD family 
SO2612    2     DNA polymerase III, delta prime subunit (holB) 
SO2613 2  2  3   2 thymidylate kinase (tmk) 
SO2614 7 11 5 9 6 9 7 5 conserved hypothetical protein TIGR00247 
SO2616 3 5 3 6 2 2 4 4 deoxycytidine triphosphate deaminase (dcd) 
SO2617 9 4 6 4 6 4 6 7 uridine kinase (udk) 
SO2618 9 9 7 8 7 4 8 6 ATP-binding protein, Mrp/Nbp35 family 
SO2619 14 27 23 27 22 9 22 28 methionyl-tRNA synthetase (metG) 
SO2621 2 2 2 3    3 conserved hypothetical protein TIGR00486 
SO2622  4  6   2  conserved hypothetical protein 
SO2625 6 4 5 3 3 4 2 4 translation initiation factor IF-1 (infA) 
SO2626 8 11 10 19 10 10 12 19 ATP-dependent Clp protease, ATP-binding subunit ClpA (clpA) 
SO2628 2        stress response protein CspD (cspD) 
SO2629 54 60 57 68 51 44 51 55 isocitrate dehydrogenase, NADP-dependent (icd) 
SO2630 2 2 3   2  2 RNA pseudouridylate synthase family protein 
SO2633 5 9 9 10 6 2 8 7 
tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase 
(trmU) 
SO2634 9 10 10 9 12 7 8 12 conserved hypothetical protein 
SO2635 16 27 16 19 23 12 21 18 adenylosuccinate lyase (purB) 
SO2636 9 7 6 4 4 4 7 4 conserved hypothetical protein 
SO2637 7 7 5 9 3 12 4 5 hypothetical protein 
SO2638 17 14 16 14 16 20 19 20 leucine dehydrogenase (ldh) 
SO2643 30 35 22 19 36 34 21 16 oxidoreductase, FAD-binding, putative 
SO2644 56 68 58 62 69 50 51 63 phosphoenolpyruvate synthase (ppsA) 
SO2645 4 3 4 4 3 3 3 4 conserved hypothetical protein 
SO2646 10 11 7 8 8 3 8 9 phospho-2-dehydro-3-deoxyheptonate aldolase, trp-sensitive (aroH) 
SO2649 9 12 10 8 13 6 13 7 cys regulon transcriptional activator (cysB) 
SO2650 5 10 7 7 10 9 9 9 conserved hypothetical protein 
SO2652 10 6 8 4 12 6 5 8 prophage MuSo2, transcriptional regulator, Cro/CI family 
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45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2654  2       transposase, putative 
SO2655 2 2 2  4    prophage MuSo2, DNA transposition protein, putative 
SO2660       2  conserved hypothetical protein 
SO2663      2 2  conserved hypothetical protein 
SO2681  2       prophage MuSo2, F protein, putative 
SO2682 4 3 3 3 3 3  3 hypothetical protein 
SO2683    2  2   hypothetical protein 
SO2697  2       conserved hypothetical protein 
SO2698 2        prophage MuSo2, DNA circulation protein, putative 
SO2705 34 40 35 31 33 35 21 31 DNA topoisomerase I (topA) 
SO2706 12 8 6 9 4 4 3 7 succinylarginine dihydrolase (astB) 
SO2707 2        acetyltransferase, GNAT family 
SO2708 3 4 2 3 2 2 3 3 nitroreductase family protein 
SO2714 2 2  2  2   hypothetical protein 
SO2715  3      3 TonB-dependent receptor 
SO2720 3 3 2 3 2 4  2 conserved hypothetical protein 
SO2721       3 2 conserved hypothetical protein 
SO2722 2 3     3 3 conserved hypothetical protein 
SO2723 2 5  3 3 4 2 4 HIT family protein 
SO2725 2      2 3 transcriptional regulator, LuxR family 
SO2726      3   cytochrome b, putative 
SO2728 6 5 8 9 6  15 10 peptidase HtpX (htpX) 
SO2730 4 6 5 6 3 3 4 8 peptidase E (pepE) 
SO2731 19 22 24 28 21 10 15 17 periplasmic glucans biosynthesis protein MdoG (mdoG-2) 
SO2737 3 2 2 3 2  3  dethiobiotin synthase (bioD) 
SO2739 2  4  2 2 3 5 8-amino-7-oxononanoate synthase (bioF) 
SO2740 7 10 10 9 7 7 6 12 biotin synthase (bioB) 
SO2741 2   2 2   2 
adenosylmethionine--8-amino-7-oxononanoate aminotransferase 
(bioA) 
SO2742 4 7 3 7 9 9 4 6 sensor histidine kinase/response regulator 
SO2743 13 15 13 15 10 10 15 18 acetyl-coenzyme A synthetase (acs) 
SO2744        2 helicase 
SO2745 7 7 7 9 6 3 8 13 glutaredoxin 
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45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2746 13 15 12 15 11 8 7 9 conserved hypothetical protein 
SO2747 13 21 15 18 12 16 17 17 peptidoglycan-associated lipoprotein (pal) 
SO2748 25 15 21 17 16 16 9 14 tolB protein (tolB) 
SO2749 12 23 14 19 10 19 15 21 tolA protein (tolA) 
SO2750  2   2   2 tolr protein (tolR) 
SO2751 9 20 12 11 15 14 10 16 MotA/TolQ/ExbB proton channel family protein 
SO2752    2     conserved hypothetical protein TIGR00051 
SO2753 28 32 24 28 38 27 22 23 prolyl endopeptidase 
SO2755  2 3 3 3  2 3 ribonuclease T (rnt) 
SO2756 21 21 25 29 23 26 26 25 antioxidant, AhpC/Tsa family, authentic frameshift 
SO2759 10 14 11 12 14 12 8 9 uracil phosphoribosyltransferase (upp) 
SO2760 13 18 11 17 13 9 13 16 phosphoribosylformylglycinamidine cyclo-ligase (purM) 
SO2761 9 11 12 12 11 5 8 10 phosphoribosylglycinamide formyltransferase (purN) 
SO2762 4 7 5 8 8 3 5 8 nagD protein 
SO2763 11 6 5 8 4 12 4 5 conserved hypothetical protein 
SO2766 30 35 34 26 31 31 35 26 conserved hypothetical protein 
SO2768     2  2  acyl-CoA dehydrogenase family protein 
SO2769       2  conserved hypothetical protein 
SO2771 2 5 4 3 7   7 2-hydroxy-3-oxopropionate reductase (garR) 
SO2774 12 14 11 13 9 7 7 10 3-oxoacyl-(acyl-carrier-protein) synthase II (fabF-1) 
SO2775 6 5  4 4 4 3 4 acyl carrier protein (acpP) 
SO2776 16 16 14 16 11 16 14 8 3-oxoacyl-(acyl-carrier-protein) reductase (fabG-1) 
SO2777 9 10 7 6 5 9 2 4 malonyl CoA-acyl carrier protein transacylase (fabD) 
SO2778 5 9 9 7 7 3 6 9 3-oxoacyl-(acyl-carrier-protein) synthase III (fabH-1) 
SO2779 4 3 3 2 5 3 2 2 fatty acid/phospholipid synthesis protein PlsX (plsX) 
SO2780 6 8 10 9 9 7 10 9 ribosomal protein L32 (rpmF) 
SO2781 3 3 5 3 2 2 2 4 conserved hypothetical protein 
SO2782 2 2 2 2 3  4 3 maf protein, putative 
SO2784 10 12 3 8 6 9 6 6 ribosomal large subunit pseudouridine synthase C (rluC) 
SO2785 82 94 87 95 91 93 87 100 ribonuclease E (rne) 
SO2787 20 18 19 17 18 14 19 18 cold shock domain family protein 
SO2788  4 2 3 5 2   ribosomal RNA large subunit methyltransferase A (rrmA) 
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45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2790 4 5 4 8 3 3 6 6 exodeoxyribonuclease I (sbcB) 
SO2794  3  3 2 3  2 conserved hypothetical protein 
SO2796 56 65 49 56 61 57 51 56 conserved hypothetical protein 
SO2797  2 4 2   2 2 conserved hypothetical protein 
SO2799 3 5  5 3 2 2 6 lipoprotein, putative 
SO2800 3 2   4 3 8 7 conserved hypothetical protein 
SO2801 3 3 2 6  4 4 6 tetraacyldisaccharide 4-kinase (lpxK) 
SO2802 15 13 16 16 12 8 15 15 ABC transporter, ATP-binding protein MsbA (msbA) 
SO2807    2   3  hypothetical protein 
SO2811 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO2813 2 2 2 2 2    oxidoreductase, short chain dehydrogenase/reductase family 
SO2815 3  3 2 3 2 3 5 CBS domain protein 
SO2817 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO2822       2 2 sensor histidine kinase 
SO2827 4 2 3 2 3    conserved hypothetical protein 
SO2831 3 4 2 2 2 2  2 GTP cyclohydrolase II (ribA) 
SO2832 7 12 7 9 5 8 3 7 conserved hypothetical protein 
SO2834     5 5  2 anaerobic ribonucleoside-triphosphate reductase (nrdD) 
SO2836        2 conserved hypothetical protein 
SO2838 15 8 3 6 9 6 5 12 ATP-dependent RNA helicase, DEAD box family 
SO2839 3 6 5 7 7 5 7 6 hypothetical protein 
SO2840       2  conserved hypothetical protein 
SO2841   3 2   2 5 hypothetical protein 
SO2842 3 4 2 4 4 6 3 3 peptidase, M23/M37 family 
SO2843 8 10 7 7 9 8 7 7 exonuclease SbcC, putative 
SO2844    2 3   4 exonuclease SbcD, putative 
SO2847    2     transcriptional regulator, LysR family 
SO2848   4 2 2    hypothetical protein 
SO2849     2    acetyltransferase, GNAT family 
SO2851 3 3 4 7 4 4 4 7 histidinol phosphatase domain protein 
SO2852 2 4 2 5 2 3 5 4 transcriptional regulator, GntR family 
SO2853 8 7 5 5 4 5 3 4 3-oxoacyl-(acyl-carrier-protein) synthase III, putative 
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45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2856 2        CBS domain protein 
SO2857  2 2 2   2  sodium/solute symporter family protein 
SO2860        3 thiol:disulfide interchange protein, DsbA family 
SO2861   3 2     conserved hypothetical protein 
SO2862       2  HDIG domain protein 
SO2866 3 2 2  3 2   chromosome initiation inhibitor (iciA) 
SO2869  4 3 7 2   5 conserved hypothetical protein 
SO2871   3 4    2 arsenate reductase, putative 
SO2877   2 2     conserved hypothetical protein 
SO2878 9 10 11 8 11 11 6 8 conserved hypothetical protein 
SO2880      2   glutaredoxin domain protein 
SO2881 5 3 4 7 3  3 7 superoxide dismutase, Fe (sodB) 
SO2882      2 2 2 conserved hypothetical protein 
SO2885 3     2 4 2 fatty acid metabolism regulator protein (fadR) 
SO2886     2    Na+/H+ antiporter (nhaB) 
SO2889 3 5 3 3  2 2  sensory box histidine kinase 
SO2893      2   conserved hypothetical protein 
SO2894 3  2 3   2  YaiI/YqxD family protein 
SO2895 3 3 6  2 4   pyridoxamine 5-phosphate oxidase (pdxH) 
SO2896 23 16 18 20 19 16 8 15 DNA ligase, NAD-dependent (ligA) 
SO2897 16 23 18 17 16 15 13 19 cell division protein ZipA (zipA) 
SO2898 2   3 3 4 2 4 SMC family protein 
SO2901       2 3 3-oxoacyl-(acyl-carrier-protein) synthase III (fabH-2) 
SO2902       2  hypothetical protein 
SO2903 37 50 52 58 37 41 52 53 cysteine synthase A (cysK) 
SO2907 40 63 34 37 41 48 32 32 TonB-dependent receptor domain protein 
SO2912 13 13 33 45 23 13 48 45 formate acetyltransferase (pflB) 
SO2915 6 7 9 10 5 3 16 17 acetate kinase (ackA) 
SO2916 24 31 32 35 32 25 30 42 phosphate acetyltransferase (pta) 
SO2917 2   2 2   2 hypothetical protein 
SO2919  2       conserved hypothetical protein 
SO2921     2  2  D-erythro-7,8-dihydroneopterin triphosphate epimerase (folX) 
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Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO2923   2  2 2  2 sodium/glutamate symporter (gltS) 
SO2926 9 10 6 9 12 8 7 11 ABC transporter, permease, putative 
SO2927 3 6 5 4 4 7 3 4 ABC transporter, ATP-binding protein 
SO2929 30 31 8 13 36 34 14 12 hypothetical protein 
SO2933 14 20 14 13 12 11 7 12 sohB protein, peptidase U7 family 
SO2934 3 5 2 4 4 7  4 conserved hypothetical protein 
SO2935 5 6 5 8 6 5 5 9 oxidoreductase, short-chain dehydrogenase/reductase family 
SO2937 13 15 12 15 16 12 10 12 RNA pseudouridylate synthase family protein 
SO2938 6 7 8 9 5 6 8 7 hypothetical protein 
SO2939      2   hypothetical protein 
SO2942    2     hypothetical protein 
SO2945  2   2 3  2 hypothetical protein 
SO2951     4 6   hypothetical protein 
SO2953     4 2   prophage LambdaSo, tail length tape meausure protein (H) 
SO2963 4 5  3 8 6 4 7 prophage LambdaSo, major capsid protein, HK97 family 
SO2967 2  2    2  conserved hypothetical protein 
SO2968  2 2 2  2  2 conserved hypothetical protein 
SO2969        2 prophage LambdaSo, holin, putative 
SO2988   2  3  3 2 conserved hypothetical protein 
SO2990 2 3 2   4   prophage LambdaSo, transcriptional regulator, Cro/CI family 
SO2991 4 8 6 4 3 4 6 5 conserved hypothetical protein 
SO2992  2 2 3   2 3 hypothetical protein 
SO2993   2  3  9 8 
prophage LambdaSo, type II DNA modification methyltransferase, 
putative, truncation 
SO3000       3 2 conserved hypothetical protein 
SO3002        2 conserved hypothetical protein 
SO3004       2 2 prophage LambdaSo, DNA modification methyltransferase, putative 
SO3006 2 2     3  
prophage LambdaSo, type II DNA modification methyltransferase, 
putative 
SO3008 2        hypothetical protein 
SO3013  2 2 2  2 2  site-specific recombinase, phage integrase family 
SO3016 4   2  3 2  Sua5/YciO/YrdC/YwlC family protein 
SO3017 2 2     3  TrpH family protein 
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Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO3019  2   3    anthranilate synthase component I (trpE) 
SO3022   2  2    
indole-3-glycerol phosphate synthase/phosphoribosylanthranilate 
isomerase (trpC/F) 
SO3023 4 7 6 6 5 2 6 7 tryptophan synthase, beta subunit (trpB) 
SO3024 7 8 6 5 2 8 2 2 tryptophan synthase, alpha subunit (trpA) 
SO3025    2   2 2 conserved hypothetical protein 
SO3030 10 8 28 28 3  33 36 siderophore biosynthesis protein (alcA) 
SO3031   3 3    2 siderophore biosynthesis protein, putative 
SO3032 5 5 12 16 3  19 17 siderophore biosynthesis protein, putative 
SO3033 23 19 44 43 4 2 54 52 ferric alcaligin siderophore receptor 
SO3034       2 3 ferric iron reductase protein, putative 
SO3036 2 2 2  2 2 2  conserved hypothetical protein 
SO3037 8 13 6 5 7 9 8 5 exodeoxyribonuclease III (xth) 
SO3043       2  hypothetical protein 
SO3044 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO3048  2     2  isoquinoline 1-oxidoreductase, beta subunit, putative 
SO3049      2   isoquinoline 1-oxidoreductase, alpha subunit, putative 
SO3052 8 7 10 10 9 6 17 13 methyl-accepting chemotaxis protein 
SO3054     3 2   metallo-beta-lactamase family protein 
SO3055       2 2 proline iminopeptidase (pip) 
SO3057     2  3 2 Pal/histidase family protein 
SO3061 6 2 5 8 3 2 11 13 DNA topoisomerase III (topB) 
SO3063    2    3 sodium:alanine symporter family protein 
SO3064 23 28 22 29 28 18 23 26 amidophosphoribosyltransferase (purF) 
SO3066 10 25 15 18 13 23 14 22 conserved hypothetical protein 
SO3067  2 2 4 3   4 FolC bifunctional protein (folC) 
SO3068 2 2    2   tRNA pseudouridine synthase A (truA) 
SO3069 14 18 18 21 14 17 16 24 conserved hypothetical protein 
SO3070 18 18 15 19 18 14 17 17 aspartate semialdehyde dehydrogenese (asd) 
SO3071 2 2       erythronate-4-phosphate dehydrogenase (pdxB) 
SO3072 21 31 30 27 25 19 25 21 3-oxoacyl-(acyl-carrier-protein) synthase I (fabB) 
SO3073 2 2       conserved hypothetical protein 
SO3077 3 5 3 5 2    conserved hypothetical protein 
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SO3080 2       2 hemK family protein 
SO3081        2 Smr domain protein 
SO3083       2  peptidase, M16 family 
SO3084 2 3 5 4 4 4 4 6 sensory box protein 
SO3088 14 17 23 11 15 6 21 23 fatty oxidation complex, alpha subunit 
SO3089 9 12 10 11 11 5 11 13 fatty oxidation complex, beta subunit 
SO3090 14 14 8 17 13 13 12 17 MoxR domain protein 
SO3091 5  2  3    conserved hypothetical protein 
SO3092 6 9 5 9 10 12 8 8 hypothetical protein 
SO3093 3 3 3 4  2 3 8 von Willebrand factor type A domain protein 
SO3094 6 11 5 4 8 10 7 12 TPR domain protein 
SO3095 6 15 16 14 17 6 16 11 conserved hypothetical protein 
SO3096 5 5 7 4 7 3 2 6 RNA polymerase sigma-70 factor, ECF subfamily 
SO3097 4 4 4 2 4  5 2 conserved hypothetical protein 
SO3099 17 21 16 22 14 19 23 26 long-chain fatty acid transport protein, putative 
SO3101 14 21 17 14 19 18 17 19 conserved hypothetical protein 
SO3102 3       2 AcrA/AcrE family protein 
SO3103 6 11 7 9 16 12 15 11 AcrB/AcrD/AcrF family protein 
SO3105 2 3 4 2  3  2 phage shock protein E (pspE-1) 
SO3108  4 6 7 5  4 9 siroheme synthase, N-terminal component, putative 
SO3110 11 10 11 12 12 11 9 7 protein-export membrane protein SecF (secF-2) 
SO3111 38 52 45 52 39 37 44 45 protein-export membrane protein SecD (secD-2) 
SO3112 4 6 6 9 2 4 5 7 preprotein translocase, YajC subunit (yajC) 
SO3113 17 23 19 21 13 17 16 21 queuine tRNA-ribosyltransferase (tgt) 
SO3114 5 9 4 6 6 2 4 5 S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) 
SO3116   2  2    conserved hypothetical protein 
SO3118 5 4 4 2 3 2 2 6 ribosomal large subunit pseudouridine synthase A (rluA-1) 
SO3120  4 6 7 6 2 8 7 oxidoreductase, Gfo/Idh/MocA family 
SO3122 3 3 4 3 4  2  sodium/dicarboxylate symporter 
SO3124   3 4 2   4 tyrosine-specific protein phosphatase, putative 
SO3125 9 12 3 7 4 3 7 6 ATP-dependent RNA helicase, DEAD box family 
SO3126     2    methylated-DNA--protein-cysteine methyltransferase (ogt) 
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SO3127       2  Ada regulatory protein, putative 
SO3128 8 9 10 6 7 7 9 6 ABC transporter, ATP-binding/permease protein, putative 
SO3133   2      hypothetical protein 
SO3134 2        C4-dicarboxylate-binding periplasmic protein (dctP) 
SO3138   2 3 3   3 C4-dicarboxylate transport transcriptional regulatory protein (dctD) 
SO3140 3  2      thymidine kinase 
SO3142 43 45 43 54 46 41 51 52 peptidyl-dipeptidase Dcp (dcp-1) 
SO3144 8 9 8 5 9 6 6 7 electron transfer flavoprotein, alpha subunit (etfA) 
SO3145 12 9 10 9 7 12 11 9 electron transfer flavoprotein, beta subunit (etfB) 
SO3146 28 37 33 33 32 36 34 36 DNA-binding protein, H-NS family 
SO3148  2       conserved hypothetical protein 
SO3149  3  3     conserved hypothetical protein 
SO3150 3 7 8 8 4 7 4 7 lipoprotein, putative 
SO3154 22 32 21 29 29 11 27 38 prolyl-tRNA synthetase (proS) 
SO3155 2 2 4   4  3 conserved hypothetical protein 
SO3157 5 5 4 6 5 5 3 5 lipoprotein, putative 
SO3158 8 9 7 6 5 9 6 4 polysaccharide synthesis-related protein 
SO3159 14 20 19 13 15 10 10 17 conserved hypothetical protein 
SO3163 2 2 3  5 5 4 4 lipoprotein 
SO3166    2     conserved hypothetical protein 
SO3168 2 2 4 4 5 2 7 5 DnaJ domain protein 
SO3171 14 19 13 11 13 10 7 11 polysaccharide biosynthesis protein 
SO3172 8 14 12 12 13 12 13 13 galactosyl transferase 
SO3173 6 3 6 6 6 5 6 7 UDP-galactose 4-epimerase, putative 
SO3174 13 6 12 11 11 10 12 16 glycosyl transferase, group 1 family protein 
SO3175 18 23 17 23 20 15 19 18 asparagine synthetase, glutamine-hydrolyzing (asnB-2) 
SO3176 3 7   2 6   glycosyl transferase, group 1 family protein 
SO3177 12 11 10 7 9 12 5 4 formyl transferase domain protein 
SO3178 18 23 21 18 18 17 22 19 hypothetical protein 
SO3180 4 5 3 2 5 2 3 3 glycosyl transferase, group 2 family protein 
SO3182 2     2  2 acetyltransferase, GNAT family 
SO3183 3 3 5 4 4 3  5 perosamine synthetase-related protein 
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SO3184 5 2  4 6  7 7 conserved hypothetical protein 
SO3185 5 7 6 8 10 3 5 6 polysaccharide biosynthesis protein 
SO3186 6 9 6 8 11 4 9 9 glucose-1-phosphate-thymidylyltransferase (rfbA) 
SO3188 5 7 7 9 9 3 8 11 dTDP-glucose 4,6-dehydratase (rfbB) 
SO3189 9 11 8 9 6 5 7 10 polysaccharide biosynthesis protein 
SO3190 22 34 33 28 28 20 26 33 polysaccharide biosynthesis protein 
SO3191 9 15 7 14 15 13 11 13 chain length determinant protein 
SO3193 53 73 62 54 49 59 63 56 polysaccharide biosynthesis protein 
SO3194 3 5 5 5 4 5 5 2 transcriptional activator rfaH, putative 
SO3197 10 11 9 9 9 8 9 9 vacJ lipoprotein, putative 
SO3198 3 4 3  5 2 2  hypothetical protein 
SO3200  2 3 5   2 3 conserved hypothetical protein 
SO3202 2   2 4 2 5 4 purine-binding chemotaxis protein CheW (cheW-3) 
SO3203 2    3    CheW domain protein 
SO3204 9 7 6 3 3 4 7 6 ParA family protein 
SO3205 2 2 5 5 2 3 4 3 hypothetical protein 
SO3206 4 10 4 8  7 2 3 protein-glutamate methylesterase CheB (cheB-3) 
SO3207 20 27 22 20 22 20 21 30 chemotaxis protein 
SO3208 3 3 5 5 4 2 7 4 chemotaxis protein CheZ (cheZ) 
SO3209 2 5  5 3 4 10 8 chemotaxis protein CheY (cheY-3) 
SO3210 4 4 3 4 3  3 6 RNA polymerase sigma-27 factor (fliA) 
SO3211 8 10 6 9 10 9 8 6 flagellar biosynthetic protein FlhG (flhG) 
SO3212 8 13 17 19 8 13 9 17 flagellar biosynthetic protein FlhF (flhF) 
SO3213 3  2 2 6 2 4 3 flagellar biosynthesis protein FlhA (flhA) 
SO3215  2      3 flagellar biosynthetic protein FlhB (flhB) 
SO3219    3   2  flagellar protein FliO (fliO) 
SO3220    2    2 flagellar motor switch protein FliN (fliN) 
SO3221 2   2 2  2 2 flagellar motor switch protein FliM (fliM) 
SO3222 3 4 4 2 3 12 4 6 flagellar protein FliL (fliL) 
SO3223   5    4  flagellar hook-length control protein FliK (fliK) 
SO3224        2 flagellar protein FliJ (fliJ) 
SO3225    3    2 flagellum-specific ATP synthase FliI (fliI) 
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SO3226  5 2 4 4 4  6 flagellar assembly protein FliH (fliH) 
SO3227 9 13 12 10 9 4 14 12 flagellar motor switch protein FliG (fliG) 
SO3228 9 11 12 13 8 14 9 5 flagellar M-ring protein FliF (fliF) 
SO3230  4   4 3  2 flagellar regulatory protein C (flrC) 
SO3231 2 3 2 6 5 7 5 8 flagellar regulatory protein B (flrB) 
SO3232 5 8 5 10 8 7 8 11 flagellar regulatory protein A (flrA) 
SO3233 6 9 9 8 5 6 8 8 flagellar protein FliS (fliS) 
SO3235 4 2 5 5 2 2  7 flagellar hook-associated protein FliD (fliD) 
SO3237 24 21 23 23 21 16 18 18 flagellin 
SO3238 22 20 20 22 22 15 18 18 flagellin 
SO3239 4 2  3 3 2   flagellar hook-associated protein FlgL (flgL) 
SO3241    2     flagellar protein FlgJ (flgJ) 
SO3242 3 6 3 4 3  2 4 flagellar P-ring protein FlgI (flgI) 
SO3243 3 5 10 5   5 5 flagellar L-ring protein FlgH (flgH) 
SO3244 2 2      4 flagellar basal-body rod protein FlgG (flgG) 
SO3245    3     flagellar basal-body rod protein FlgF (flgF) 
SO3247 8 12 8 8 6 7 5 3 flagellar hook protein FlgE (flgE) 
SO3248  3  2 2    basal-body rod modification protein FlgD (flgD) 
SO3251 6 5 5 3 3 3 2 7 chemotaxis protein methyltransferase CheR (cheR-2) 
SO3252      2   chemotaxis protein CheV (cheV-3) 
SO3254   4 4  4 2  negative regulator of flagellin synthesis FlgM (flgM) 
SO3255   2 4   2 2 flagellar biosynthetic protein FlgN (flgN) 
SO3256 3 3 2   2 2 2 conserved hypothetical protein 
SO3257 2  2 3 4  2  conserved hypothetical protein 
SO3259   2  3 3  2 conserved domain protein 
          
SO3261 2        polysaccharide biosynthesis related-protein 
SO3262 4 6 9 4 9 2 4 6 acetolactate synthase isozyme I, large subunit (ilvB) 
SO3263     3   2 3-oxoacyl-(acyl-carrier-protein) reductase, putative 
SO3264        2 hypothetical protein 
SO3265 5 6 7 6 3   4 conserved hypothetical protein 
SO3266   3 2   2 3 conserved domain protein 
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SO3267 5 2 4  5  3 2 conserved domain protein 
SO3268    2     alpha amylase domain protein 
SO3271 10 11 9 6 13 9 7 8 polysaccharide biosynthesis protein 
SO3273       2  conserved hypothetical protein 
SO3275  3 2 2 2  2 2 hypothetical protein 
SO3279     2   2 AcrB/AcrD/AcrF family protein 
SO3282 8 12 3 6 18 20 6 11 methyl-accepting chemotaxis protein 
SO3285  2   3    cytochrome d ubiquinol oxidase, subunit II (cydB) 
SO3286 19 19 16 19 26 21 14 17 cytochrome d ubiquinol oxidase, subunit I (cydA) 
SO3287 42 57 38 47 52 26 33 49 phosphoribosylformylglycinamidine synthase (purL) 
SO3288 2 3 2  4 3 6 2 transglycosylase, Slt family 
SO3291 2        cytidine/deoxycytidylate deaminase family protein 
SO3292 11 17 16 13 19 4 16 16 GMP synthase (guaA) 
SO3293 51 62 50 49 48 55 47 47 inosine-5-monophosphate dehydrogenase (guaB) 
SO3294 3  3  2    exodeoxyribonuclease VII, large subunit (xseA) 
SO3297  2   2 2   transcriptional regulator, LysR family 
SO3298        2 conserved hypothetical protein 
SO3299 2 5 5 8 6 3 3 8 Pal/histidase family protein 
SO3306       2  sensor histidine kinase 
SO3308 19 23 17 14 20 14 14 18 GTP-binding protein EngA (engA) 
SO3309 14 13 11 14 13 12 12 13 PQQ enzyme repeat domain protein 
SO3310 33 42 32 37 35 35 33 36 conserved hypothetical protein 
SO3311 11 12 12 11 16 11 4 16 histidyl-tRNA synthetase (hisS) 
SO3312 9 7 4 7 5 6 7 9 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase (ispG) 
SO3313 13 12 11 11 12 11 13 14 conserved hypothetical protein 
SO3314 13 7 11 11 8 5 8 10 fimbrial biogenesis and twitching motility protein, putative 
SO3315 4 4 3 3 5  3 5 conserved hypothetical protein TIGR00048 
SO3316 13 20 16 21 14 11 11 13 conserved hypothetical protein 
SO3317 2 2 2 5 3  4 5 5-nucleotidase, putative 
SO3325 3 2 2 4 5 5 2 4 nrfJ-related protein 
SO3335    2  2  2 conserved hypothetical protein 
SO3338 7 2 6 6 4 7 2 7 L-allo-threonine aldolase (ybjU) 
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SO3339  2 3 5     OmpA family protein 
SO3340 5 6 7 5 10  8 11 conserved hypothetical protein 
SO3341 9 12 13 17 9 5 8 10 antioxidant, AhpC/TSA family 
SO3343 17 19 19 21 17 10 15 15 conserved hypothetical protein 
SO3345 3 4 6 4 2 4 3 4 translation initiation factor, putative 
SO3346  2 3 2 3  4 6 conserved hypothetical protein 
SO3347 2 3 3 2     conserved hypothetical protein TIGR00250 
SO3348 8 9 7 6 4 4 9 7 ferrochelatase (hemH-2) 
SO3349   2     2 glutathione peroxidase, putative 
SO3350  3   6  4 3 twitching motility protein PilU (pilU) 
SO3351 15 7 9 6 11 3 18 14 twitching motility protein PilT (pilT) 
SO3352 3 2  2  2 2  conserved hypothetical protein TIGR00044 
SO3354 8 5 5 7 3 5 3 3 pyrroline-5-carboxylate reductase (proC) 
SO3355       2  conserved hypothetical protein 
SO3358 5 3 2 3  2  4 HAM1 protein 
SO3360 4 3 3  2 4 3 2 ISSo5, transposase 
SO3361 9 9 11 11 6 7  4 conserved hypothetical protein 
SO3363 4 2 3 5 5 2 4 4 transcriptional regulator, LysR family 
SO3364     2    conserved hypothetical protein 
SO3365     2  3  glutaminase A (glsA) 
SO3367 7 9 7 9 4 4 9 12 conserved hypothetical protein TIGR00091 
SO3368 2 5 2 3 3  4 3 A/G-specific adenine glycosylase (mutY) 
SO3369 5 7 7 8 6 4 5 9 conserved hypothetical protein 
SO3370 2 4 4 6   4 5 conserved hypothetical protein 
SO3374 2 2  2 3 3 3 3 conserved hypothetical protein 
SO3379   3 5    2 cyclopropane-fatty-acyl-phospholipid synthase (cfa) 
SO3380   2     2 conserved hypothetical protein 
SO3381     2 2 2 2 conserved hypothetical protein 
SO3384   3 2 2  2  deoxyribodipyrimidine photolyase (phrB) 
SO3388 5 7 4 5 7 2 5 6 ATP-dependent RNA helicase, DEAD box family 
SO3389    2     sensory box protein 
SO3391 7 10 5 7 7 5 7 7 ATP-dependent protease, putative 
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SO3392 2 4 3 3 3  4 6 oxidoreductase, FMN-binding 
SO3396 4 4 3 6 5 4 4 5 methyl-accepting chemotaxis protein, truncation 
SO3399 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO3401 10 6 7 11 7 8 4 4 conserved hypothetical protein TIGR01033 
SO3403 4 8 11 10 10 10 12 14 ribosomal subunit interface protein (yfiA-1) 
SO3404 3 3 3 2 3 5 2 3 methyl-accepting chemotaxis protein 
SO3407 5 8 8 10 4 3 13 14 conserved hypothetical protein 
SO3409 2 4 2  3 3 4 3 OsmC/Ohr family protein 
SO3411 26 21 18 23 19 22 20 25 protease, putative 
SO3413 3  2      threonine synthase (thrC) 
SO3415   2 3 2   5 
aspartokinase I/homoserine dehydrogenase, threonine-sensitive 
(thrA) 
SO3417 6 6 7 5 5 6 8 5 peptidyl-prolyl cis-trans isomerase SlyD (slyD) 
SO3420 11 16 19 21 13 10 15 17 cytochrome c 
SO3422 4 4 8 5 5 4 5 5 ribosomal subunit interface protein (yfiA-2) 
SO3424 23 32 24 34 27 17 27 40 valyl-tRNA synthetase (valS) 
SO3426 4 3 3 5 4 4 6 3 carbon storage regulator (csrA) 
SO3427 3 2   3 3 2  aspartokinase 
SO3428 48 41 34 43 42 36 33 41 alanyl-tRNA synthetase (alaS) 
SO3430 40 41 47 47 38 42 51 52 recA protein (recA) 
SO3431 13 11 12 14 20 7 12 13 DNA mismatch repair protein MutS (mutS) 
SO3432     3    RNA polymerase sigma-38 factor (rpoS) 
SO3433 2 2 4  5 7 6 5 lipoprotein NlpD (nlpD) 
SO3434 3 3  2 2   2 protein-L-isoaspartate O-methyltransferase (pcm) 
SO3435 2        stationary-phase survival protein SurE (surE) 
SO3436 7 5 5 7 6 4 11 9 conserved hypothetical protein 
SO3437  2     3  2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (ispF) 
SO3438 2 7 5 5 5 2 8 7 4-diphosphocytidyl-2C-methyl-D-erythritol synthase (ispD) 
SO3439 2 3 2 2 3  2 4 conserved hypothetical protein 
SO3440 24 29 36 37 22 29 34 32 enolase (eno) 
SO3441 37 43 29 35 33 23 26 34 CTP synthase (pyrG) 
SO3442 3  2 6  3 4 2 MazG family protein 
SO3443 15 22 15 15 16 18 15 15 ISSo4, transposase 
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SO3444       2  hypothetical protein 
SO3449 2 6 2 4 4  2 4 conserved domain protein 
SO3451 15 22 15 15 16 18 15 15 ISSo4, transposase 
SO3455 16 15 21 19 28 20 21 26 GTP pyrophosphokinase (relA) 
SO3456 9 11 3 5 7 4 2 6 RNA methyltransferase, TrmA family 
SO3457 6 6 5 5 7 7 5 8 sensor histidine kinase/response regulator 
SO3458     3  2 2 conserved hypothetical protein 
SO3462 4  6 12  2 12 15 DNA repair protein RecN (recN) 
SO3463 2        phosphatidylglycerophosphatase A (pgpA) 
SO3464 2 3 2 4  2 7 6 thiamin-monophosphate kinase (thiL) 
SO3465 3 8 8 8 7 7 9 9 N utilization substance protein B (nusB) 
SO3466 19 23 18 18 21 22 19 20 riboflavin synthase, beta subunit (ribH) 
SO3467 19 20 14 19 19 15 15 12 
3,4-dihydroxy-2-butanone 4-phosphate synthase/GTP cyclohydrolase 
II, putative (ribBA) 
SO3468  2 3 2 5 3 3 3 riboflavin synthase, alpha subunit (ribE-2) 
SO3469 2 4 2 2 2   4 riboflavin biosynthesis protein RibD (ribD) 
SO3470 4 4 6 7 2   4 conserved hypothetical protein TIGR00244 
SO3471 26 32 31 28 29 20 22 28 serine hydroxymethyltransferase (glyA) 
SO3472 41 32 39 46 30 32 31 33 ABC transporter, ATP-binding protein 
SO3480    2     conserved hypothetical protein 
SO3483 13 9 13 17 8 9 7 13 HlyD family secretion protein 
SO3484 10 11 12 6 9 8 8 9 AcrB/AcrD/AcrF family protein 
SO3494 2 5 4 2    2 transcriptional regulator, TetR family 
SO3496  3  4 4 2 3 2 aldehyde dehydrogenase 
SO3506   2 4   2 2 SIS domain protein 
SO3509 11 14 14 13 18 12 16 18 beta-hexosaminidase b precursor (hex) 
SO3516 6 2 4 4 4 4  4 transcriptional regulator, LacI family 
SO3517 13 12 12 9 12 14 9 8 NADH dehydrogenase (ndh) 
SO3518  3 2 2  2   ISSo4, transposase 
SO3519 6   4  3 4 2 nitrogen regulatory protein P-II 1 (glnB-2) 
SO3521   2 2 2  2  type IV pilus biogenesis protein, putative 
SO3524 2   4   2 2 type IV pilus biogenesis protein PilE (pilE) 
SO3529 9 10 7 9 5 3 7 10 penicillin tolerance protein LytB (lytB) 
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SO3532 17 27 23 29 27 13 24 35 isoleucyl-tRNA synthetase (ileS) 
SO3533    2 3  4  riboflavin biosynthesis protein RibF (ribF) 
SO3537 7 6 7 8 6 7 6 6 ribosomal protein S20 (rpsT) 
SO3538 5 3   6 3   transcriptional regulator HlyU (hlyU) 
SO3539 23 30 25 24 28 23 25 26 peptidase, M28D family 
SO3540 2  2      conserved hypothetical protein 
SO3541 4 2 3 3 3 2 3 3 sodium:alanine symporter family protein 
SO3542 2 5  2 6    conserved hypothetical protein 
SO3543        2 ISSo13, transposase 
SO3544   2 3    3 ISSo7, transposase 
SO3545 48 56 50 52 51 48 59 59 OmpA family protein 
SO3546 11 11 10 9 10 9 7 7 transaldolase (tal) 
SO3547 10 7 6 6 6 6 2 5 glucose-6-phosphate isomerase (pgi) 
SO3550 2 4 3 3 3  7 8 hypothetical protein 
SO3551   2  2   3 RNA polymerase sigma-70 factor, ECF subfamily 
SO3552        2 von Willebrand factor type A domain protein 
SO3553 2 4 3  5 2   sulfate permease family protein 
SO3554 9 13 6 6 6 4 6 6 phosphoribosylaminoimidazole carboxylase, catalytic subunit (purE) 
SO3555 3 5 3 6 3 2 2  phosphoribosylaminoimidazole carboxylase, ATPase subunit (purK) 
SO3556 4 5 2 3 8 6 6 3 GAF/GGDEF domain protein 
SO3557   2 7 4 2 4 3 conserved hypothetical protein 
SO3558   2     2 hypothetical protein 
SO3559 5 6 3 6 4   3 glutamate--cysteine ligase (gshA) 
SO3560 62 66 63 58 74 56 61 59 peptidase, M16 family 
SO3562 2 5 5 4 2 3 2 3 proton/glutamate symporter, putative 
SO3564 54 64 46 54 58 57 46 57 peptidyl-dipeptidase Dcp (dcp-2) 
SO3565 34 47 29 31 44 44 22 21 2,3-cyclic-nucleotide 2-phosphodiesterase (cpdB) 
SO3571 4 5 4 3  3 3 3 conserved hypothetical protein 
SO3575  3   2 2 2 2 CDP-diacylglycerol--serine O-phosphatidyltransferase, putative 
SO3577 30 37 55 71 39 41 66 67 clpB protein (clpB) 
SO3578       3 2 conserved hypothetical protein TIGR00726 
SO3579 4 7 5 4 3 4 3 6 ribosomal large subunit pseudouridine synthase D (rluD) 
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SO3580 14 21 13 16 12 15 12 12 conserved hypothetical protein 
SO3582 8 12 8 7 8 11 9 12 methyl-accepting chemotaxis protein 
SO3584  2  2    5 conserved hypothetical protein 
SO3585   10 9   5 4 Azoreductase, putative 
SO3586   5 6   8 3 glyoxalase family protein 
SO3587  2 5 7 3 2 4 3 hypothetical protein 
SO3594 2 5 7 6 6 2 6 7 transcriptional regulatory protein RstA, putative 
SO3595 2 3 5 3 4 5 3 4 sensor protein RstB, putative 
SO3597 4 10 8 7 5 6 7 8 conserved hypothetical protein 
SO3598 6 6 4 5 3  6 6 cysteine synthase B (cysM) 
SO3599 11 20 28 32 2 5 23 23 sulfate ABC transporter, periplasmic sulfate-binding protein (cysP) 
SO3602 11 25 21 14 11 13 17 23 sulfate ABC transporter, ATP-binding protein (cysA-1) 
SO3611  2      2 ATPase, AAA family 
SO3613 2 3 3  3 4   phosphoribosylglycinamide formyltransferase 2 (purT) 
SO3614        2 hypothetical protein 
SO3615 16 22 12 14 19 15 12 15 hypothetical protein 
SO3622 3 2 5 8  3 2 5 conserved domain protein 
SO3631 3 4 3 4 2 3 6  glycerate dehydrogenase (hprA) 
SO3633 7 6 4 4 7 3 6 8 DnaJ domain protein 
SO3636 10 16 8 12 9 8 13 15 organic solvent tolerance protein (imp) 
SO3637 19 17 17 22 17 13 20 19 survival protein surA (surA) 
SO3638   2 2 3 2  3 pyridoxal phosphate biosynthetic protein PdxA (pdxA) 
SO3639 3 4 2 4 6 2 2 6 dimethyladenosine transferase (ksgA) 
SO3642 20 36 21 25 27 31 23 25 methyl-accepting chemotaxis protein 
SO3646 3 4  2 2  2 2 dihydrofolate reductase (folA) 
SO3649 14 13 16 11 16 10 12 17 GTP-binding protein, GTP1/Obg family 
SO3651 8 10 11 11 7 9 11 11 ribosomal protein L27 (rpmA) 
SO3652 16 18 13 14 16 17 14 17 ribosomal protein L21 (rplU) 
SO3653 3 8 4 8 4 2  5 octaprenyl-diphosphate synthase (ispB) 
SO3654  2      2 uracil-DNA glycosylase (ung) 
SO3655  2  2  2   pilin, putative 
SO3656 3 2 2 3 4 3   hypothetical protein 
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SO3664 13 13 6 10 7 4 4 6 long-chain-fatty-acid--CoA ligase (fadD-2) 
SO3665 4 3 5 4 2 4 5 6 ABC transporter, ATP-binding/permease protein, putative 
SO3667 4 10 30 27   29 31 conserved hypothetical protein 
SO3668   5 6    3 conserved hypothetical protein 
SO3669 14 14 53 64 3 5 67 71 heme transport protein (hugA) 
SO3670   3 4   3 4 TonB1 protein (tonB1) 
SO3671 3 4 5 4   6 7 TonB system transport protein ExbB1 (exbB1) 
SO3673 2 6 22 22   16 17 hemin ABC transporter, periplasmic hemin-binding protein (hmuT) 
SO3675 4 3 13 9   12 9 hemin ABC transporter, ATP-binding protein (hmuV) 
SO3676  3 2 4 3  2 4 hypothetical protein 
SO3678 2 3   2 3   conserved hypothetical protein 
SO3680 2 2 2   2 3  universal stress protein family 
SO3681 3 5 5 6 6 5 8 7 universal stress protein family 
SO3683 13 15 17 14 13 13 19 10 coniferyl aldehyde dehydrogenase 
SO3689   2     2 sigma-54 dependent nitrogen response regulator 
SO3692   2 2    3 ABC transporter, ATP-binding protein 
SO3695 7 12 7 6 8 8 9 6 dihydroorotase, homodimeric type (pyrC) 
SO3696  2 2      hypothetical protein 
SO3698        3 hypothetical protein 
SO3705 3 2 4 4 3  7 4 
5-methylthioadenosine nucleosidase/S-adenosylhomocysteine 
nucleosidase, putative 
SO3711     3    conserved hypothetical protein 
SO3714    2     sugar-binding protein, putative 
SO3715 8 8 14 12 9 5 11 13 oxygen-insensitive NAD(P)H nitroreductase 
SO3718 7 9 8 7 9 8 5 10 thiol:disulfide interchange protein, DsbA family 
SO3720 6 5 6 4 12 7 6 4 conserved hypothetical protein 
SO3722 3 5   5 4  2 conserved hypothetical protein 
SO3723    3   5 4 adenylylsulfate kinase (cysC) 
SO3726 5 11 17 19 7 2 17 23 sulfate adenylyltransferase, subunit 1 (cysN) 
SO3727 14 15 24 23 10 5 28 32 sulfate adenylyltransferase, subunit 2 (cysD) 
SO3728    2   4 4 uroporphyrin-III C-methyltransferase (cobA) 
SO3731      2   hypothetical protein 
SO3733 28 34 30 30 38 24 37 30 hypothetical protein 
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SO3735 2   2    2 monofunctional biosynthetic peptidoglycan transglycosylase (mtgA) 
SO3736 4 3 4 4 2  5 5 phosphoadenosine phosphosulfate reductase (cysH) 
SO3737 19 17 35 39 13 8 41 57 
sulfite reductase (NADPH) hemoprotein beta-component (cysI) 
(cysI) 
SO3738 2 5 11 9 2  13 15 sulfite reductase (NADPH) flavoprotein alpha-component (cysJ) 
SO3740 35 35 33 36 39 34 43 43 NAD(P) transhydrogenase, alpha subunit (pntA) 
SO3741 13 15 14 14 16 8 16 15 NAD(P) transhydrogenase, beta subunit (pntB) 
SO3743 4 8 7 6 5 3 4 7 transcriptional regulator, TetR family 
SO3745 7 9 4 6 7 4 4 8 ADP-heptose synthase (rfaE) 
SO3746 9 15 12 11 12 9 13 17 lipid A biosynthesis lauroyl acyltransferase (htrB) 
SO3747 2 3  3   2 3 sodium/hydrogen exchanger family/TrkA domain protein 
SO3748 22 27 21 19 19 23 21 21 LysM domain protein 
SO3749  2 3 3 2  2 2 hypothetical protein 
SO3757        2 rubisco operon transcriptional regulator (rbcR) 
SO3760 3 3 2      glutamate-ammonia-ligase adenylyltransferase (glnE) 
SO3761 2 14 9 8 9 11 8 12 hypothetical protein 
SO3763 6 4 3 2 4 3 3 5 spermine/spermidine synthase family protein 
SO3765 32 40 37 45 37 41 43 49 conserved hypothetical protein 
SO3767   2  2    hypothetical protein 
SO3768   2 2   2  ion transporter 
SO3769        2 conserved hypothetical protein 
SO3770 17 15 14 15 11 8 10 16 conserved hypothetical protein TIGR00153 
SO3772 16 26 19 23 18 20 21 21 conserved hypothetical protein 
SO3774 71 75 40 57 65 62 47 46 
proline dehydrogenase/delta-1-pyrroline-5-carboxylate 
dehydrogenase, putative 
SO3775 5  3 3 5 5 5 9 hypothetical protein 
SO3776  2    2  2 conserved hypothetical protein 
SO3777        2 hypothetical protein 
SO3778       2  adenylate cyclase CyaB, putative 
SO3779 3 2 2 4 8 3 6 6 ABC transporter, ATP-binding protein CydC (cydC) 
SO3780 4 8 4  7 7  3 ABC transporter, ATP-binding protein CydD (cydD) 
SO3781 4 5 7 5 5 5 5 4 hypothetical protein 
SO3783 9 11 2 5 5 6  2 ATP-dependent RNA helicase, DEAD box family 
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SO3786 2 3 4 5 3 2 4 7 hypothetical protein 
SO3787 3 3 4 5  3 4 4 hypothetical protein 
SO3789  2 2    2  aminotransferase, class V 
SO3790    2 3  4  conserved hypothetical protein 
SO3791   2    2 3 renal dipeptidase family protein 
SO3796     3    conserved hypothetical protein 
SO3797 9 8 3 8 4 6 5 4 peptidase, U32 family 
SO3798  3 2 2 2  2  ribosomal large subunit pseudouridine synthase A (rluA-2) 
SO3799 4 4 4 3 5  2 5 regulatory protein AsnC (asnC) 
SO3800 7 5 3  6 5   serine protease, subtilase family 
SO3802 8 9 13 18 10 7 13 12 ABC transporter, ATP-binding protein 
SO3803 5 9 5 10 9 3 8 10 hypoxanthine phosphoribosyltransferase (hpt-2) 
SO3804   3 3 2  4 2 
phenylacrylic acid decarboxylase, 3-octaprenyl-4-hydroxybenzoate 
carboxy-lyase, putative 
SO3805 9 12 7 10 6 5 6 10 
UDP-N-acetylmuramate:L-alanyl-gamma-D-glutamyl-meso-
diaminopimelate ligase (mpl) 
SO3810 2      2 3 OmpA-like transmembrane domain protein 
SO3811 16 16 14 12 17 10 17 19 lipoprotein, putative 
SO3812 4 7 5 5 4 3 3 4 peptidyl-prolyl cis-trans isomerase A (ppiA) 
SO3815 9 8 11 11 10 8 5 11 conserved hypothetical protein 
SO3817   2      2-dehydropantoate 2-reductase (panE) 
SO3821 2 2       rtn protein 
SO3827 9 12 10 11 7 9 10 9 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA) 
SO3828     2    conserved hypothetical protein 
SO3832 3  2 3 3  2 3 hemK family protein 
SO3833 8 15 10 12 7 7 11 11 peptide chain release factor 1 (prfA) 
SO3834 12 15 8 6 16 14 10 5 glutamyl-tRNA reductase (hemA) 
SO3835 6 4 6 5 3 4 5 4 outer membrane lipoprotein LolB (lolB) 
SO3836 3 7 7 8 5   4 4-diphosphocytidyl-2C-methyl-D-erythritol kinase (ispE) 
SO3837 29 31 26 26 27 29 17 25 ribose-phosphate pyrophosphokinase (prsA) 
SO3838 16 15 14 21 17 13 14 18 methyl-accepting chemotaxis protein 
SO3841    2     hypothetical protein 
SO3842 12 12 11 17 8 8 11 9 conserved hypothetical protein 
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SO3843  4 3 4    2 ribosomal small subunit pseudouridine synthase A (rsuA-2) 
SO3844 89 112 90 81 91 97 80 93 peptidase, M13 family 
SO3848 2 4 2   2  2 hypothetical protein 
SO3854     2  2 2 ISSo12, transposase 
SO3855 21 30 21 23 25 16 24 25 malate oxidoreductase (sfcA) 
SO3856 8 12 6 5 6 9 4 6 hypothetical protein 
SO3862        2 molybdenum transport regulatory protein ModE (modE) 
SO3863 12 14 12 15 10 19 6 9 
molybdenum ABC transporter, periplasmic molybdenum-binding 
protein (modA) 
SO3865 17 16 9 13 25 17 13 10 molybdenum ABC transporter, ATP-binding protein (modC) 
SO3866 2   3  2 2  site-specific recombinase, phage integrase family 
SO3867 2       2 transcriptional regulator, Cro/CI family 
SO3872       2  arylsulfate sulfotransferase 
SO3878 4 3 3  2 4 3 2 ISSo5, transposase 
SO3880        2 ISSo13, transposase 
SO3888 2        conserved hypothetical protein 
SO3890 4 3 5 5 6 3 5 8 methyl-accepting chemotaxis protein 
SO3892  2 3  2 2 4  hypothetical protein 
SO3895 4 4  4 3 2  3 HesA/MoeB/ThiF family protein 
SO3896 50 57 49 49 56 64 55 51 outer membrane porin, putative 
SO3897 13 14 7 8 11 10 7 14 DNA topoisomerase IV, A subunit (parC) 
SO3899 4 6 4 8 5 2 8 6 DNA topoisomerase IV, B subunit (parE) 
SO3901     3    lacZ expression regulator (icc) 
SO3904 56 72 63 68 63 63 66 65 outer membrane protein TolC (tolC) 
SO3905 2 3   2   3 conserved hypothetical protein 
SO3906 9 13 18 17 13 14 18 17 conserved hypothetical protein 
SO3907 2 2 5 5   3 6 conserved hypothetical protein 
SO3908 2  4  3  2 3 enoyl-CoA hydratase/isomerase family protein 
SO3912 2 2 5 7 2   6 TIM-barrel protein, yjbN family 
SO3913   5 4   4 4 conserved hypothetical protein 
SO3914 33 41 59 60 9 9 67 67 TonB-dependent receptor, putative 
SO3917 8 7 4 4 5 5 2 5 replicative DNA helicase (dnaB) 
SO3918 26 28 28 25 26 19 23 27 conserved hypothetical protein 
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SO3920     8 7   periplasmic Fe hydrogenase, large subunit (hydA) 
SO3921     3 4   periplasmic Fe hydrogenase, small subunit (hydB) 
SO3927 30 33 32 29 28 44 25 26 ribosomal protein L9 (rplI) 
SO3928 16 19 16 17 18 17 13 17 ribosomal protein S18 (rpsR) 
SO3930 22 24 20 23 19 26 23 22 ribosomal protein S6 (rpsF) 
SO3931  2 2  3  6 6 conserved hypothetical protein 
SO3934 14 15 8 11 10 11 12 11 RNA methyltransferase, TrmH family, group 3 
SO3935 8 15 10 11 13 9 14 21 ribonuclease R (vacB) 
SO3936 3  3 4 2    sodium-type flagellar protein MotX (motX) 
SO3937 19 17 17 20 21 6 16 14 adenylosuccinate synthetase (purA) 
SO3939 10 10 12 13 10 6 9 11 ribosomal protein S9 (rpsI) 
SO3940 21 30 25 27 23 26 26 25 ribosomal protein L13 (rplM) 
SO3941      2 2  conserved hypothetical protein 
SO3942 34 37 43 51 43 40 44 47 serine protease, HtrA/DegQ/DegS family 
SO3943 5 13 6 6 9 13 8 10 protease DegS (degS) 
SO3948 7 5 8 11 5 7 8 10 UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) 
SO3949 2 8 4 4 7  3 4 BolA/YrbA family protein 
SO3950 7 3 4 4 4 5 6 3 SpoIIAA family protein 
SO3951    2 3  2 3 conserved hypothetical protein 
SO3952 4 6 4 4 2 2 4 5 mce-related protein 
SO3954 17 18 14 14 15 15 15 16 ABC transporter, ATP-binding protein, putative 
SO3956 10 9 8 14 6 9 15 7 carbohydrate isomerase, KpsF/GutQ family 
SO3957 2 4 2 5 2  2 5 conserved hypothetical protein 
SO3958   3 2   2 2 conserved hypothetical protein 
SO3959 7 12 9 10 6 11 5 7 conserved hypothetical protein 
SO3960 14 23 13 16 19 20 15 19 ABC transporter, ATP-binding protein 
SO3961 11 8 7 11 8 8 7 14 RNA polymerase sigma-54 factor (rpoN) 
SO3962       2  ribosomal subunit interface protein (yfiA-3) 
SO3963 2 5 3 3 2 4 2 3 nitrogen regulatory IIA protein (ptsN) 
SO3964  3   2   2 conserved hypothetical protein 
SO3965       2  phosphocarrier protein NPR (ptsO) 
SO3966 7 8 8 9 5 4 7 11 magnesium transporter (mgtE-2) 
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SO3967 8 10 7 6 12 14 4 3 
molybdenum ABC transporter, periplasmic molybdenum-binding 
protein, putative 
SO3969 11 18 17 19 16 11 15 19 OmpA family protein 
SO3973  4 6 4 3 4 5 4 RIO1/ZK632.3/MJ0444 family, putative 
SO3974 4     2  2 conserved domain protein 
SO3980 18 15 22 24 13 15 8 12 cytochrome c552 nitrite reductase 
SO3981     2    nitrate/nitrite sensor protein NarQ (narQ) 
SO3982 3  3  4 2   DNA-binding nitrate/nitrite response regulator 
SO3984 6 5 3 2 4  2 8 magnesium transporter, putative 
SO3988 23 26 27 28 28 27 30 26 aerobic respiration control protein ArcA (arcA) 
SO3990 5 6 6 2 8  4 3 dipeptidyl peptidase IV 
SO3991 10 14 11 13 11 7 9 11 fructose-1,6-bisphosphatase (fbp) 
SO3994 8 7 11 12 7 4 12 12 hypothetical protein 
SO4002 2 6 3 5 7 6 7 6 sensory transduction histidine kinase 
SO4003 2 3 4 3 5 2 7 7 response regulator 
SO4006 3 3 3  3 3 4 4 hypothetical protein 
SO4007 2 4 3 2  3 2 2 hypothetical protein 
SO4008 39 58 34 51 43 49 37 45 hypothetical protein 
SO4011 2  2  3    conserved hypothetical protein 
SO4012 2 2 3  3 4 3 2 hypothetical protein 
SO4013 8 8 9 9 8 6 8 10 hypothetical protein 
SO4014 19 28 17 17 24 22 24 21 AcrB/AcrD/AcrF family protein 
SO4015 7 6 9 11 4 8 3 5 conserved hypothetical protein 
SO4016 2 3 2 2 3   2 conserved hypothetical protein 
SO4017 11 15 16 14 12 15 13 17 transglycosylase, Slt family 
SO4018 2  2      hypothetical protein 
SO4019   2  5    hypothetical protein 
SO4022 3   2 3 3  2 peptidase, M16 family 
SO4028 9 12 5 9 8 9 4 4 single-strand binding protein (ssb) 
SO4029        2 transporter, putative 
SO4030 15 19 22 19 23 7 10 20 excinuclease ABC, A subunit (uvrA) 
SO4034 58 55 39 42 48 42 52 48 ATP-dependent RNA helicase DeaD (deaD) 
SO4036 2 2 2  5  2 4 hypothetical protein 
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SO4038 2  2  5  2 3 hypothetical protein 
SO4043 2 2  3 3    TonB domain protein 
SO4047 4 6 6 5 6 4  2 cytochrome c family protein 
SO4048 2 3 3 4 4 3   cytochrome c family protein 
SO4052      2   transcriptional regulator, MarR family 
SO4053 13 12 4 7 19 11 6 9 methyl-accepting chemotaxis protein 
SO4054    2   2 4 5,10-methylenetetrahydrofolate reductase (metF) 
SO4055   4 4 3  3 2 
aspartokinase II/homoserine dehydrogenase, methionine-sensitive 
(metL) 
SO4057 2 2 3 3 2  4 4 met repressor (metJ) 
SO4062   2      polysulfide reductase, subunit A (psrA) 
SO4066 21 22 16 15 15 11 10 12 
phosphoribosylaminoimidazole-succinocarboxamide synthase, 
putative 
SO4068 9 14 18 16 17 15 14 18 hypothetical protein 
SO4070 4 3 6 7 4 5 6 7 conserved hypothetical protein 
SO4072 6 11 7 12 8 3 6 6 MiaB-like putative RNA modifying enzyme YliG (yliG) 
SO4077 8 7 15 14 5 5 19 21 TonB-dependent receptor, putative 
SO4078 6 4 5 4 9   5 pmba protein (pmbA) 
SO4079 4 10 7 15 4 6 6 16 conserved hypothetical protein 
SO4080 21 24 19 18 22 21 20 14 conserved hypothetical protein 
SO4085  2  2   3  chitinase A (chiA) 
SO4089 10 14 14 13 12 11 15 18 HlyD family secretion protein 
SO4090 4 2 6 4 2 4 6 5 outer membrane efflux protein 
SO4091 6 9 9 6 3 7 6 5 tldD protein (tldD) 
SO4093 3 2 2 2 3 5 2 3 conserved hypothetical protein 
SO4094 7 4 6 6 5 5 7 5 ribonuclease G (cafA) 
SO4095     3    maf protein (maf) 
SO4097 10 12 13 12 8 9 9 6 rod shape-determining protein MreC (mreC) 
SO4098 18 25 25 28 23 19 27 28 rod shape-determining protein MreB (mreB) 
SO4100  2 3 3  2 2  MSHA biogenesis protein MshQ (mshQ) 
SO4102   2     2 MSHA biogenesis protein MshO (mshO) 
SO4105 21 18 25 22 19 20 23 25 MSHA pilin protein MshA (mshA) 
SO4106 6 8 11 11 7 7 9 10 MSHA pilin protein MshB (mshB) 
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SO4107     2    hypothetical protein 
SO4108 4 4 6 7 7 3 6 5 MSHA biogenesis protein MshG (mshG) 
SO4109 9 15 8 12 13 7 6 10 MSHA biogenesis protein MshE (mshE) 
SO4110 5 11 8 8 11 11 7 9 MSHA biogenesis protein MshN, putative 
SO4111 6 3 3 4 3 7  2 MSHA biogenesis protein MshM (mshM) 
SO4112 4 4 7 12 9 3 8 6 MSHA biogenesis protein MshL (mshL) 
SO4113 3  2  4 2 2  MSHA biogenesis protein MshK (mshK) 
SO4114 6 5 5 8 4 4 6 4 MSHA biogenesis protein MshJ (mshJ) 
SO4116 2 2   3   2 MSHA biogenesis protein MshH (mshH) 
SO4118 13 14 13 12 9 8 9 13 malate oxidoreductase, putative 
SO4120 6 6 7 8 4 3 8 11 ribosomal protein L31 (rpmE) 
SO4121  2  2 4   3 hypothetical protein 
SO4122 3 2  3 2   2 primosomal protein N' (priA) 
SO4123 12 13 7 6 9 6 12 4 arginyl-tRNA synthetase (argS) 
SO4124 8 3 4 6 11 8 6 4 cell division protein FtsN, putative 
SO4128 18 19 21 13 23 14 20 24 SPFH domain/Band 7 family protein 
SO4129 24 33 27 29 26 17 28 30 SPFH domain/Band 7 family protein 
SO4130  2       conserved hypothetical protein 
SO4131 3   2 2    conserved hypothetical protein 
SO4133 10 11 13 14 16 12 16 12 uridine phosphorylase (udp) 
SO4134  2  2 4 5 9 7 conserved hypothetical protein 
SO4135   2 3    3 ISSo7, transposase 
SO4138  2  2 2    conserved hypothetical protein 
SO4139 15 24 16 19 20 20 20 27 conserved domain protein 
SO4140  2 3  3  2  transcriptional regulator, LysR family 
SO4141 2 5 3 3 5  5 6 oxidoreductase, short-chain dehydrogenase/reductase family 
SO4149 2        RTX toxin, putative 
SO4151   2    3 3 polysaccharide deacetylase family protein 
SO4154  3       transcriptional regulator, LysR family 
SO4155 4    4 4   sensor histidine kinase 
SO4157 2    3    DNA-binding response regulator 
SO4160    2     flagellar biosynthesis protein, putative 
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SO4162 5 7 10 9 7 6 9 8 ATP-dependent protease HslV (hslV) 
SO4163 42 48 51 59 38 43 54 57 heat shock protein HslVU, ATPase subunit HslU (hslU) 
SO4164 2 4 3 4 2  2 4 conserved hypothetical protein 
SO4173 4 5 4 5 5 5 3 3 sensor histidine kinase 
SO4177 2   2   2 2 hypothetical protein 
SO4178 2 4 2 6  5 3 2 conserved hypothetical protein 
SO4181 2 4       RNA pseudouridylate synthase family protein 
SO4189  2  3   3  conserved hypothetical protein 
SO4190 16 15 10 13 11 6 12 10 inorganic pyrophosphatase, manganese-dependent (ppaC) 
SO4193 5 5 3 5 4 4 6 6 conserved hypothetical protein 
SO4199 17 20 15 22 21 20 15 23 ubiquinone/menaquinone biosynthesis methlytransferase UbiE (ubiE) 
SO4200 3 2 2  4 3   conserved hypothetical protein 
SO4201 11 9 6 11 6 10 10 12 ubiquinone biosynthesis protein AarF (aarF) 
SO4202 6 9 7 6 6 7 7 11 Sec-independent protein translocase protein TatA (tatA) 
SO4203 5 12 5 7 10 7 9 10 Sec-independent protein translocase protein TatB (tatB) 
SO4205      2   hypothetical protein 
SO4206 2        hydrolase, TatD family 
SO4207 4 11 3 4 3 8 3  GGDEF domain protein 
SO4208 10 11 5 7 9 8 5 7 delta-aminolevulinic acid dehydratase (hemB-2) 
SO4211 97 110 101 118 117 95 111 128 preprotein translocase, SecA subunit (secA) 
SO4212   2      peptidase, M23/M37 family 
SO4214 2        UDP-3-0-acyl N-acetylglucosamine deacetylase (lpxC) 
SO4215 16 23 27 25 16 17 29 23 cell division protein FtsZ (ftsZ) 
SO4216 14 16 20 17 17 10 15 16 cell division protein FtsA (ftsA) 
SO4217 2 4 3 2 3 3 4 3 cell division protein FtsQ (ftsQ) 
SO4218 5 6 9 5 8 2 4 8 UDP-N-acetylmuramate--alanine ligase (murC) 
SO4219 21 21 21 16 17 17 25 28 
UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-acetylglucosamine transferase 
(murG) 
SO4221 4 2 7 6 7  6 7 UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD) 
SO4223 6 14 10 14 8 6 10 16 
UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate--D-
alanyl-D-alanyl ligase (murF) 
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SO4224  2 2 4 3  2 2 
UDP-N-acetylmuramoylalanyl-D-glutamate--2,6-diaminopimelate 
ligase (murE) 
SO4225 11 12 8 11 8 7 8 10 peptidoglycan synthetase FtsI (ftsI) 
SO4226  2    3   cell division protein FtsL (ftsL) 
SO4227 7 13 8 6 9 8 4 7 conserved hypothetical protein TIGR00006 
SO4228  2 2 3 2  2  conserved hypothetical protein TIGR00242 
SO4230 2  2 2    7 glycerol kinase (glpK) 
SO4232   2 3    4 long-chain fatty acid transport protein 
SO4233  3     2  3-isopropylmalate dehydratase, small subunit (leuD) 
SO4234     2  2  3-isopropylmalate dehydratase, large subunit (leuC) 
SO4235   2 2     3-isopropylmalate dehydrogenase (leuB) 
SO4236  2       2-isopropylmalate synthase (leuA) 
SO4241     3    ATP-dependent DNA helicase RecQ (recQ) 
SO4244  4 3 2  5   hypothetical protein 
SO4246 6 8 9 12 7 9 7 8 ribosomal protein L33 (rpmG) 
SO4247 11 11 12 15 12 10 12 14 ribosomal protein L28 (rpmB) 
SO4249 10 10 8 7 7 8  6 DNA/pantothenate metabolism flavoprotein (dfp) 
SO4250 4 7 2 5 5 2 2 5 deoxyuridine 5-triphosphate nucleotidohydrolase (dut) 
SO4251  2 3  2 2 2  transcriptional regulator, TetR family 
SO4252  6 2  2  3  prolyl oligopeptidase family protein 
SO4254 8 7 7 6 8 6 5 5 GTP cyclohydrolase I (folE) 
SO4255 3 6 8 6 7 4 8 10 orotate phosphoribosyltransferase (pyrE) 
SO4256 8 10 4 6 5 9 7 6 ribonuclease PH (rph) 
SO4257 12 9 8 10 8 9 9 7 conserved hypothetical protein TIGR00255 
SO4258 5 7 12 13 5 2 11 10 site-specific recombinase, phage integrase family 
SO4261  2       hypothetical protein 
SO4262     2  2 2 hypothetical protein 
SO4263    2 2  2  conserved hypothetical protein 
SO4264 7 7 6 8 13 4 3 8 type I restriction-modification system, S subunit (hsdS-2) 
SO4265 12 12 10 10 14 9 12 18 type I restriction-modification system, M subunit (hsdM-2) 
SO4266  2       conserved hypothetical protein 
SO4267    2    3 type I restriction-modification system, R subunit (hsdR-2) 
SO4270   2      hypothetical protein 
348 
45 min Control 45 min Cr 90 min Control 90 min Cr 
Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO4280    2     hypothetical protein 
SO4281  2   2    potassium uptake protein KtrA, putative 
SO4283  3 2  3 4 4  apbE family protein 
SO4284 4 3 3  2 4 3 2 ISSo5, transposase 
SO4286 2 3  5  3 2 3 chemotaxis motB protein (motB) 
SO4289  2 3 2 2    phosphate ABC transporter, ATP-binding protein (pstB-2) 
SO4299     2   2 chloramphenicol acetyltransferase (cat) 
SO4308 2 2 4 2 3  2  diaminopimelate epimerase (dapF) 
SO4309 4 2 2 4 4 4 3 5 diaminopimelate decarboxylase (lysA) 
SO4310        3 hypothetical protein 
SO4311 4 4 5 4 5 3 4 5 cyay protein (cyaY) 
SO4313 12 15 11 17 15 16 10 14 porphobilinogen deaminase (hemC) 
SO4315 19 33 23 31 24 30 29 28 hemX protein (hemX) 
SO4316 12 18 16 21 18 19 18 18 hemY protein, putative 
SO4317 3 7 3 5 7 2 6 6 RTX toxin, putative 
SO4318 9 8 7 7 10 13 8 6 toxin secretion ATP-binding protein (rtxB) 
SO4319 17 18 17 17 26 15 11 12 HlyD family secretion protein 
SO4320 40 46 21 32 43 34 28 34 agglutination protein (aggA) 
SO4321 15 16 22 17 11 15 17 16 OmpA family protein 
SO4323 9 14 10 8 19 15 8 10 GGDEF domain protein 
SO4325  4  2   4 6 ATP-dependent DNA helicase Rep (rep) 
SO4326 2   3     transcriptional regulator, TetR family 
SO4327 21 25 24 27 21 21 20 30 HlyD family secretion domain protein 
SO4329 10 13 13 7 8 14 8 8 conserved hypothetical protein 
SO4334 5 2 3 6 6 5 6 4 inner membrane protein, putative 
SO4340 5 9 9 5 8 7 8 5 conserved hypothetical protein 
SO4343 4 7 6 6 4 2 9 9 aminotransferase, class V 
SO4344  4 2 2 2 2   threonine dehydratase (ilvA) 
SO4345  2 5  3  2  dihydroxy-acid dehydratase (ilvD) 
SO4349 4 6 2 8 5  9 11 ketol-acid reductoisomerase (ilvC) 
SO4350 2  2  2   2 transcriptional regulator ilvY (ilvY) 
SO4351 3 5 2 3  2  3 CBS domain protein 
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SO4356 7 13 9 5 12 7 11 10 conserved domain protein 
SO4358 3  2 4  2  4 anaerobic dimethyl sulfoxide reductase, A subunit (dmaA-2) 
SO4364  5 6 2 4  3 5 ATP-dependent DNA helicase RecG (recG) 
SO4365 19 18 22 22 18 19 17 18 hypothetical protein 
SO4367    2 2    acyltransferase family protein 
SO4371 2     2  2 conserved hypothetical protein 
SO4372 2        thioester dehydrase family protein 
SO4373 8 12 4 4 8 10 7 10 glycosyl transferase, group 2 family protein 
SO4374  6 2 3  4  4 histidine ammonia-lyase, putative 
SO4377 2 4 4 4 3 2 3 5 membrane protein, putative 
SO4378 2 3 3 4 3 2 2 4 FAD-binding protein 
SO4380       2  3-oxoacyl-(acyl-carrier-protein) synthase II, putative 
SO4381    2     thioester dehydrase family protein 
SO4382 5 3 2 7 4 4 6 5 3-oxoacyl-(acyl-carrier-protein) reductase (fabG-2) 
SO4383  2  2 3   2 3-oxoacyl-(acyl-carrier-protein) synthase II (fabF-2) 
SO4384 28 30 22 23 22 27 12 22 hypothetical protein 
SO4385    2     von Willebrand factor type A domain protein 
SO4391 5 3 3 5 6 5 8 9 hypothetical protein 
SO4393    2     acetyltransferase, GNAT family 
SO4394  2       phage shock protein E (pspE-2) 
SO4396   2 3 2  3 3 acyl carrier protein phosphodiesterase (acpD) 
SO4397     2    conserved hypothetical protein 
SO4398    2     conserved hypothetical protein TIGR00256 
SO4399 6 11 10 5 8 5 9 11 hypothetical protein 
SO4403 5 14 11 8 5 13 9 10 hypothetical protein 
SO4405     2 2   catalase/peroxidase HPI (katG-2) 
SO4408 22 31 24 22 29 20 15 27 virulence regulator BipA (bipA) 
SO4410 22 30 15 24 25 21 33 28 glutamine synthetase, type I (glnA) 
SO4414    3   3  conserved domain protein 
SO4418  2 2 3  2 2 3 trypanothione synthetase domain protein 
SO4420 2 2  3 3 3 3 2 peptidase, M23/M37 family 
SO4426 2 2     2  RNA pseudouridylate synthase family protein 
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SO4427   2 2 3   3 sensor histidine kinase 
SO4428 5 8 7 8 9  5 8 DNA-binding response regulator 
SO4438   3 2 3  2 2 hypothetical protein 
SO4439        2 conserved hypothetical protein 
SO4443      2   hypothetical protein 
SO4445 2        response regulator/sensor histidine kinase 
SO4446 5 3 2 3 3  3 2 molybdenum ABC transporter, ATP-binding protein 
SO4448  2 2 5 2    
molybdenum ABC transporter, periplasmic molybdenum-binding 
protein 
SO4449 4 4 6 5 5  8 9 molybdenum cofactor biosynthesis protein E (moaE) 
SO4450 2 2  2     molybdenum cofactor biosynthesis protein D (moaD) 
SO4451  6 6 2  3 3 4 molybdenum cofactor biosynthesis protein C (moaC) 
SO4452  3 2 3 2  3 3 molybdenum cofactor biosynthesis protein A (moaA) 
SO4453 24 21 17 17 24 16 16 20 electron transfer flavoprotein-ubiquinone oxidoreductase, putative 
SO4454 10 12 5 16 15 11 10 13 methyl-accepting chemotaxis protein 
SO4456   2  3  3 2 conserved hypothetical protein 
SO4457  3     3 3 GGDEF domain protein 
SO4465   2      conserved domain protein 
SO4466 3 2   2  2  methyl-accepting chemotaxis protein 
SO4469 2 4 7 5 5  5  alcohol dehydrogenase, iron-containing 
SO4470    3 2  2  conserved hypothetical protein 
SO4471      2   nitrogen regulation protein (ntrB) 
SO4472   3 3   5 3 nitrogen regulation protein NR(I) (ntrC) 
SO4473  3  2   3 2 outer membrane protein, putative 
SO4475        2 cation efflux family protein 
SO4476  3       spheroplast protein y precursor, putative 
SO4477 2      3 2 transcriptional regulatory protein CpxR (cpxR) 
SO4478   4  2  4 3 sensor protein CpxA (cpxA) 
SO4479 3    2  2 3 sigma-54 dependent transcriptional regulator 
SO4480   4 2 3  6 11 aldehyde dehydrogenase (aldA) 
SO4488 2       2 sensor histidine kinase 
SO4490       2  hypothetical protein 
SO4492 8 7 6 9 10 5 6 9 conserved hypothetical protein 
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SO4497 4 3 3  2 4 3 2 ISSo5, transposase 
SO4503 2  2      formate dehydrogenase accessory protein FdhD, putative 
SO4505 5 7 7 8 5 6 6 6 conserved hypothetical protein 
SO4506 10 7 3 6 11 3 3 3 iron-sulfur cluster-binding protein 
SO4509 38 50 44 51 38 32 38 38 formate dehydrogenase, alpha subunit 
SO4510 8 5 5 8 6 2 6 8 formate dehydrogenase, iron-sulfur subunit (fdhB-1) 
SO4511 2   2 2    formate dehydrogenase, C subunit, putative 
SO4513 16 18 5 3 48 36 4 3 formate dehydrogenase, alpha subunit 
SO4514 4 2 4 3 5  3 4 formate dehydrogenase, iron-sulfur subunit (fdhB-2) 
SO4516 6 10 15 10  3 15 12 ferric vibriobactin receptor (viuA) 
SO4520 24 24 20 20 36 15 20 20 oxygen-independent coproporphyrinogen III oxidase, putative 
SO4523 28 41 40 44 20 26 63 63 iron-regulated outer membrane virulence protein (irgA) 
SO4525      2 2  conserved hypothetical protein 
SO4529 5 7  6 3  5 5 RNA methyltransferase, TrmH family, group 2 
SO4537 12 13 10 11 14 14 5 11 peptidase, putative 
SO4557 13 23 17 24 17 19 20 23 methyl-accepting chemotaxis protein 
SO4558    2    3 hypothetical protein 
SO4559     3    conserved domain protein 
SO4561 8 5 4 7 5 7   conserved hypothetical protein 
SO4564      2   TonB2 protein, putative 
SO4567        2 transcriptional regulator, AsnC family 
SO4573 4 4  3 2  3 4 
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylic acid 
synthase/2-oxoglutarate decarboxylase (menD) 
SO4575 3 7 4 4 6  3 8 O-succinylbenzoate-CoA synthase (menC) 
SO4583 2       2 RNA polymerase sigma-32 factor (rpoH) 
SO4584 2 7 2 3 4 5 3 4 cell division permease protein FtsX (ftsX) 
SO4585 10 10 13 15 8 7 9 12 cell division ATP-binding protein FtsE (ftsE) 
SO4586 24 31 41 41 25 29 38 41 cell division protein FtsY (ftsY) 
SO4587  2 2 2 2  2 2 conserved hypothetical protein TIGR00095 
SO4591 3 3 3 2 6 7  4 tetraheme cytochrome c (cymA) 
SO4593     3 4 2 4 hypothetical protein 
SO4597  2 3 3 5 9 2 4 heavy metal efflux system protein, putative 
SO4598  4 2 3 8 8 3 5 heavy metal efflux pump, CzcA family 
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Locus Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Run 1 Run 2 Description 
SO4599 5 4 6 4 4  3 5 ribonuclease, T2 family 
SO4602 35 53 37 39 40 44 43 40 glycerol-3-phosphate acyltransferase (plsB) 
SO4603 4  4 4 5 2  2 LexA repressor (lexA) 
SO4615    2     SCO1/SenC family protein 
SO4616  2     2  polysaccharide deacetylase family protein 
SO4618     2    prolyl oligopeptidase family protein 
SO4619 5 9 6 10 7 7 6 10 yhgI protein (yhgI) 
SO4620 4 2 5 3 9 10 3 7 fumarate reductase, flavoprotein subunit precursor (ifcA-2) 
SO4626     2    bioH protein (bioH) 
SO4628 13 11 10 16 11 11 9 10 sulfatase 
SO4629 21 22 22 20 19 14 26 27 conserved hypothetical protein 
SO4633 4 5 7 4 3 3 2 5 transcriptional regulatory protein OmpR (ompR) 
SO4634 3 5 5 3 4 3 3 5 osmolarity sensor protein EnvZ (envZ) 
SO4635  2    2 2 2 methyl-accepting chemotaxis protein 
SO4637    2    3 DNA-binding response regulator 
SO4638 2   2 2  2 2 sensor histidine kinase 
SO4640 11 15 10 9 10 9 11 13 antioxidant, AhpC/Tsa family 
SO4642    2  2  2 conserved hypothetical protein 
SO4643  3 3  2 3 3 3 hypothetical protein 
SO4645  2   2    hypothetical protein 
SO4647 2 2    3 3 2 DNA-binding response regulator 
SO4648   2 2  2  2 sensor histidine kinase 
SO4650        4 conserved hypothetical protein 
SO4651   3 5   4 6 conserved hypothetical protein 
SO4652   10 10   13 24 sulfate ABC transporter, periplasmic sulfate-binding protein (sbp) 
SO4653        2 sulfate ABC transporter, permease protein (cysT-2) 
SO4655 3 6 19 11   26 26 sulfate ABC transporter, ATP-binding protein (cysA-2) 
SO4656  2  2     hypothetical protein 
SO4658 2 2    2 2  conserved hypothetical protein 
SO4659 6 6 4 6 2 5 7 5 conserved hypothetical protein 
SO4661 2 4  2 2 6 2  hypothetical protein 
SO4662 6 10 7 12 10 7 10 11 lemA protein 
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SO4666 22 27 23 22 23 18 18 19 cytochrome c (cytcB) 
SO4667 8 8 3 6 5 9 7 7 GTP-binding protein EngB (engB) 
SO4669 11 17 15 12 17 8 14 12 DNA polymerase I (polA) 
SO4670 3 4 4 5 3  4 3 enhancing lycopene biosynthesis protein (elbB) 
SO4672   3 3 2   2 glpE protein (glpE) 
SO4673 9 7 12 11 14 4 11 7 threonine 3-dehydrogenase (tdh) 
SO4674 13 13 16 12 15 10 13 17 2-amino-3-ketobutyrate coenzyme A ligase (kbl) 
SO4675    2     transcriptional regulator, TetR family 
SO4676 7 6 6 6 6 7 5 9 3-deoxy-D-manno-octulosonic-acid (KDO) transferase (kdtA) 
SO4677 4 8 3 6 5 7 4 4 conserved hypothetical protein 
SO4678 11 8 4 10 9 12 13 10 heptosyl transferase, glycosyltransferase family 9 protein 
SO4679 19 19 16 16 15 21 16 21 glycosyl transferase, group 1 family protein 
SO4680 13 15 17 14 15 13 17 16 conserved hypothetical protein 
SO4681 21 23 20 21 25 19 19 19 glycosyl transferase, group 1 family protein 
SO4682 3 3 2 3 5  6 4 glycosyl transferase, group 1 family protein 
SO4684 5 6 5 2 2 3 2 5 phosphopantetheine adenylyltransferase (coaD) 
SO4685 15 24 16 14 13 16 19 21 conserved hypothetical protein 
SO4686   2  2    NAD dependent epimerase/dehydratase family protein 
SO4687 2        UDP-glucose 6-dehydrogenase (ugd) 
SO4688     2 2  4 glycosyl transferase, group 2 family protein 
SO4690     2 2   conserved hypothetical protein 
SO4692 35 40 33 39 25 28 31 36 AcrB/AcrD/AcrF family protein 
SO4693 40 47 42 44 39 44 44 46 multidrug resistance protein, AcrA/AcrE family 
SO4696   2  2  2  conserved hypothetical protein 
SO4697       2  glutathione S-transferase (gst) 
SO4699 10 15 15 14 13 5 14 16 oligopeptidase A (prlC) 
SO4702 13 15 13 11 14 4 9 15 glutathione reductase (gor) 
SO4704      2   hypothetical protein 
SO4711  3       HD domain protein 
SO4712    2     ABC transporter, ATP-binding protein, putative 
SO4713  2   2  2  menaquinone-specific isochorismate synthase, putative 
SO4716       2  acetyltransferase, GNAT family 
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SO4717 10 8 4 5 3 5 6 12 sensor histidine kinase 
SO4718 8 10 6 8 8 6 5 12 sigma-54 dependent response regulator 
SO4719 31 36 31 30 24 35 18 19 conserved hypothetical protein 
SO4721 3 2   2 2 4 2 ABC transporter, ATP-binding protein 
SO4722 2   3 2 2  2 molybdopterin-guanine dinucleotide biosynthesis protein (mobA) 
SO4723 16 20 11 13 13 11 12 12 molybdopterin biosynthesis MoeA protein, putative 
SO4724  2  2  2   molybdenum cofactor biosynthesis protein A, putative 
SO4725 3 5 3 4 4 6 3 3 conserved hypothetical protein 
SO4726 5 4 4 3 7 2 2 3 formamidopyrimidine-DNA glycosylase (mutM) 
SO4728 5 6 9 8 9 6 6 10 conserved hypothetical protein 
SO4729 9 7 8 12 6 4 7 11 conserved hypothetical protein 
SO4730 4 10 9 8 13 3 13 11 oxygen-independent coproporphyrinogen III oxidase (hemN) 
SO4731  4 5 5 5  5 8 adenosine deaminase (add) 
SO4732 7 12 6 9 7 6 7 8 conserved hypothetical protein 
SO4733 7 4 4 6 5 5 5 5 lysophospholipase L2 (lypA) 
SO4734   3    2 2 sensory box protein 
SO4737 3 5 2 3 7 2 3 5 iron-sulfur cluster-binding protein 
SO4738 4 3 2 4 3 4 4 4 hypothetical protein 
SO4739 8 4 2 10 7 6 12 9 naphthoate synthase (menB) 
SO4741 12 19 12 18 16 9 14 19 
glucosamine--fructose-6-phosphate aminotransferase (isomerizing) 
(glmS) 
SO4742 4 3 5 6 3 3 2  transcriptional regulator, DeoR family 
SO4743 46 64 55 58 29 32 63 63 TonB-dependent receptor, putative 
SO4745 11 11 7 6 4 7 8 12 UDP-N-acetylglucosamine pyrophosphorylase (glmU) 
SO4746 12 12 16 15 12 12 17 15 ATP synthase F1, epsilon subunit (atpC) 
SO4747 72 82 78 75 81 64 86 79 ATP synthase F1, beta subunit (atpD) 
SO4748 49 51 46 45 49 51 50 43 ATP synthase F1, gamma subunit (atpG) 
SO4749 94 106 94 95 102 103 98 105 ATP synthase F1, alpha subunit (atpA) 
SO4750 16 17 16 15 14 18 15 12 ATP synthase F1, delta subunit (atpH) 
SO4751 40 47 41 42 39 43 41 45 ATP synthase F0, B subunit (atpF) 
SO4755 11 16 13 10 12 9 14 19 ParB family protein 
SO4756   3 3   3 2 ParA family protein 
SO4757 3 7  4 6  2 3 glucose-inhibited division protein B (gidB) 
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SO4758 29 35 28 34 26 30 27 32 glucose-inhibited division protein A (gidA) 
SOA0003 10 4 8 6 9 3 7 5 type II restriction endonuclease, putative 
SOA0004 12 9 6 16 8 4 9 14 type II DNA modification methyltransferase 
SOA0005  2  3 4  2 3 hypothetical protein 
SOA0006     2  2 3 ParA family protein 
SOA0008   2      hypothetical protein 
SOA0011 5 5 6 4 4 3  5 conserved hypothetical protein 
SOA0018 2    2 2  4 TnSon1, conserved hypothetical protein 
SOA0019 5 5 2 6 4 4 3 3 TnSon1, resolvase 
SOA0022   2    2 2 proteic killer active protein (higB) 
SOA0023 3  2 3 2 3  2 proteic killer suppressor protein (higA) 
SOA0031   3    3 6 partition protein, ParB family, putative 
SOA0032  2    2   conserved hypothetical protein 
SOA0033  2 2 2   2 3 hypothetical protein 
SOA0040       3 2 hypothetical protein 
SOA0041 5 7 5 5 9 6 7 5 transcriptional regulator, PemK family 
SOA0042 3  5 6   4 4 hypothetical protein 
SOA0045      2   site-specific recombinase, phage integrase family 
SOA0048 18 22 26 23 24 17 23 24 prolyl oligopeptidase family protein 
SOA0049 4 5 3  7 5 4 6 
toxin secretion ABC transporter, ATP-binding subunit/permease 
protein, putative 
SOA0051 9 10 8 10 6 8 6 7 hypothetical protein 
SOA0056  2 2 2    2 hypothetical protein 
SOA0059 2 2 5 4 3 6  2 conserved hypothetical protein 
SOA0060 3 5 8 7 4 3 6 8 acetyltransferase, GNAT family 
SOA0061 4 4 7 5 3 7 6 6 parA protein, putative 
SOA0062 7  4 6 4 4 4 3 hypothetical protein 
SOA0067       2  hypothetical protein 
SOA0069        3 conserved hypothetical protein 
SOA0070 3  7  3  5  hypothetical protein 
SOA0075      2   hypothetical protein 
SOA0077 3 4 3 3 2  2 2 site-specific recombinase, resolvase family 
SOA0079   2 2   2  conserved hypothetical protein 
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SOA0080   6 3    4 hypothetical protein 
SOA0086  2 2   4  2 site-specific recombinase, resolvase family 
SOA0088   3  2    plasmid stabilization protein ParE, putative 
SOA0095 3 4 3 6 6 2 5 10 partitioning protein A 
SOA0096 11 14 14 13 13 14 15 15 partitioning protein B 
SOA0099 6 4 12 7 8 4 6 11 conserved hypothetical protein 
SOA0100 7 17 21 26 17 9 21 19 conserved hypothetical protein 
SOA0106 26 28 22 28 18 22 28 23 methyl-accepting chemotaxis protein 
SOA0108        2 hypothetical protein 
SOA0110 14 19 18 24 24 22 18 24 lipoprotein, putative 
SOA0112 18 21 24 32 29 23 26 31 lipoprotein, putative 
SOA0114 15 20 17 18 16 23 23 20 outer membrane protein A (ompA) 
SOA0115 18 21 24 32 29 23 26 31 lipoprotein, putative 
SOA0119        2 ISSo13, transposase 
SOA0131    2   3 3 hypothetical protein 
SOA0132 3 2 3 3 5 2 5 2 conserved hypothetical protein 
SOA0135 6 5 6 4 6 5 7 6 hypothetical protein 
SOA0138 12 11 12 11 11 6 12 10 hypothetical protein 
SOA0139  2 2 3 2  2  hypothetical protein 
SOA0140 33 35 30 19 31 19 30 30 hypothetical protein 
SOA0141 15 16 4 2 11 6  3 hypothetical protein 
SOA0142        2 ISSo13, transposase 
SOA0149    2    3 conserved hypothetical protein 
SOA0150 2 3 2 2 3 3 3 5 hypothetical protein 
SOA0151        2 ISSo13, transposase 
SOA0153  3 2 4 12 11 7 6 heavy metal efflux pump, CzcA family 
SOA0154   3 3 13 13 8 10 heavy metal efflux protein, putative 
SOA0157 2    2 2   hypothetical protein 
SOA0160 3 5 8 5 11  5 4 esterase, putative 
SOA0161 6 6 8 8 7 3 9 13 zinc-binding dehydrogenase 
SOA0164    3    3 iron-containing alcohol dehydrogenase 
SOA0165 11 11 12 8 14 9 7 13 transcriptional regulator, LysR family 
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SOA0169 2    2 2  4 TnSon1, conserved hypothetical protein 
SOA0170 5 5 2 6 4 4 3 3 TnSon1, resolvase 
SOA0171 3 8 3 2 2 3 2 3 hypothetical protein 
SOA0172  2  4 4    site-specific recombinase, resolvase family 
SOA0173   3 6 2  4 3 hypothetical protein 
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